0001019687-14-004145.txt : 20141110 0001019687-14-004145.hdr.sgml : 20141110 20141110144729 ACCESSION NUMBER: 0001019687-14-004145 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20140930 FILED AS OF DATE: 20141110 DATE AS OF CHANGE: 20141110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RadNet, Inc. CENTRAL INDEX KEY: 0000790526 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133326724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33307 FILM NUMBER: 141208147 BUSINESS ADDRESS: STREET 1: 1516 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 3104787808 MAIL ADDRESS: STREET 1: 1516 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: PRIMEDEX HEALTH SYSTEMS INC DATE OF NAME CHANGE: 19930518 FORMER COMPANY: FORMER CONFORMED NAME: CCC FRANCHISING CORP DATE OF NAME CHANGE: 19920703 10-Q 1 radnet_10q-093014.htm RADNET, INC.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2014

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-33307

RadNet, Inc.

(Exact name of registrant as specified in charter)

Delaware	13-3326724
(State or other jurisdiction of Incorporation or organization)	(I.R.S. Employer Identification No.)


1510 Cotner Avenue
Los Angeles, California	90025
(Address of principal executive offices)	(Zip Code)

(310) 478-7808

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer o	Accelerated filer x	Non-accelerated filer o	Smaller reporting company o
		(do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes o No x

The number of shares of the registrant’s common stock outstanding on November 5, 2014, was 42,710,676 shares.

RADNET, INC.

Table of Contents

	Page

PART I – FINANCIAL INFORMATION

ITEM 1. Condensed Consolidated Financial Statements (unaudited)	3

Condensed Consolidated Balance Sheets at September 30, 2014 and December 31, 2013	3

Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2014 and 2013	4

Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, 2014 and 2013	5

Condensed Consolidated Statement of Stockholders’ Equity (Deficit) for the Nine Months Ended September 30, 2014	6

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2014 and 2013	7

Notes to Condensed Consolidated Financial Statements	9

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	20

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk	36

ITEM 4. Controls and Procedures	37

PART II – OTHER INFORMATION

ITEM 1. Legal Proceedings	38

ITEM 1A. Risk Factors	38

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds	38

ITEM 3. Defaults Upon Senior Securities	38

ITEM 4. Mine Safety Disclosures	38

ITEM 5. Other Information	38

ITEM 6. Exhibits	38

SIGNATURES	39

INDEX TO EXHIBITS	40

PART I - FINANCIAL INFORMATION

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS EXCEPT SHARE DATA)

	September 30,			December 31,
	2014			2013
	(unaudited)
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	274		$	8,412
Accounts receivable, net		155,011			133,599
Current portion of deferred tax assets		16,692			13,321
Prepaid expenses and other current assets		25,272			21,012
Total current assets		197,249			176,344
PROPERTY AND EQUIPMENT, NET		225,597			218,547
OTHER ASSETS
Goodwill		200,304			196,395
Other intangible assets		48,392			50,042
Deferred financing costs, net of current portion		6,682			8,735
Investment in joint ventures		27,474			28,949
Deferred tax assets, net of current portion		39,004			39,914
Deposits and other		3,817			3,650
Total assets	$	748,519		$	722,576
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable, accrued expenses and other	$	100,931		$	106,316
Due to affiliates		1,120			2,655
Deferred revenue		1,948			1,344
Current portion of notes payable		19,558			3,103
Current portion of deferred rent		2,256			1,896
Current portion of obligations under capital leases		5,708			3,075
Total current liabilities		131,521			118,389
LONG-TERM LIABILITIES
Deferred rent, net of current portion		19,282			18,989
Revolving credit facility		25,100			–
Notes payable, net of current portion		555,920			572,669
Obligations under capital lease, net of current portion		7,573			2,779
Other non-current liabilities		6,505			7,540
Total liabilities		745,901			720,366


STOCKHOLDERS' EQUITY
Common stock - $.0001 par value, 200,000,000 shares authorized; 42,703,602, and 40,089,196 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively		4			4
Paid-in-capital		177,141			173,622
Accumulated other comprehensive loss		(88	)		(50	)
Accumulated deficit		(176,485	)		(173,656	)
Total RadNet, Inc.'s stockholders' equity (deficit)		572			(80	)
Noncontrolling interests		2,046			2,290
Total stockholders' equity		2,618			2,210
Total liabilities and stockholders' equity	$	748,519		$	722,576

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(IN THOUSANDS EXCEPT SHARE DATA)

(unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2014			2013			2014			2013
NET REVENUE
Service fee revenue, net of contractual allowances and discounts	$	171,098		$	165,373		$	498,536		$	496,424
Provision for bad debts		(7,532	)		(7,033	)		(21,945	)		(20,810	)
Net service fee revenue		163,566			158,340			476,591			475,614
Revenue under capitation arrangements		20,493			16,848			55,426			49,034
Total net revenue		184,059			175,188			532,017			524,648
OPERATING EXPENSES
Cost of operations, excluding depreciation and amortization		153,000			151,770			445,838			450,030
Depreciation and amortization		14,423			14,762			45,193			44,050
Loss on sale and disposal of equipment		1,289			(5	)		1,581			357
Severance costs		112			72			976			312
Total operating expenses		168,824			166,599			493,588			494,749
INCOME FROM OPERATIONS		15,235			8,589			38,429			29,899
OTHER INCOME AND EXPENSES
Interest expense		10,395			11,052			32,503			34,542
Meaningful use incentive		–			–			(1,762	)		–
Equity in earnings of joint ventures		(2,009	)		(1,617	)		(4,722	)		(4,481	)
Gain on sale of imaging centers		–			–			–			(2,108	)
Loss on early extinguishment of Senior Notes		–			–			15,927			–
Other expenses		6			4			4			152
Total other expenses		8,392			9,439			41,950			28,105
INCOME (LOSS) BEFORE INCOME TAXES		6,843			(850	)		(3,521	)		1,794
(Provision for) benefit from income taxes		(2,334	)		483			911			(766	)
NET INCOME (LOSS)		4,509			(367	)		(2,610	)		1,028
Net income attributable to noncontrolling interests		58			100			219			151
NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	$	4,451		$	(467	)	$	(2,829	)	$	877

BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	$	0.11		$	(0.01	)	$	(0.07	)	$	0.02

DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	$	0.10		$	(0.01	)	$	(0.07	)	$	0.02

WEIGHTED AVERAGE SHARES OUTSTANDING
Basic		41,644,606			39,235,863			40,734,083			39,105,522
Diluted		44,033,580			39,235,863			40,734,083			39,886,140

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(IN THOUSANDS)

(unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2014			2013			2014			2013
NET INCOME (LOSS)	$	4,509		$	(367	)	$	(2,610	)	$	1,028
Foreign currency translation adjustments		(1	)		13			(38	)		(104	)
COMPREHENSIVE INCOME (LOSS)		4,508			(354	)		(2,648	)		924
Less comprehensive income attributable to non-controlling interests		58			100			219			151
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	$	4,450		$	(454	)	$	(2,867	)	$	773

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)

(IN THOUSANDS EXCEPT SHARE DATA)

(unaudited)

	Common Stock				Paid-in		Accumulated			Accumulated Other Comprehensive			Total Radnet, Inc.'s Stockholders' (Deficit)			Noncontrolling			Total Stockholders'
	Shares		Amount		Capital		Deficit			Loss			Equity			Interests			Equity
BALANCE - JANUARY 1, 2014	40,089,196	$	4	$	173,622	$	(173,656	)	$	(50	)	$	(80	)	$	2,290		$	2,210
Issuance of common stock upon exercise of options/warrants	1,572,621		–		1,546		–			–			1,546			–			1,546
Stock-based compensation	–		–		1,854		–			–			1,854			–			1,854
Issuance of restricted stock	1,041,785		–		–		–			–			–			–			–
Purchase of non-controlling interests	–		–		119		–			–			119			(315	)		(196	)
Dividends paid to noncontrolling interests	–		–		–		–			–			–			(148	)		(148	)
Change in cumulative foreign currency translation adjustment	–		–		–		–			(38	)		(38	)		–			(38	)
Net (loss) income	–		–		–		(2,829	)		–			(2,829	)		219			(2,610	)
BALANCE - SEPTEMBER 30, 2014	42,703,602	$	4	$	177,141	$	(176,485	)	$	(88	)	$	572		$	2,046		$	2,618

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

(unaudited)

	Nine Months Ended
	September 30,
	2014			2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net (loss) income	$	(2,610	)	$	1,028
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization		45,193			44,050
Provision for bad debts		21,945			20,810
Equity in earnings of joint ventures		(4,722	)		(4,481	)
Distributions from joint ventures		7,358			5,624
Deferred rent amortization		653			2,893
Amortization of deferred financing costs		1,708			1,676
Write off of deferred loan costs due to refinance		665			–
Amortization of bond and term loan discounts		2,071			1,651
Loss on sale and disposal of equipment		1,581			357
Loss on early extinguishment of Senior Notes		15,927			–
Gain on Sale of Imaging Centers		–			(2,108	)
Stock-based compensation		2,069			2,045
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:
Accounts receivable		(42,887	)		(25,096	)
Other current assets		(4,754	)		(1,504	)
Other assets		(72	)		172
Deferred taxes		(2,461	)		575
Deferred revenue		604			175
Accounts payable, accrued expenses and other		(8,225	)		(5,357	)
Net cash provided by operating activities		34,043			42,510
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of imaging facilities		(9,428	)		(5,918	)
Purchase of noncontrolling interests		(196	)		–
Purchase of property and equipment		(33,895	)		(39,291	)
Proceeds from sale of equipment		766			510
Proceeds from sale of imaging facilities		–			3,290
Proceeds from sale of joint venture interests		–			2,640
Equity contributions in existing joint ventures		(1,161	)		(1,803	)
Net cash used in investing activities		(43,914	)		(40,572	)
CASH FLOWS FROM FINANCING ACTIVITIES
Principal payments on notes and leases payable		(16,733	)		(7,476	)
Proceeds from borrowings		210,000			35,122
Payments on Senior Notes		(211,344	)		–
Deferred financing costs		(6,650	)		(432	)
Net proceeds (payments) on revolving credit facility		25,100			(29,600	)
Distributions to noncontrolling interests		(148	)		(11	)
Proceeds from issuance of common stock upon exercise of options/warrants		1,546			469
Net cash provided by (used in) financing activities		1,771			(1,928	)
EFFECT OF EXCHANGE RATE CHANGES ON CASH		(38	)		(104	)
NET DECREASE IN CASH AND CASH EQUIVALENTS		(8,138	)		(94	)
CASH AND CASH EQUIVALENTS, beginning of period		8,412			362
CASH AND CASH EQUIVALENTS, end of period	$	274		$	268

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the period for interest	$	32,389		$	26,614

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(unaudited)

Supplemental Schedule of Non-Cash Investing and Financing Activities

We acquired equipment and certain leasehold improvements for approximately $16.6 million and $11.3 million during the nine months ended September 30, 2014 and 2013, respectively, which were not paid for as of September 30, 2014 and 2013, respectively. The offsetting amounts due were recorded in our consolidated balance sheet under accounts payable, accrued expenses and other.

During the nine months ended September 30, 2014, we added capital lease debt of approximately $12.6 million relating to radiology equipment.

Detail of non-cash investing activities related to acquisitions can be found in Note 2.

RADNET, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION

We provide diagnostic imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. At September 30, 2014, we operated directly or indirectly through joint ventures, 263 imaging centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York. Our operations comprise a single segment for financial reporting purposes.

The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or “Radnet Management”) and Beverly Radiology Medical Group III, a professional partnership (“BRMG”). The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc., Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc. (“DIS”), all wholly owned subsidiaries of Radnet Management. All of these affiliated entities are referred to collectively as “RadNet”, “we”, “us”, “our” or the “Company” in this report.

Accounting Standards Codification (“ASC”) Section 810-10-15-14 stipulates that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics specified in the ASC which evidence a controlling financial interest, is considered a Variable Interest Entity (“VIE”). We consolidate all VIEs in which we own a majority voting interest and all VIEs for which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE’s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.

Howard G. Berger, M.D. is our President and Chief Executive Officer, a member of our Board of Directors and is deemed to be the beneficial owner, directly and indirectly, of approximately 13.1% of our outstanding common stock as of September 30, 2014. Dr. Berger also owns, indirectly, 99% of the equity interests in BRMG. BRMG provides all of the professional medical services at the majority of our facilities located in California under a management agreement with us, and employs physicians or contracts with various other independent physicians and physician groups to provide the professional medical services at most of our other California facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly or through subsidiaries, in order to comply with California’s prohibition against the corporate practice of medicine. However, as a result of our close relationship with Dr. Berger and BRMG, we believe that we are able to better ensure that medical service is provided at our California facilities in a manner consistent with our needs and expectations and those of our referring physicians, patients and payors than if we obtained these services from unaffiliated physician groups. BRMG is a partnership of ProNet Imaging Medical Group, Inc., Breastlink Medical Group, Inc. and Beverly Radiology Medical Group, Inc., each of which is 99% or 100% owned by Dr. Berger.

John V Crues, III, M.D. is our Medical Director, a member of our Board of Directors and a 1% owner of BRMG. Dr. Crues owns a controlling interest in four medical groups (“Crues Entities”) which provide professional medical services at some of our facilities in Manhattan and Brooklyn, New York while Dr. Berger owns a controlling interest in two medical groups (“NY Berger Entities”) which provide professional medical services at one of our Manhattan, New York facilities. The Crues Entities and the NY Berger Entities are collectively hereinafter referred to as the “B&C Entities.”

RadNet provides non-medical, technical and administrative services to BRMG and the B&C Entities for which it receives a management fee, pursuant to the related management agreements. Through these management agreements and our relationship with both Dr. Berger and Dr. Crues, we have exclusive authority over all non-medical decision-making related to the ongoing business operations of BRMG and the B&C Entities and we determine the annual budget of BRMG and the B&C Entities. BRMG and the B&C Entities both have insignificant operating assets and liabilities, and de minimis equity. Through these management agreements, we are paid the fair market value of our services, the result of which is that generally all net cash flows of both BRMG and the B&C Entities are transferred to us.

We have determined that BRMG and the B&C Entities are VIEs, and that we are the primary beneficiary, and consequently, we consolidate the revenue, expenses, assets and liabilities of each such entity. BRMG and the B&C Entities on a combined basis recognized $23.6 million and $24.7 million of revenue, net of management service fees to RadNet for the three months ended September 30, 2014 and 2013, respectively, and $23.6 million and $24.7 million of operating expenses for the three months ended September 30, 2014 and 2013, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $98.0 million and $98.3 million of total billed net service fee revenue relating to these VIE’s for the three months ended September 30, 2014 and 2013, respectively, of which $74.4 million and $73.6 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the three months ended September 30, 2014 and 2013, respectively.

BRMG and the B&C Entities on a combined basis recognized $65.6 million and $58.2 million of revenue, net of management service fees to RadNet for the nine months ended September 30, 2014 and 2013, respectively, and $65.6 million and $58.2 million of operating expenses for the nine months ended September 30, 2014 and 2013, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $279.6 million and $256.6 million of total billed net service fee revenue relating to these VIE’s for the nine months ended September 30, 2014 and 2013, respectively, of which $213.9 million and $198.4 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the nine months ended September 30, 2014 and 2013, respectively.

The cash flows of BRMG and the B&C Entities are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at September 30, 2014 and December 31, 2013, we have included approximately $80.3 million and $65.2 million, respectively, of accounts receivable and approximately $9.4 million and $11.9 million, respectively, of accounts payable and accrued liabilities, related to BRMG and the B&C Entities combined.

The creditors of both BRMG and the B&C Entities do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of BRMG and the B&C Entities. However, because of the relationship RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.

Aside from certain centers in California and all of our centers in New York City where we contract with BRMG and the B&C Entities, respectively, for the provision of professional medical services, at all of our other centers, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice group’s professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us. We have no financial controlling interest in the independent (non-BRMG or non-B&C Entities) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended September 30, 2014 and 2013 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December 31, 2013 filed on March 17, 2014, as amended.

Significant Accounting Policies

During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended.

Revenues

Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payers and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the B&C Entities, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the B&C Entities as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the B&C Entities. As it relates to non-BRMG and B&C Entity centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and B&C Entity centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.

Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payers.

Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2014 and 2013 is summarized in the following table (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2014			2013			2014			2013
Commercial Insurance	$	109,472		$	103,934		$	314,300		$	310,147
Medicare		41,203			38,276			118,627			113,916
Medicaid		6,248			5,869			18,214			18,358
Workers' Compensation/Personal Injury		7,821			8,566			22,708			27,666
Other		6,354			8,727			24,688			26,337
Service fee revenue, net of contractual allowances and discounts		171,098			165,373			498,536			496,424
Provision for bad debts		(7,532	)		(7,033	)		(21,945	)		(20,810	)
Net service fee revenue		163,566			158,340			476,591			475,614
Revenue under capitation arrangements		20,493			16,848			55,426			49,034
Total net revenue	$	184,059		$	175,188		$	532,017		$	524,648

Provision for Bad Debts

We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patient’s ability to pay nor are revenues recognized based on an assessment of the patient’s ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.

Deferred Tax Assets

Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.

Deferred Financing Costs

Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.

Meaningful Use Incentive

Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a Radiology Information System (RIS) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $1.8 million during the nine months ended September 30, 2014 relating to this incentive. This amount was earned under a Medicare program to promote the use of electronic health record technology.

Liquidity and Capital Resources

We had cash and cash equivalents of $274,000 and accounts receivable of $155.0 million at September 30, 2014, compared to cash and cash equivalents of $8.4 million and accounts receivable of $133.6 million at December 31, 2013. We had a working capital balance of $65.7 million and $58.0 million at September 30, 2014 and December 31, 2013, respectively. We had net income (loss) attributable to RadNet, Inc. common stockholders for the three months ended September 30, 2014 and 2013 of $4.5 million and ($467,000) respectively, and net (loss) income attributable to RadNet, Inc. common stockholders for the nine months ended September 30, 2014 and 2013 of ($2.8 million) and $877,000, respectively. We also had stockholders’ equity of $2.6 million and $2.2 million at September 30, 2014 and December 31, 2013, respectively.

We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.

Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.

On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.

We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.

Included in our condensed consolidated balance sheet at September 30, 2014 are $572.2 million of senior secured term loan debt (net of unamortized discounts of $12.7 million), broken down by loan agreement as follows (in thousands):

	Face Value		Discount			Total Carrying Value
2014 First Lien Term Loans	$	404,942	$	(9,922	)	$	395,020
Second Lien Term Loans	$	180,000	$	(2,772	)	$	177,228
Total	$	584,942	$	(12,694	)	$	572,248

Our revolving credit facility has a $25.1 million aggregate principal amount outstanding as of September 30, 2014.

The following describes our most recent financing activities:

2014 Amendment to the Refinance Agreement and Second Lien Credit and Guaranty Agreement:

On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:

2014 Amendment of the Refinance Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012, by that certain first amendment dated April 3, 2013 (the “2013 Amendment”) (collectively, the Refinance Agreement”), by entering into a second amendment to the Refinance Agreement (the “2014 Amendment”) to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the “2014 First Lien Term Loans”).

Second Lien Credit and Guaranty Agreement. Radnet Management entered into a Second Lien Credit and Guaranty Agreement (the “Second Lien Credit Agreement”) to provide for, among other things, the borrowing by Radnet Management of $180.0 million of second lien term loans (the “Second Lien Term Loans”). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the senior notes, as more fully described below under the heading “Senior Notes”, to pay the expenses related to the transaction and for general corporate purposes.

Revolving Credit Facility. The $101.25 million revolving credit line established in the Credit and Guaranty Agreement dated October 10, 2012 was unaltered by the agreements above and remains in place.

The 2014 Amendment provides for the following:

Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates currently payable under the Refinance Agreement, as amended by the 2013 Amendment, which are (a) the Adjusted Eurodollar Rate plus 3.25% or (b) the Base Rate (as defined in the Refinance Agreement) plus 2.25%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on all of the term loans under the Refinance Agreement. The Adjusted Eurodollar Rate at September 30, 2014 was 0.33%.

Payments. The scheduled amortization of the term loans under the Refinance Agreement has been increased from quarterly payments of $975,000 to quarterly payments of $5.2 million which started in June 2014, with the remaining balance to be paid at maturity.

The other material terms of the Refinance Agreement remain unchanged as described in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended.

The Second Lien Credit Agreement provides for the following:

Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate plus 7.0% or (b) the Base Rate plus 6.0%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at September 30, 2014 was 0.33%.

Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. All principal will be due and payable on the termination date described below.

Termination. The termination date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by acceleration or otherwise.

Restrictive Covenants. In addition to certain customary covenants, the Second Lien Credit Agreement places restrictions on indebtedness, liens, and investments, and places limits on distributions to stockholders (including the repurchase of shares) and other junior payments.

Financial Covenants. The Second Lien Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.

Events of Default. In addition to certain customary events of default, events of default under the Second Lien Credit Agreement include failure to pay principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements, subject to applicable grace periods and/or notice requirements, or a material breach of any representation or warranty contained in the loan documents. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

These limitations are subject to a number of important qualifications and exceptions, as described in the Second Lien Credit Agreement. As of September 30, 2014, we were in compliance with all covenants.

Senior Notes

On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the “senior notes”). All payments of the senior notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Management’s current and future domestic wholly owned restricted subsidiaries. The senior notes were issued under an indenture dated April 6, 2010 (the “Indenture”), by and among Radnet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee.” We paid interest on the senior notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.

Optional Redemption. Under the Indenture, Radnet Management could redeem the senior notes, in whole or in part, at any time on or after April 1, 2014, at the redemption prices specified under the Indenture. Prior to April 1, 2014, Radnet Management was also permitted to redeem the senior notes, in whole or in part, at a redemption price equal to 100% of the principal amount redeemed, plus a make-whole premium established by the Indenture and accrued and unpaid interest, if any.

Senior Notes Tender Offer and Exercise of Optional Redemption

Radnet Management completed the retirement of its $200 million in Senior Notes on April 24, 2014 and following such retirement the Company completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:

Tender Offer and Exercise of Optional Redemption on March 7, 2014. On March 7, 2014, Radnet Management commenced a tender offer to purchase for cash any and all outstanding senior notes. In connection with the tender offer, Radnet Management also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014 (the “Initial Payment Date”), Radnet Management made a payment in cash for all senior notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the “Consent Payment Deadline”). As of the Consent Payment Deadline, Radnet Management had received tenders and consents in respect of $193,464,000 aggregate principal amount of the senior notes, representing 96.73% of the outstanding senior notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of senior notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88 (the “Total Consideration”), which amount included a consent payment (the “Consent Payment”) of $30.00 per $1,000 principal amount of senior notes. In addition, all senior notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional senior notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.

Tender Offer and Exercise on Optional Redemption of March 25, 2014. On March 25, 2014, Radnet Management called for redemption all of its remaining outstanding senior notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the “Redemption Date”). Upon redemption on April 24, 2014, the holders of the senior notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the senior notes being redeemed (or $1,051.88 per $1,000 in principal amount of the senior notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date. As of that date, Radnet Management completed the satisfaction and discharge of the Indenture in accordance with its terms and no senior notes remained outstanding. With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.

Capital Lease Investments

During the nine months ended September 30, 2014, we added capital lease debt of approximately $12.6 million relating to radiology equipment.

NOTE 2 – FACILITY ACQUISITIONS

On September 1, 2014 we completed our acquisition of Hematology Oncology Consultants located in Van Nuys, CA for cash consideration of $553,000. We have made a preliminary fair value determination of the acquired assets and approximately $15,000 of fixed assets, $163,000 of medical supplies inventory, $39,000 of other assets, $100,000 covenant not to compete intangible asset, and $235,000 of goodwill were recorded with respect to this transaction.

On September 1, 2014 we completed our acquisition of Imaging Centers of Pasadena consisting of a single multi-modality imaging center located in Pasadena, CA for cash consideration of $1.8 million. The facility provides MRI, PET/CT, Ultrasound and X-ray services. We have made a preliminary fair value determination of the acquired assets and approximately $1.7 million of fixed assets and $105,000 of a covenant not to compete intangible asset were recorded with respect to this transaction.

On July 3, 2014 we completed our acquisition of certain imaging center equipment from Healthcare Partners for which we agreed to pay $2.1 million. We paid cash of $300,000 and a promissory note in the amount of $1.8 million.

On July 1, 2014 we completed our acquisition of Moreno Valley Imaging consisting of a single multi-modality imaging center located in Moreno Valley, CA for cash consideration of $700,000. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a preliminary fair value determination of the acquired assets and approximately $285,000 of fixed assets, $3,000 of other assets, $50,000 for a non compete covenant and $362,000 of goodwill were recorded with respect to this transaction.

On July 1, 2014 we completed our acquisition of Liberty Pacific Imaging Long Beach consisting of a single multi-modality imaging center located in Signal Hill, CA for cash consideration of $1.9 million and assumed liabilities of $65,000. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a preliminary fair value determination of the acquired assets and assumed liabilities and $577,000 of fixed assets, $100,000 for a covenant not to compete and $1.3 million of goodwill were recorded with respect to this transaction. We also assumed capital lease debt of $65,000.

On July 1, 2014 we completed our acquisition of Medical Imaging of Manhattan consisting of a single modality mammography center located in New York, New York for cash consideration of $2.4 million. We have made a preliminary fair value determination of the acquired assets and approximately $672,000 of fixed assets, $139,000 of other assets, a covenant not to compete of $150,000 and $1.4 million of goodwill were recorded with respect to this transaction.

On April 1, 2014, we acquired the diagnostic imaging practice of Sidney Friedman, M.D. located in Westchester, CA for $1.4 million. We have made a fair value determination of the assets acquired and have allocated $600,000 to Imaging equipment, $470,000 to accounts receivable, a covenant not to compete of $100,000 and $231,000 to goodwill.

On January 2, 2014, we acquired the diagnostic imaging practice of Leslie A. Saint-Louis, MD located in New York, New York for $360,000. Upon acquisition, we relocated the practice to a nearby existing center in New York, New York. We have made a fair value determination of the assets acquired and have allocated $310,000 to goodwill and $50,000 to other intangible assets related to a covenant not to compete contract with Dr. Saint-Louis.

NOTE 3 – NEW ACCOUNTING STANDARDS

In May 2014, the Financial Accounting Standard Board issued a GAAP update "Revenue from Contracts with Customers". This GAAP update requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. This GAAP update also requires more detailed disclosures to enable users of the financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The GAAP update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2016. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

NOTE 4 – EARNINGS PER SHARE

Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2014		2013			2014			2013
Net income (loss) attributable to RadNet, Inc.'s common stockholders	$	4,451	$	(467	)	$	(2,829	)	$	877
BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS
Weighted average number of common shares outstanding during the period		41,644,606		39,235,863			40,734,083			39,105,522
Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders	$	0.11	$	(0.01	)	$	(0.07	)	$	0.02

DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS
Weighted average number of common shares outstanding during the period		41,644,606		39,235,863			40,734,083			39,105,522
Add nonvested restricted stock subject only to service vesting		1,001,190		–			–			311,419
Add additional shares issuable upon exercise of stock options and warrants		1,387,784		–			–			469,199
Weighted average number of common shares used in calculating diluted net income per share		44,033,580		39,235,863			40,734,083			39,886,140
Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders	$	0.10	$	(0.01	)	$	(0.07	)	$	0.02

For the three months ended September 30, 2013 and the nine months ended September 30, 2014 we excluded all outstanding options, warrants and restricted stock awards in the calculation of diluted earnings per share because their effect would be antidilutive.

NOTE 5 – INVESTMENT IN JOINT VENTURES

We have nine unconsolidated joint ventures with ownership interests ranging from 35% to 50%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture. Our investment in these joint ventures is accounted for under the equity method.

The following table is a roll forward of our investment in joint ventures during the nine months ended September 30, 2014 (in thousands):

Balance as of December 31, 2013	$	28,949
Equity contributions in existing joint ventures		1,161
Equity earnings in these joint ventures		4,722
Distribution of earnings		(7,358	)
Balance as of September 30, 2014	$	27,474

We earned management service fees from the centers underlying these joint ventures of approximately $2.3 million in each of the three months ended September 30, 2014 and 2013, and $6.9 million and $7.0 million for the nine months ended September 30, 2014 and 2013, respectively.

The following table is a summary of key financial data for these joint ventures as of and for the nine months ended September 30, 2014 and 2013 (in thousands):

Balance Sheet Data:	September 30, 2014
Current assets	$	14,181
Noncurrent assets		48,306
Current liabilities		(5,623	)
Noncurrent liabilities		(6,944	)
Total net assets	$	49,920
Book value of Radnet joint venture interests	$	23,232
Cost in excess of book value of acquired joint venture interests		3,857
Elimination of intercompany profit remaining on Radnet's consolidated balance sheet		385
Total value of Radnet joint venture interests	$	27,474
Total book value of other joint venture partner interests	$	26,688

Income Statement Data for the nine months ended September 30,	2014		2013
Net revenue	$	73,859	$	68,912
Net income	$	9,801	$	9,819

NOTE 6 – STOCK-BASED COMPENSATION

Stock Incentive Plans

Options and Warrants

We have two long-term incentive plans which we refer to as the 2000 Plan and the 2006 Plan. The 2000 Plan was terminated as to future grants when the 2006 Plan was approved by the stockholders in 2006 and as of September 30, 2014 no options or warrants were outstanding under our 2000 Plan. As of September 30, 2014, we have reserved for issuance under the 2006 Plan 11,000,000 shares of common stock. Certain options granted under the 2006 Plan to employees are intended to qualify as incentive stock options under existing tax regulations. In addition, we may issue non-qualified stock options and warrants under the 2006 Plan from time to time to non-employees, in connection with acquisitions and for other purposes and we may also issue restricted stock under the 2006 Plan. Stock options and warrants generally vest over two to five years and expire five to ten years from date of grant.

As of September 30, 2014, 2,037,509, or approximately 96.9%, of the 2,102,509 outstanding stock options and warrants granted under our 2006 Plan are fully vested. During the nine months ended September 30, 2014, we did not grant options or warrants under our 2006 Plan.

We have issued warrants outside the 2006 Plan under various types of arrangements to employees, and in exchange for outside services. All warrants issued to employees or consultants after our February 2007 listing on the NASDAQ Global Market have been characterized as awards under the 2006 Plan. All warrants outside the 2006 Plan have been issued with an exercise price equal to the fair value of the underlying common stock on the date of grant.

As of September 30, 2014, no warrants remain outstanding outside the 2006 Plan.

The following summarizes all of our option and warrant transactions during the nine months ended September 30, 2014:

Outstanding Options and Warrants Under the 2006 Plan and 2000 Plan	Shares			Weighted Average Exercise price Per Common Share		Weighted Average Remaining Contractual Life (in years)		Aggregate Intrinsic Value

Balance, December 31, 2013		4,701,250		$	3.15
Granted		–			–
Exercised		(2,283,741	)		2.38
Canceled or expired		(315,000	)		5.91
Balance, September 30, 2014		2,102,509			3.57		1.44	$	7,017,488
Exercisable at September 30, 2014		2,037,509			3.62		1.36		6,719,788

Non-Plan Outstanding Warrants

Weighted Average Exercise price Per Common Share

Weighted Average Remaining Contractual Life (in years)

Aggregate Intrinsic Value

Balance, December 31, 2013

200,000

2.62

Granted

–

Exercised

(200,000

)

2.62

Canceled or expired

–

Balance, September 30, 2014

–

Exercisable at September 30, 2014

–

Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on September 30, 2014 and the exercise price, multiplied by the number of in-the-money options or warrants, as applicable) that would have been received by the holder had all holders exercised their options or warrants, as applicable, on September 30, 2014. Total intrinsic value of options and warrants exercised during the nine months ended September 30, 2014 and 2013 was approximately $5.9 million and $2.3 million, respectively. As of September 30, 2014, total unrecognized stock-based compensation expense related to non-vested employee awards was $39,000, which is expected to be recognized over a weighted average period of approximately 2.1 years.

Restricted Stock Awards (“RSA’s”)

The 2006 Plan permits the award of restricted stock. On January 2, 2014, we granted awards for 1,011,785 shares of our common stock to certain employees and outside directors. Of these awards granted, 337,262 shares vested on the award date, with the remaining 674,524 shares vesting at the completion of each year’s service by 337,262 shares per year over the next two years. We valued this award based on the closing market price of our stock on January 2, 2014 which was $1.62 per share.

At September 30, 2014, the total unrecognized fair value of all restricted stock awards was approximately $1.1 million, which will be recognized over the remaining vesting period of 2.50 years.

In sum, of the 11,000,000 shares of common stock reserved for issuance under the 2006 Plan, at September 30, 2014, we had 4,834,294 options, warrants and shares of restricted stock outstanding, 2,296,241 options exercised and 3,869,465 shares of common stock available for grant.

NOTE 7 – FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS – Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:

Level 1—Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.

Level 2—Fair value is determined by using inputs other than Level 1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.

Level 3—Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.

The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):

	As of September 30, 2014
	Level 1		Level 2		Level 3		Total Fair Value		Total Face Value
2014 First Lien Term Loans	$	–	$	402,411	$	–	$	402,411	$	404,942
Second Lien Term Loans			$	180,000	$	–		180,000	$	180,000

		As of December 31, 2013
	Level 1		Level 2		Level 3		Total		Total Face Value
Senior Term Loan	$	–	$	380,508	$	–	$	380,508	$	349,125
Senior Notes		–		199,000		–		199,000		200,000

The carrying value of our revolving credit facility at September 30, 2014 and December 31, 2013 of $25.1 million and $0, respectively, approximated its fair value.

We consider the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes and other financial information appearing elsewhere in this quarterly report.

Forward-Looking Statements

This quarterly report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect current views about future events and are based on our currently available financial, economic and competitive data and on current business plans. Actual events or results may differ materially depending on risks and uncertainties that may affect our operations, markets, services, prices and other factors.

In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “assumption” or the negative of these terms or other comparable terminology. Statements in this quarterly report concerning our ability to successfully acquire and integrate new operations, to grow our contract management business, our financial guidance, our future cost saving efforts, our increased business from new equipment or operations and our ability to finance our operations and repay our outstanding indebtedness, including our increased amortization payments, are forward-looking statements.

The factors included in “Risk Factors,” in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended or supplemented by the information, if any, in Part II – Item 1A in our quarterly reports on Form 10-Q for the quarters ended March 31, 2014 and June 30, 2014, and in Part II – Item 1A below, among others, could cause our actual results to differ materially from those expressed in, or implied by, the forward-looking statements. You should consider the inherent limitations on, and risks associated with, forward-looking statements and not unduly rely on the accuracy of predictions contained in such forward-looking statements. These forward-looking statements speak only as of the date when they are made. Except as required under the federal securities laws or by the rules and regulations of the Securities and Exchange Commission, we do not undertake any responsibility to release publicly any revisions to these forward-looking statements to take into account events or circumstances that occur after the date of those statements. Additionally, we do not undertake any responsibility to update you on the occurrence of any unanticipated events which may cause actual results to differ from those expressed or implied by the forward-looking statements contained in this quarterly report.

Overview

We are the leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States based on number of locations and annual imaging revenue. At September 30, 2014, we operated directly or indirectly through joint ventures, 263 centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures.

We seek to develop leading positions in regional markets in order to leverage operational efficiencies. Our scale and density within selected geographies provides close, long-term relationships with key payors, radiology groups and referring physicians. Each of our facility managers is responsible for managing relationships with local physicians and payors, meeting our standards of patient service and maintaining profitability. We provide corporate training programs, standardized policies and procedures and sharing of best practices among the physicians in our regional networks.

We derive substantially all of our revenue, directly or indirectly, from fees charged for the diagnostic imaging services performed at our facilities. For the nine months ended September 30, 2014 and 2013, we performed 3,570,949 and 3,387,665 diagnostic imaging procedures, respectively, and generated total net revenue of $532.0 million and $524.6 million, respectively.

Aside from certain centers in California and all of our centers in New York City where we contract with BRMG and the B&C Entities, respectively, for the provision of professional medical services, at all of our other centers, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. The contracted radiology practices generally have outstanding physician and practice credentials and reputations; strong competitive market positions; a broad sub-specialty mix of physicians; a history of growth and potential for continued growth. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice group’s professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us. We have no financial controlling interest in the independent (non-BRMG or non-B&C Entities) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.

We typically experience some seasonality to our business. During the first quarter of each year we generally experience the lowest volumes of procedures and the lowest level of revenue for any quarter during the year. This is primarily the result of two factors. First, our volumes and revenue are typically impacted by winter weather conditions in our northeastern operations. It is common for snowstorms and other inclement weather to result in patient appointment cancellations and, in some cases, imaging center closures. Second, in recent years, we have observed greater participation in high deductible health plans by patients. As these high deductibles reset in January for most of these patients, we have observed that patients utilize medical services less during the first quarter, when securing medical care will result in significant out-of-pocket expenditures.

Critical Accounting Policies

Use of Estimates

Our discussion and analysis of financial condition and results of operations are based on our consolidated financial statements that were prepared in accordance with U.S. generally accepted accounting principles, or GAAP. Management makes estimates and assumptions when preparing financial statements. These estimates and assumptions affect various matters, including:

our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements;

our disclosure of contingent assets and liabilities at the dates of the financial statements; and

our reported amounts of net revenue and expenses in our consolidated statements of operations during the reporting periods.

These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management’s control. As a result, actual amounts could differ materially from these estimates.

The Securities and Exchange Commission defines critical accounting estimates as those that are both most important to the portrayal of a company’s financial condition and results of operations and require management’s most difficult, subjective or complex judgment, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. In Note 2 to our consolidated financial statements in our annual report on Form 10-K for the year ended December 31, 2013, as amended, we discuss our significant accounting policies, including those that do not require management to make difficult, subjective or complex judgments or estimates. The most significant areas involving management’s judgments and estimates are described below.

During the period covered in this report, there were no material changes to the critical accounting estimates we use, and have described in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended.

Revenues

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2014 and 2013 is summarized in the following table (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2014			2013			2014			2013

Commercial Insurance	$	109,472		$	103,934		$	314,300		$	310,147
Medicare		41,203			38,276			118,627			113,916
Medicaid		6,248			5,869			18,214			18,358
Workers' Compensation/Personal Injury		7,821			8,566			22,708			27,666
Other		6,354			8,727			24,688			26,337
Service fee revenue, net of contractual allowances and discounts		171,098			165,373			498,536			496,424
Provision for bad debts		(7,532	)		(7,033	)		(21,945	)		(20,810	)
Net service fee revenue		163,566			158,340			476,591			475,614
Revenue under capitation arrangements		20,493			16,848			55,426			49,034
Total net revenue	$	184,059		$	175,188		$	532,017		$	524,648

Provision for Bad Debts

Accounts Receivable

Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.

Depreciation and Amortization of Long-Lived Assets

We depreciate our long-lived assets over their estimated economic useful lives with the exception of leasehold improvements where we use the shorter of the assets useful lives or the lease term of the facility for which these assets are associated.

Deferred Tax Assets

Valuation of Goodwill and Long-Lived Assets

Goodwill at September 30, 2014 totaled $200.3 million. Goodwill is recorded as a result of business combinations. Management evaluates goodwill, at a minimum, on an annual basis and whenever events and changes in circumstances suggest that the carrying amount may not be recoverable in accordance with ASC 350, Intangibles – Goodwill and Other. Impairment of goodwill is tested at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill, to the fair value of the reporting unit. The fair value of a reporting unit is estimated using a combination of the income or discounted cash flows approach and the market approach, which uses comparable market data. If the carrying amount of the reporting unit exceeds its fair value, goodwill is considered impaired and a second step is performed to measure the amount of impairment loss, if any. We tested goodwill for impairment on October 1, 2013. Based on our test, we noted no impairment related to goodwill as of October 1, 2013. However, if estimates or the related assumptions change in the future, we may be required to record impairment charges to reduce the carrying amount of goodwill.

We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment whenever indicators of impairment exist. The accounting standards require that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset’s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell. No indicators of impairment were identified with respect to our long-lived assets as of September 30, 2014.

New Accounting Standards

Industry Updates

Sequestration spending cuts took effect on April 1, 2013, which reduced our Medicare payments by 2%. These spending cuts were extended through 2014 and 2015 by a two-year funding bill signed into law on December 26, 2013, which will continue to negatively impact our condensed consolidated financial results.

On March 31, 2014, Congress passed its seventeenth delay to the implementation of the SGR formula, which would have led to a 24% reduction in Medicare payments to physicians. This delay extends implementation for an additional twelve months, during which time Congress hopes to be able to pass a more permanent solution to the SGR formula.

On October 31, 2014, CMS published its final Medicare Physician Fee Schedule rule for 2015.

Results of Operations

The following table sets forth, for the periods indicated, the percentage that certain items in the statements of operations bears to revenue, net of contractual allowances and discounts and inclusive of revenue under capitation contracts.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(IN THOUSANDS EXCEPT SHARE DATA)

(unaudited)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2014		2013		2014		2013
NET REVENUE
Service fee revenue, net of contractual allowances and discounts	89.3	%	90.8	%	90.0	%	91.0	%
Provision for bad debts	-3.9	%	-3.9	%	-4.0	%	-3.8	%
Net service fee revenue	85.4	%	86.9	%	86.0	%	87.2	%
Revenue under capitation arrangements	10.7	%	9.2	%	10.0	%	9.0	%
Total net revenue	96.1	%	96.1	%	96.0	%	96.2	%
OPERATING EXPENSES
Cost of operations, excluding depreciation and amortization	79.9	%	83.3	%	80.5	%	82.5	%
Depreciation and amortization	7.5	%	8.1	%	8.2	%	8.1	%
Loss on sale and disposal of equipment	0.7	%	0.0	%	0.3	%	0.1	%
Severance costs	0.1	%	0.0	%	0.2	%	0.1	%
Total operating expenses	88.1	%	91.4	%	89.1	%	90.7	%

INCOME FROM OPERATIONS	8.0	%	4.7	%	6.9	%	5.5	%

OTHER INCOME AND EXPENSES
Interest expense	5.4	%	6.1	%	5.9	%	6.3	%
Meaningful use incentive	0.0	%	0.0	%	-0.3	%	0.0	%
Equity in earnings of joint ventures	-1.0	%	-0.9	%	-0.9	%	-0.8	%
Gain on sale of imaging centers	0.0	%	0.0	%	0.0	%	-0.4	%
Loss on early extinguishment of Senior Notes	0.0	%	0.0	%	2.9	%	0.0	%
Other expenses	0.0	%	0.0	%	0.0	%	0.0	%
Total other expenses	4.4	%	5.2	%	7.6	%	5.2	%

INCOME (LOSS) BEFORE INCOME TAXES	3.6	%	-0.5	%	-0.6	%	0.3	%
(Provision for) Benefit from income taxes	-1.2	%	0.3	%	0.2	%	-0.1	%
NET INCOME (LOSS)	2.4	%	-0.2	%	-0.5	%	0.2	%
Net income (loss) attributable to noncontrolling interests	0.0	%	0.1	%	0.0	%	0.0	%
NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	2.3	%	-0.3	%	-0.5	%	0.2	%

Three Months Ended September 30, 2014 Compared to the Three Months Ended September 30, 2013

Service Fee Revenue

Service fee revenue for the three months ended September 30, 2014 was $171.1 million compared to $165.4 million for the three months ended September 30, 2013, an increase of $5.7 million, or 3.5%.

Service fee revenue, including only those centers which were in operation throughout the third quarters of both 2014 and 2013 increased $973,000, or 0.6%. This comparison excludes revenue contributions from centers that were acquired or divested subsequent to July 1, 2013. For the three months ended September 30, 2014, service fee revenue from centers that were acquired or divested subsequent to July 1, 2013 and excluded from the above comparison was $5.9 million. For the three months ended September 30, 2013, service fee revenue from centers that were acquired or divested subsequent to July 1, 2013 and excluded from the above comparison was $1.2 million.

Provision for Bad Debts

Provision for bad debts increased $499,000, or 7.1%, to approximately $7.5 million, or 3.9% of gross revenue, for the three months ended September 30, 2014 compared to $7.0 million, or 3.9% of gross revenue, for the three months ended September 30, 2013.

Revenue Under Capitation Arrangements

Revenue under capitation arrangements for the three months ended September 30, 2014 was $20.5 million compared to $16.8 million for the three months ended September 30, 2013, an increase of $3.6 million or 21.6%.

Revenue under capitation arrangements, including only those centers which were in operation throughout the third quarters of both 2014 and 2013 increased $2.6 million, or 15.6%. This 15.6% increase was mainly due to new contractual relationships with private insurers. This comparison excludes revenue contributions from centers that were acquired or divested subsequent to July 1, 2013. For the three months ended September 31, 2014, revenue under capitation arrangements from centers that were acquired or divested subsequent to July 1, 2013 and excluded from the above comparison was $1.0 million.

Operating Expenses

Cost of operations for the three months ended September 30, 2014 increased approximately $1.2 million, or 0.8%, from $151.8 million for the three months ended September 30, 2013 to $153.0 million for the three months ended September 30, 2014. The following table sets forth our cost of operations and total operating expenses for the three months ended September 30, 2014 and 2013 (in thousands):

	Three Months Ended September 30,
	2014		2013
Salaries and professional reading fees, excluding stock-based compensation	$	84,422	$	80,128
Stock-based compensation		432	$	463
Building and equipment rental		16,088	$	16,630
Medical supplies		10,314	$	9,260
Other operating expenses *		41,744		45,289
Cost of operations		153,000		151,770
Depreciation and amortization		14,423		14,762
Loss (gain) on sale and disposal of equipment		1,289		(5	)
Severance costs		112		72
Total operating expenses	$	168,824	$	166,599

* Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, utilities, marketing, travel and other expenses.

Salaries and professional reading fees, excluding stock-based compensation and severance

Salaries and professional reading fees increased $4.3 million, or 5.4%, to $84.4 million for the three months ended September 30, 2014 compared to $80.1 million for the three months ended September 30, 2013.

Salaries and professional reading fees, including only those centers which were in operation throughout the third quarters of both 2014 and 2013, increased $1.4, or 1.7%. This comparison excludes expenses from centers that were acquired or divested subsequent to July 1, 2013. For the three months ended September 30, 2014, salaries and professional reading fees from centers that were acquired or divested subsequent to July 1, 2013 and excluded from the above comparison was $3.7 million. For the three months ended September 30, 2013, salaries and professional reading fees from centers that were acquired or divested subsequent to July 1, 2013 and excluded from the above comparison was approximately $786,000.

Stock-based compensation

Stock-based compensation decreased $31,000, or 6.7%, to approximately $432,000 for the three months ended September 30, 2014 compared to $463,000 for the three months ended September 30, 2013.

Building and equipment rental

Building and equipment rental expenses decreased $542,000, or 3.3%, to $16.1 million for the three months ended September 30, 2014 compared to $16.6 million for the three months ended September 30, 2013.

Building and equipment rental expenses, including only those centers which were in operation throughout the third quarters of both 2014 and 2013, decreased $1.0 million, or 6.3%. This 6.3% decrease mainly related to the re-negotiation of radiology equipment operating leases into capital leases, thus reducing equipment rental expense. This comparison excludes expenses from centers that were acquired or divested subsequent to July 1, 2013. For the three months ended September 30, 2014, building and equipment rental expenses from centers that were acquired or divested subsequent to July 1, 2013 and excluded from the above comparison was $678,000. For the three months ended September 30, 2013, building and equipment rental expenses from centers that were acquired or divested subsequent to July 1, 2013 and excluded from the above comparison was approximately $183,000.

Medical supplies

Medical supplies expense increased $1.1 million, or 11.4%, to $10.3 million for the three months ended September 30, 2014 compared to $9.3 million for the three months ended September 30, 2013.

Medical supplies expenses, including only those centers which were in operation throughout the second quarter of both 2014 and 2013, increased $784,000, or 8.5%. This 8.5% increase is primarily due to higher film prices over the three months ended September 30, 2014 compared to the three months ended September 30, 2013 as a result of a decrease in price rebates. This comparison excludes expenses from centers that were acquired or divested subsequent to July 1, 2013. For the three months ended September 31, 2014, medical supplies expenses from centers that were acquired or divested subsequent to July 1, 2013 and excluded from the above comparison was $329,000. For the three months ended September 30, 2013, medical supplies expense from centers that were acquired or divested subsequent to July 1, 2013 and excluded from the above comparison was $59,000.

Other operating expenses

Other operating expenses decreased $3.5 million, or 7.8%, to $41.7 million for the three months ended September 30, 2014 compared to $45.3 million for the three months ended September 30, 2013.

Other operating expenses, including only those centers which were in operation throughout the third quarters of both 2014 and 2013, decreased $4.0 million, or 8.9%. This 8.9% decrease is primarily due to reduced rates on certain of our maintenance contracts along with decreased license fees and insurance expense. This comparison excludes expenses from centers that were acquired or divested subsequent to July 1, 2013. For the three months ended September 30, 2014, other operating expense from centers that were acquired or divested subsequent July 1, 2013 and excluded from the above comparison was $1.0 million. For the three months ended September 30, 2013, other operating expense from centers that were acquired or divested subsequent to July 1, 2013 was $556,000.

Depreciation and amortization

Depreciation and amortization decreased $339,000, or 2.3%, to $14.4 million for the three months ended September 30, 2014 compared to $14.8 million for the three months ended September 30, 2013.

Depreciation and amortization, including only those centers which were in operation throughout the third quarter of both 2014 and 2013, decreased $936,000, or 6.4%. This comparison excludes expenses from centers that were acquired or divested subsequent to July 1, 2013. For the three months ended September 30, 2014, depreciation expense from centers that were acquired or divested subsequent to July 1, 2013 and excluded from the above comparison was $707,000. For the three months ended September 30, 2013, depreciation and amortization from centers that were acquired or divested subsequent to July 1, 2013 and excluded from the above comparison was $110,000.

Loss on sale and disposal of equipment

We recorded a net loss on sale of equipment of approximately $1.3 million for the three months ended September 30, 2014. The loss on disposal of equipment primarily relates to the write-off of certain leasehold improvements due to the closing of certain centers during the period.

Interest expense

Interest expense for the three months ended September 30, 2014 decreased approximately $0.7 million, or 6.3%, to $10.4 million for the three months ended September 30, 2014 compared to $11.1 million for the three months ended September 30, 2013. Interest expense for the three months ended September 30, 2014 included $1.3 million of combined non-cash amortization and write- off of deferred loan costs as well as discount on issuance and refinance of debt. Interest expense for the three months ended September 30, 2013 included $1.2 million of non-cash amortization of deferred loan costs and discount on issuance of debt. Excluding these non-cash amounts for each period, interest expense decreased approximately $0.8 million for the three months ended September 30, 2014 compared to the three months ended September 30, 2013. This decrease was primarily due to a reduction in interest expense stemming from the redemption of the $200 million Senior Notes. See “Liquidity and Capital Resources” below for more details on our debt refinancing.

Equity in earnings from unconsolidated joint ventures

For the three months ended September 30, 2014 and 2013, we recognized equity in earnings from unconsolidated joint ventures of $2.0 million and $1.6 million respectively.

Nine Months Ended September 30, 2014 Compared to the Nine Months Ended September 30, 2013

Service Fee Revenue

Service fee revenue for the nine months ended September 30, 2014 was $498.5 million compared to $496.4 million for the nine months ended September 30, 2013, an increase of $2.1 million, or 0.4%.

Service fee revenue, including only those centers which were in operation throughout the first nine months of both 2014 and 2013 decreased $9.2 million, or 1.9%. This 1.9% decrease is primarily due to a reduction in procedure volumes experienced at these centers. This comparison excludes revenue contributions from centers that were acquired or divested subsequent to January 1, 2013. For the nine months ended September 30, 2014, service fee revenue from centers that were acquired or divested subsequent to January 1, 2013 and excluded from the above comparison was $13.4 million. For the nine months ended September 30, 2013, service fee revenue from centers that were acquired or divested subsequent to January 1, 2013 and excluded from the above comparison was $2.1 million.

Provision for Bad Debts

Provision for bad debts increased $1.1 million, or 5.5%, to $21.9 million, or 4.0% of gross revenue, for the nine months ended September 30, 2014 compared to $20.8 million, or 3.8% of gross revenue, for the nine months ended September 30, 2013.

Revenue Under Capitation Arrangements

Revenue under capitation arrangements for the nine months ended September 30, 2014 was $55.4 million compared to $49.0 million for the nine months ended September 30, 2013, an increase of $6.4 million or 13.0%.

Revenue under capitation arrangements, including only those centers which were in operation throughout the first nine months of both 2014 and 2013 increased $6.4 million, or 13.0%. This 13.0% increase was mainly due to new contractual relationships with private insurers. For the nine months ended September 30, 2014, revenue under capitation arrangements from centers that were acquired or divested subsequent to January 1, 2013 and excluded from the above comparison was approximately $1.6 million.

Operating Expenses

Cost of operations for the nine months ended September 30, 2014 decreased approximately $4.2 million, or 0.9%, from $450.0 million for the nine months ended September 30, 2013 to $445.8 million for the nine months ended September 30, 2014. The following table sets forth our cost of operations and total operating expenses for the nine months ended September 30, 2014 and 2013 (in thousands):

	Nine Months Ended September 30,
	2014		2013
Salaries and professional reading fees, excluding stock-based compensation	$	244,479	$	241,349
Stock-based compensation		2,068		2,045
Building and equipment rental		47,374		49,421
Medical supplies		30,620		27,553
Other operating expenses *		121,297		129,662
Cost of operations		445,838		450,030
Depreciation and amortization		45,193		44,050
Loss on sale and disposal of equipment		1,581		357
Severance costs		976		312
Total operating expenses	$	493,588	$	494,749

* Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, utilities, marketing, travel and other expenses.

Salaries and professional reading fees, excluding stock-based compensation and severance

Salaries and professional reading fees increased $3.1 million, or 1.3%, to $244.5 million for the nine months ended September 30, 2014 compared to $241.3 million for the nine months ended September 30, 2013.

Salaries and professional reading fees, including only those centers which were in operation throughout the first nine months of both 2014 and 2013, decreased $4.1 million, or 1.7%. This 1.7% decrease is in line with our decrease in procedure volumes at these centers coupled with employee headcount reduction. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2013. For the nine months ended September 30, 2014, salaries and professional reading fees from centers that were acquired or divested subsequent to January 1, 2013 and excluded from the above comparison was approximately $7.7 million. For the nine months ended September 30, 2013, salaries and professional reading fees from centers that were acquired subsequent to January 1, 2013 and excluded from the above comparison was approximately $541,000.

Stock-based compensation

Stock-based compensation increased approximately $23,000 to $2.1 million or 1.1% for the nine months ended September 30, 2014 compared to $2.0 million for the nine months ended September 30, 2013.

Building and equipment rental

Building and equipment rental expenses decreased $2.0 million, or 4.1%, to $47.4 million for the nine months ended September 30, 2014 compared to $49.4 million for the nine months ended September 30, 2013.

Building and equipment rental expenses, including only those centers which were in operation throughout the first nine months of both 2014 and 2013, decreased $4.2 million, or 8.6%. This 8.6% decrease is primarily due to equipment operating leases being converted to capital leases. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2013. For the nine months ended September 30, 2014, building and equipment rental expenses from centers that were acquired or divested subsequent to January 1, 2013 and excluded from the above comparison was approximately $2.4 million. For the nine months ended September 30, 2013, building and equipment rental expenses from centers that were acquired or divested subsequent to January 1, 2013 and excluded from the above comparison was $253,000.

Medical supplies

Medical supplies expense increased $3.1 million, or 11.1%, to $30.6 million for the nine months ended September 30, 2014 compared to $27.6 million for the nine months ended September 30, 2013.

Medical supplies expenses, including only those centers which were in operation throughout the first nine months of both 2014 and 2013, increased $3.2 million, or 12.1%. This 12.1% increase is primarily due to increases in the cost of film and other key medical supplies over the nine months ended September 30, 2014 compared to the nine months ended September 30, 2013 as a result of decreases in rebates. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2013. For the nine months ended September 30, 2014, medical supplies expense from centers that were acquired or divested subsequent to January 1, 2013 and excluded from the above comparison was $683,000. For the nine months ended September 30, 2013, medical supplies expense from centers that were acquired or divested subsequent to January 1, 2013 and excluded from the above comparison was $853,000

Other operating expenses

Other operating expenses decreased $8.4 million, or 6.5%, to $121.3 million for the nine months ended September 30, 2014 compared to $129.7 million for the three months ended September 30, 2013.

Other operating expenses, including only those centers which were in operation throughout the first nine months of both 2014 and 2013, decreased $10.7 million, or 8.3%. This 8.3% decrease is primarily due to reduced rates on certain of our maintenance contracts along with decreased license fees and insurance costs. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2013. For the nine months ended September 30, 2014, other operating expense from centers that were acquired or divested subsequent January 1, 2013 and excluded from the above comparison was $3.0 million. For the nine months ended September 30, 2013, other operating expense from centers that were acquired or divested subsequent to January 1, 2013 was $674,000.

Depreciation and amortization

Depreciation and amortization increased $1.1 million, or 2.6%, to $45.2 million for the nine months ended September 30, 2014 compared to $44.1 million for the same period last year.

Depreciation and amortization, including only those centers which were in operation throughout the first nine months of both 2014 and 2013, decreased $502,000, or 1.1%. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2013. For the nine months ended September 30, 2014, depreciation and amortization from centers that were acquired or divested subsequent to January 1, 2013 and excluded from the above comparison was $1.8 million. For the nine months ended September 30, 2013, depreciation and amortization from centers that were acquired or divested subsequent to January 1, 2013 and excluded from the above comparison was $201,000.

Loss on sale and disposal of equipment

We recorded a net loss on sale and disposal of equipment of approximately $1.6 million and $357,000 for the nine months ended September 30, 2014 and 2013, respectively. The loss on disposal of equipment for the nine months ended September 30, 2014 primarily relates to the write-off of certain leasehold improvements due to the closing of certain centers during the period.

Interest expense

Interest expense for the nine months ended September 30, 2014 decreased approximately $2.0 million, or 5.8%, to $32.5 million for the nine months ended September 30, 2014 compared to $34.5 million for the nine months ended September 30, 2013. Interest expense for the nine months ended September 30, 2014 included $4.4 million of combined non-cash amortization and write- off of deferred loan costs as well as discount on issuance and refinance of debt. Interest expense for the nine months ended September 30, 2013 included $3.3 million of non-cash amortization of deferred loan costs and discount on issuance of debt. Excluding these non-cash amounts for each period, interest expense decreased approximately $3.1 million for the nine months ended September 30, 2014 compared to the nine months ended September 30, 2013. This decrease was primarily due to a reduction in interest expense stemming from the redemption of the $200 million Senior Notes. See “Liquidity and Capital Resources” below for more details on our debt refinancing.

Meaningful use incentive

For the nine months ended September 30, 2014, we recognized other income from meaningful use incentive in the amount of $1.8 million. This amount was earned under a Medicare program to promote the use of electronic health record technology. See Note 1 to the condensed consolidated financial statements contain herein for more detail regarding this meaningful use incentive.

Equity in earnings from unconsolidated joint ventures

For the nine months ended September 30, 2014, we recognized equity in earnings from unconsolidated joint ventures of $4.7 million compared to $4.5 million for the nine months ended September 30, 2013, a 5.4% increase of $241,000.

Loss on early extinguishment of Senior Notes

For the nine months ended September 30, 2014, we recognized a $15.9 million loss on early extinguishment of debt through our tender offers for our senior notes. Completion of the tenders was conditioned on the closing of the amendment to the First Lien and the Second Lien Credit and Guaranty Agreement. See “Liquidity and Capital Resources” below and Note 1 to the condensed consolidated financial statements contained herein for more details on our debt refinancing.

Adjusted EBITDA

We use both GAAP and non-GAAP metrics to measure our financial results. We believe that, in addition to GAAP metrics, these non-GAAP metrics assist us in measuring our cash generated from operations and ability to service our debt obligations. We believe this information is useful to investors and other interested parties because we are highly leveraged and our non-GAAP metrics remove non-cash and certain other charges that occur in the affected period and provide a basis for measuring the Company's financial condition against other quarters.

One non-GAAP measure we believe assists us is Adjusted EBITDA. We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations and exclude losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishments, bargain purchase gains and non-cash equity compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events taking place during the period.

Adjusted EBITDA is a non-GAAP financial measure used as an analytical indicator by us and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.

Adjusted EBITDA is reconciled to its nearest comparable GAAP financial measure, net income (loss) attributable to RadNet, Inc. common stockholders. The following is a reconciliation of GAAP net income (loss) attributable to Radnet, Inc. common stockholders to Adjusted EBITDA for the three and nine months ended September 30, 2014 and 2013, respectively:

	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2014		2013			2014			2013
Net income (loss) attributable to RadNet, Inc. common stockholders	$	4,451	$	(467	)	$	(2,829	)	$	877
Plus provision for (benefit from) income taxes		2,334		(483	)		(911	)		766
Plus other (income) expense		6		4			4			152
Plus loss on early extinguishment of Senior Notes		–		–			15,927			–
Plus interest expense		10,395		11,052			32,503			34,542
Plus severance costs		112		72			976			312
Plus loss on sale and disposal of equipment		1,289		(5	)		1,581			357
Less gain on sale of imaging centers		–		–			–			(2,108	)
Plus depreciation and amortization		14,423		14,762			45,193			44,050
Plus non-cash employee stock-based compensation		433		463			2,069			2,045
Adjusted EBITDA	$	33,443	$	25,398		$	94,513		$	80,993

Liquidity and Capital Resources

We had cash and cash equivalents of $274,000 and accounts receivable of $155.0 million at September 30, 2014, compared to cash and cash equivalents of $8.4 million and accounts receivable of $133.6 million at December 31, 2013. We had a working capital balance of $65.7 million and $58.0 million at September 30, 2014 and December 31, 2013, respectively. We had net income (loss) attributable to RadNet, Inc. common stockholders for the three months ended September 30 and 2013 of $4.5 million and ($467,000) respectively, and net (loss) income attributable to RadNet, Inc. common stockholders for the nine months ended September 30, 2014 and 2013 of ($2.8 million) and $877,000, respectively. We also had stockholders’ equity of $2.6 million and $2.2 million at September 30, 2014 and December 31, 2013, respectively.

Under the 2014 Amendment to the Refinance Agreement explained in further detail below, the scheduled annual amortization payments on the First Lien Term Loan increased from 1% per annum to 5% per annum. As a result, scheduled amortization increased by $16.8 million from pre-amendment terms. This $16.8 million additional cash obligation will be partially offset by annual interest savings of approximately $5.0 million under the terms of the Second Lien Term Loan as compared to that under the retired Senior Notes. We expect to fund this approximately $11.8 million net increase in amortization payments from cash provided by operating activities.

At September 30, 2014 we had borrowed $25.1 million under our $101 million revolving credit facility, which expires in October 2017. Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.

	Face Value		Discount			Total Carrying Value
2014 First Lien Term Loans	$	404,942	$	(9,922	)	$	395,020
Second Lien Term Loans	$	180,000	$	(2,772	)	$	177,228
Total	$	584,942	$	(12,694	)	$	572,248

Sources and Uses of Cash

Cash provided by operating activities was $34.0 million for the nine months ended September 30, 2014 compared to $42.5 million for the nine months ended September 30, 2013.

Cash used in investing activities was $43.9 million and $40.6 million for the nine months ended September 30, 2014 and 2013, respectively. For the nine months ended September 30, 2014, we purchased property and equipment for approximately $33.9 million, acquired the assets and businesses of an additional imaging facilities for $9.4 million (see Note 2 to the condensed consolidated financial statements contained herein), and purchased additional equity interests in non-consolidated joint ventures for $1.2 million.

Cash provided by financing activities was $1.8 million for the nine months ended September 30, 2014 compared to cash used in financing activities of $1.9 million for the nine months ended September 30, 2013. The cash provided by financing activities for the nine months ended September 30, 2014, was primarily due to amounts received through the First and Second Lien Credit and Guaranty Agreements and borrowings under our revolving line of credit, offset by the redemption of $200.0 million face value senior notes and principal payments on our notes and capital leases. (See Note 1 to the condensed consolidated financial statements herein).

The following describes our most recent financing activities:

2014 Amendment to the Refinance Agreement and Second Lien Credit and Guaranty Agreement:

On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:

2014 Amendment of the Refinance Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012, as amended by that certain first amendment date April 3, 2013 (the “2013 Amendment”) (collectively, the “Refinance Agreement”), by entering into a second amendment to the Refinance Agreement (the “2014 Amendment”) to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the “2014 First Lien Term Loans”).

The 2014 Amendment provides for the following:

Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates currently payable under the Refinance Agreement, as amended by the 2013 Amendment, which are (a) the Adjusted Eurodollar Rate plus 3.25% or (b) the Base Rate plus 2.25%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on all of the term loans under the Refinance Agreement. The Adjusted Eurodollar Rate at September 30, 2014 was 0.33%.

Payments. The scheduled amortization of the term loans under the Refinance Agreement has been increased from quarterly payments of $975,000 to quarterly payments of $5.2 million starting in June 2014, with the remaining balance to be paid at maturity.

The other material terms of the Refinance Agreement remain unchanged as described in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended.

The Second Lien Credit Agreement provides for the following:

Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. All principal will be due and payable on the termination date described below.

Financial Covenants. The Second Lien Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.

Senior Notes

Senior Notes Tender Offer and Exercise of Optional Redemption

Tender Offer and Exercise of Optional Redemption of March 7, 2014. On March 7, 2014, Radnet Management commenced a tender offer to purchase for cash any and all outstanding senior notes. In connection with the tender offer, Radnet Management also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014 (the “Initial Payment Date”), Radnet Management made a payment in cash for all senior notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the “Consent Payment Deadline”). As of the Consent Payment Deadline, Radnet Management had received tenders and consents in respect of $193,464,000 aggregate principal amount of the senior notes, representing 96.73% of the outstanding senior notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of senior notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88 (the “Total Consideration”), which amount included a consent payment (the “Consent Payment”) of $30.00 per $1,000 principal amount of senior notes. In addition, all senior notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional senior notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.

Tender Offer and Exercise of Optional Redemption of March 25, 2014. On March 25, 2014, Radnet Management called for redemption all of its remaining outstanding senior notes not purchased prior to the expiration of the tender offer described in Note 1of our condensed consolidated financial statements contained herein, with a redemption date of April 24, 2014 (the “Redemption Date”). Upon redemption on April 24, 2014, the holders of the senior notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the senior notes being redeemed (or $1,051.88 per $1,000 in principal amount of the senior notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date. As of that date, Radnet Management completed the satisfaction and discharge of the Indenture in accordance with its terms and no senior notes remained outstanding. With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $470,800 was recorded in the second quarter of 2014.

Capital Lease Investments

During the nine months ended September 30, 2014, we added capital lease debt of approximately $12.6 million relating to radiology equipment.

ITEM 3. Quantitative and Qualitative Disclosures about Market Risk

Foreign Currency Exchange Risk. We sell our services exclusively in the United States and receive payment for our services exclusively in United States dollars. As a result, our financial results are unlikely to be affected by factors such as changes in foreign currency, exchange rates or weak economic conditions in foreign markets.

We maintain research and development facilities in Prince Edward Island, Canada and Budapest, Hungary for which expenses are paid in the local currency. Accordingly, we do have currency risk resulting from fluctuations between such local currency and the United States Dollar. At the present time, we do not have any foreign exchange currency contracts to mitigate this risk. A hypothetical 1% decline in the currency exchange rates between the U.S. dollar against the Canadian dollar and the Euro would have resulted in an annual increase of approximately $15,000 in operating expenses.

Interest Rate Sensitivity. RadNet Inc. pays interest on various types of debt instruments to its suppliers, investors and lending institutions. The agreements entail either fixed or variable interest rates. Instruments which have fixed rates are mainly leases on radiology equipment. Variable rate interest obligations relate primarily to amounts borrowed under our outstanding credit facilities, which allows elections of either Adjusted Eurodollar or prime rates of interest. Under the 2014 Amendment to the Refinance Agreement and Second Lien Credit Agreement’s election facilities’, borrowed funds bear a 1.00% floor or 6 month Adjusted Eurodollar Rate plus an applicable margin of 3.25% for the 2014 First Lien Term Loans and 7% for the Second Lien Term Loans. At September 30, 2014, we had $404.9 million outstanding subject to an Adjusted Eurodollar election on the 2014 First Lien Term Loans and $180.0 million on the Second Lien Term Loans. As the Adjusted Eurodollar floor exceeds the current spot rate of 6 month Adjusted Eurodollar, the spot rate would have to increase more than 67 basis points before an additional interest expense would be accrued. An increase of 167 basis points would be necessary to realize a hypothetical 1% increase in the borrowing rate and an annual increase of $5.8 million of interest expense. At September 30, 2014, an additional $30.3 million was tied to the prime rate. A hypothetical 1% increase in the prime rate for 2013-2014 would have resulted in an annual increase in interest expense of approximately $303,000.

ITEM 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure.

In November 2013 the Company identified a deficiency in controls relating to the accounting for income taxes and concluded at that time that such a deficiency represented a material weakness in its internal control over financial reporting. As a result of this discovery, the Company’s Chief Executive Officer and Chief Financial Officer concluded that its disclosure controls and procedures were not effective as of December 31, 2013. Subsequent to November 2013 effort was put forth towards strengthening controls over the accounting for income taxes including placing a senior accounting professional in a leadership position within the accounting department to ensure the quality of information delivered to, and improve the review of completed work received from, the Company’s outside tax consultant, and although some improvements were achieved, the Chief Executive Officer and Chief Financial Officer of RadNet, Inc. concluded that the Company’s disclosure controls and procedures remain ineffective as of September 30, 2014 as a result of a material weakness in internal control over financial reporting.

Changes in Internal Control over Financial Reporting

During the quarterly period ended September 30, 2014, management implemented the following in internal control over financial reporting that materially affected, or was reasonably likely to materially affect, the Company’s internal control over financial reporting:

The Company continued to take steps to improve the overall processes and controls in its tax function:

placing a senior accounting professional in a leadership position within the accounting department to ensure the quality of information delivered to, and improve the review of completed work received from, Company’s outside tax consultant;

revised and implemented controls over our identification and assessment of uncertain tax positions.

Each of these changes is designed to improve the Company’s internal controls over financial reporting and remediate the material weakness discussed above regarding the Company’s accounting for income taxes

Limitations on Disclosure Controls and Procedures

Our management, including our Chief Executive Officer and Chief Financial Officer, do not expect that our disclosure controls or internal controls over financial reporting will prevent all errors or all instances of fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and any design may not succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitation of a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

PART II – OTHER INFORMATION

ITEM 1. Legal Proceedings

We are engaged from time to time in the defense of lawsuits arising out of the ordinary course and conduct of our business. We do not believe that the outcome of any of our current litigation will have a material adverse impact on our business, financial condition and results of operations. However, we could be subsequently named as a defendant in other lawsuits that could adversely affect us.

ITEM 1A. Risk Factors

For information about risks and uncertainties related to our business, please see the risk factors set forth in Part I, Item 1A, of our annual report on Form 10-K for the year ended December 31, 2013, as supplemented and amended by the risk factors in Part II, Item 1A of our quarterly reports on Form 10-Q for the quarters ended March 31, 2014 and June 30, 2014. Those risks are not the only risks relevant to our business; we may face additional risks and uncertainties not currently known to us or that we currently deem to be immaterial as of the date of this report on Form 10-Q.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

ITEM 3. Defaults Upon Senior Securities

None.

ITEM 4. Mine Safety Disclosures

Not applicable.

ITEM 5. Other Information

None.

ITEM 6. Exhibits

Reference is made to the Exhibit Index immediately following the signature page of this report on Form 10-Q.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	RADNET, INC.
	(Registrant)

Date: November 10, 2014	By:	/s/ Howard G. Berger, M.D.
		Howard G. Berger, M.D., President and Chief Executive Officer (Principal Executive Officer)


Date: November 10, 2014	By:	/s/ Mark D. Stolper
		Mark D. Stolper, Chief Financial Officer (Principal Financial and Accounting Officer)

INDEX TO EXHIBITS

Exhibit Number		Description

31.1		Certification of Howard G. Berger, M.D. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Mark D. Stolper pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certification of Howard G. Berger, M.D pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*		Certification of Mark D. Stolper pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS**		XBRL Instance Document

101.SCH**		XBRL Schema Document

101.CAL**		XBRL Calculation Linkbase Document

101.LAB**		XBRL Label Linkbase Document

101.PRE**		XBRL Presentation Linkbase Document

101.DEF**		XBRL Definition Linkbase Document

*	This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section 18 of the Exchange Act and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

**	Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

EX-31.1 2 radnet_10q-ex3101.htm CERTIFICATION

EXHIBIT 31.1

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Howard G. Berger, M.D., certify that:

1. I have reviewed this quarterly report on Form 10-Q of RadNet, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d –15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 10, 2014

/s/ Howard G. Berger, M.D.

Howard G. Berger, M.D.

President, Chief Executive Officer and Chairman of the Board of Directors

(Principal Executive Officer)

EX-31.2 3 radnet_10q-ex3102.htm CERTIFICATION

EXHIBIT 31.2

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark D. Stolper, certify that:

1. I have reviewed this quarterly report on Form 10-Q of RadNet, Inc.;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 10, 2014

/s/ Mark D. Stolper

Mark D. Stolper

Executive Vice President and

Chief Financial Officer

(Principal Financial Officer)

EX-32.1 4 radnet_10q-ex3201.htm CERTIFICATION

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of RadNet, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2014, as filed with the Securities and Exchange Commission on November 10, 2014 (the “Report”), I, Howard G. Berger, M.D., Chairman of the Board of Directors and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.

/s/ Howard G. Berger, M.D.

Howard G. Berger, M.D.

Chairman, President and Chief Executive Officer

(Principal Executive Officer)

November 10, 2014

A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 radnet_10q-ex3202.htm CERTIFICATION

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of RadNet, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2014, as filed with the Securities and Exchange Commission on November 10, 2014 (the “Report”), I, Mark D. Stolper, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

/s/ Mark D. Stolper

Mark D. Stolper

Chief Financial Officer

(Principal Financial Officer)

November 10, 2014

A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 6 rdnt-20140930.xml XBRL INSTANCE FILE 0000790526 2014-01-01 2014-09-30 0000790526 2014-09-30 0000790526 2013-12-31 0000790526 2012-12-31 0000790526 2013-09-30 0000790526 2013-01-01 2013-09-30 0000790526 rdnt:OutstandingOptionsandWarrantsUnderthe2006Planand2000PlanMember 2014-01-01 2014-09-30 0000790526 rdnt:NonPlanOutstandingWarrantsMember 2014-01-01 2014-09-30 0000790526 rdnt:NonPlanOutstandingWarrantsMember 2014-09-30 0000790526 rdnt:OutstandingOptionsandWarrantsUnderthe2006Planand2000PlanMember 2014-09-30 0000790526 us-gaap:FairValueInputsLevel1Member 2014-09-30 0000790526 us-gaap:FairValueInputsLevel1Member 2013-12-31 0000790526 us-gaap:FairValueInputsLevel2Member 2013-12-31 0000790526 us-gaap:FairValueInputsLevel3Member 2013-12-31 0000790526 rdnt:TotalFairValueMember 2013-12-31 0000790526 us-gaap:FairValueInputsLevel2Member 2014-09-30 0000790526 us-gaap:FairValueInputsLevel3Member 2014-09-30 0000790526 rdnt:TotalFairValueMember 2014-09-30 0000790526 rdnt:OutstandingOptionsandWarrantsUnderthe2006Planand2000PlanMember 2013-12-31 0000790526 rdnt:NonPlanOutstandingWarrantsMember 2013-12-31 0000790526 us-gaap:RestrictedStockMember 2014-09-30 0000790526 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-09-30 0000790526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-01-01 2014-09-30 0000790526 2014-07-01 2014-09-30 0000790526 2013-07-01 2013-09-30 0000790526 us-gaap:RestrictedStockMember 2014-01-01 2014-09-30 0000790526 us-gaap:CommonStockMember 2013-12-31 0000790526 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000790526 us-gaap:RetainedEarningsMember 2013-12-31 0000790526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000790526 us-gaap:NoncontrollingInterestMember 2013-12-31 0000790526 us-gaap:CommonStockMember 2014-01-01 2014-09-30 0000790526 us-gaap:RetainedEarningsMember 2014-01-01 2014-09-30 0000790526 us-gaap:NoncontrollingInterestMember 2014-01-01 2014-09-30 0000790526 us-gaap:CommonStockMember 2014-09-30 0000790526 us-gaap:AdditionalPaidInCapitalMember 2014-09-30 0000790526 us-gaap:RetainedEarningsMember 2014-09-30 0000790526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-09-30 0000790526 us-gaap:StockholdersEquityTotalMember 2014-01-01 2014-09-30 0000790526 us-gaap:StockholdersEquityTotalMember 2013-12-31 0000790526 us-gaap:StockholdersEquityTotalMember 2014-09-30 0000790526 us-gaap:NoncontrollingInterestMember 2014-09-30 0000790526 us-gaap:SeniorNotesMember rdnt:FirstLienTermLoans2014Member 2014-09-30 0000790526 us-gaap:SeniorNotesMember rdnt:SecondLienTermLoansMember 2014-09-30 0000790526 rdnt:Plan2006Member 2014-09-30 0000790526 2014-11-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

2618000

2210000

4000

173622000

-173656000

-50000

2290000

4000

177141000

-176485000

-88000

-80000

572000

2046000

2283741

1572621

40089196

42703602

1546000

1854000

1011785

1041785

-38000

2102509

4701250

2102509

315000

3.57

3.15

2.38

5.91

3.62

P1Y5M9D

P1Y4M10D

7017488000

6719788000

5900000

2300000

39000000

1100000

404942000 349125000 0 0 380508000 0 380508000 402411000 0 402411000 180000000 200000000 0 0 199000000 0 199000000 180000000 0 180000000

25100000

P2Y1M6D

P2Y9M

11000000

2037509

200000

2.62

3869465 2296241

24688000

26337000

6354000

8727000

22708000 27666000 7821000 8566000

18214000

18358000

6248000

5869000

118627000 113916000 41203000 38276000

314300000

310147000

109472000

103934000

572248000

395020000

177228000

-12694000

9922000

2772000

584942000

404942000

180000000

65600000

58200000

23600000

24700000

65600000

58200000

23600000

24700000

213900000

198400000

74400000

73600000

80300000

65200000

9400000

11900000

1800000

12600000

279600000

256600000

98000000

98300000

469199 1387784

311419

1001190

40734083

39105522

41644606

39235863

1161000

26688000 27474000

3857000

23232000

49920000

-6944000

-5623000

48306000

14181000

385000

9801000

9819000

73859000 68912000

6900000

7000000

2300000

NOTE 3 NEW ACCOUNTING STANDARDS   In May 2014, the Financial Accounting Standard Board issued a GAAP update "Revenue from Contracts with Customers". This GAAP update requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. This GAAP update also requires more detailed disclosures to enable users of the financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The GAAP update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2016. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

NOTE 4 EARNINGS PER SHARE   Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="text-align: center"> </td> <td colspan="6" style="text-align: center">Three Months Ended</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="6" style="text-align: center">Nine Months Ended</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center"> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">September 30,</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">September 30,</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2013</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2013</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 44%; padding-left: 10pt; text-indent: -10pt">Net income (loss) attributable to RadNet, Inc.'s common stockholders</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">4,451</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">(467</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">(2,829</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">877</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; text-indent: -10pt">Weighted average number of common shares outstanding during the period</td> <td> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">41,644,606</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">39,235,863</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">40,734,083</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">39,105,522</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt; text-align: right">0.11</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt; text-align: right">(0.01</td> <td>)</td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt; text-align: right">(0.07</td> <td>)</td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.02</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; text-indent: -10pt"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; text-indent: -10pt">Weighted average number of common shares outstanding during the period</td> <td> </td> <td> </td> <td style="text-align: right">41,644,606</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">39,235,863</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">40,734,083</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">39,105,522</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">Add nonvested restricted stock subject only to service vesting</td> <td> </td> <td> </td> <td style="text-align: right">1,001,190</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">311,419</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; text-indent: -10pt">Add additional shares issuable upon exercise of stock options and warrants</td> <td> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">1,387,784</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right"></td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right"></td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">469,199</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">Weighted average number of common shares used in calculating diluted net income per share</td> <td> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">44,033,580</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">39,235,863</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">40,734,083</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">39,886,140</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; text-indent: -10pt">Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt; text-align: right">0.10</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt; text-align: right">(0.01</td> <td>)</td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt; text-align: right">(0.07</td> <td>)</td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.02</td> <td> </td></tr> </table>   For the three months ended September 30, 2013 and the nine months ended September 30, 2014 we excluded all outstanding options, warrants and restricted stock awards in the calculation of diluted earnings per share because their effect would be antidilutive.

NOTE 5 INVESTMENT IN JOINT VENTURES   We have nine unconsolidated joint ventures with ownership interests ranging from 35% to 50%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.  Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.  Our investment in these joint ventures is accounted for under the equity method.      The following table is a roll forward of our investment in joint ventures during the nine months ended September 30, 2014 (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 82%; text-align: justify">Balance as of December 31, 2013</td> <td style="width: 3%; text-align: justify"> </td> <td style="width: 1%; text-align: justify">$</td> <td style="width: 13%; text-align: right">28,949</td> <td style="width: 1%; text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 11pt; text-align: justify">Equity contributions in existing joint ventures</td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right">1,161</td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 11pt; text-align: justify">Equity earnings in these joint ventures</td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right">4,722</td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 11pt; text-align: justify">Distribution of earnings</td> <td style="text-align: justify"> </td> <td style="border-bottom: black 1pt solid; text-align: justify"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(7,358</td> <td style="text-align: justify">)</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: justify">Balance as of September 30, 2014</td> <td style="text-align: justify"> </td> <td style="border-bottom: black 2.25pt double; text-align: justify">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">27,474</td> <td style="text-align: justify"> </td></tr> </table>   We earned management service fees from the centers underlying these joint ventures of approximately $2.3 million in each of the three months ended September 30, 2014 and 2013, and $6.9 million and $7.0 million for the nine months ended September 30, 2014 and 2013, respectively.   The following table is a summary of key financial data for these joint ventures as of and for the nine months ended September 30, 2014 and 2013 (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>Balance Sheet Data:</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">September 30, 2014</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 87%">Current assets</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">14,181</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Noncurrent assets</td> <td> </td> <td> </td> <td style="text-align: right">48,306</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Current liabilities</td> <td> </td> <td> </td> <td style="text-align: right">(5,623</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Noncurrent liabilities</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(6,944</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt">Total net assets</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">49,920</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Book value of Radnet joint venture interests</td> <td> </td> <td>$</td> <td style="text-align: right">23,232</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt">Cost in excess of book value of acquired joint venture interests</td> <td> </td> <td> </td> <td style="text-align: right">3,857</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Elimination of intercompany profit remaining on Radnet's consolidated balance sheet</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">385</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 22pt">Total value of Radnet joint venture interests</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">27,474</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 22pt">Total book value of other joint venture partner interests</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">26,688</td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>Income Statement Data for the nine months ended September 30,</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2013</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 72%">Net revenue</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">73,859</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">68,912</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net income</td> <td> </td> <td>$</td> <td style="text-align: right">9,801</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">9,819</td> <td> </td></tr> </table>

NOTE 6 STOCK-BASED COMPENSATION   Stock Incentive Plans   Options and Warrants   We have two long-term incentive plans which we refer to as the 2000 Plan and the 2006 Plan. The 2000 Plan was terminated as to future grants when the 2006 Plan was approved by the stockholders in 2006 and as of September 30, 2014 no options or warrants were outstanding under our 2000 Plan. As of September 30, 2014, we have reserved for issuance under the 2006 Plan 11,000,000 shares of common stock. Certain options granted under the 2006 Plan to employees are intended to qualify as incentive stock options under existing tax regulations. In addition, we may issue non-qualified stock options and warrants under the 2006 Plan from time to time to non-employees, in connection with acquisitions and for other purposes and we may also issue restricted stock under the 2006 Plan. Stock options and warrants generally vest over two to five years and expire five to ten years from date of grant.   As of September 30, 2014, 2,037,509, or approximately 96.9%, of the 2,102,509 outstanding stock options and warrants granted under our 2006 Plan are fully vested. During the nine months ended September 30, 2014, we did not grant options or warrants under our 2006 Plan.   We have issued warrants outside the 2006 Plan under various types of arrangements to employees, and in exchange for outside services. All warrants issued to employees or consultants after our February 2007 listing on the NASDAQ Global Market have been characterized as awards under the 2006 Plan. All warrants outside the 2006 Plan have been issued with an exercise price equal to the fair value of the underlying common stock on the date of grant.   As of September 30, 2014, no warrants remain outstanding outside the 2006 Plan.   The following summarizes all of our option and warrant transactions during the nine months ended September 30, 2014:   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center">Outstanding Options and Warrants Under the 2006 Plan and 2000 Plan</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Shares</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Weighted Average Exercise price Per Common Share</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Weighted Average Remaining Contractual Life (in years)</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Aggregate Intrinsic Value</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 44%">Balance, December 31, 2013</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">4,701,250</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">3.15</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Exercised</td> <td> </td> <td> </td> <td style="text-align: right">(2,283,741</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">2.38</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Canceled or expired</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(315,000</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">5.91</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Balance, September 30, 2014</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">2,102,509</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3.57</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.44</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">7,017,488</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercisable at September 30, 2014</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">2,037,509</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3.62</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.36</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">6,719,788</td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 44%; border-bottom: black 1pt solid; text-align: center">Non-Plan Outstanding Warrants</td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: center"> </td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: center">Shares</td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: center"> </td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: center">Weighted Average Exercise price Per Common Share</td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: center"> </td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: center">Weighted Average  Remaining  Contractual Life  (in years)</td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: center"> </td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: center">Aggregate Intrinsic Value</td> <td style="width: 1%; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Balance, December 31, 2013</td> <td> </td> <td> </td> <td style="text-align: right">200,000</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">2.62</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Exercised</td> <td> </td> <td> </td> <td style="text-align: right">(200,000</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">2.62</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Canceled or expired</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Balance, September 30, 2014</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercisable at September 30, 2014</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> </table>   Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on September 30, 2014 and the exercise price, multiplied by the number of in-the-money options or warrants, as applicable) that would have been received by the holder had all holders exercised their options or warrants, as applicable, on September 30, 2014. Total intrinsic value of options and warrants exercised during the nine months ended September 30, 2014 and 2013 was approximately $5.9 million and $2.3 million, respectively. As of September 30, 2014, total unrecognized stock-based compensation expense related to non-vested employee awards was $39,000, which is expected to be recognized over a weighted average period of approximately 2.1 years.   Restricted Stock Awards (RSAs)   The 2006 Plan permits the award of restricted stock. On January 2, 2014, we granted awards for 1,011,785 shares of our common stock to certain employees and outside directors. Of these awards granted, 337,262 shares vested on the award date, with the remaining 674,524 shares vesting at the completion of each years service by 337,262 shares per year over the next two years. We valued this award based on the closing market price of our stock on January 2, 2014 which was $1.62 per share.   At September 30, 2014, the total unrecognized fair value of all restricted stock awards was approximately $1.1 million, which will be recognized over the remaining vesting period of 2.50 years.   In sum, of the 11,000,000 shares of common stock reserved for issuance under the 2006 Plan, at September 30, 2014, we had 4,834,294 options, warrants and shares of restricted stock outstanding, 2,296,241 options exercised and 3,869,465 shares of common stock available for grant.

NOTE 7 FAIR VALUE MEASUREMENTS   FAIR VALUE MEASUREMENTS Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:   Level 1Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.   Level 2Fair value is determined by using inputs other than Level 1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.   Level 3Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.   The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="18" style="border-bottom: black 1pt solid; text-align: center">As of September 30, 2014</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Fair Value</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Face Value</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 30%">2014 First Lien Term Loans</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right"></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">402,411</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right"></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">402,411</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">404,942</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Second Lien Term Loans</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">180,000</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">180,000</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">180,000</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td colspan="17" style="border-bottom: black 1pt solid; text-align: center">As of December 31, 2013</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Face Value</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Senior Term Loan</td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">380,508</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">380,508</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">349,125</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Senior Notes</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">199,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">199,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">200,000</td> <td> </td></tr> </table>    The carrying value of our revolving credit facility at September 30, 2014 and December 31, 2013 of $25.1 million and $0, respectively, approximated its fair value.   We consider the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.

The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="18" style="border-bottom: black 1pt solid; text-align: center">As of September 30, 2014</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Fair Value</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Face Value</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 30%">2014 First Lien Term Loans</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right"></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">402,411</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right"></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">402,411</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">404,942</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Second Lien Term Loans</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">180,000</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">180,000</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">180,000</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td colspan="17" style="border-bottom: black 1pt solid; text-align: center">As of December 31, 2013</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Face Value</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Senior Term Loan</td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">380,508</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">380,508</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">349,125</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Senior Notes</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">199,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">199,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">200,000</td> <td> </td></tr> </table>

The following summarizes all of our option and warrant transactions during the nine months ended September 30, 2014:   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center">Outstanding Options and Warrants Under the 2006 Plan and 2000 Plan</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Shares</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Weighted Average Exercise price Per Common Share</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Weighted Average Remaining Contractual Life (in years)</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Aggregate Intrinsic Value</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 44%">Balance, December 31, 2013</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right">4,701,250</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">3.15</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Exercised</td> <td> </td> <td> </td> <td style="text-align: right">(2,283,741</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">2.38</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Canceled or expired</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(315,000</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">5.91</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Balance, September 30, 2014</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">2,102,509</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3.57</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.44</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">7,017,488</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercisable at September 30, 2014</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">2,037,509</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3.62</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.36</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">6,719,788</td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 44%; border-bottom: black 1pt solid; text-align: center">Non-Plan Outstanding Warrants</td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: center"> </td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: center">Shares</td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: center"> </td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: center">Weighted Average Exercise price Per Common Share</td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: center"> </td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: center">Weighted Average  Remaining  Contractual Life  (in years)</td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; text-align: center"> </td> <td style="width: 1%; border-bottom: black 1pt solid; text-align: center"> </td> <td style="width: 11%; border-bottom: black 1pt solid; text-align: center">Aggregate Intrinsic Value</td> <td style="width: 1%; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Balance, December 31, 2013</td> <td> </td> <td> </td> <td style="text-align: right">200,000</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">2.62</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Exercised</td> <td> </td> <td> </td> <td style="text-align: right">(200,000</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">2.62</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Canceled or expired</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Balance, September 30, 2014</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Exercisable at September 30, 2014</td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td></tr> </table>

The following table is a roll forward of our investment in joint ventures during the nine months ended September 30, 2014 (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 75%">Balance as of December 31, 2013</td> <td style="width: 3%"> </td> <td style="width: 1%">$</td> <td style="width: 20%; text-align: right">28,949</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 11pt">Equity contributions in existing joint ventures</td> <td> </td> <td> </td> <td style="text-align: right">1,161</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 11pt">Equity earnings in these joint ventures</td> <td> </td> <td> </td> <td style="text-align: right">4,722</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 11pt">Distribution of earnings</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(7,358</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Balance as of September 30, 2014</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">27,474</td> <td> </td></tr> </table>

The following table is a summary of key financial data for these joint ventures as of and for the nine months ended September 30, 2014 and 2013 (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>Balance Sheet Data:</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">September 30, 2014</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 87%">Current assets</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">14,181</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Noncurrent assets</td> <td> </td> <td> </td> <td style="text-align: right">48,306</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Current liabilities</td> <td> </td> <td> </td> <td style="text-align: right">(5,623</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Noncurrent liabilities</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(6,944</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt">Total net assets</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">49,920</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Book value of Radnet joint venture interests</td> <td> </td> <td>$</td> <td style="text-align: right">23,232</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt">Cost in excess of book value of acquired joint venture interests</td> <td> </td> <td> </td> <td style="text-align: right">3,857</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Elimination of intercompany profit remaining on Radnet's consolidated balance sheet</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">385</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 22pt">Total value of Radnet joint venture interests</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">27,474</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 22pt">Total book value of other joint venture partner interests</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">26,688</td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>Income Statement Data for the nine months ended September 30,</td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2013</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 72%">Net revenue</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">73,859</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">68,912</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net income</td> <td> </td> <td>$</td> <td style="text-align: right">9,801</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">9,819</td> <td> </td></tr> </table>

Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="text-align: center"> </td> <td colspan="6" style="text-align: center">Three Months Ended</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="6" style="text-align: center">Nine Months Ended</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center"> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">September 30,</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">September 30,</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2013</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2013</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 44%; padding-left: 10pt; text-indent: -10pt">Net income (loss) attributable to RadNet, Inc.'s common stockholders</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">4,451</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">(467</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">(2,829</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">877</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; text-indent: -10pt">Weighted average number of common shares outstanding during the period</td> <td> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">41,644,606</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">39,235,863</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">40,734,083</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">39,105,522</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt; text-align: right">0.11</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt; text-align: right">(0.01</td> <td>)</td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt; text-align: right">(0.07</td> <td>)</td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.02</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; text-indent: -10pt"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; text-indent: -10pt">Weighted average number of common shares outstanding during the period</td> <td> </td> <td> </td> <td style="text-align: right">41,644,606</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">39,235,863</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">40,734,083</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">39,105,522</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">Add nonvested restricted stock subject only to service vesting</td> <td> </td> <td> </td> <td style="text-align: right">1,001,190</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">311,419</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; text-indent: -10pt">Add additional shares issuable upon exercise of stock options and warrants</td> <td> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">1,387,784</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right"></td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right"></td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">469,199</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">Weighted average number of common shares used in calculating diluted net income per share</td> <td> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">44,033,580</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">39,235,863</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid; padding-left: 10pt; text-align: right">40,734,083</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">39,886,140</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 10pt; text-indent: -10pt">Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders</td> <td> </td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt; text-align: right">0.10</td> <td> </td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt; text-align: right">(0.01</td> <td>)</td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 10pt; text-align: right">(0.07</td> <td>)</td> <td style="padding-left: 10pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">0.02</td> <td> </td></tr></table>

Included in our condensed consolidated balance sheet at September 30, 2014 are $572.2 million of senior secured term loan debt (net of unamortized discounts of $12.7 million), broken down by loan agreement as follows (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Face Value</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Discount</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Carrying Value</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 52%">2014 First Lien Term Loans</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">404,942</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(9,922</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">395,020</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Second Lien Term Loans</td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">180,000</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">(2,772</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">177,228</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Total</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">584,942</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(12,694</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">572,248</td> <td> </td></tr> </table>

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2014 and 2013 is summarized in the following table (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center">Three Months Ended </td> <td> </td> <td> </td> <td colspan="6" style="text-align: center">Nine Months Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">September 30, </td> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">September 30,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2013</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2013</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 44%">Commercial Insurance</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">109,472</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">103,934</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">314,300</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">310,147</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Medicare</td> <td> </td> <td> </td> <td style="text-align: right">41,203</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,276</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">118,627</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">113,916</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Medicaid</td> <td> </td> <td> </td> <td style="text-align: right">6,248</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5,869</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">18,214</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">18,358</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Workers' Compensation/Personal Injury</td> <td> </td> <td> </td> <td style="text-align: right">7,821</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">8,566</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">22,708</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">27,666</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Other</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">6,354</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">8,727</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">24,688</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">26,337</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">Service fee revenue, net of contractual allowances and discounts</td> <td> </td> <td> </td> <td style="text-align: right">171,098</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">165,373</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">498,536</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">496,424</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Provision for bad debts</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(7,532</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(7,033</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(21,945</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(20,810</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net service fee revenue</td> <td> </td> <td> </td> <td style="text-align: right">163,566</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">158,340</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">476,591</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">475,614</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Revenue under capitation arrangements</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">20,493</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">16,848</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">55,426</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">49,034</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total net revenue</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">184,059</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">175,188</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">532,017</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">524,648</td> <td> </td></tr> </table>

NOTE 1 NATURE OF BUSINESS AND BASIS OF PRESENTATION   We provide diagnostic imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. At September 30, 2014, we operated directly or indirectly through joint ventures, 263 imaging centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York.  Our operations comprise a single segment for financial reporting purposes.   The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or Radnet Management) and Beverly Radiology Medical Group III, a professional partnership (BRMG).  The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc.,  Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc. (DIS), all wholly owned subsidiaries of Radnet Management.  All of these affiliated entities are referred to collectively as RadNet, we, us, our or the Company in this report.   Accounting Standards Codification (ASC) Section 810-10-15-14 stipulates that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics specified in the ASC which evidence a controlling financial interest, is considered a Variable Interest Entity (VIE). We consolidate all VIEs in which we own a majority voting interest and all VIEs for which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIEs economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIEs variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.   Howard G. Berger, M.D. is our President and Chief Executive Officer, a member of our Board of Directors and is deemed to be the beneficial owner, directly and indirectly, of approximately 13.1% of our outstanding common stock as of September 30, 2014. Dr. Berger also owns, indirectly, 99% of the equity interests in BRMG. BRMG provides all of the professional medical services at the majority of our facilities located in California under a management agreement with us, and employs physicians or contracts with various other independent physicians and physician groups to provide the professional medical services at most of our other California facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly or through subsidiaries, in order to comply with Californias prohibition against the corporate practice of medicine. However, as a result of our close relationship with Dr. Berger and BRMG, we believe that we are able to better ensure that medical service is provided at our California facilities in a manner consistent with our needs and expectations and those of our referring physicians, patients and payors than if we obtained these services from unaffiliated physician groups. BRMG is a partnership of ProNet Imaging Medical Group, Inc., Breastlink Medical Group, Inc. and Beverly Radiology Medical Group, Inc., each of which is 99% or 100% owned by Dr. Berger.     John V Crues, III, M.D. is our Medical Director, a member of our Board of Directors and a 1% owner of BRMG.  Dr. Crues owns a controlling interest in four medical groups (Crues Entities) which provide professional medical services at some of our facilities in Manhattan and Brooklyn, New York while Dr. Berger owns a controlling interest in two medical groups (NY Berger Entities) which provide professional medical services at one of our Manhattan, New York facilities.  The Crues Entities and the NY Berger Entities are collectively hereinafter referred to as the B&C Entities.   RadNet provides non-medical, technical and administrative services to BRMG and the B&C Entities for which it receives a management fee, pursuant to the related management agreements. Through these management agreements and our relationship with both Dr. Berger and Dr. Crues, we have exclusive authority over all non-medical decision-making related to the ongoing business operations of BRMG and the B&C Entities and we determine the annual budget of BRMG and the B&C Entities. BRMG and the B&C Entities both have insignificant operating assets and liabilities, and de minimis equity. Through these management agreements, we are paid the fair market value of our services, the result of which is that generally all net cash flows of both BRMG and the B&C Entities are transferred to us.   We have determined that BRMG and the B&C Entities are VIEs, and that we are the primary beneficiary, and consequently, we consolidate the revenue, expenses, assets and liabilities of each such entity.  BRMG and the B&C Entities on a combined basis recognized $23.6 million and $24.7 million of revenue, net of management service fees to RadNet for the three months ended September 30, 2014 and 2013, respectively, and $23.6 million and $24.7 million of operating expenses for the three months ended September 30, 2014 and 2013, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $98.0 million and $98.3 million of total billed net service fee revenue relating to these VIEs for the three months ended September 30, 2014 and 2013, respectively, of which $74.4 million and $73.6 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the three months ended September 30, 2014 and 2013, respectively.   BRMG and the B&C Entities on a combined basis recognized $65.6 million and $58.2 million of revenue, net of management service fees to RadNet for the nine months ended September 30, 2014 and 2013, respectively, and $65.6 million and $58.2 million of operating expenses for the nine months ended September 30, 2014 and 2013, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $279.6 million and $256.6 million of total billed net service fee revenue relating to these VIEs for the nine months ended September 30, 2014 and 2013, respectively, of which $213.9 million and $198.4 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the nine months ended September 30, 2014 and 2013, respectively.   The cash flows of BRMG and the B&C Entities are included in the accompanying consolidated statements of cash flows.  All intercompany balances and transactions have been eliminated in consolidation.  In our consolidated balance sheets at September 30, 2014 and December 31, 2013, we have included approximately $80.3 million and $65.2 million, respectively, of accounts receivable and approximately $9.4 million and $11.9 million, respectively, of accounts payable and accrued liabilities, related to BRMG and the B&C Entities combined.   The creditors of both BRMG and the B&C Entities do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of BRMG and the B&C Entities. However, because of the relationship RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.   Aside from certain centers in California and all of our centers in New York City where we contract with BRMG and the B&C Entities, respectively, for the provision of professional medical services, at all of our other centers, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice groups professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us.  We have no financial controlling interest in the independent (non-BRMG or non-B&C Entities) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.   The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended September 30, 2014 and 2013 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December 31, 2013 filed on March 17, 2014, as amended.   Significant Accounting Policies   During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended.   Revenues   Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payers and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the B&C Entities, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the B&C Entities as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the B&C Entities. As it relates to non-BRMG and B&C Entity centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and B&C Entity centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.   Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payers.   Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.   Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2014 and 2013 is summarized in the following table (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center">Three Months Ended </td> <td> </td> <td> </td> <td colspan="6" style="text-align: center">Nine Months Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">September 30, </td> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">September 30,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2013</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2013</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 44%">Commercial Insurance</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">109,472</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">103,934</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">314,300</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">310,147</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Medicare</td> <td> </td> <td> </td> <td style="text-align: right">41,203</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,276</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">118,627</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">113,916</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Medicaid</td> <td> </td> <td> </td> <td style="text-align: right">6,248</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5,869</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">18,214</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">18,358</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Workers' Compensation/Personal Injury</td> <td> </td> <td> </td> <td style="text-align: right">7,821</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">8,566</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">22,708</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">27,666</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Other</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">6,354</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">8,727</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">24,688</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">26,337</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">Service fee revenue, net of contractual allowances and discounts</td> <td> </td> <td> </td> <td style="text-align: right">171,098</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">165,373</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">498,536</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">496,424</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Provision for bad debts</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(7,532</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(7,033</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(21,945</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(20,810</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net service fee revenue</td> <td> </td> <td> </td> <td style="text-align: right">163,566</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">158,340</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">476,591</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">475,614</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Revenue under capitation arrangements</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">20,493</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">16,848</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">55,426</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">49,034</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total net revenue</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">184,059</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">175,188</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">532,017</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">524,648</td> <td> </td></tr> </table>   Provision for Bad Debts   We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patients ability to pay nor are revenues recognized based on an assessment of the patients ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.   Deferred Tax Assets   Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.   Deferred Financing Costs   Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.   Meaningful Use Incentive   Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a Radiology Information System (RIS) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $1.8 million during the nine months ended September 30, 2014 relating to this incentive. This amount was earned under a Medicare program to promote the use of electronic health record technology.   Liquidity and Capital Resources   We had cash and cash equivalents of $274,000 and accounts receivable of $155.0 million at September 30, 2014, compared to cash and cash equivalents of $8.4 million and accounts receivable of $133.6 million at December 31, 2013. We had a working capital balance of $65.7 million and $58.0 million at September 30, 2014 and December 31, 2013, respectively. We had net income (loss) attributable to RadNet, Inc. common stockholders for the three months ended September 30, 2014 and 2013 of $4.5 million and ($467,000) respectively, and net (loss) income attributable to RadNet, Inc. common stockholders for the nine months ended September 30, 2014 and 2013 of ($2.8 million) and $877,000, respectively.  We also had stockholders equity of $2.6 million and $2.2 million at September 30, 2014 and December 31, 2013, respectively.   We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations.  In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment.  Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.   Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.   On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.   We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.   Included in our condensed consolidated balance sheet at September 30, 2014 are $572.2 million of senior secured term loan debt (net of unamortized discounts of $12.7 million), broken down by loan agreement as follows (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Face Value</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Discount</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Carrying Value</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 52%">2014 First Lien Term Loans</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">404,942</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(9,922</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">395,020</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Second Lien Term Loans</td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">180,000</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">(2,772</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">177,228</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Total</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">584,942</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(12,694</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">572,248</td> <td> </td></tr> </table>   Our revolving credit facility has a $25.1 million aggregate principal amount outstanding as of September 30, 2014.   The following describes our most recent financing activities:   2014 Amendment to the Refinance Agreement and Second Lien Credit and Guaranty Agreement:   On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:   2014 Amendment of the Refinance Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012, by that certain first amendment dated April 3, 2013 (the 2013 Amendment) (collectively, the Refinance Agreement), by entering into a second amendment to the Refinance Agreement (the 2014 Amendment) to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the 2014 First Lien Term Loans).   Second Lien Credit and Guaranty Agreement. Radnet Management entered into a Second Lien Credit and Guaranty Agreement (the Second Lien Credit Agreement) to provide for, among other things, the borrowing by Radnet Management of $180.0 million of second lien term loans (the Second Lien Term Loans). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the senior notes, as more fully described below under the heading Senior Notes, to pay the expenses related to the transaction and for general corporate purposes.   Revolving Credit Facility. The $101.25 million revolving credit line established in the Credit and Guaranty Agreement dated October 10, 2012 was unaltered by the agreements above and remains in place.   The 2014 Amendment provides for the following:   Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates currently payable under the Refinance Agreement, as amended by the 2013 Amendment, which are (a) the Adjusted Eurodollar Rate plus 3.25% or (b) the Base Rate (as defined in the Refinance Agreement) plus 2.25%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on all of the term loans under the Refinance Agreement. The Adjusted Eurodollar Rate at September 30, 2014 was 0.33%.   Payments. The scheduled amortization of the term loans under the Refinance Agreement has been increased from quarterly payments of $975,000 to quarterly payments of $5.2 million which started in June 2014, with the remaining balance to be paid at maturity.   The other material terms of the Refinance Agreement remain unchanged as described in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended.   The Second Lien Credit Agreement provides for the following:   Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate plus 7.0% or (b) the Base Rate plus 6.0%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at September 30, 2014 was 0.33%.   Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. All principal will be due and payable on the termination date described below.   Termination. The termination date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by acceleration or otherwise.   Restrictive Covenants. In addition to certain customary covenants, the Second Lien Credit Agreement places restrictions on indebtedness, liens, and investments, and places limits on distributions to stockholders (including the repurchase of shares) and other junior payments.   Financial Covenants. The Second Lien Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.   Events of Default. In addition to certain customary events of default, events of default under the Second Lien Credit Agreement include failure to pay principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements, subject to applicable grace periods and/or notice requirements, or a material breach of any representation or warranty contained in the loan documents. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.   These limitations are subject to a number of important qualifications and exceptions, as described in the Second Lien Credit Agreement. As of September 30, 2014, we were in compliance with all covenants.   Senior Notes   On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the senior notes).  All payments of the senior notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Managements current and future domestic wholly owned restricted subsidiaries.  The senior notes were issued under an indenture dated April 6, 2010 (the Indenture), by and among Radnet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee. We paid interest on the senior notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.   Optional Redemption. Under the Indenture, Radnet Management could redeem the senior notes, in whole or in part, at any time on or after April 1, 2014, at the redemption prices specified under the Indenture. Prior to April 1, 2014, Radnet Management was also permitted to redeem the senior notes, in whole or in part, at a redemption price equal to 100% of the principal amount redeemed, plus a make-whole premium established by the Indenture and accrued and unpaid interest, if any.   Senior Notes Tender Offer and Exercise of Optional Redemption   Radnet Management completed the retirement of its $200 million in Senior Notes on April 24, 2014 and following such retirement the Company completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:   Tender Offer and Exercise of Optional Redemption on March 7, 2014. On March 7, 2014, Radnet Management commenced a tender offer to purchase for cash any and all outstanding senior notes. In connection with the tender offer, Radnet Management also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014 (the Initial Payment Date), Radnet Management made a payment in cash for all senior notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the Consent Payment Deadline). As of the Consent Payment Deadline, Radnet Management had received tenders and consents in respect of $193,464,000 aggregate principal amount of the senior notes, representing 96.73% of the outstanding senior notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of senior notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88 (the Total Consideration), which amount included a consent payment (the Consent Payment) of $30.00 per $1,000 principal amount of senior notes. In addition, all senior notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional senior notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.   Tender Offer and Exercise on Optional Redemption of March 25, 2014. On March 25, 2014, Radnet Management called for redemption all of its remaining outstanding senior notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the Redemption Date). Upon redemption on April 24, 2014, the holders of the senior notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the senior notes being redeemed (or $1,051.88 per $1,000 in principal amount of the senior notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date.  As of that date, Radnet Management completed the satisfaction and discharge of the Indenture in accordance with its terms and no senior notes remained outstanding.  With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.   Capital Lease Investments   During the nine months ended September 30, 2014, we added capital lease debt of approximately $12.6 million relating to radiology equipment.

We provide diagnostic imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. At September 30, 2014, we operated directly or indirectly through joint ventures, 263 imaging centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York.  Our operations comprise a single segment for financial reporting purposes.   The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or Radnet Management) and Beverly Radiology Medical Group III, a professional partnership (BRMG).  The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc.,  Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc. (DIS), all wholly owned subsidiaries of Radnet Management.  All of these affiliated entities are referred to collectively as RadNet, we, us, our or the Company in this report.   Accounting Standards Codification (ASC) Section 810-10-15-14 stipulates that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics specified in the ASC which evidence a controlling financial interest, is considered a Variable Interest Entity (VIE). We consolidate all VIEs in which we own a majority voting interest and all VIEs for which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIEs economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIEs variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.   Howard G. Berger, M.D. is our President and Chief Executive Officer, a member of our Board of Directors and is deemed to be the beneficial owner, directly and indirectly, of approximately 13.1% of our outstanding common stock as of September 30, 2014. Dr. Berger also owns, indirectly, 99% of the equity interests in BRMG. BRMG provides all of the professional medical services at the majority of our facilities located in California under a management agreement with us, and employs physicians or contracts with various other independent physicians and physician groups to provide the professional medical services at most of our other California facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly or through subsidiaries, in order to comply with Californias prohibition against the corporate practice of medicine. However, as a result of our close relationship with Dr. Berger and BRMG, we believe that we are able to better ensure that medical service is provided at our California facilities in a manner consistent with our needs and expectations and those of our referring physicians, patients and payors than if we obtained these services from unaffiliated physician groups. BRMG is a partnership of ProNet Imaging Medical Group, Inc., Breastlink Medical Group, Inc. and Beverly Radiology Medical Group, Inc., each of which is 99% or 100% owned by Dr. Berger.     John V Crues, III, M.D. is our Medical Director, a member of our Board of Directors and a 1% owner of BRMG.  Dr. Crues owns a controlling interest in four medical groups (Crues Entities) which provide professional medical services at some of our facilities in Manhattan and Brooklyn, New York while Dr. Berger owns a controlling interest in two medical groups (NY Berger Entities) which provide professional medical services at one of our Manhattan, New York facilities.  The Crues Entities and the NY Berger Entities are collectively hereinafter referred to as the B&C Entities.   RadNet provides non-medical, technical and administrative services to BRMG and the B&C Entities for which it receives a management fee, pursuant to the related management agreements. Through these management agreements and our relationship with both Dr. Berger and Dr. Crues, we have exclusive authority over all non-medical decision-making related to the ongoing business operations of BRMG and the B&C Entities and we determine the annual budget of BRMG and the B&C Entities. BRMG and the B&C Entities both have insignificant operating assets and liabilities, and de minimis equity. Through these management agreements, we are paid the fair market value of our services, the result of which is that generally all net cash flows of both BRMG and the B&C Entities are transferred to us.   We have determined that BRMG and the B&C Entities are VIEs, and that we are the primary beneficiary, and consequently, we consolidate the revenue, expenses, assets and liabilities of each such entity.  BRMG and the B&C Entities on a combined basis recognized $23.6 million and $24.7 million of revenue, net of management service fees to RadNet for the three months ended September 30, 2014 and 2013, respectively, and $23.6 million and $24.7 million of operating expenses for the three months ended September 30, 2014 and 2013, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $98.0 million and $98.3 million of total billed net service fee revenue relating to these VIEs for the three months ended September 30, 2014 and 2013, respectively, of which $74.4 million and $73.6 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the three months ended September 30, 2014 and 2013, respectively.   BRMG and the B&C Entities on a combined basis recognized $65.6 million and $58.2 million of revenue, net of management service fees to RadNet for the nine months ended September 30, 2014 and 2013, respectively, and $65.6 million and $58.2 million of operating expenses for the nine months ended September 30, 2014 and 2013, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $279.6 million and $256.6 million of total billed net service fee revenue relating to these VIEs for the nine months ended September 30, 2014 and 2013, respectively, of which $213.9 million and $198.4 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the nine months ended September 30, 2014 and 2013, respectively.   The cash flows of BRMG and the B&C Entities are included in the accompanying consolidated statements of cash flows.  All intercompany balances and transactions have been eliminated in consolidation.  In our consolidated balance sheets at September 30, 2014 and December 31, 2013, we have included approximately $80.3 million and $65.2 million, respectively, of accounts receivable and approximately $9.4 million and $11.9 million, respectively, of accounts payable and accrued liabilities, related to BRMG and the B&C Entities combined.   The creditors of both BRMG and the B&C Entities do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of BRMG and the B&C Entities. However, because of the relationship RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.   Aside from certain centers in California and all of our centers in New York City where we contract with BRMG and the B&C Entities, respectively, for the provision of professional medical services, at all of our other centers, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice groups professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us.  We have no financial controlling interest in the independent (non-BRMG or non-B&C Entities) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.   The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended September 30, 2014 and 2013 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December 31, 2013 filed on March 17, 2014, as amended.

Significant Accounting Policies   During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended.

Revenues   Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payers and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the B&C Entities, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the B&C Entities as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the B&C Entities. As it relates to non-BRMG and B&C Entity centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and B&C Entity centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.   Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payers.   Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.   Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2014 and 2013 is summarized in the following table (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center">Three Months Ended </td> <td> </td> <td> </td> <td colspan="6" style="text-align: center">Nine Months Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">September 30, </td> <td> </td> <td> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">September 30,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2013</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2013</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 44%">Commercial Insurance</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">109,472</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">103,934</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">314,300</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">310,147</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Medicare</td> <td> </td> <td> </td> <td style="text-align: right">41,203</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">38,276</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">118,627</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">113,916</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Medicaid</td> <td> </td> <td> </td> <td style="text-align: right">6,248</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5,869</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">18,214</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">18,358</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Workers' Compensation/Personal Injury</td> <td> </td> <td> </td> <td style="text-align: right">7,821</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">8,566</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">22,708</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">27,666</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Other</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">6,354</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">8,727</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">24,688</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">26,337</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-indent: -10pt">Service fee revenue, net of contractual allowances and discounts</td> <td> </td> <td> </td> <td style="text-align: right">171,098</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">165,373</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">498,536</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">496,424</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Provision for bad debts</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(7,532</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(7,033</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(21,945</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(20,810</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net service fee revenue</td> <td> </td> <td> </td> <td style="text-align: right">163,566</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">158,340</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">476,591</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">475,614</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Revenue under capitation arrangements</td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">20,493</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">16,848</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">55,426</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">49,034</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total net revenue</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">184,059</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">175,188</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">532,017</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">524,648</td> <td> </td></tr> </table>

Provision for Bad Debts   We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patients ability to pay nor are revenues recognized based on an assessment of the patients ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.

Deferred Tax Assets   Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.

Deferred Financing Costs   Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.

Meaningful Use Incentive   Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a Radiology Information System (RIS) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $1.8 million during the nine months ended September 30, 2014 relating to this incentive. This amount was earned under a Medicare program to promote the use of electronic health record technology.

Liquidity and Capital Resources   We had cash and cash equivalents of $274,000 and accounts receivable of $155.0 million at September 30, 2014, compared to cash and cash equivalents of $8.4 million and accounts receivable of $133.6 million at December 31, 2013. We had a working capital balance of $65.7 million and $58.0 million at September 30, 2014 and December 31, 2013, respectively. We had net income (loss) attributable to RadNet, Inc. common stockholders for the three months ended September 30, 2014 and 2013 of $4.5 million and ($467,000) respectively, and net (loss) income attributable to RadNet, Inc. common stockholders for the nine months ended September 30, 2014 and 2013 of ($2.8 million) and $877,000, respectively.  We also had stockholders equity of $2.6 million and $2.2 million at September 30, 2014 and December 31, 2013, respectively.   We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations.  In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment.  Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.   Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.   On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.   We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.   Included in our condensed consolidated balance sheet at September 30, 2014 are $572.2 million of senior secured term loan debt (net of unamortized discounts of $12.7 million), broken down by loan agreement as follows (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Face Value</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Discount</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Carrying Value</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 52%">2014 First Lien Term Loans</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">404,942</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">(9,922</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">395,020</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Second Lien Term Loans</td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">180,000</td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">(2,772</td> <td>)</td> <td> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">177,228</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Total</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">584,942</td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(12,694</td> <td>)</td> <td> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">572,248</td> <td> </td></tr> </table>   Our revolving credit facility has a $25.1 million aggregate principal amount outstanding as of September 30, 2014.   The following describes our most recent financing activities:   2014 Amendment to the Refinance Agreement and Second Lien Credit and Guaranty Agreement:   On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:   2014 Amendment of the Refinance Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012, by that certain first amendment dated April 3, 2013 (the 2013 Amendment) (collectively, the Refinance Agreement), by entering into a second amendment to the Refinance Agreement (the 2014 Amendment) to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the 2014 First Lien Term Loans).   Second Lien Credit and Guaranty Agreement. Radnet Management entered into a Second Lien Credit and Guaranty Agreement (the Second Lien Credit Agreement) to provide for, among other things, the borrowing by Radnet Management of $180.0 million of second lien term loans (the Second Lien Term Loans). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the senior notes, as more fully described below under the heading Senior Notes, to pay the expenses related to the transaction and for general corporate purposes.   Revolving Credit Facility. The $101.25 million revolving credit line established in the Credit and Guaranty Agreement dated October 10, 2012 was unaltered by the agreements above and remains in place.   The 2014 Amendment provides for the following:   Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates currently payable under the Refinance Agreement, as amended by the 2013 Amendment, which are (a) the Adjusted Eurodollar Rate plus 3.25% or (b) the Base Rate (as defined in the Refinance Agreement) plus 2.25%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on all of the term loans under the Refinance Agreement. The Adjusted Eurodollar Rate at September 30, 2014 was 0.33%.   Payments. The scheduled amortization of the term loans under the Refinance Agreement has been increased from quarterly payments of $975,000 to quarterly payments of $5.2 million which started in June 2014, with the remaining balance to be paid at maturity.   The other material terms of the Refinance Agreement remain unchanged as described in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended.   The Second Lien Credit Agreement provides for the following:   Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate plus 7.0% or (b) the Base Rate plus 6.0%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at September 30, 2014 was 0.33%.   Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. All principal will be due and payable on the termination date described below.   Termination. The termination date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by acceleration or otherwise.   Restrictive Covenants. In addition to certain customary covenants, the Second Lien Credit Agreement places restrictions on indebtedness, liens, and investments, and places limits on distributions to stockholders (including the repurchase of shares) and other junior payments.   Financial Covenants. The Second Lien Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.   Events of Default. In addition to certain customary events of default, events of default under the Second Lien Credit Agreement include failure to pay principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements, subject to applicable grace periods and/or notice requirements, or a material breach of any representation or warranty contained in the loan documents. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.   These limitations are subject to a number of important qualifications and exceptions, as described in the Second Lien Credit Agreement. As of September 30, 2014, we were in compliance with all covenants.   Senior Notes   On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the senior notes).  All payments of the senior notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Managements current and future domestic wholly owned restricted subsidiaries.  The senior notes were issued under an indenture dated April 6, 2010 (the Indenture), by and among Radnet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee. We paid interest on the senior notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.   Optional Redemption. Under the Indenture, Radnet Management could redeem the senior notes, in whole or in part, at any time on or after April 1, 2014, at the redemption prices specified under the Indenture. Prior to April 1, 2014, Radnet Management was also permitted to redeem the senior notes, in whole or in part, at a redemption price equal to 100% of the principal amount redeemed, plus a make-whole premium established by the Indenture and accrued and unpaid interest, if any.   Senior Notes Tender Offer and Exercise of Optional Redemption   Radnet Management completed the retirement of its $200 million in Senior Notes on April 24, 2014 and following such retirement the Company completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:   Tender Offer and Exercise of Optional Redemption on March 7, 2014. On March 7, 2014, Radnet Management commenced a tender offer to purchase for cash any and all outstanding senior notes. In connection with the tender offer, Radnet Management also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014 (the Initial Payment Date), Radnet Management made a payment in cash for all senior notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the Consent Payment Deadline). As of the Consent Payment Deadline, Radnet Management had received tenders and consents in respect of $193,464,000 aggregate principal amount of the senior notes, representing 96.73% of the outstanding senior notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of senior notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88 (the Total Consideration), which amount included a consent payment (the Consent Payment) of $30.00 per $1,000 principal amount of senior notes. In addition, all senior notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional senior notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.   Tender Offer and Exercise on Optional Redemption of March 25, 2014. On March 25, 2014, Radnet Management called for redemption all of its remaining outstanding senior notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the Redemption Date). Upon redemption on April 24, 2014, the holders of the senior notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the senior notes being redeemed (or $1,051.88 per $1,000 in principal amount of the senior notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date.  As of that date, Radnet Management completed the satisfaction and discharge of the Indenture in accordance with its terms and no senior notes remained outstanding.  With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.   Capital Lease Investments   During the nine months ended September 30, 2014, we added capital lease debt of approximately $12.6 million relating to radiology equipment.

532017000

524648000

184059000

175188000

55426000 49034000 20493000 16848000

476591000

475614000

163566000

158340000

21945000

20810000

7532000

7033000

498536000

496424000

171098000

165373000

-0.07

0.02

0.10

-0.01

40734083

39886140

44033580

39235863

-0.07

0.02

0.11

-0.01

40734083

39105522

41644606

39235863

-2829000

877000

4451000

-467000

27474000

28949000

4722000

4481000

7358000

5624000

RadNet, Inc. 0000790526 10-Q 2014-09-30 false --12-31 No No Yes Accelerated Filer 42710676 Q3 2014

274000

8412000

362000

268000

155011000

133599000

16692000

13321000

25272000

21012000

197249000

176344000

225597000

218547000

200304000

196395000

48392000

50042000

6682000

8735000

39004000

39914000

3817000

3650000

748519000

722576000

100931000

106316000

1120000

2655000

1948000

1344000

19558000

3103000

2256000

1896000

5708000

3075000

131521000

118389000

19282000

18989000

25100000

555920000

572669000

7573000

2779000

6505000

7540000

745901000

720366000

4000

177141000

173622000

-88000

-50000

-176485000

-173656000

572000

-80000

2046000

2290000

748519000

722576000

0.0001

200000000

42703602

40089196

42703602

40089196

445838000

450030000

153000000

151770000

45193000

44050000

14423000

14762000

-1581000

-357000

-1289000

5000

976000

312000

112000

72000

493588000

494749000

168824000

166599000

38429000

29899000

15235000

8589000

32503000

34542000

10395000

11052000

-1762000

-4722000

-4481000

-2009000

-1617000

0 2108000 0 0

-15927000

-4000

-152000

-6000

-4000

41950000

28105000

8392000

9439000

-3521000

1794000

6843000

-850000

-911000

766000

2334000

-483000

-2610000

1028000

4509000

-367000

-2829000

219000

-2829000

219000

151000

58000

100000

-38000

-104000

-1000

13000

-2648000

924000

4508000

-354000

219000

151000

58000

100000

-2867000

773000

4450000

-454000

-196000

119000

-315000

119000

-148000

-11000

-148000

21945000

20810000

653000 2893000

1708000

1676000

-665000 0

2071000

1651000

-1581000

-357000

-15927000

2108000

2069000

2045000

42887000

25096000

4754000

1504000

72000

-172000

-2461000

575000

604000

175000

-8225000

-5357000

34043000

42510000

9428000

5918000

33895000

39291000

766000

510000

0 3290000 0 2640000

1161000

1803000

-43914000

-40572000

16733000

7476000

210000000

35122000

-211344000 0

6650000

432000

25100000

-29600000

1546000

469000

1771000

-1928000

-38000

-104000

-8138000

-94000

32389000

26614000

16600000 11300000 12600000

2037509

4834294 On September 1, 2014 we completed our acquisition of Hematology Oncology Consultants located in Van Nuys, CA for cash consideration of $553,000. We have made a preliminary fair value determination of the acquired assets and approximately $15,000 of fixed assets, $163,000 of medical supplies inventory, $39,000 of other assets, $100,000 covenant not to compete intangible asset, and $235,000 of goodwill were recorded with respect to this transaction.   On September 1, 2014 we completed our acquisition of Imaging Centers of Pasadena consisting of a single multi-modality imaging center located in Pasadena, CA for cash consideration of $1.8 million. The facility provides MRI, PET/CT, Ultrasound and X-ray services. We have made a preliminary fair value determination of the acquired assets and approximately $1.7 million of fixed assets and $105,000 of a covenant not to compete intangible asset were recorded with respect to this transaction.   On July 3, 2014 we completed our acquisition of certain imaging center equipment from Healthcare Partners for which we agreed to pay $2.1 million. We paid cash of $300,000 and a promissory note in the amount of $1.8 million.   On July 1, 2014 we completed our acquisition of Moreno Valley Imaging consisting of a single multi-modality imaging center located in Moreno Valley, CA for cash consideration of $700,000. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a preliminary fair value determination of the acquired assets and approximately $285,000 of fixed assets, $3,000 of other assets, $50,000 for a non compete covenant and $362,000 of goodwill were recorded with respect to this transaction.   On July 1, 2014 we completed our acquisition of Liberty Pacific Imaging Long Beach consisting of a single multi-modality imaging center located in Signal Hill, CA for cash consideration of $1.9 million and assumed liabilities of $65,000. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a preliminary fair value determination of the acquired assets and assumed liabilities and $577,000 of fixed assets, $100,000 for a covenant not to compete and $1.3 million of goodwill were recorded with respect to this transaction. We also assumed capital lease debt of $65,000.   On July 1, 2014 we completed our acquisition of Medical Imaging of Manhattan consisting of a single modality mammography center located in New York, New York for cash consideration of $2.4 million. We have made a preliminary fair value determination of the acquired assets and approximately $672,000 of fixed assets, $139,000 of other assets, a covenant not to compete of $150,000 and $1.4 million of goodwill were recorded with respect to this transaction.    On April 1, 2014, we acquired the diagnostic imaging practice of Sidney Friedman, M.D. located in Westchester, CA for $1.4 million. We have made a fair value determination of the assets acquired and have allocated $600,000 to Imaging equipment, $470,000 to accounts receivable, a covenant not to compete of $100,000 and $231,000 to goodwill.   On January 2, 2014, we acquired the diagnostic imaging practice of Leslie A. Saint-Louis, MD located in New York, New York for $360,000. Upon acquisition, we relocated the practice to a nearby existing center in New York, New York. We have made a fair value determination of the assets acquired and have allocated $310,000 to goodwill and $50,000 to other intangible assets related to a covenant not to compete contract with Dr. Saint-Louis.

200000

2.62

EX-101.SCH 7 rdnt-20140930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 2. FACILITY ACQUISITIONS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 3. NEW ACCOUNTING STANDARDS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 4. EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 5. INVESTMENT IN JOINT VENTURES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 6. STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 7. FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 4. EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 6. STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 7. FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Revenue breakdown) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Senior Secured Notes) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 4. EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Details-Key financial data) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - 6. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 6. STOCK-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 7. FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 7. FAIR VALUE MEASUREMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 rdnt-20140930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 rdnt-20140930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 rdnt-20140930_lab.xml XBRL LABEL FILE Parent [Member] Legal Entity [Axis] Subsidiary Issuer [Member] Guarantor Subsidiaries [Member] Non-Guarantor Subsidiaries [Member] Eliminations [Member] Outstanding Options and Warrants [Member] Plan Name [Axis] Non-Plan Outstanding Warrants [Member] Warrant [Member] Award Type [Axis] Level 1 FairValueByFairValueHierarchyLeve [Axis] Level 2 Level 3 Total Fair Value Restricted Stock [Member] Additional Paid-In Capital Equity Components [Axis] Accumulated Other Comprehensive Income (Loss) Common Stock Accumulated Deficit Total Radnet Inc Equity Deficit Noncontrolling Interest Retained Earnings / Accumulated Deficit Total RadNet, Inc.&amp;amp;amp;amp;#146;s Equity Deficit Total RadNet, Inc.&amp;amp;amp;amp;amp;amp;amp;#146;s Equity Deficit 2014 First Lien Term Loans [Member] LongtermDebtType [Axis] Second Lien Term Loans [Member] Paid-in Capital Accumulated Other Comprehensive Loss Total Radnet, Inc.'s Stockholders' Deficit Noncontrolling Interests Senior Notes [Member] Debt Instrument [Axis] Leslie A. Saint-Louis Business Acquisition [Axis] Sidney Friedman 2006 Plan NonPlanOutstandingWarrantsMember Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer Is Entity a Voluntary Filer Is Entity's Reporting Status Current Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents Accounts receivable, net Current portion of deferred tax assets Prepaid expenses and other current assets Total current assets PROPERTY AND EQUIPMENT, NET OTHER ASSETS Goodwill Other intangible assets Deferred financing costs, net of current portion Investment in joint ventures Deferred tax assets, net of current portion Deposits and other Total assets LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable, accrued expenses and other Due to affiliates Deferred revenue Current portion of notes payable Current portion of deferred rent Current portion of obligations under capital leases Total current liabilities LONG-TERM LIABILITIES Deferred rent, net of current portion Revolving credit facility Notes payable, net of current portion Obligations under capital lease, net of current portion Other non-current liabilities Total liabilities STOCKHOLDERS' EQUITY Common stock - $.0001 par value, 200,000,000 shares authorized; 42,703,602, and 40,089,196 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively Paid-in-capital Accumulated other comprehensive loss Accumulated deficit Total RadNet, Inc.'s stockholders' equity (deficit) Noncontrolling interests Total stockholders' equity Total liabilities and stockholders' equity Common stock - par value (in Dollars per share) Common stock - shares authorized Common stock - shares issued Common stock - shares outstanding Income Statement [Abstract] NET REVENUE Service fee revenue, net of contractual allowances and discounts Provision for bad debts Net service fee revenue Revenue under capitation arrangements Total net revenue OPERATING EXPENSES Cost of operations, excluding depreciation and amortization Depreciation and amortization Loss on sale and disposal of equipment Severance costs Total operating expenses INCOME FROM OPERATIONS OTHER INCOME AND EXPENSES Interest expense Meaningful use incentive Equity in earnings of joint ventures Gain on sale of imaging centers Loss on early extinguishment of Senior Notes Other expenses Total other expenses INCOME (LOSS) BEFORE INCOME TAXES (Provision for) benefit from income taxes NET INCOME (LOSS) Net income attributable to noncontrolling interests NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS WEIGHTED AVERAGE SHARES OUTSTANDING Basic Diluted Statement of Comprehensive Income [Abstract] NET INCOME (LOSS) Foreign currency translation adjustments COMPREHENSIVE INCOME (LOSS) Less comprehensive income attributable to non-controlling interests COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS Statement [Table] Statement [Line Items] Beginning balance, shares Beginning balance, value Issuance of common stock upon exercise of options/warrants, shares issued Issuance of common stock upon exercise of options/warrants, value Stock-based compensation Issuance of restricted stock, shares Issuance of restricted stock, value Purchase of non-controlling interests Dividends paid to noncontrolling interest Change in cumulative foreign currency translation adjustment Net (loss) income Ending balance, shares Ending balance, value Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Adjustments to reconcile net (loss) income to net cash provided by operating activities: Provision for bad debts Equity in earnings of joint ventures Distributions from joint ventures Deferred rent amortization Amortization of deferred financing costs Write off of deferred loan costs due to refinance Amortization of bond and term loan discounts Loss on sale and disposal of equipment Loss on early extinguishment of Senior Notes Gain on Sale of Imaging Centers Stock-based compensation Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions: Accounts receivable Other current assets Other assets Deferred taxes Deferred revenue Accounts payable, accrued expenses and other Net cash provided by operating activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of imaging facilities Purchase of noncontrolling interests Purchase of property and equipment Proceeds from sale of equipment Proceeds from sale of imaging facilities Proceeds from sale of joint venture interests Equity contributions in existing joint ventures Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Principal payments on notes and leases payable Proceeds from borrowings Payments on Senior Notes Deferred financing costs Net proceeds (payments) on revolving credit facility Distributions to noncontrolling interests Proceeds from issuance of common stock upon exercise of options/warrants Net cash provided by (used in) financing activities EFFECT OF EXCHANGE RATE CHANGES ON CASH NET DECREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, beginning of period CASH AND CASH EQUIVALENTS, end of period SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid during the period for interest EX-101.PRE 11 rdnt-20140930_pre.xml XBRL PRESENTATION FILE EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0#!^N8GSP$``)84```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%U/PC`4AN]-_`]+;\W6 MM2BB87#AQZ62B#^@K@>VL+5-6Q#^O=WXB"&((9)X;EC8VO,^Z\63[.T/EW45 M+<"Z4JN,L"0E$:A*"DJK2`C*W!D.+B\Z(]7!EP4=BN7 MD<)[3+2MA0]_[90:D<_$%"A/TR[-M?*@?.R;&630?X2) MF%<^>EJ&VVL2"Y4CT<-Z89.5$6%,5>;"!U*Z4'(O)=XD)&%GN\85I7%7`8/0 M@PG-DY\#-OM>P]'84D(T$M:_B#I@T&5%/[6=?6@]2XX/.4"I)Y,R!ZGS>1U. M(''&@I"N`/!UE;37I!:EVG(?R6\7.]I>V)E!FO=K!Y_(P9%P=)!P7"/AN$'" MT47"<8N$HX>$XPX)!TNQ@&`Q*L.B5(;%J0R+5!D6JS(L6F58O,JPB)5A,2O' M8E:.Q:PYT7-"V?!'D@F[:MXN`+``#__P,`4$L# M!!0`!@`(````(0"U53`C]0```$P"```+``@"7W)E;',O+G)E;',@H@0"**`` M`@`````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````C)+/3L,P#,;O2+Q#Y/OJ;D@(H:6[3$B[(50> MP"3N'[6-HR1`]_:$`X)*8]O1]N?//UO>[N9I5!\<8B].P[HH0;$S8GO7:GBM MGU8/H&(B9VD4QQJ.'&%7W=YL7WBDE)MBU_NHLHN+&KJ4_"-B-!U/%`OQ['*E MD3!1RF%HT9,9J&74"T\U<%J"`=[!ZH^^CSYLK$SO+=N5#9@NIS]NHFD++28,5\YS3$$X4UD^&'!Q0]47P```/__`P!02P,$%``& M``@````A`)7F>IS2`0``;Q,``!H`"`%X;"]?[[-TZOVF;0M%HK#+;E&VU:=:%>GUYO)JIS`?35&;7-K90 M!^O5_>+RXN[)[DR('_EZT_DL9FE\H>H0NENM?5G;O?&CMK--?+-JW=Z$N'1K MW9ER:]96\W@\U>YG#K4XRYDMJT*Y946YREX.7=SZ_^3M:K4I[4-;ONUM$W[9 M0W^T;NMK:T-,:MS:AD*ED-?'-Y2/(F:E_X`3^9"%,T-P>"H,AZ<(CG2M8*F8 MI+DAR,UD2#B^-LY6S\'%0?4Q\:F9S\((SURF1%O(+Z)A]4RG&I MCT_(B;0)0`\@:30$X?"@EI2:HR]2"GWW"SYX2M\1&-X12-H4")H"29L"05/( MI:4OAV,NK7Q0^*0K!0M%TM00Y(8'-84D,$!SX$&4I>\L#.\LN;3FY%!SI`4Y MZ;$^^TVV^`(``/__`P!02P,$%``&``@````A`/2O2-4O`P``>`H```\```!X M;"]W;W)K8F]O:RYX;6R45EUSHC`4?=^9_0\,[UL@4/LQU0Y5NIM=Q:Z@G7W* M4(DU4P0'XMK^^[W@BA>HC#Z12\SAW'-.8N[NWU>1\I>GF4CBKFI@I$L M%F+.!\E\L^*QW(&D/`HDT,^68IVIO;N%B/ALUY$2K-=NL`+>[Y&J1$$FG5!( M'G;52RB3+:^\2#?KAXV(8/;&U$U5ZY5-/J5*R!?!)I(^M+='![V(14@G_V4N MQ4SP;798E)?*^[.(PV2;_Q2D_2@K$PALBZEG$*>^2,#"7'4*G1FJDMX*&*0T-'+B&*4_ M=@>.ZSD#!B-O/*0#VX?BP1[:;M]!*"9!,.0\&&!0LC$13"'X"6P\'TB-,!L+ MH5@GDOF/@LF`^J4TE^?!@!R'GG!3139.;PJ6ECA7B,Y5G8[!7-N?3APV?F0/ M4X^ZCN8:E_?'4]:G[G8&L[L">#"H0'=2)H=^S)F3#OASW!YII8!Z,1 MV4M&W9GC^2/']6'(?HXI#&90@3H5%G"0E?8:CH)]8.=B M8"UN,$0CKU<@)IVPF3V<.FSDV!XPR&EA%A8<`@<6C;"VVXK#:E4VRD8CKY^YP_S@)8+_@4-6+1.WU4AKNTF5MG!C[I44,*$<&R-1FZ/ M6M7`P=F%$[QV8+;+#**4NYE@OZ`X"PA$*8$LO!]((\?MC$"5$HA@SZ"H,?K4 M^`&7@8BP\P0;!D4-I=UYG$."'8/B+*"*TA7+&H%N9X25)A6E&Z$^GL5<)2PT M/GG(&9G.59L.1'6M@Q)V>S^?8QKV;15?5AY;.%[L_*PKC?5X67E_?W7YWGLS=JN.&R*77TH5][WLO4^ M/?WXP^-[W7QI7\NRFX&'0[OR7KON^+!'SCAIREW1P?S;U^K8 MGKSMUU/<[8OFR]MQOJ[W1W#Q7.VJ[GOOU)OMUP^_OASJIGC>`>]O3!3KD^_^ MP\C]OEHW=5MONP6X6YJ)CCDGRV0)GIX>-Q4PT,L^:\KMRON)/>1!X"V?'OL% M^J*[K+QKZZT9_!8.7H]&?^PC\TR[;[G.E77JS]5O;U?M_#8A95\8)MTY@A'7" M^(+'DLGPMI>EF5%/4!5=\?38U.\SR!IX9GLL=`ZR!_!\8F;F<>9ZB2IPU$Y^ MTEYZ7\"BA?A\?8JBQ^576-*UA:0&$GFS`9)@2':"Z`74;M7IBV$,PT/R$T)' M#QB=:<%B45H!A/WC@)U8Z$&$18R?EXXA'".R,2+V,42-(<1)/D8X3A#1`!.] M3E"#(?><&,1D05,#$0Y$XMEG-Q'J)B*_AD#T8"+WQU$/6GFPAN=4B\D"IP82 M]ZG*(N8G)-`9`H0RB`*\#,H%B"2608@!.0:$@HLS`%&$7>=2O!Y!#2;4R,12 M`PE[:O-(!H1ZANU^0,8K9.]"!"D2QM M:B"&(O=%0F*3N786QH)DK7+M4@I.5BAW[2+Q@POTM&YQFL+UE-1@0HL\-C40 M&[E8^))6?@2()(LI,1<`*>TSTEYR!.`B=)8&12ZYAYH&DWI)GIL:".SU@Q:')NZ*9E9C^*Q)!$(+48&T09^#[971E!L"@B"(400L`6 M)4_),4+Z?C#XP$1UYY^[ZTUD9C8!8D7*=LI..T(J3,1*/#)DC8E7(FD2D9N7(#$+]X^;-=)>?SLEH M`L1I<&PC93`V4F$<.[JA1V3],U?>"0%MC$13(01T$4GK:4X0(A*##QPTW>VG M$S3:`!$DVRC5+TY05>WT)0](MF4($$N:JPK9@UCP8>K]`N4(P)/861_,3;?[ MZ=R,.("4.Y?Z9.B?-G@&V??3LCH`D1H*+XV)0W&3@L.CLANR1@"L)!**X4!(N)# M,.Q^0QZ$).+FN*WLT%B7T+2VUF(^C=!\RK<`S)]I@I);3B*F(Q7 MR)RP$4%W]#QRCBHPP;L4"#?2P2WWS">[);4@$SLA1^7>VFWL@I"4!X7&SWGH MG.[8O#2SL`7&YY=J(]$=$V,WUA]NXMO8&9"A((?GV\"YUE$=4MPUP_$6SHL< MF9D[ICA"9R-`H`9RA),-2;D!)_Z[I+^C>R9!][B]HZ548$"W@*,+] MB?(Y*6@Y&@$>!SLBK<_P[B?=CZ+MCV1E:D%GTCCM,F3^B#,&3.&,1ESA_+\T M3&`DB/LR!(?HF%1J0=?>AFY#U&U(?A6"(WR7L`D^$#:T'J869`LN"X4(Z:;. M$`:T`KR1A[2C((SP(SB^IETG1Y@@@=(H'36.F=XE>>#V="3AZ,9,+<@R%7!U M()UK*5.>$.824_,PZ^<"4Q<3)'$,9_'#ZYAA:NYKS77FOFQ>RJS<[=K9NG[3 M=[$#7!]>RQ>RM^+YJ4ZM+-=N067_B*" M(M^8"V#SH:N/_97A<]W!Q6W_[RMDO`+RMZ^[T05]2GJ_^G_X#``#_ M_P,`4$L#!!0`!@`(````(0`+DYNYK`(````'```9````>&PO=V]R:W-H965T MU:FDE?0NN)/+Q6-]04=:`./""ZY<&BE%)HX>L$I(<"O#][$\(;=G- M8(0O.95"B50[@'-MHF//2W?I`FFS2C@X,&5'DJ5K?.='^PEV-ZNF/C\X.ZF+ M9Z1R?*)5PR*#6TR#3@(\6BD#XF9@F!W%'W?-."+1`E+R;'07\7I(^-9 MKJ';4S!D?$7)2\P4A8("Q@FFAD1%`0G`+RJYV1E0$/+<_)]XHO,U#F?.=.Z% M/LC1@2E]SPT2(WI46I0_K<@_HRPD.$,@X@SQ`R=83/WI[#K%M1DU!F.BR68E MQ0G!IH%WJIJ8+>A'0&Z=V3PZKW^S"AX-Y,Y0&A:X4-">I\TDF*W<)Z@I/6NV M5C/'J-/,EWW)KI68"AINW$[\CO'[(?M68=H'ECI?4*VAKQ#Z_N>.M39,4-]& MZ/7?MQU+@KYB-U8L!I!X+!E`]F/%!:1G-/P?HR8(-N%%+T)_D.36:B87FNG` MZ55%?%6Q?TW1\PF)_'M#3=`:0S&[/3<)YGT76ZM9-+LV"+U!&7:O+\>7R[/E M,!HN)9.`A<^]BV7KS=XX]D"63&9LQXI"(2J.YC8)(*=NUEYT6S^"4P*;?3`? MPP78S+O=`EQ`-9P).8A4PPD[3_OL=>P@!9Z^EJI2&S,N;9V9L M,]E\>:TKZX5V@O$FL!?9EI!Y4^85;VABOU%A?]G^ M^&=_FN@KQ?29`7%V]]<6-?LZ+C@N_E`NP?OU)V.$IH]Q(R4HFMR[<' M*@JH*-@L/(U1\`H`X-6JF5H:4)'\5?\_LU(>$]L/%\N5ZQ.06SLJY"-3EK95 MG(3D]7\H(@IJ,/%Z$Q_H^[BW\*(E688?NSA(I!-\R&6^W73\;,&J@>\4;:[6 M(%F#\R4SY!AR_;]4`4^9W"L7[059".C/RS8@\<9Y@9H6O29%SGWI;<2;ZK(;A71U63""+4;,[[/IL2P M!D:E"+RKKRYIBII@I%D:<.\I)FQ@,I]-B1,;$A_:%'A&HU+41+K1)""1$<\P M#J^#QY5]0@:K?SZ9$IMD1L-2U(2X!"/?#8V:87P&6?@9,B4VR?SI-Z>H0;([ MV+)&/,/X##+80?-KIL0F66"0H:8G"^/`B&<8GT&F'G>CL^3]/:#$)MEUE>`> M0$W?S3@V]TB&\1ED\91,G7(?GR#JIBFA?W.$H`8)/1_^IK7-,#Z#D,"!-B[> M/$1]E\EH[,:T%R&D'RU7!F,?GP/YFZ=%`%OJ_4X3/-?'1XIO%BKM18'>N0!I M,J+''$9U9H]6X_-/*&1LAU9:)C<^U.'*-C:1&3)7@)3Z:<)`,YT< MZNEFQR4,C/KM$7X@4)C&W`6(]YS+RX6:IX:?'-M?````__\#`%!+`P04``8` M"````"$`(WTZ!OX"``!2"```&0```'AL+W=O?UZ^><8XX[OWUI&^^9"LEXMT#8#Y%'NX*7K-LNT,\?#SJ42W2X_?ICON7B2-:7*`X=.+E"M5#\+`EG4M"72YSWM(%)QT1(% MCV(;R%Y04II%;1-$89@&+6$=L@XS\1X/7E6LH/>\V+6T4]9$T(8HX)8]<2\;3K;PK>]F"Q80U3K\84>6TQ>]QV7)!-`WF_X(041V_S<&'?LD)P MR2OE@UU@02]SG@;3`)R6\Y)!!KKLGJ#5`MWAV3I'P7)NZO.+T;T\^^[)FN\_ M"59^81V%8D.;=`,VG#]IZ6.I?X+%P<7J!].`;$K:45VC?K.]Y\IV]8*NCV! MA'1>L_+UGLH""@HV?C313@5O```^O9;IDP$%(2_F[YZ5JEZ@./4G61ACD'L; M*M4#TY;(*W92\?:W%>&#E36)#B8QT!_BD1_E$SQ)WW8)+)%)$XHLIP+OO?@ MT,">LB?Z".(9.!\SLQQ#KO]*%7+4)G?:Q7A!%A+:\[Q,<#H/GJ&FQ4&SLIH, M>8,&NXKU4:%;`7@#(V0^9HRAAW^O_A%)+W*1XM#=;W4IB5S%^E*1GTP<1JC= M_S/J17`6SDH2XY._*>W*:I(SS60$>4WA,(+).>/U^FGQ`D$!AG8E.'-W7EE- M;AH>Y=-DZL;7-@Z?@\>)W2&#M^"<3)_"MSNL%[F$.!TU<&4UJ2'$.!V?.!M^ M!V#J`EXOG1:[8/'%VV`U%BS)HA'WV@DG^8G;*1N\3.=ENTZEQ6.J<4.MQE+= M9/$D'S74B@VM M8&GH9W"*A+T4[(/BO9D\&ZY@F)NO-=S=%"9EZ(.XXEP='_2L&_X;6/X!``#_ M_P,`4$L#!!0`!@`(````(0`IY>!=,P0``%@/```9````>&PO=V]R:W-H965T M:=T#?94P2;!I(>]$6_*T?_U[+I]6W]ZK4WDC#"EJO=6P@72-U1O.B M/JSU?_Y^602ZQMJTSM.2UF2M?Q"F?]O\^LOJ0IM7=B2DU4"A9FO]V+:GI6FR M[$BJE!GT1&IHV=.F2EMX;`XF.S4DS;N@JC0MA#RS2HM:%PK+YAD-NM\7&8EI M=JY(W0J1AI1I"_UGQ^+$KFI5]HQ_;T4>7M#:CK#VI>"2NI:=64NK_P2$>RDA8O4B$-&+ M8,NP`A>[WKR**7K4&8S3-MVL&GK1H&K@F^R4\AK$2U"^.A/]N'E]9!4\B03CZ]J-\4,9V5X1/H)<-[Z^N,=@.22Y$CQ] M8.GF"T9+]65#WC_/V-4&#Y)M^('\O6B,6#*Q'1,!DI%XC"@BR9@8B$A&;=GH MM$$.0_$-2!ZUU&,1;K5FA6H^" M"42U.JY26-MA\\+Q?'D,8JG9"BQE%)-A>^#?HR5O,.%4;PZ\F\XA#U)R&-[U MNWD3"0;Z)9(J0?'ICG_.3D0>I.51GHV"\?L7Q',=#GIRH[1"Q M0\MV`\^6D7B(.,BW'10H2#)$[!`CU[7N4U;R"@O)9(J0?(9CG_,ES(/4M*HE+)C)$AXB#TIXB#PHX2$R7<(8-DHU MJ?-FNRC9K8V4>13UD+"+$<(X5#;';8\,,^]@9?F*GX$2Z6,VQ@Z^SRDIN9B? M(I0J?L*P.'L,=QD;*1V-.NFUWANV82L(E(UHVR,SAL7')J%$^ICCA3A\9)B? M+Q3#\],6BU.);%A9;Z,>Z@O:03:LN*,4"R'!/*AH6>?S55EB[#`(/.SN:7%`NVD-M;<8&*\!(.WW"&5M['_&+578UN#7"O.:4'\D?:'(J: M:279@R0R?#@,-.)F)!Y:>NJ.TCO:PHVF^_<(-U@"QWID`+RGM+T^\,/[[4Z\ M^1\``/__`P!02P,$%``&``@````A`/V\.XQH!```?Q$``!D```!X;"]W;W)K M&ULE%A=KZ)($'W?9/\#X?T*S9=HU,GPM3O);++9 M[,P^([9*+M`&N-=[__U64Z!TH\"\J%"G#WU.53==;KY\Y)GR3LLJ9<56)0M= M56B1L$-:G+;JCW^C%U=5JCHN#G'&"KI5/VFE?MG]_MOFRLK7ZDQIK0!#46W5 M:Q]6"76@!D2,K\[B&R_*D59>2QH=F4)YIAJX[6AZGA8H,ZW(. M!SL>TX0&+'G+:5$C24FSN(;Y5^?T4G5L>3*'+H_+U[?+2\+R"U#LTRRM/QM2 M5MRJ7\DZ(I:J[3:-03]3>JUZOY7JS*Y_E.GA>UI0`HT"P,FS,E M+(,)P*>2I[PTP)'XH_F^IH?ZO%5-9V$O=9,`7-G3JHY23JDJR5M5L_P_!)&6 M"DF,EL2!V;=Q8V&X-K&=:18-9]0(#.(ZWFU*=E6@:N"9U27F-4C6P-PIPWG< MM#Z3"AHYR5?.TG"!B@KR\[ZS=&NCO8.G28OQ$+-4E1MFN1(A?@?A#G+>H+MQ M'T/$(6&'Z(9$>*.Q3@.--Z%@GRS4A$)XG,).%Q\DZC)U<0+>$&*("'^(<"62 M8`B12,(A0B:)AA#S[I;@A3GTPGI:SIT7?!`4;B]_Q#5%J1YBK![&%A'^)"*8 M1(23B&@,(3@!4^U7Q7@U^)KG8%F[]-KR$(/:77V07Q_CCV>&[[D)AG"2(>HS.'9_7Q!6 M_>I7M'.PI)U(^XV'F+;V!TGQ,3PF?9P@G"2(^@2$]`M'4$[@93\_[0U:U&X8 M\H[7@D;4^=.0H(6@A02V#W%EA=,4T2A$=($?CV87/\'#5/^-9ZX&YSH$X?SM MI6%8TM[@MS0C/@4MY#E).$T2C4)$&_A9:;X->++JVV"1^]&J6<(>01`J>"&& M(QOEMXA1&Z9(PFF2:!0BVL#/2?-MP%.5:(-T3O4(@M`&PR9R.?LM8-2%"8YP MFB.Z07@S`I$DI)-C&RQIPDKO=Q3[;(VOHT:#5DNX'9`V-&-S7 M;@%H?R_QB?X5EZ>TJ)2,'H%27RSAE%9B`XT7-;LT#=:>U=#X-C_/\$<'A>Y/ M7P#XR%C=7?`'W/XZV?T/``#__P,`4$L#!!0`!@`(````(0!9)]V"-`,``*0) M```9````>&PO=V]R:W-H965T7;`!*N`D>TT[=_OV$Y((,VE>4A".'/.S!PSD_GM M:U,[+U1(QML,8=='#FUS7K!VE:$_OQ]OILB1BK0%J7E+,_1&);I=?/XTWW#Q M+"M*E0,,K%.R45#%%R*E2<[04EA@IK:"WQ_XC6$ MM<@RS,0U'+PL64X?>+YN:*LLB:`U49"_K%@G=VQ-?@U=0\3SNKO)>=,!Q9+5 M3+T94N0T^>QIU7)!EC74_8HCDN^XS<41?<-RP24OE0MTGDWTN.;42SU@6LP+ M!A7HMCN"EAFZP[-['")O,3<-^LOH1AY\=V3%-U\%*[ZSED*WP2?MP)+S9PU] M*O1/$.P=13\:!WX*IZ`E6=?J%]]\HVQ5*;`[AHIT8;/B[8'*'#H*-&X0:Z:< MUY``O#L-TT<#.D)>S>>&%:K*4#AQX\0/,<"=)97JD6E*Y.1KJ7CSSX+PELJ2 M!%L2^-R2X,`-IC&.)Y=9/)N1*?"!*+*8"[YQX-2`INR(/H-X!LRZLNAD95"2 MCKG30284T!+L>%E$/IY[+]#"?(NYMY@$.3TFZ!$>B/<9@.HX@Q`<>K^WNPQT MT#"#T._I39+W%I(88P_UPJ'>>1T-SA!0[:L(XY&0Q4Q-'^)IE$8G"HT^(JS! M8^')2-AB)D88!Y,TZN\/&@QV'C;X?,$:/-9->E[;68NQNG$2!-&T!PR$)T-A M?;8N.ZN#A@E$_KZA-@&+@?)[5_:>##*`XW=]Z1H\5`Z.O+886WKDG_9:3_Z# MQ^I\SS5X+#SVVF*L\$V:!ON6#`I./Z*KP6/=L=<68W7#-/:#_6,V$,;PR!Y6 M?)W9)FJ80N2'_6FR;F]!5]B-1]/L?-L->BA^;/@69!N`ISZ\^O2C-L0O: M=CH-!\O8\O2+\WT\:V&\H,V:&&03D8/^-V6=I=TE"Q MHE]H74LGYVN]"#$,I?Y7NZ3O84D'9AKW-V!'=F1%?Q"Q8JUT:EI"J.\F,&"$ MW;+V0O'.#/LE5[`=S=<*_@U1V$6^"^"2<[6[T'N\_W^U^`\``/__`P!02P,$ M%``&``@````A`(#3&ULG%A=;^(X%'T?:?]#E/P00,!HJJJ[(\U(H]5^/(=@("J)49*6 M]M_/M:_!L5-HTGF8EIGC>WSNQ['QXNMK>?!>>-T4HEKZ)(A\CU>YV!35;NG_ M^\_CW=3WFC:K-ME!5'SIO_'&_[KZX\OB).JG9L]YZT&$JEGZ^[8]SL.PR?>\ MS)I`''D%_[,5=9FU\+'>A5 MJ+/U`72_$I;EY]CJ0R]\6>2U:,2V#2!:O3C]61>;'T7%(=M0)UF!M1!/$OI](_\)%H>] MU8^J`K]J;\.WV?.A_5N<_N+%;M]"N1-0)(7--V\/O,DAHQ`FB!,9*1<'V`#\ M[96%;`W(2/:J?IZ*3;M?^G02)&E$"<"]-6_:QT*&]+W\N6E%^3^"B`Z%06(= M!'[J('$\-$B(&U+Z'K(V6RUJD>,:R#22X(*P4`Z:;@MG0)AO[I1&4TNL1%9L0, M8(92#V>68$WF-,QS!+L M,!.WT1##E.0K:N4YT)FRVP668(>3FM9%M8BYR3D;PRG!;E/12^60$S$#FHK` M^`Z7J]"N7N9P:]`,^RJ8F'Q8747>L;./S42M=)KU^0T.[.>)DE)F,F5KJ"4>#0_*81%!MTQ&6 M\GB4P2FT2VYRBN0:I,DCFEXG_Y3'Q7@?ZUX;:-+;!((&3%L\RN84VLD`-;G5 M&4";0X.E`3$#8>?><;K;!AM+M,W<'S4-ZLIF5^FE:PWVN%BB77IWY#3H?+)0 M,Q2V\%$&)[]7])A-9)UR!"%S$LQ,/]C,H]PM1N.RSK3>K&G0N=B).71LYE$& M%Z-WV,]#FX3*9N:@;25C_(X>/AP1YTQUV0T",DG M*9FE/7)\_<#7@6.VXS^S>E=4C7?@6VC^*$C!+6I\^\`/K3BJ[^!KT<*;A?IU M#V]4')X(H@#`6R':\P?YNG)Y]5K]!@``__\#`%!+`P04``8`"````"$`IYPK MV>\#``!G#@``&0```'AL+W=O>'7`2U("1[72Z_W[+%*'!I!/RDH1P M?'Q\JEQEK[^^E87URH3,>;6QR*X;.27-*QL95F(*!]_O\Y0]\?14LDHAB6`%5:!?'O-:7MC*=`I= M2<7+J?Z2\K(&BEU>Y.J](;6M,EU]/U1I>/D+0:2E0A*O)8'OEL0C#Y/X+0E\MR3$FWF+D(31?2D.+JMQ MZ8DJNET+?K8@]4"XK*E.9+("YHL]N)C.L,_\`J,TR3?-TG"!%1*"_+H-@OG: M>87`I"TF1LSM!0TGPQG"\>0[PA M(ADC%FX'&6@$[Q[7J`=M;)BDLR0(3)&(632FADOW8_K&^:3_VO-[KP?J@K&Z MX---<'%0#S+5+;O5-]/'B(D:=3ZH,^7A>_CL5AAV#`.%H.9Q__0@0V%H*(@1 MTU<0A&;BC3&?J(R&*F]GH`:;ZHP$BQ'35_F;DM3H--<8$A#C$HSB.N%[I&:B:(F*!M M^8@V#3:U&2&+$=-J<_WY6!LB)F@C4.?ZQNGZ?+_V-:-,E9'A8`M"F<'"#[RE M87+20J;H-/K([0`3K/2#PA>.^@6"6AN]9>0%YKYM>:;HTY6\EX`3?<3Z/]1I M%FB"(-3I+Z)E$!D)D;20*3J-/G+'QRL-)#3V04P0='URK#$W(8-]3(#&]/%^ M)VE&&?D8C'1JZHV-G4[7FV&^)BW)]74,11K-Y(Z)U[K(2-RM%M&:>`LRU&>T MD8G)>*V?&";%9-PN@L@`)5=`'QD[5/I04X%S_*@X1L:>C5L0;A?B$C)??$S> M.GF_K>!Y'T^R)1,'EK"BD%;*3_HL3^`\TOV+]XQ8WS.:FT+W`H[Y-3VP'U0< M\DI:!=O#4'\[5Y4$?7;LK MXO9_````__\#`%!+`P04``8`"````"$`@^VP\0<$```J$```&0```'AL+W=O M7(G>>62TR7NY< M,O-=AY4)3[/RO'/__>?Q\\IUA*1E2G->LIW[RH3[9?_'I^V-UT_BPIATP$(I M=NY%RFKC>2*YL(**&:]8"2LG7A=4PF5]]D15,YKJ347N!;Z_\`J:E2Y:V-3W MV."G4Y:P!YY<"U9*-%*SG$K0+RY9)=ZL%UM_;`TGZ;9N"! M"KM3L]/._4HV<4!<;[_5`?HO8S?1^>Z("[_]66?ICZQD$&W(D\K`D?,GA7Y/ MU2W8[`UV/^H,_%4[*3O1:R[_YK=O+#M?)*1[#AXIQS;IZP,3"404S,R"N;*4 M\!P$P*=39*HT("+T1?^_9:F\[-QP,9LO_9``[AR9D(^9,NDZR55(7OR/D/:H M-1(T1D)0WZP'LV`U)_/%QU8\5*0=?*"2[K*!->G MBU2;3)&AWYK7?AP06>J,*'05#%#N>A\N>[P=DH@XS-[7% M-L+0!D;NUZ;@G0MNMEF)%J'YRP=D5IA7/UI'/?%Q%PBC-11Q:\%0!K5]OS(% M]Y5%K5W,%S(+K8RL?/@S@;@+0(_L`H:RQ11E"C:5A:M^S)"!P+1Q_1T3K3VV M$88V>&3NCYJ"/ZHU9&S:;(2A31UHG6YA?PX4;,9M6&O(8$8C/XC([PZ`8>L" MXY\OR;LY::F?KV1MX:OCM.!IO%%4Q/$K#SM9`5GUH9QPQ]4TZ%,CP5!AVMP:RM#>#L/4W,NE8T+29W6@QJ#AL M^Y86UYAI"%N/FW0PD.')$*YZ+QF'!AI/7%-[:&<<,7,[Z7@@V-KAF6M/\^$; M7`.-_WBC#^V,(X:^8-(9H>E^=OMO)`TTWN/>630U33H7`NSG]A[70/AJV>]Q M[RRB)AS-<'(I6'UF,Q='P@/9P.L]C&*]^[$:%?6PUR[` MI%;1,_M)ZW-6"B=G)S#ISY;0.6J<]?!"\DK/$T]^&'IY]_ M>GAKNR_]MJZ'`"(<^L=P.PS'^^6R7VWK?=4OVF-]@)5-V^VK`3YV+\O^V-75 M>KQHOUO**$J6^ZHYA!CAOIL3H]ULFE7]J5V][NO#@$&Z>E<-P+_?-L?^%&V_ MFA-N7W5?7H]WJW9_A!#/S:X9OH]!PV"_NO_MY=!VU?,.]OU-Q-7J%'O\,`F_ M;U9=V[>;80'AEDATNN=\F2\ATM/#NH$=F+0'7;UY##^*^S(6X?+I84S0OTW] MUGM_!_VV??NE:]:_-X<:L@UU,A5X;MLO!OK;VGP%%R\G5W\>*_!G%ZSK3?6Z M&_YJWWZMFY?M`.76L".SL?OU]T]UOX*,0IB%U";2JMT!`?@WV#>F-2`CU;?Q M_[=F/6P?0Y4L=!HI`?#@N>Z'SXT)&0:KUWYH]_\A:-S1.8BT012PM^MR(3,M M=/)^E"4R&C?XJ1JJIX>N?0N@:^">_;$R/2CN(;+9F8+\_'AGL"5SS4=ST7@I MH'LHQ]AB'**4.(,60*],T?8^>T%X0`),8G<#TY!@Q)]':N)+LQ0F(/HBFBO(8@U"#(?&H&_!C" M+L]%48K>N$!(AD5-8[I:^JM9+-R^""?HZ?F<#)AQ8GA!5/BYVO>#)J+&+V$ M5JM`"-*36J:<'ED7T:5R&A?S).)Z]QLPHY4R6@BQ6TF4+() M.3=EXZT+BT%R<:8F8TH`.HIB-RB4FE%EC]J\016HY82BNX&EB!BDF"096R]M M#%S/4G4I=T:?/8+O%!;5G!#C=B`08PN;QA-'H(`L]X:9YHZ9PLS<3=W!$P.; M.U_]50[EHV-=FBIB4'+,'F86%C4>VOZL9YZ8 MVNPAYJKF78-0FLPL9M*8VV9*2)1XD(NY4V^,:*II7G3 MASFT&.PP(:3K,*1&UF6B70>3[,F;'&-$4V)>:UMBZ"J66,ZS6MH8=OWB(X`T M^C];\48T(\;=PF).Q+1F]2X)0(G(229-&3.+ZT,KIR:AF0D4%H/,8")=$]E: M^B8BLMRM4V+,).9-@IR:A78[MS7US0)>;R>9\]=5E%YJ-F85[V1N:A':";PE MYCN`4$)[3^(V=P0A,I4Y0:39N\DD)!J`+W/>B%ERB('(J>H21"KAU?',G)`S/\7X\C9O5L>KF,RY M&V#760SF+M4IF^62K,LT===3@C<9@YJ^2B2N+):8;PSP2,1GP<8X$?=>12BQ MFXQ!&33-6,*-P6+LC6.=1PQ14H2,5')!@M5-WC"BZ?MAPKW!8JZ)R%4(S9W1 M:<]43=?E[_XHJ%#=_8E-6%<5%H,#R52ZO+!(J=WD#6KJ#0F[:V$Q6%:1IB*> ME)5X0ZH2Z;)/R3%OF#FM*.XD;ZSI"W4R`/-;ZUW&C94N>\]:E-Y-WJ"FWN"U MLYU5Q&#N[D2:P)O$6LP?9F9OZA,)]PF%&.PZ/?D9C"S? M94Z0*+V;?$)-?2)A52LL!E,C(_Z25M)UF5\@%C./N&Y@(YHIG=-V+*O%6&*) M8,1+NB[%)6+,&^85%,YQN!2G[@:6(&+P5^H?OK[:*!;QH]=7/.S!LY!]W;W4 M9;W;]<&J?34'.1(>&<[?XB%3(>X+:ZC^J[J4Y M],&NWD#(:)&"D'1X>H0?AO8X'E$\MP.<^HQ_;N&4KX:SB&@!X$W;#J&PO M=V]R:W-H965T&ULE)5=;]HP%(;O)^T_6+YOG`1(`1&J0M>M MTB9-TSZNC>,0JW$:C_W['-I0F=*SE`F+\GM?/.<=V9C=[6:,MUT:H)L=) M%&/$&Z8*T:QS_.OG_=48(V-I4]!:-3S'3]S@F_G'#[.=TH^FXMPB<&A,CBMK MVRDAAE5<4A.IEC.FO6)*MF"Q$K6P3]X4(\FF#^M&:;JJ M(>]],J3LZ.T'9_92,*V,*FT$=B2`GN<\(1,"3O-9(2`#5W:D>9GCVV2ZS#"9 MSWQ]?@N^,R^>D:G4[K,6Q5?1<"@VM,DU8*74HY,^%.XO""9GT?>^`=\U*GA) M-[7]H79?N%A7%KH]@H1<7M/BZ8X;!@4%FR@=.2>F:@"`;R2%VQE0$+KWOSM1 MV"K'@RP:7<>#!.1HQ8V]%\X2([8Q5LD_090C`9`/UA/HW2\2@99?]W M(8'()WA'+9W/M-HAV#2PIFFIVX+)%)Q=9@.HS^N904HNYM8%^5!0&^C&=GZ= MS,@6*L@.DL6Y).TJEN>*PYMT[<@^JMN@B2 MS$/!110^/;++F@X>'(&WXSEQ#Z_7M$60!+QA"J))/L.8$. M7/8>."?NP9UL_=%9!,E%N([D=;AP4X6#W-(U_T;U6C0&U;R$O11'UY"@#O=4 M&%C5^@.[4A;N%_]8P>N$PVF.(Q"72MGCP-V$SR^H^5\```#__P,`4$L#!!0` M!@`(````(0`=1KI+04\``%7\```4````>&PO_^VIS?>.KK)@,RN%HRD^MU75[/9S6^>/*D&5\5U7JV7-\6$;R[*Z74^ MX]?IY9/J9EKDP^JJ*&;7XR=;&QO/GUSGH\E7V:"<3V:,N_V"@>>3T;_/BUW_ MZ.GSYU^]_K8:O?YV]GJO',ROB\DL8Q[9_F0VFMUF!Q,?@'E_^V3V^MLG:NK- M7V7OR\GLJJ+IL!BVOSTM;M:S[8W5;&MC\VG[R\/RXWJV\6S9EY/C<3XYFL^, M(I#HQWPZS2>SZGUQ?5Y,VYU]T_X@3/VDN!Q5,SV8'>;71;O5-R?Y\+"8K;+$ MP7K[R]#%+M28YF.:#(O/V;\5M^UVWVSPWXM7&\^VGK>_JJEY=GO3'7QS8^WW M2Y\X+J:C4ELPS/;R6>?A'39I:!OU=IQ?MGOYYB(?5YUG=N?3*8O)WHZJ`0OZ MJ[/=\X&VVK@BSWXLQN.UGR?EITEV6N053#O,#JIJWK,] MA^5='?U0CN>363Z]96KC[M/UF-]4V4EQ4TYG\$-V.LMG\RH+BVIW_\U/1=7^ M+$SIE.>WNYLY@4#`)OA[V3R=TLUM>7Y>L?%8.?E[-3J_R:5%E"<.V M1Z]Y(9`_;/!;!*XSTV]^OWW?X[9[_0_W2=ONT>'>_N'I_E[&3Z='[P[V=L[X MYE3-$[.XVQR='Q_LG M9S]E.X=[V?[O/QP3CT4U,U4TFF1_+!D0 M*S>9S9&'=MMZK(;B#QUF#\&O1NQSO0/MSIWD_=OQ[F#GS<&[@[.#_5.C]NG9 MT>Z_?7_T;F__Y/0;H_W93^W^:LZZR6^=K?+!8#J'7[KQ=Y2^@]H7YZ/1Y?Y#"M?(>-#>&>0 MWXS$QF.T>W<)BRS.,L]9ZVS4;?CNZ/"[M;/]D_=9L@WM"=6LH=D^E"E.BH_E M^*.Q+'(\FF47^4"3Z&CUPY1V#^W]Z&Z"/+@;D\-).5F+DG0'K9RH=S1X".<& MTU3)-&5KV:-U`,HFG#/-4*)S]".P<)7/]#>KW'+E\]E5.1W]J1C^-GNZM?IB M8WOU^<;6JHG;4UJ^?+6Z^>IY;#V2F1^Z+#88+%6.$8CJ&[-$0.*5T$/'5!Z60'H`8SD>BRU1 MA@7K[!H6'ZJO[_9:.QQA]'S(DP^T^<<@%S!\,1N!"A\OPP""6X5I>4S"6S<5 MJ(9C*6541O;?=\X%M`>S_]%>0(L;:S;,5K`7>Q`JGZ+64#?&B1V*MA[OL.L] MPX7VSK`/:ULV'-UYH!]&G9Z!IF2\3[.CMYFL^L[9`3AK&3$7`57Q>8#0.(3, MAODL_Q*,M?U@#VR[O1AP1G:R_\/^X8?]]E>GQ?3C:%!D%T6!G)J%:M2=^)N- MGK/]^7A& MVI?-7+!2QH3F(UX:FW;DW^5(F&:)R0W;=OA=MO^'8V'ET_:XN^`B(2+<;OP# M&[1^_WL[7T/`@:,0X7KNC]T4^@9H7\W$VQ[<8,7_\S8\=@+3/LE'$J!#< M6#T!A2[N@9_?$0BIZ4CKT75^J9W3$&CW]E0BV1E@?,M\Y7;.1]55U(*GQ60$ M-Q\*6[2?/3*COXRF@?9WM@FT7'EW='KZ.'NS__;H9#\+'Y[M_*'+G2L+0O8X M.R\FF#DPT;2\%AW+:S!I_KD[5^F!A=':BY%8A@[RV6PZ.I_/!(B%<($U#[)W MG3&RG;.SDX,W'\YVWKS;S\Z.LI.=/1H1BCG<7<=)??_^Z#!+P4Y[4F]V3@]V MY2LMSCU#^>+.[D"L7SK"WL&[#W*2_YEC_+A_\-WW&F3G!XS&=_+$F3IFY,,9 M1N5P[^#PN\["\VHT:'^X-QK/B5BT/UX"`1;M%<0^/MG_'I5W\$/-8H'OED0$ M%M``%AIE%K$7H31QVG(\\+:<%J/+2?`K![>9XG,58,[TYO"/<__MN#W8.SI:CM'J#1 MIAL[6<>TVM_M#'&PV"*!/J%SNMZ]'YWCUO4A[12,NZKL9:(5J>`.(G3M"4S' MF'OH%IA^*F>GANE+AFVA\VB+VDNU`=H?OB&4/)&A`;X0FA[@1IDW):?GSD!7 MSX,1Q-[SI(*I9L"Q57"SML9P?S:_X*LMJHXYW;?=S_3.YWC^71P MQ61$&G.\'^*2[8T^CH9$U15C(>2WW+BU)[A[181-4`659EZI7%!P[D.T7+LO MF=H5N:^/@\5M-R`AT,^#=R9;VD\U#'CG8_OCOZ<:F[D[1( M821(>V?W[.`'"\NUU[G3&`)M!6`9I$%VP**2"Q2RG8)L%BF^D:-!*BH[OXTP M'8G%6V%S%9OZ37N6'A&@$YQTK/3"&*:_Y3HR_D^!_<2(Q`X\WMR*M[2G] M.!W-Q+J(=?+0N,QA,$5FLZ%'%Z?H5H5L.]BX/?!Y*6^$OZ#<:X(C=+344XL8 M^52^!N,?!(RL-%@/1G;>K\3\C2OA,5@;,8EDU0YD_'H`A%?X73-+VBE.30YR MJ#YOHB`;1M`VLDN=/<2:M',`;9JZD8D!N/X@L;?I_PZ#4N<*>A#T0]FO/:VV M9!P<_K!_>@;HNT,R4N46/9@0]^P)OJ:M'PK6TV<0*+Q=/"WMTE)?$]=C4!2H M3G,VS$^%=[ZP^0,6TSO,@KS"-4M";L%C-+17"SP\5GQ&!4BG+O33@9_2S*9B M<$N--T>6^-"#C7JY;W_?'AR2;[MG?Z=@U=$-.(M8OWQ-\_TG%L$V4;%H_+)$ MP.).G)?3:?F).7:6)6GS`!6?9 M-@_!`Y9!#..]148[XRK+:[!K.(?]+S-"(V$HBQA&H6X_MS#NZ>[W^WL?B"8P MZN'1X9J-G&A4B/(@^8LV)]5@;J0D>?(QB!R)(SS0",*<9;=B?\%&<%][DL%- M\C2:!3X1"?F[6B?0)A^.RG%Y28AI62AO%F6X^!XN@9_X!5OZW#^[6?7]WA MT/^2J1T>(0N;V=_^_!^_:(4_PBTNHB";_'("3!H-ZOA>""D+I<1@+:AFHHP' M.U'ATRI*&LW/RON3@\>KYL8HI,(679>7T_SFBK3/[AG?6")Z*@_L>E194#MM M!Y9VPW#NYN,1[#X9D;!X3_4.7C'+ M>3LFC3CDHSUX''^4I1\6G[)_!3P6MZO9R54Y+"@34F,3*GWY4SG]>?VO?_GK M7X[FTX@C!<WYR\_TX=&JV^=$64A)5!`HKN,C)&)W2WS@Y98"59(5,+WVF+XOQ' MGWL?H`0L>`PAAU3%9I$?Z@8D'FUUL4'#)DN:&!WW&OGN'\DHA0T2H:#H>)Q] M0F>+Z3^I0JV:GU'Q_B2W1?WQ3(.$+"*W_0DC`W;1:>@ MA+?&XYC-QH,)O`"`8!JK^NU3$7^:5_&G61*\8B2C6)0D#*AVA%%/PE=YFGT8S"K$4C:CFD&$P@@)FJ'`),%XN M.RA/4&H#@NPITJA9W@0-H7LY)79AVB,1N?F-UA?5MSGN&EZL#YU719SSQW'$ M$."S^;*WC)E=2GI6LW%.K8.H2.!'V4G@C6P`^?M8G>84+:BBVH4C1@/*RBS@ M@^K/I1KJI'TSN0@[5C,V@B8P#NE\]%;V`_QC.9`80XQED:+Z#P?[HOHZ%9+V ME%M;AH&I^$[*)OYU'E0'*@%WTRQ M7-1.>KZ'!.3TUD8>%A#A&MO#(P4->?3.A\3O+.Q@GU[='N39OY/DI01("3AF MDH]O*PAAS*)0V4Q5?U68T<=(D7KJOED9@3C?F#M)''>'\=>I-BP(K@8*M_M# MFJW/4UX`.[S)9>&_S0C%:V?-2F M%$M#Y^=5.3VWHA936283VOGIZ/**GBTZ1NUC$5-^[H:OQC'YEZD1(@&XWN!& MLF\FY>>8TV:JZD>=V@8<$'KQN8FFJ*EZ]PU01%$PC@:+%!]584T00EJ`=0Q& M4T*A6%-P%2))B7E/0FI2)IW4?IFC[S$I, M'.&0TA]"NP"&DKZ,WAU60@*;`J:K\I.FA:JC,\*+ETB@*2E3?4@Q,4;T?A M?T^AQ728?;>>O2FFE\44S+6^MRXFUO8<`P%-)&TRNU>CXB+;_UP,B&O"%T?2 MW'H$1>-E6#"N'GM3JD]^V3,LR&KL>3H=%G@WMF381!.NU0N&$4-*9S5^-&&J MX23LB2*Y`! M8IB`L56D0AT[VI-B\7= MXHEI`O5CB26*WZQ,`QK*\YGJ*^[NW0(TM@\T31T("FHT$*K*NI!E!JIAI.MM MB)LMTD0+E8(YZ1F^&ZH7X3%H&N!+,XZI`V9X-3KWLK7\DCFCLT6708GOH,)_ MUB`=#S"`"-\^00&'X@#O@+;RXR-0#N$%M\NQIN*\F,&ZZ(%*NLQ:M'A24A]V%##").9+MD@D,09$8,5/F&_I M?^<^/36QJ*VX1K4J`X\!N!*@'I0E!39PJ"MC4',7O(M^$Q[T]L3\I#]L!T<7 MYG<:1TB+&(RN=]*88#Y)8'7=:6#9(*LL$X\H<8*8S?&T5%@N8O_WJ1,5/8DW MG(&J9E1@_ISU?&\J[AYW+/94Y+`@H[IZ9SZF:*;9YL8&"L<<"C)-S2Z;\]#V M/?^UO)ID/V2[%(]#-'/T4MT=IQAU\(/5=)Y)JTH9:XJFX_[Z%YN,#65J$@*: M'@$@:?=J,`5C7(@!(F<9C*[,=_*']X.G8_Y#L&Y!B=PMXO!CI0J0P#F)FF1, M_&8X'F#@FS`MRY_'MQ,/$2@*($+CYC<$O6\1LT]EWQH.?PIFTG$YVNKO60=' MFN(RZHDG.94#/N!5O_EM^ M??/;W7I%ZRRIS6IXLY*.H!PJRWZ'+08A%8.KB84<)/#Y$.=`V4^'][5THCQ- M0:N-)M\>U@*R01Y43*EC-^#2!3M'W2C:83Y5_0+*U9%E#%KUV4.,R5GP.EQ9 M]#8R@HIKNXK6O(&$;31[_1J$#A5[E:-OK5S3:L1#P3M(@4`N^!8TH%*!*`]# M2CD5A5F[SG^6X,3)A[64DTM.NE`+,BA+,;&`P9B[B:@YL:$&@=-9,XG M$U74GL^'EVQ@D.>:@]J;$!3DTCTRL[#,)4F^.IC%]HHW M"&\&-/6@W3'#)J_4ZR=8TT4^BO`Y%,L$I1"9S5%[8TIK-6M6K\$6MCN0Q1)P M%[AZ1F5;Y#VDE@55?5D3J9EW@X,_!NZH=T2Z6) M[IXV82#9A.MS&)=P"]6$=GBNQ&GE]$?V:&M[_3G;C[U02]CCT=;3]1?U)XQ9 M3Y`0NN:0R&K86!6.&^X,^DB!"RT-W%;`6T0".#,L]#KLP?LV*(<8MQ?/B#CU M'C"]IA`A$M!4UB\=?UVA0I2K0P.(,(@DPZXI_L7&`L<[X>4ZJ&RFI%$3CUZ] M7-^HR6J$YI/M^A,(.[-3A)RK&D,H$3LA;]P%_A7H1*)=-8'98ISA'T-UYN%B M^>C%T_6G]?1LPB]27OF$J=*0779(T.J]UJ5>C@O0"!`?=&YCOH#I%LY\*(G^ M$83H..2_3,J>/VM+V;.7ZULU=5G9WR]E5"G^0B&[?W9W"-DO&![M]0\6LJT7 MK]J$WGKV//GHH3Q4\^52,?L%Z[:829"R+:(EKVI&,#';1#$TDO>?7\Y^`24Z M8G:&V5@T^W<+G@"(!QS1F6AFJ7TE\"RQ(C4I^QO,[3#-^,$(S3@RHSM`0O.7 MPL.Q\-?M<%J1YMCRO"C("8^!39[D8/!F+(RI^CP@1`%^;3YGDJ&>F))=+NV@ M\[X\KME$RHS;AR@CKJU7O!AX>_1R([$HQDN(=JUFV@86$M2Y3@?V%I/0I$TBC1S%G4.5>0Q$A3#_'V'E@Q2-8TP-PXE!' M66:^C[+LN"Z@%2*-;%:`H=G`^K2=@*E@,[':A#;ZC5^`F>'LF:-'C[B#011' M(7!'=ZKL!1@!K,Z+JWQL%9YWLG,2=3HO!CFE1UJ0>-KU$;RLY'"`6=>YTD!\ M%2HK&3%X@FF2.V3<^'+@K@_IMAYU#OOJ9**.GC%/QRV(3S!+71"]HP"T%P`. MJ!A4+#`6#?!C$X,S`H;@J\D"P)47:RSBNIXJ63$E M3M,H[;1._(=8"PLVY42P2KP1=ZJ)A44O23/R:%P2<5"\03QZ-2*"KQC9;5)) M%`.8-?!:7'/L.$G-$&QEB\,A34FT:;Z;:=&4!9$T;U?6,.=!8?4G'GV%7CVM M`O'D1,*<-1F:2>J&(F,8COUQ:X8G"MTO%X66;UY#19VS2(D&#TE#,&"S-JMS9&"SJ>2Z M4B"@F4N9-(A9BX5<]'QMQEOF[\/ZZ7J$3ZA0:*';00"37E`G!L7+5[4[5TK9 MI`2UQR3;DVDTN_[;C%R]I^""M)0WA"DA35`%#;=CQ;$D>7*(2&P5"OUI/5'9 MQ5ARSC5.FD?:]$%TTD;^W;02_9T3$-?1=2AU?D!(+.&RZWQ8!,5BJ M`^W,D-=C8+`$6FSRQ_G$Y,`UIT;6/M7N64/@A@N,[Z*7X(S-#97[&I(*P"#V"0.@K%5?09D4F,G.()HV M$1'3D'\J;&$.0D9`#Y:!"(>\R,T8$U2@7=B8!Y+NPB\2O(N""Y0R_)>JI_." M4+Z2V34**2>P(SL)&D4/6*6$UJ/C:OA.RH?_\Z;W;>MRRQ-4#=>,=';LM'M# M27VV31QXW^4HJBTW7602J[!NR*.;:?[K7P+XH#!9-S?$L@\<9WE)VK'0G-WF M&M"J&"O]YB!+0!H"^OE@1(8;K(@JF!VKIZ5PLC2>*AU(+=AE?BC+>(^+U,;" M*AH=2HTY6Z6<'Q:),25QP7E+6I,C,70)M]IT3["%_ MC;S$%@LYPMNX-7?1&8/#5+2*D'M=7$::(78CJ\6E6=*+H+X#/6S]GNSMW:0( MUN30BFH/FG[C"'"A#D3U?:A')L^LLH3HVW/L@D/E:$11)%T`M@T'MRHGDV+, M62@*#WXNBAO-V%HVBKIQIJ*DJ$',U0L.+0P8&5"-.+.KJB%37JAZ3K07!(UF MJF1E3,FUG=.W$2U^.)B._)-F4/.%BXDA1HQQ[%Z,3(FWJ^Q\2,IZQIHGESI8 MHO+$N!#F=DT!H]W3($_+JRN[1JJKP]`MJ%F,"@ATSYJ3/6=50"R$==^0%TF"[G<*XK3@"1*]UP0*#J/8]WJ2D,+)&48]>M@=3K6?[8:FFTA?4 M9Z-9?5Y+AS12NAJO*1@4H!W<[BEECTIH8K6HE:W1E8G:'6;SEQX'HT$23$.R_GY M3#<^!:C"'OJP30H0]8.UH-S69+L11LN1C+@(_&&\8)H/%0E%G4AC4P[AM(/'!&-+O,C1/+@T:.?*- M5GZ1!Z.M@&#%=*V8Z%I!\NK_QVD_)9O]D28$[)KK[ZC4A.FUUJ"B`UTS<78OP6VT(Q6JAUEU&J(F! MIO/LG6/D^!#!ZR-?1^<=87$"+K@'KZFVN2)\7YKZ\SLFMI7M8@ MYOJBS)?HQ%4'*'"KO`AT:LXR^"U;NB:16(=?O_RX??F!;H;_3763#[@Q'@$5 MX8JO7E-+!9^\1_SCW>Q9FRD/E21.6[0:]'>\6)W=>N3UPK?M+W<;A7H0%6J[ MS:/V!ZZTIYTK+J(R;[?_D1I"%/(WJ+X0R\04/CDVPX\F/YC\<=Z]\_N(/>R< MVEUYL?IL>ZO=?^OJL^_'&*D>P6A_W4_IX@>?>P'-[ MNC*QLX\_AOBX"]!:X,-P0RODFV>;+-5>. M8[`>=Q-Q/LR!C&,HAY&8C.;P"NE",/:"\YQ4FM0PWZ!FJ@A88^,0E0"6<&W# MHK4!&GQR+3P_O9271.B2&(WI30K<]5#\"@,;<%]OQ7:?'KH MPC/*E`IFNF_-#[6=J#?_"SL54(SIV&@(R`+I;`Y+%9?383B&%3E<+,8%/@+4 MQLCX?#&$$M0P\^*0EBKT[*R@/IWCMEFTI.DOL"H^BDK.!8'GG$"P@&2Z*VU. M0+C.*=$A@J>+BI9LE:V+8%M:#+'$N#B^VP-AFIYW6EU5FIMQ<1!^!0W M!8S7^07VC9*Q3%$^@2&[LU+SJ8N5:&7N(3YHRTUN< M&O@;KX`/O9T?/H!\(6!77%Q(#P'"=%-\0)$.HTQC>`>8Z7@"EPV0"FONE5\8 M48`]%)FZ]X%$<=*#0#CG9:D,%7RT!+343A-S;(Z5BS6CGZ(05#U8NPD2T%^K M:9O)PG,%L:*PU--/Y@T17>\J%$>@.L;L\5F1(JE%`ZT*U.JRCT(#524:B*LX]'/.L5%]Q,3 M>A.J=.[01F\@L"_AZ]@=BM9TON<6&BUO2Y0[Z^HP,3-IIX%SF*&**Z/%4/ZR M;5#>HE1D:KI/*Z(#3Q)MPUVL^S`G[6*./!O'F&WR/57T,UX1(P+IB.3@ MKO/"$'/J4071#])7E"FP+3K7MGP64GG]I#1%$`G6EL-^9+`7F?ZMW]/!''0S M<1<:^*.DXA9/L!(U-6,2OR3CA+`5A47\OQ0ZE(U"!6^]?B26#_Y^ICHY`B]U` M:"QM7JGBCHT*@!U\`IX*"2VB8<%T2'TJ/6('?4/$VO3:C!<1_(D8B``5EX5P MVC?X=K)XE&Q8.MGO?1&+^X4RT1180&*=U\EP*WIY,=,U&FP;-^67-QX3+W+= MZ4M5S20?YF+L.M0+)W'`B[SE9.#KAD MN!X*MI\!<*[=?.I(M=6VZ3H/R6QKDP:*1<5K!RQ(:3HZ?$Q[.L\J'PC19ZE. M)TF_QQUU58#$)\9-0U394AZPBT\<]S_8DBVC=]#K^F4(,L*JF'=@4+H`'T?5A,%>FT!%0[]E4[$)T MDXA-QIE&@&"A4VI(YMV;8+>B-0P([O9U'4T M#"(#LCBT^4<^8YY/]"DJYM'F^LNZ,C@)T#XHZF!.BL:#"4QRZC4*FXBA'%B8 M6O2T@&]#7K-7Y,D0JB'0[-YA8.P'Z+J.PG_'B^BXCH6HK[1FO"KKA%N9N(:K MFWN#BZYPA:WL0`_8#ZJ3PK>$;;6+VK<=O1,`>;3Y[EIZ^Z*NY MM1@P$6GI*3)=R]Y()7E]E-9GWSGL=GIB`M^DDW.V_=<:\^P3P0QMF`?C.!OF M%P_;@)3Q-F=R-.(CS@\DQTGZ%F0D[@QHY1WUFUCJX06H7#CBA;0HNX6[W[$H MA_5Q&*0(I0=^:*YA;H7'S!E_2(F#Z/ET_5G-Z%K=RJ.GSXFT;&PHRMN\-\9= M>4UU\4K8OWNJ#Y(D34CGD[01*X^V&IE\;!1^]/*%3;5%V%!G98%P[6]**ESE M>&^!5K^5G$^PO=UJ:K;1.,O.3-VWM:VXTVN$R16A9=4Y%!;>]V39>!V27"7H MSKU@%Z//Q9!KTK%T5(I@]P!99O)"H3%1S*3FP=6(26+L$/$A7P?$)`!C]LNK MS@Y0G^&"($E8\VW0VE;%+%#:Z5V4CYU',T\ET$S9&K#0=+;&C5JB7`J:>&;" M96,]8?&F9M0A1ZZK:<.+;7@J3I+.FY;6_9+^ZL)-*ZY[$PNW03A)O919BV;- M#AT,9RG?5-^U%&F'^Z158WM!$7'M80.$"8ED?`I5?.%F"(/TLM4A)6!OQE(? MC3O@"CX6MJ<5[*%8+187X_AT5/<;"W@@]()N@_`Z/,)I,L]UQ3A`R"9VGEYX M4%/!XV`)$;1G309#[=B1DA.Q\K!L3LVWS>6FH1NF4?D[.(^S62:54P3QJ*!@WWEQ M2V?.',I#EF.@MMT+H6\M>!A>(F)K"O%DD_F&GWM.-%1`UP61C%ZPA5CH6LX@ M&T)Y%$YJ2-R:ND(^ZMT/0X=+2QJ)<*DT=@L01(XQ55:@6D?<%BZ`='-VD@`- MZAC1[`C'D;SI$+&3#3=7VB3!#$`=DX@!2RL'@)A&>GK']!(50-0KO9\M7*7E MP7=1O^`:!;D%8MIZ6SS$I6G508Q$DXGQT.G5S-G0]G?QRF,C($,JGF[Z>V%2 MV@H?@?XCXY@D@VW]WE]$H$;^7*EN;DSD;0+.T(%PJ[QB&@;?63RC.%8RT85Y MJNG"+#,B"KHPSM@3Y>:Q=[+Z\6:K6N@$2486`2`NB:-"N!JVN)%*D,]O2,<# M82X)D%4S"2*13$BG*'!-IRJ5-!UTM_YJ]%*Z$_6GKJRBE6S4F>MB;>A]2DPT MB;Z8+)#,#0":3TVSZ&XK*\#O,"4&WT178RQ<@XA_A\'A');*NK31[LHH1P`O M*E>@I1BWV=@%KEY5DM)1GI0*%[@6US-D!_NZ6-* M**#=\K3QZ[=DC+,?]#K(-BK<"ZGO]N?V5A0\M)`(['U6KQ[F^N`I2/$=11G9 MF5;[CM5VBBA77JV^VNJD5[FG4C;COF=Y/^6+SK,KFUNKSU\];4_[B$TEV]1_ M`SF@"[4.X'ZVOMGX&Y>4T/`F5.D*-*E=Q1Y\XY1K>9+]64AYVXO..RQVAI9J MDOK$%ZGZ.I>"969VU1;>/@`N@65BY=[W54SUCG8C\@XV+"L^`0;*"]:"7I**X!J@6`Z+^ MEK-S:V5-S!3)HDI5FVLQ51A(N,S'>N&=@N9EJ)Z4J]#=:=L![2J:D-;7LO M6&6;CX?H>J,97BS13_YT%D^5/7`QLEGP5`CP"LX37"!F$0M.%3N\!$.IV\:6 MHX*[9);:)AC91&/X(/4AC53<_^:XTG0X^KHASA(5JBD&Y9)*SW*6?+#H_U]D MR04ISE&GC0&XFS$CO7J>J%7:/WI3-SE.O["K@>^6[64ZM\84VC[:68@:.->1 MX_XG3)&+/Y;;5YQ_X`>!6'/:`O+2(P%_3'0"#(X.*5U/645;I%,Y.HDQK\/N MY*IT,D_2>IJ\YI*IRQ\7RC=!,+]6J?&(PH/<)8Z#S5W.<70$R'[=A&L6HY-; MFY[:)"QG:BH0@RT/_`&2L;&YOI6$Z/L(`S+G^)LU7DY@V-% M=C=3]VM;RU2"$,=N\-`YVMC$W.7G9#Z-T-06J.1+8)TDWB#BW51?S%YK`2US M%=2>9SG5>PU8'FP`#\P>5[-?=1\4JL3,>U+9\D[FGLMECXOLA:.6"%<3RV,A M%?K9ZDQB)`OP`I=;;XU8]-@DDRDS/(A>V)I%`X?7;W!$88\5KE+74/YZ,Y[8 MGT_+(75='$([,<@YGE?9-JSUM?R6%:X^5W.%VOS[%>9*`C_FOO1ESZ0>L_OT M@ROR[&OSZIX9L#]^ MK:P3=Y5L?_U%%NXX9#M_59ZK!ARIXI`NX0+WV6I0J=V`']W!2\NI>[;(7(\0 M[AU8J"<<^"(J.:43YS]A*?,S'KUZ\B2@:'.P1 M^^6P3/P4.OM5E7%G$8*:R]E(Y-:W%#<"VJWDIQR0*Y+)6QD]7HA"4,-O9%L9 M\84>,B)!+#?G=PQ"S%YFDQ86=$2G6L%H>Q]0R\+A">Q.][6ME`0C/`\&RE`J M@I..P?)T`YPIX%N^:2<@)XKGK-!V%PC)J<-9]:MMW\%B^EW364LAMIK04EWD<=9ZPV3:('&FDVZ%Y'00(T^\T59IX MJF(W8V$C5.ZT-]#I=R'W94^_B'+[D,OA$S6S.<'#_SR\S?K#U$#SFAK7_;8_ M>J!B"&3&9^/D'QGFZ*`WAD#Q)U(O2A80[O;4;C`"IM-0+)B`.4F>5A=ZJG:Q M>"+V(M]$/W/>LTZOQ/JQ:&4:'R$5W`1W"(=*!:K,?YC?,BV[O$AZ59I2,VLF ME"P!*=(I8;`J6K5^R8.F$Q6&32]&P9'O).%-01WW<)A;QR%@[%Y+E6*S1,I3%2>`Y:][<":$PD'P>4S:QU,56R'EHGE"6-Y@!-'J\`BW,I8[[NTF*XHL,@/[L&(@]$4T5A.KFW2U);Q MFG?3F_:+*]')AV%32I(:*0/E.+FF?XV4;`DS3K*;<]#&U#RH]MA6;URPS0S>M8\MZB;#)2XCQ>U`*K>%4*A(W< MUZV424-HB[Z(;//K(VI8+5#^W`+EQ-BI5$C>4$2F5;=P;RR$'CQ!;B;"6MM#J/:?064%\ MX0C\:J.1?6@M7]$M6U\@JQ(4MC4QDW\;">X'W]@!-D]#VC5<;W+>AG)HDH4. MXTR7W5EGB7O&Y#XR#@(4>J6$WEIG$8!:`013D?*`MLYY=M,9&D;6'^4-STG_ MC?C[S\D?_O4OG0'_.0.)2W)@6E^7'87+(4@-$SJIFT39U7/L2WB?6./8 MF5J\41E$0SM[YN4789HCTVQLX0G5%1P,90=_-53S07;'F*[F[;[WA;K!6IJ# M0'U*'`TY\+.L.=(MN<6HJ^0$^LCB&AH(3&:$>FK-Q//JV]?NJHV:MOHUCPWN MJ">YGAUS@XEY>ZW^.G)HL78KT0(88'`EWNS5M[!M=.8O#XJG/%HE M!CZ2S++%5(0[?B[6G&`@C>L1&!K]5><50LBY7JM)/.XA+QM"V<"+\\F"-*.] M#0WV,-V,`_SFIAR:"3DSF*&7Q['IZHD7RG$A"D8:8>AA0Y?+)LK6I:U937^5 MGFVBBH($A=2AO*X%&P=K+$RGEIHM^,#2%YI3G:=`E0/*O-#(^A2?[&*F'1CZ MM8(FF<3\9Z.*2EZ+?*@35=Q09H<[PD3T7$U-QVA).@L/,:3&V$AGQ705^F1A MUL(P38C3XBH/SJA\Z09(<+R,XH53Z%=3#$>M@?NU`K@1P`17$B0W3>+U61"R M=IX5O;'J.NV:ML8L_GP&PU.8BKI-C9`=W0)D>5E>9Y$C#-[&2]ZEISAG-+K0=5L>OHC@0EY-@P@YQ+406Z), M*B:P#T+=^K''!K(]((4CAJX`V6$NO1+-P@C@$">6J"9"I<0)-(;<8#37?<]^ M`X0\7G^_GKS#RF[:]@*_FGNVO,JCF>)N($\]141`"4Y#C+H4+HC-LG9]>Z`C M$"I\@DY(I?&#H_>P%Y;#A)@ZF:+^'VV^VEY]^CR<[+FC1*L/L-9.FECHU?/U M%]M?QSFG)5TI_;`U4)2!/=IG@-8+@)FO"!YY-J@(>U6+YJZCQNX+JI6!AD>; MEKI)P')]ACL=4M52HR$PU].RX_ M\91@.F4S-4EV*,>85@ M$_R(2Q3@7R1_$E'@)4VS<`;8VNFUM*J#UA;6L3!'[)4?%E$5F^_UJ`;982_;*M)`SU6#"#CWH M1ZYX?VG?V7(@-.D#0AIDL9SQUS?$=Q52ZD+[H,02(!W4G7!8DQA>IAV-I:,& M3$S,_3R6H"$K6R%6X)R43,6$!R(Z6*_Q7E0O)PWZC\:2D[\W<$O2![\M/NYR MYRKOZ0NWI'V: MCXB@JNGO5WVSU[OAH-H[.W-T4-^=T:G;WZ,B!"'1SCWDK*R%,K$HD"]F<_"? M<"&C_FXQ$Z<=FIO9V9_?@W<'93]G. M[N\__!_FSBXWCB2YXU]P_H`3/^E*.R\&_/84`_?!J?UO/KSZ"UF0;3"OY3OKS3HL=35V\_>H`G/L6FH MV'%K2E6\?Y95)([QDG"]SUX$A"H/_H?N<(MSARJO;K!K`SN.X6OLCI.[+_/U M:F]D\J>I22`X$S@9\<'VMIW'D,>-$A)U!J!IK:EPK.+E^21A4UX6U/'DN8], MS%8)'\1ZGOI.EHCR:"1FM.S@\.8ZO&LG\0,9^U6*-];#91OR;=Q\(L+[P?!9 M9!L>1>13:8#'C^V7J#S958,N)D"J,P!F21HM>?U.+8_C`I'3%S*MZ,/-S87% M/IC(DN0!NV>BT&?:NX(!<-7,W130HJ>O0NE!J/V\QT[EI`%")^=SLDVO75[& MJRR2YK$2FVE^`89`]R7%ZBX0_W%L-:N@Y#00!UI&`UF9")97._G9%'R.&C=]KLJYSJB,!C*PFN)DE]2-W9C1]]`X(U1 MEU'Y$]_^0@K_/Z?NP=-$O#EEBP'V\+]M1ZK9=,"D^QK%^!+I&[\;[@SB`+\A MO[L7#1R2QB9/_`D1^-0+2E1PJ*R97;-\?"M!J)D&-\A+JLLM(X>L`:'Q#25_ M

?S.XB\/=@PA_]^HIF.QAN9MKR52=!&8Z32"MENDBQ#^9A83Q(=XH[)RL@%).N/^YS!8"XW651HOT9_.J4=# MA`?=]$(GA/PBC8T&,T.HP-@C4@UJV?Q[7X8[3]*I+MC%9I_`U'\G&L\/["30 M0=U%]AOHH$3LKW00*Y]QGQ2N-F[0)%=*?>BHPW(K\3M$*DPO"=K[4CVGN/L% M.:7KU=&C_4IU5:GA M[W+X@YUPY2)Y1+),5SQGS\' M=<]Q>3#T&XTNFV]@R4#@"V+2.A%O!!K/A^2<\E^__(XC#[TQ:ELS2GNN[ M(')(*BOEI"1"1O"ZM!G."\]=+RG5#2'TRI0RVT@?/N%/IDRZ=6N?SED9?%N( M'#ZJ)N,W**U[QV>3V<'D136=C2;[H]/]EO(J^(RP%L*BB+?7F/J!1">#[-?Z?[&G4M_S+$Z,EK1#T4RII83*!$ M?FL\`)Y\8(MN5.B<5#U\V2KG<8.HC&P@U",5J.0&O4^I-V;:Y;1QPQ[B% MO.XA'$S>`YDZ<'KPD6`62H&S6?TO7R["=J@!(D>PR!-77XJ^OE\_Q-89WZ)+ MS.ATPN&>HGB?5M.7H]-Q>6V.*;S(.N?5"4ZRJ4K_++!++1]NHI.]92=[^'-G7']\3^P@54*U=I;.Q'.'B\:"/HL8)1U%AGV'E(JUZ'Z#RO-4Z MXX_M+ADE.JAOR.2LGLQ->:0(Z5]0!/$A=8:RG0=70SGF&I4,6\\&ZT\'S\JG MNZ/IP1XL>58=3/:.C\;5VN'QE#J]B7JJT6QV>K![-AOM'HZKV7%U.MKG=6() M)WN/'DXK/CHZGG"7'._]Z>7QX?[XM'6=O.G'9]R+J!"TUM;O=F^HULHI'/W. M?(--Z-48^0W@B#,Y!!_6)N`U'K:@NW]P>#8;[W]G2(XNY*LWRSG'`Y"E&%/5 MQ$R!S*G#8>C`916YKC^4$.0R+A]I@MPYZWB1)]7O!3G`ZL!KSJ/->V,A@AY: M$2+36[+"RD1@]04XC5AUW]TA!8FE7I!T($:I:BT!VPG-Y1;VV^^&CZ>S(XF$!Y/JU?$!?[SF?V>GXQ9/&'L]L2/O MTI`Y@PQ6KVZXLJO7L&]$BD5NDWM,V>UWM]MKVVZO16-UM<0QO=M6J&]VNI)7H$ZR;M(L1J[L9\NU=P5-!;'NJ#) ML#14N"@,LM"NS;#V\XX?F)29%?I+4]Q;!*UT(!HKL?JIJN!5I^OQIU;)`O/6N(39FVV`Q`PIU,*GB:Y6#H<63.2`<<*J!ME>O:RZG ML62E7MS+1;JL4MMNJ/J,W,/L2=[%/"#U:UBRV'!X$P/I`5?YV7Z6[:AYXO?E M>_2[&FX_+9\VUUC[00.3;15EPY"H"4`4IAW2`"VJ)]"DY1KYN1-E1L(S;%Y9 M#ZI.]+/FPD4YR*R>0"$F;6G056Z&+3M>`G'P,.9Q$3IY#TB'3T7CXB%=Z1;1 MUSXP'+0NO5U"M9? MI121SH09Q!2=SI9"DYOKE,/3^4+\/#/IES!;VU[?&;0.13;RHF]W:-K6HM69 M179*NG$7=3GC+NW%@C,=&@PQNPV64%\KY;?JT"*&)M5%\6X_6F/:>K1D,%UQ MO'$(3%9*/X.9;HT8?ZMH:HP>/V*PR&*[Z)EBB52FMV1W9*P&8L4NRR4[.#QX MX-[[]8_5?+?>HYO9FAO4Q<`MV@^X`U?*L'ZYT- MGUYU4KE#..\B"6O%!2R0KG9,NNH;IR5934VE`/BRMQ%;\ M":)P"1(N`!/15+?Q"G?AAJ)00'<6.79L?N>K[5L/=1#Q3'@V62^I!1:6DFL.+JG(])36_2A$P;5'-=NZ`8_+ M0^T^G9V;'@C\LJQ@6Z!!:=-\"6;P[K;2T"LXY"_$!1ML&+N6HNKA@"#I5U:>=@P92;PUI8Z,B)AG3]E(_KD'B+N3_D5=(0? M;=/(!:8W&%);ZN'(;IXN2L,9.:0/JOIF29#7@4AQHJ11//L]S]V,.EC??#S0 MFPV5>`&"FO05:-^/L)&45RC4MBG5_>LO^_<3JNV07%#&ZIHP(9NJ\R0Z/AJ3 MMZ`3696A-*,P'6!"J2(_"DOW$5-5]UA)W=B@R[G&@#**$]FZ"%![#^+844V# M&Z"$).(.2P'/:1SA1XINC!ST[$GM[/G[MY_NS$7X^/$3HB%">(Y'!TU&T_W1 MOU8OKFZX]!6TKG+:QERL--D[;$RX9*E[H`YQG.A@O.BBXU]_::PQ;J')5^NA M(S@M^#LS7!7QU?H\<]P&:K/Y71F(5DH_1+ZKKR5W^'6"LU&H?FZW@ET>8<(\$/'>*F1+SC[.S%)=UW%U9OEW3=RX M5A(NUO+"GIJUL7R:#(>CX`U(*:*.QA-N;>0=.0-L@*7?GUK]2@%N+W@"E3-[ MJ,:#5-QQEM;JP3Q*V6`'.%TI?XD%A,"T=FGSH*:N+]>B7T@R>']1KC=NK_7# MVF!]\'2X_F2K99&F19]*-6$ZP&CG>3SEJ&M#G%=(-.7SM-PV:RY?#0LSJP6& ME>4?H!%MF&B0D\J;7FE-3>/80T`ST>\)4?Q=HHI'_1,^7$F^46&ZGU+B' MTZQH-05R1P-&DC.3@=U>IN^)8GY2K((/(8 M\V5QJ8:"-#^P37#G)MV:4>+0]B3),+Z[E6#2,&0X2DQHB0LSAR\&XN7S<7=W M;14!VL!9PE&LJ\.7D%P.^*OO=T<;3&4&`2!PQX9P\6`[2T(18R(4=AB-+45C MK062LA/&W74*"@@R8U"QI!HG54R>?-(9H2T<&Z`SR(8N@:2+-MZ`6G*(84?6 M\!;1.!D8@^O2/GZKH5)S:Q0)64);[E-LJ9>T0@:X30`H\M>DN];]$K^-7#LB,? M^LD%L,"(7%8(,G0+$U$[%B%N/@(@6HAI=RV2&77=")X/UW%"FN*6>$Q)&!$G M'>=VLXY8C^,G?7!UF8< M)^.C.A'#]:<[S\AWS\]30]0]_W>"A.R^U_&ST]'"^Q,E1!V<5J]'AV?CZF@\ MFN+NDP^PY?)[KHP@DYFJVEJUR/2TXKCFPGMB1J85O^AYS888A0A-X).9<9-K M'?:2T2YM50D8"2%1$^5^6.^5:[5H-U9PB:$H>87;F:VL>)( MBEU7EK7$#/5X!^/.P>N[)O\Y6ZTV3NVW^9P(_7JK6G/V4MJL%%&D%;$_>R6I M,0I__7##_#$@*#`NM!P9)KSKGVV5#SE!>,[RKHU@I@'=##60L+VK7W_9 M_)^___?S&A\,F$!GHI9R^#Y@G3J_^.N=;`3@@*P72T6V.#ZM0INOSPE[4WBQ MI<1)S_74&V]WK#2U;KBW#E58WV"E]07LN[4(R%Q7<7M]Z_4K$(L/.+Z$6<`U M/^M_;\7`=-YE'C.24I\[+&Q7=Q@AFIL71Z!;#OP!F:/[S+2!P3?M499!1P2# M9;4!UD: MF0,IX;P/N\/[8-^F,DMH09FK6D`9JI[8=*=\"@PXDGJ:3;6*5D8%;>6H\&*KF00P`-B MEJ#_Y#'FKJBU)LZ26%I":XNT$4-E(>1(>SQ)6KY'!1L2+>17M&9_9)&:FEAZ MJ#C0G`L(8D)];KAS;2?Q47YSB?O7Z]3-@K!1+U3EL<]A!O'6,04,(H?KS3^J MU6,M$EIYN*C`BYZYD@C3"=PC:@Q8@*AGZ+'0VHM/F'0S(DFO+O\S<9Q0V85+ M.!4^T2V,O+<(6A';S12HNH6867E7VK6VT5(+&YPN"0_P=>P-'%]MJ2:_B+]L M.L2%@)O`;HQCMDABD[R#D6+`JN/GU>[9]&`RGDXK,@\JQ9Y.]?2$`#$D1G-L M5FLG5B#K_;RE7IXHL7@NO[,NGUTDY7T*;[=\@]1A?D^5SHN8+V"&/N*MRN-U M[X7-C#!;RYIR:2JA2(6*>UR\X:3'\JG<,%F#QG)=G4''FSIK9(P M^H9B(1T=+7N'^>J=3Z2$2KCMW>SNZ=$+8]&[_W3^T^T_[\7ST**DUHMUB&&P MD;4^P0)_1%L7RRC M_.*LJQ%K^=(AM>]T`;R#Q"X_E[_&6BI>Z*0.%2S?Z^$EX<#TXO%A5[KE4DX3 M1MUX9=&['$2+WNV=9#>EV81@H'+Q8R_'V//KRLMI<[K>);5?M:MF,5?<:THH M&TN8:!8G%O2F95_$"7)Y9]DWV2SW^F^K*-S(W M7/E3OZOT1!7%RM?K`^C&X&3<+5],X\:$K.@(JOS#9)V,SUN^RW"4E\R3`^@X M\P,EH,3[LUQ@QX?E*[99Z?O!XUG^'E;8]ZN7)18WE_%6HO'[Z]8N$YRBJSIY M,%O^RW+ZA^Z*J;9C+LDSZU?1]QH9Z)YR0HE^];4HWZL]G4%OK.W"RUX-..RZ MN%8Y5"N<=&YVDT__ILONJNK'"P&#@3_<59Z]]=_?8WE^OXQ7,^/SI.K(&(8#W1'^-X=='I MK.>/CF^OWX0'WNF?8\D\T^E,3[[CP* MU^$R?@_B.N%RZ7P<:W_'BMS<--$$]T(S^D)=]\7$STTD.&WB`)4;Z.]^%,.'! M3J+AM'KN$4UFTPAA<#;U\0BUR0>3;#Q8;Y/]TPZ;.%V#9EV'^(_3Q:RHMTN: MKG)>E'QXB*X\5D1/]'`_T2T+.*37[:);:<".I&P\ZX*^DRD['YS,LK[5MX92 M+>-RL1PW5-BW9+JR0:'U87A],G?*5U9E74K#I^H!V.'D>M&%KEO3OX<6_ITB M3TX\H!TE8N6QC/6\@AKO7-]9:[?.5^V'T+<#]"L=T]BON2&9YIU\Z33X\J5O M2&K)EXZ>.19^%H(UQ,;UO'RZV1_@A`R.7%W"S#=VHL""#UKZ_NYE!=.Q`";I M&-1.\KN&7S]$]DO/8),2L0;KT',7B.)AQB:!Z2`\.[^Q9C=,+T$FBJ)"J&7- MAD<0>C,=S^0CG8W'LH4:%OQ)%OIA@'^2A5KP;R;-IRD-F[)`YO*TV,5%6_?] M<#P>CWKGH]%H;/9[ILF2&7BH/*H$@:*H$@2*HLKFP1+[*I0F%?=5@D!15`D"15&5 M-OE,&7BL/*H$@:*H$@2GCFJZK+IA_Y"&RS,S:?/C5!=.XBU69VFCBZT:89UZ M'T8+.(>4G1CIF;!&3(Y=77K.,@83(O?A$5_C<(4&A7$,9URN+A>N_1`&M@=O M.UF+[+6F)9R3@M-/$SU^=.=/H(RK^250<2T/.>B:N)LRAV1V:`^,\6;!) M4NT["W?CEZW+=>_,2W`C^K;9<.+#(%>2ID-1=NM@%-+P";9@H6:1%FP`.9&E MA&`+&386)6A1&TD+,1M)`T$;20M1&Z'K[.I'1QC9M;05^*?6-J8%_;':\P]*&%F4[&QKLL+*A MA:B-?-YDT>6$YZ4+I.<=2+;\S?U\/QB@*&F8X=DBP92?\"Q$/9+I^T`"=^T:J=,A&V8`<\?S/N.8_,]E/@V`RMK5Y?.2;&2` MW25XIA_W2>!;*%^G;Y,A/_D`NJH:&96--'NU\EYN-_Z]$UELRPE3P8YBF;SX M-&5SE>+S!\]]"'R'U0;U1,SW41@[\YAMB6'G::KPP+Z)G4;T4D$B>`[1;U;H M!S\)^^,0_5![VFD_^$6I?D@N8?TR\P$W_Z1)#2&@25V'1R8"J#!D""`(*A#@ M9J74!Y">*A#`RBU#``E:(``X-5EQ2#_H$3:#'"A4@OYCJ02.R:SD5![1RBKZ M!?TU5EH<_1[D9L*WD.B%F^%##8"#5%91K"J*(6&'GE:X`#[4N,""45?.D->K MXGQE#B&D"Q@*CP`-U'E$7E82S@6=!8!ZCTPESD-(4B`5J88`<)1`(('H*1I_ M>Q2#HA&89H.B(9A"X,;@$_8)&@ENA%2$`?`HZ17%/*''C1@G=`.!H(HA2388 MJBB28E#%D44H#%4422"H8D@:"54423&HXD@2"E4422"`1Y0P)(V$*HJD&%1Q M9!&*OBJ*)!!4,22)1/_(%-FA9=.DB$KJI\/]ZJ?:\[*QD-JK6C1!W+/FR>HI M63E"+-A:BBRE\?(P.ZN=:H]AY/X"BTR\3&P.Q50GTO&RPMB=TR-?(WMUYSS# M4C0Y]?2\K*[U`I*LOK&=C#S"2DR%?BBNZUH;Y=+]BBM@@-0;E;#L]>;1=38GT4"A-6J.G],TR)9JXAEXT\KA"1@ M_>U521W"I+K=B*\1"V$_7*9GR=.`93<'\SDEB)#2$]NEL'_&][>75"H=6(_E ME3J0R\"F3L('6+C+R$G),KCV+A6&_,ISE,+#K4%\#]+PVJ)D^($M#IVZN6\U M`Y3=7=?9U3L6;AE12_"GSEV.#(606H*47W2DJY"&%97SFE3Q/WZ@25Q>A^V_^&KH5/P< M0RA]RNCV725R0[5\H')'YE;X]II)M'ISI'>6.'4G_5IR^`_K^O'>DQ=5)7/V6J(;C\++3WQ[5G'JQ MT)[UJZCFU,AW]-=]J8:#WBK]A:8L!Z\*CG%VB%*)9(#E?BA]A#P<,1?S$XSI MDA'+S](:)F"W)A8__<*1\FL`2C?K5*[_RUDK,GKL-;\[M,X,/KUGI_G3:X'K M*O-"#+6#2]O,?3@\/>A9=8#V\MBK![A72$DIBJ?X3W9CMI(:]T^1.%/Q]*/*= MUAK>#1L>WM']O7:F?9BCT+R2@,/I_<;UX)9V.!CA+O@Y;/\+_6ER,-VW7"<(4Y`EJ8Q%'WO<# M0=]O,RJ?\89@QB=2BMC!.^(C',I%?)1(*:+&9WE?,,L3*46\^/PV!?,[D5)$ M"N01BTSX0MRB/$9]WKNFH'>G]B)C73YA<)P1@0&/>9IO/'C\5H@/[V*7&V'1 M@1B$81X+L6A6T3$)S=X-@"DB*1;9Q-' M=IY_?)+V&(401G_L*,`>PO7=;=RM,*BXB)* MF/TOGHO[SS&_Q_@P0'9GNGP]`(Y:.$M[X\5W^9<3O7C_5W;?54BF]%??NU_" MF(F8Z,7[3WA#6^C%4%H"NOFTAINDPJNVB=R)_M^;Z7!\?6,99Z/N='1F]IW! MV7@PO3X;F+/I];4U[AK=V?_`9?CDQ`MX]-X!3R9D3U"$RRA[YL7:@^<71JFQ M*?C/Q;&)3CXD\-E=+`$V[$?/C.BL\R<[7OT?``#__P,`4$L#!!0`!@`(```` M(0#[8J5ME`8``*<;```3````>&PO=&AE;64O=&AE;64Q+GAM;.Q93V_;-A2_ M#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE]&]KC@`'#NF&7`;OM M,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_W^,C=?7:@XBA0R(D MY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$COVM;[[UW%FRHD$4&P M/I:;N.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T0LYEEPETB%G;`SYC M?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I@O%TS?`4P2AG6NO7 M6U=VJ^>?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$NCH/BPI???O;GUQ^C M/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+KS[]_;O')?!M@4=% M^)!&1*);Y`@=\`AT,X9Q)2"M.69EN`YQC7=7 M0/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX.(N#UO5D"53,+2L?VW9`X8NXS'"LY1ZMAUC_J"2SY1 MZ!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$'Q+F MF/$ZGBD".S1P1%H$B)Z9B1)?7B?-AOZ'&(KA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@K,S6KZ1$0;?785;3 M0IV96\V(9HJBPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D)QW[-&LX[F)&QMKOU M4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q>Q,O91&\\!)0.YF.+"XF)XO14=MK-=8:'O)QTO8F<%2&QR@!KTO= M3&(6P'V3KX0-^U.3V63YPINM3#$W"6IP^V'MOJ2P4P<2(=4.EJ$-#3.5A@"+ M-2[\JIB4OR!5BF'\/U-%[R=P!;$^UA[PX798 M8*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@A_J_S3E+PZ0UG"35 M`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/R"%A0UT#FWIO]U`( MH6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N'38-36;_7,2\ M/5CLJG:]69[MO45%],2BS:IG60',"EM!*TW[UQ3AG%NMK5A+&J\U,N'`B\L: MPV#>$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[A28&80-1?F#R`Y+<< MS=*MOP```/__`P!02P,$%``&``@````A`"D\C?]\`@``T04``!D```!X;"]W M;W)K&ULE%1=;]L@%'V?M/^`>*_Q1YRT5IRJ2=6M MTB9-TSZ>"<8VBC$6D*;]][M`ZN9CZK*7Q,"YQ^>(]4Y7HFQ+__/%P=8V1L;2O:*=Z7N(7;O#MXN.'^4[IC6DYMP@8>E/BUMJA M(,2PEDMJ(C7P'DYJI26UL-0-,8/FM/)%LB-I'$^)I*+'@:'0EW"HNA:,WRNV ME;RW@43SCEK0;UHQF%9UB>^28C7!9#'W M^?P2?&<.GI%IU>Z3%M47T7,(&]KD&K!6:N.@CY7;@F)R5OW@&_!-HXK7=-O9 M[VKWF8NFM=#M'`PY7T7UYTD^_3<+"8J\ MP7MJZ6*NU0[!I8%WFH&Z*Y@4P.R<99#/WYV!)5=SYXI\*:`-=.-I,9GF<_($ M$;(]9ADP,XQ&3'J,6)TCLF2$$-`WB@3K_R_2%1V+S.*1WOM8!LC,Q^R,K0XV MC@1`,H<"WD_'@2'%`^?9[,U8>'/`3`XP)_FMWD,<:0.2R[4Y<(G!YMB527+2 MEV7`7/N^IGD2GZ0&@^8XPOG;6=`41BC<,,EUPU>\ZPQB:NO&(P7.<3=,[C(I MH`TP,B?[*YAHOT_&`YBH@3;\*]6-Z`WJ>`V4<32#$=)A)L/"JL'W?:TLS))_ M;.'3R:'!<03@6BG[NG!3/WZ,%W\```#__P,`4$L#!!0`!@`(````(0"'-A\W MMP,``)(-```8````>&PO=V]R:W-H965T&ULE)=?;]H\%,;O M)^T[1+X?B4.!@@A3DZK;I$V:WC_;M4D,6$WBS#:E_?8[CD.PG;*E-T"2)\_Y M^=C'/JP_/E=E\$2%9+Q.$)Y$**!US@M6[Q/T_W\/'VY1(!6I"U+RFB;HA4KT M$-K>++CHB(*+L4^E(V@I&A? MJLHPCJ)Y6!%6(^.P$F,\^&['[<7`OF*YX)+OU`3L0@,Z M'/,R7(;@M%D7#$:@TQX(NDO0'5YE>(["S;I-T`]&3]+Z'<@#/WT2K/C*:@K9 MAGE29/LO+6FN:`$SAP(](UO.'_6K7^!6!$%D*]!!Y*]SF+M81PG[,/;O<\B' M=MJ^BZ"@.W(LU3_\])FR_4%!I!FD06=C5;S<4YG#-$"L23S3KCDOP0(^@XKI M]01I),^&CA7JD*#I?#);1%,,\F!+I7I@VA(%^5$J7OTT(MQ9&9.X,X'O4_?\ M[2;3S@2^SR;Q6)+0C*I-V#U19+,6_!3`<@5NV1"]^/$*C%_/"J1#:^^T.$$+ MF+<$29B:ITVT#I\@^7FG2(T"/GL%=A796:'G#QAZ$$C->!`MUB!ZNC19:F[8 M<6,O[E`Q[14."&1A/(@6PXJPQGO3NQHRH[BQ%#-7D?U)X9"!R7@R+4X0C+J? MB;D;-S4*FVSA*K*AXL+ND$$EC"?38I?LUHV;&H5-MG05V5!QA6S^%C(M=LFP MO\"-Q$;#_@H?2JZP02&-SYH6>VS>$D^-9-86Y@U>8N]Y9I[;[%?`]($Y>E/0 M8@_L4EFF!HS$#HR],LF&DBMLR[>P:;''=K$U;$;BL'F%D@TE%Q.G##`<:>,3 MUZH].J\"TT[CX'G5DKVBN<:G-]_1$XO-5FUO(=BKP[33_)G/^-B::WQZDQ[/ M9[9TFR_VRQ4;C1T[]NOU%;?^Q53_:*YAH?C-/F MT[W.%-;D7TYU_9:[#F.O/%-L-'8>+PQM(66=9&ZVGWB!H_GB4DENG;SIO-#= MFL_G!4\[CU/'P4(@'=3S47(9I\F[CE"MK:]NB"8AWG*OSA6[F^G]3F]\```#__P,`4$L# M!!0`!@`(````(0!?".)H800``,X.```9````>&PO=V]R:W-H965T%&)?-L>U_=>? MST^1;75]WNSS2C1\;;_SSOZR^?FGU56T+]V)\]X"AJ9;VZ>^/R\=IRM.O,Z[ MA3CS!B('T=9Y#X_MT>G.+<_WPZ"Z\N].Y;F[L=7%(W1UWKY@70.>H1.>:8R=V@&FSVI>@0);=:OEA;7\ERRUA MMK-9#07ZN^373OMM=2=Q_:4M]]_+AD.UP2?IP$Z(%PG]MI>O8+`S&_T\./![ M:^WY(;]4_1_B^BLOCZ<>[/9!D12VW+]GO"N@HD"SH+YD*D0%"<"G59>R-:`B M^=OP?2WW_6EMLV#AARXC`+=VO.N?2TEI6\6EZT7]CP*1D4J1T)$$1HPDA"YH MY!,_^)S%41D-`K.\SS>K5EPMZ!KXS^ZD-(BLH>;/;BVD,,8=L;PAI'TBZ MZX)J85T,?/]OQVXRY"!3!L,JYA!J9I3.$1$BR>801+*=(S020RB;"_5^V)HW MH7(0-*'F!8F8J2-1&$_#^"8B_121?8K8?H0P=$(BNJ$?&RG!:QN*>.\UZJ)F M2Q0F&KJ5N+$7(@]2$\!BYIGZ,QW`B,=PRV]-@$N\\,Y@:`._'M1MJL=91,/@GI>:=WJMB/`N1YIH=)1`ER=&O&F3_1&ZI@$=/]DHOFYXN+'(35(5\2 MA5'J0L@/J=/#D1],-5>NZ6%*0W?*7IEFQ,-`&V^HDZ<6;4OX>*9),%:%JIHH MS.@9\U$XU<-1B%LMT\/4"R*LRH@'C$VM:JB*356/>28'F>HBW)`*HL21$!82 ME%]J``*?A0SY.O6!`0>G2IH2"2PP3WNW(!&XE!JR8A1ZIY"GR'U M*0*X##%D)H"2V$.[R!8AW(A,VZ4I3^[U#S[&J[I2E2[OB:R(^7%SC5SV8@^N=DQ(P[ M>>2Y/EKV4Q,1^@0O(IF!@#9WR;2,J,731,!"I)5("537!W6ZKGE[Y"FOJLXJ MQ$5>#2ALQO>WZMJ2D"4<>>'DBMYG\CHS7$CN`;A-G/,C_RUOCV73614_`*6[ M"&$?;M5]1#WTXCP<8'>BAWO$\/,$]T8.AVEW`>"#$/WM01Z9[S?1S;\```#_ M_P,`4$L#!!0`!@`(````(0"(3_6'O`D``(PO```9````>&PO=V]R:W-H965T M[%_ONG__M?QCUNT<3ZO]\VI;[HN[[H_BV/WS_M__NOTH#U^.;T5Q MZI#"_GC7?3N=WN?]_G']5NQ6QU[Y7NSI7U[*PVYUHC\/K_WC^Z%8/5=.NVW? M'`PF_=UJL^_6"O/#)1KER\MF75CE^NNNV)]JD4.Q79VH_L>WS?M1J.W6E\CM M5H[=Y)XVFPWIQ^5:+>S6\^]UWUY6#UMJ=W?C=%J+;2K/T!^MUD? MRF/Y^=0O-QU'XQY;@Z[_?O;JH/^V10? MQ];OG>-;^>$<-L_A9E]0;U.<6`2>RO(+,_6>&2+G/G@OJPBDA\YS\;+ZNCWE MY8=;;%[?3A3N,;6(-6S^_,,JCFOJ49+IF6.FM"ZW5`'Z?V>W8:E!/;+Z?M#-\^GMKCN<],;3P=`@\\Y3<3PM-TRRVUE_/9[*W7]J(X-+U2)D68G03RXR MZXW,\71VC%;,:%03&FHC;T"Z^-.;BT2_MUGE1I9ZU.J_O;0_G1H;%, MF7!\7[&9P9@;U,\BX>K.;5+P?V4@I1Y3>6`R=UVJ&277D8;-M_OAS>RV_XU2 M?N#CP=^#H(=!#J(-)!K(-$!ZD.,AWD M+="G\#0QHL'\_X@1DV$Q$KW[*(`,FJD%1%@(%TL'M@Z6.G!TX.K`TX&O@T`' MH0XB'<0Z2'20ZB#30=X"2D!H/H"`C&A&.C]+BS'"O&@^;H^1X8W:X8_(!\8$$0$(@$9`82`(D M!9(!R=M$B1IUH3*R/A]1S+H*CNC4QYJ,:-_5C)_A2%N(%HV1<+.`V$"60!P@ M+A`/B`\D`!("B8#$0!(@*9`,2-XF2BPHYZ^(!;-68U$3BH7HY@40"X@-9`G$ M`>("\8#X0`(@(9`(2`PD`9("R8#D;:)T/&VCE(YG>S)SR#;\G=/;9OWEL21` MFX4S@V-(>Z]Z1\9$U'C4A&UF6V-#6X`6W,AL@F;5I"J\V=N-M1G0;HQ$K)<@ MY`!Q&Z]6C<;:IM!KC(2T#T(!D+#Q:DMKVYNH,1+2,0@E0-+&JRT]5)>$K#$2 MTGE;2`DW.[NWM^!GPDJ]+^+*K-6XUL20(5L`L6HRJ4ZN57[80);@Y0!QP$7',VNUXVMBT&(F!]1XI";" MHC$2B6`!L3EA0?YV/YH.Z)RM#;`E.#E`W(;(^IB&)N351N:L/J3U#&U[Z39J_'CB)W+6P'4.F0AK43; M+$0V1R,E&09:,BS1T4'D(O(NDO?1,4`4(HJDO&ACC%8)HA11AEJY8J4&D9UY M+Y_\C/J(3-MQ4<]'CK11.-%&H;02CA8BFR,:'.V$F*I:2^DHK4Q#*]&15J)$ M%Y$G2V1#W^P-M;VJCSX!HA!1))5%^3%:)8A21!EJY8J5&E)V:FZ'M+Y2ZK$K MN\NW+[21\UJ.M;F"A]]`D0AHDA5-GHC;2F)T2=!E$K4SF"M)S-A56]`:/\Q'_RK?J^/*%8.?WP^T4Z)&ZN"?:&-HP3*&)8YT MM#@RVRE16]%WG"HE!L/IF90`)0?%740>1WR<#WL3[=#AHT^`*$04J(&G]V@P#Q'\L)7R3`YP<;=CFG;;`Y:E\A M(+(0V8B6B!Q$+B(/D8\H0!0BBA#%B!)$*:(,4:X@-4;LLD&/T=5W"FSTZ2&J MT80-]N9Z0,_Y!7>RT^0T&300RU'#>9=\IZ[5;K*46(EN@>L6A1P;TG[[-!B%'>,EK`U1\<`48@HDO*BC3%: M)8A21!EJY8J5&D1VNW%%$.O+$"6(S?U(.XC:SF!A-%:B@18BFR/U^#O1-IY+ MZ2A+/',H@A)=Z2@JX*65:+?% M4?O`*Y"BA;%M2A1:#LJ[B#R.U$E"E_?1,4`4(HHNDH_1,4&42B1[%?8&V44E MYE*+^DM-BK/W7;]S_*6SJK[-YD@=_'#\E58BJ!9']$,@FZ,1S=`RV?0(+E'+ M0>0B\H3\I_GGHV.`*$04720?HV."*$64722?*XYJ-OSL3NRRPS#=34`*U*A] M&.96+60ALA$M$3F(7$0>(A]1@"A$%"&*$26(4D09(O9,EW5AW3EUC.IGM_7[ MQUUQ>"T6Q79[[*S+K^Q)+6W3[F\;W+SW?:B&CL8?Z1UP]6A6YR:]#V9#3>?# M>5Y]?-7XPVC^0!4]XS":TRN9,WP\IQ<;9_AD3@\*SG"#'.A>X,R_F%2GLV5; MTSE]T$*+"#ZBKJ4+^FKO\X\3O)I_)$KZ"KZ\DW M>O5>T*-3>E/;[;R4Y4G\007WFW?T]_\%``#__P,`4$L#!!0`!@`(````(0"* M^F/=B@(``'\&```9````>&PO=V]R:W-H965T5[2KM2JU45;T\$XQM%&,L(,GNWW>`C>ML(JW[8IOA MS#DSPPQ>W3_+&AVY-D(U&8ZC$4:\82H739GA7S^W=PN,C*5-3FO5\`R_<(/O MUQ\_K$Y*[TW%N47`T)@,5]:V*2&&55Q2$ZF6-[!3*"VIA:4NB6DUI[EWDC5) M1J,9D50T.#"D>@B'*@K!^*-B!\D;&T@TKZF%^$TE6G-FDVP(G:1Z?VCOF)(M M4.Q$+>R+)\5(LO2I;)2FNQKR?HXGE)VY_>**7@JFE5&%C8".A$"OP4VKO MH$^Y,X$SN?+>^@/XKE'."WJH[0]U^L)%65DX[2DDY/)*\Y=';A@4%&BB9.J8 MF*HA`'@B*5QG0$'HLW^?1&ZK#(\3C';>C<0Q:[Y"0$(C/ZY%:NEYI=4+0*R!I6NHZ+TZ!^'8BD('#;APXPW., M(%8#Q3^ND\5X18Y0,?:*>0@8>':8N$,0$.V406VXL@,[95=2%\I#,/1EDMLR MX_^1<6`XDU[PR6+2\0;E@)GT,-,.<9$@0(8GZ,"@/.O1)HM_Q$$Z@`9(0S\, MEW9@+]T5-UAB&(_N$)/%[':6$/%P*0>^E`H6D')CUV\/Z+(^KY^TY;L=ZKPN M!8(EONB4Q?Q-+F'@PV!(KDO^B=>U04P=W#`GT.J=M;MG-HF+^:U]DFY\EY)N M`^:_I27_1G4I&H-J7@#E*)I#D76X0<+"JM:/XTY9N`'\9P47/8=N'T4`+I2R MYX4K5O?K6/\%``#__P,`4$L#!!0`!@`(````(0!6@&PO=V]R:W-H965T&ULE%;;CMHP$'VOU'^(\KX$ATL`$59L M5]NNU$I5U?^69\XKDXJ+ M(G3)8.@ZK(A$S(MMZ/[Y_70W)Z*4I93-1`E*^"?1,B<:GB46T^5DM'8',HSSQ\.IUY.>>%:A(7L M@R&2A$?L442[G!7:@DB640WQJY27ZH"61WW@MX60=).![C>W,/D%;+F(,"3+LC M61*Z:[)X('/76RU-@OYRME>-WXY*Q?ZKY/%W7C#(-M0)*[`1X@5=GV,TP6'O MY/23J-SJ$;N`[$ MJJ`,KRL_($OO%5(753X/U@<^:Y^CAP>D-3.P]6=&9V3&W&(H#];0I/'K0%HT MHUMHT!F*TPC>#XZXEMGZC!L^D_/,X-)?(#H#\[0!ZP>C&MA26Z<>U-!436K3 MKV2$S7FEPGC0A%$GVEK&D.^ZH'XPK@-KY1JB;])^W$SHW*:R%F*ZOH4+'=?$ M-7+\\>"J&CS7IK"6CIH+]H,#:-I?+5&I!H?38YJ6K2OS^R"HILF!JE'QE&1-9U3A->XT8,,+WM$9S*]/"F('0ZL]K*FM<';MV$;)[0L[DEGUA6::< M2.QPR?'AS5];ZP5L[>/-ZMK'B[5=S+SZ'UB,2KIE/ZC<\D(Y&4L`/L/L:")$/KP`,Q>O52O_@,``/__`P!02P,$ M%``&``@````A`*2+CV$X*```L`L!`!@```!X;"]W;W)K:KN'SB9A[4.A\+`(@05)A>\(":K^OF+76L5JF;45+HD.D MV]UW/U\"E/7W[]X?7_^9_\OVY>OWIX?/_EY_>?[K_<_?#Z7W7VF$+P\_O/[M\?'WMV_>/'SX[>[S^X?O[G^_^Z(M MO]Q__?S^4?_SZZ]O'G[_>O?^Y\-.GS^]65]<;-]\?O_QR^OC"&^_?LL8][_\ M\O'#W?[^PQ^?[[X\'@?Y>O?I_:/N_\-O'W]_L*-]_O`MPWU^__7O?_S^7Q_N M/_^N(?[V\=/'QW\=!GW]ZO.'M]6O7^Z_OO_;)_W=_UQ=OO]@QS[\#PS_^>.' MK_W;S32C]___%%_@3GLK[[>_?+#ZY]6;^?5Y//[<6SHD+S_YP^OU[KACS\__O;#Z\WVNZOKB\U*Y:_^ M=O?PF'\T0[Y^]>&/A\?[S__O6+1:ACH.LED&T7_M()??W5Q=76YOKC7*$WM> M+GOJO\N>UT_6:[3#W=5_EWIS-Y^X@>VR@_Z[[*!_/5&OFS_<@/Y[YI^BECKL MJ?]^TY]RN]3KO]_VIZSTX#C<@OG'-_TQ*YNN^<>9?\Y*CXCCK;F'QM/9K.S# MP/SC&_\DF__*/0">SL<\MH]WRST$-M_X8%O9!X/YQW('G_F3[,-AY1X/SSS@ M5O9Q8/[Q5$IOCIUX:.S]^\?W/W[_]?[/5WJZ5%8/O[\W3[ZKMV80V]+'1^VI MR?^JQ]7<9I2?S#`_O-;]5OL^Z)GI'S^N;M;?O_F'GDP^+#7O$C5AQ4D7KBWY&1&<9D M9(_N.PLNM"BRG:VPN^QCR&+(8RAB*&.H8JAC:&)H8^ABZ&,88AACF&*8/0@" MT5,.`KG44T3Z==#VB-E+KWA!CVS"#GBWU&BL4R-=A26[4\DI%$@&R2$%I(14 MD!K20%I(!^DA`V2$3)#9ER`C/<I#./:@OELD M?"&*.^A49'?;0S)(#BD@):2"U)`&TD(Z2`\9("-D@LR^!%GH,7]&%J8ZS&(1 M]X*S@^PA&22'%)`24D%J2`-I(1VDAPR0$3)!9E^"`Z]';W#@S3G9>OV=@CKS MRL@`&2$39/8EB,FL'`0Y/=T@A_(P#4M>BY#VI(R4DPI22:I(-:DAM:2.U),& MTDB:2'-`819F;AG/\S>;[]R*V;=/]8_35)T2VX?_.[/B8QHI;)N;J&U>%;;3,7/TV M6BALH]NXC4Y5-J>]60.-HP/EK"I():DBU:2&U)(Z4D\:2"-I(LT!A=&9.:+RW$6H)Q5!:DD5:2:U)!:4D?J20-I)$TDO17E'8DP M"S/G]+-X\1F<6=$Q1]N/::&@BVXOXBXZ5;DN`F5V>!=Y3BI():DBU:2&U)(Z M4D\:2"-I(LT!A?0DMY#?1:"]>4,O M//`9*2<5I))4D6I20VI)':DG#:21-)'F@,(LS/PU[J(7GM(M4V&_C4ZS8[^- MXK?95JR=W=&%N2=EI)Q4D$I21:I)#:DE=:2>-)!&TD2:`PJ3 M,Y-=/[EGNFB9&_OQ^-/EX_M!:]">E)%R4D$J216I)C6DEM21>M)`&DD3:0XH MS,),Y,_(8IGW^UF^;E9ED(\./!VL!N#=J3,E).*D@EJ2+5I(;4 MDCI23QI((VDBS0&%69BINI^%Z:&7K2"LEUF_G]-I(UT M*&-53BI():DBU:2&U)(Z4D\:2"-I(LT!!=%MSEM!.)2'*PB6;D_OAN](>U)& MRDD%J215I)K4D%I21^I)`VDD3:0YH#"+>`7AZ:>T#9<)+.F![RT3Q)-)!&TD2:`PKC.6\M0-=YQ.^$6O);9:ERM&=5 M1LI)!:DD5:2:U)!:4D?J20-I)$VD.:`PB]1:P,OF,1LN!UC2'/-T:'F3E)%R4D$J216I)C6DEM21>M)`&DD3:0XHS,+,N_TL7OP>SF:9 MP?LQ+:1HO"Z*KR>P._I/@*<=71>!-)!&TD2:`PJ2 MNSQO->!0'JX&6'('?D?:DS)23BI():DBU:2&U)(Z4D\:2"-I(LT!A5F51DI)Q6DDE21:E)#:DD=J2<-I)$TD>:`PBS.6PVXY&J`I;!5 MXBL#7)5K%:X&L"HG%:225)%J4D-J21VI)PVDD321YH#">,Y;#;CD:L!">K*T M!WY'VI,R4DXJ2"6I(M6DAM22.E)/&D@C:2+-`859G+<:8-X(C2Z\74@?$7)9 M'*L\VB]5YA(%[S0MNGX@71T^N/CXV\N)+KEN ML)!W=':D_4+F8@8OR.C=M\Q5V:.3DPI22:I(]4+>76U(K=O1OZO1NQ^=J[)W MM2<-I)$TD>:%4D&F5A?.#Y(+"Y='\H[.CK1?2%="F"^GTL)#].J6N0)[8'(. M4Y!*M^,RPXSD$:W8_H^3Z[`CCP'PX0] M:A8*_!GOTVNL^H9"/*L>R7QBS&NS^.V(94=5V3NU=^3MN(H69S-;=77\9K*+ MV\OK:,JWN=U$C[;:EKB;:TBMHR=NKK-5QYO;K"XW M\>IT;TO;"Q\J9LWAC(?*LD3AK8!<'LE\ M+,H]5%;Q.J*K<@^5TXZ6,EMU?7A<7*[6%U'OYK;"W8&"5)(J2\>A-S?KZ^@E MM;85;NB&U)(Z2\>A5_K^EG440&]+W-@#:21-ENS8F]M5=+]G6W(8.PCWZKSU MDT-YN'ZR4/@\L(IZ=>>J;))[4F;I^#C=KB^CE\+<%KBF*$@EJ;)T'/GJ9AL] M4=6VP(W;V^OHB.?F\KW-`#:21-EI:AK[?QO9YMQ6'HL&/C99P7 MG5U?<75GH:B1HU?!G:NRX>XMN36@S-+MX5EZN[F*ALEM@>N)@E1::WO)D;>QX/FG7&VB MIXS>EKBQ!])(FBS9L;>7Z^B!/]N21&/'BTXO:VRN15T=*6CLF^AX[ER1Z^ME M/_=`SI8J\\FTT^-GO8H627(WEE\5'>7"5=E;+"VY6ZS2MQBU3VUWU#WV[E=T MBXVKLK?86G*WV*5O,7IL]W;')V]Q<%7V%D=+[A:G]"U&9RBSW?&O;C%\E3`+ M7-]^TGYU7`_3A0;V?KY;*'CYC[]%=>>*['Y[4F;)MO,&K]*Y+7%WH""5I,K2 M,O;5S>8RFDK6ML2-W9!:4F=I:>?K[57\;0J]+7%C#Z21-%FR8U]MX_/&V98< MQ@[3_;>LL%UQA6VA\*DB:N^=*W*A'X?21_8M9;9J>A+I;84;>B"-EMS0DZ7C MT)>W%_$*PVPK$B;N]IH MA3)Z7>HY]D`:[4!/WMQDJY:;TPEJ_+"?@['#9XQXO2\^N?B?^]__:DU>9YIV M4?Z*ZX`+^>]TD?:DC)23"E))JD@UJ2&UI([4DP;22)I(GI=P&W7%"R%+[BQ*O_KLJURC*6]XK#JIQ4D$I21:I)#:DE=:2>-)!& MTD2:`PKC,0LPWSZ)WYKRJ%46HG-5KHN6L5R8&:MR4D$J216I)C6D MEM21>M)`&DD3:0XH3"Y>+'GF28ZK(MN%W%'>D?:DC)23"E))JD@UJ2&UI([4 MDP;22)I(!W=5IU8A9:2<5)!*4D6J20VI M)76DGC201M)$F@,*XSEOQG_-&;\EOU66*D=[5F6DG%202E)%JDD-J25UI)XT MD$;21)H#"K.(9_PO7SB[YFJ`I?`5)WI39.>J7!LM8[G3AHQ5.:D@E:2*5),: M4DOJ2#UI((VDB30'%$9WWFK`-5<#++FCO"/M21DI)Q6DDE21:E)#:DD=J2<- MI)$TD>:`PBSBU8!G7G$XY3>_XF46:\)7G.@JDYVKE)%R4D$J216I)C6D MEM21>M)`&DD3:0XH3,Y,W+]]!GIMRJ,ISD)^%X'V=D=7E9%R4D$J216I)C6D MEM21>M)`&DD3:0XHS,+,Y?TL7MY%RZJ`MU!PO9"B<0L%F_BR`5?ENNBTHZ6, M53FI()6DBE23&E)+ZD@]:2"-I(DT!Q0D=W/>0L&A/.PB2ZX_=J0]*2/EI()4 MDBI236I(+:DC]:2!-)(FTAQ0F$6\4/#B+KKA&H*EL(OBJP96L(-UQ#L.1WT5+E:,^JC)23"E))JD@U MJ2&UI([4DP;22)I(G5MANN$U@*6R6^:L!5N599QG(A9JS*206I)%6DFM206E)' MZDD#:21-I#F@,!X=U6!N^DP\ICR:X1S)_PS!#6A/RD@YJ2"5I(I4DQI22^I( M/6D@C:2)-`<49I%:)SC[*WMNN$:PD/^5/0OI%V];/_0WG8&PL%'\E;;^(W"ER5O5-[1][!PO?LV*KC=TQ M"E+IZ(F;JY8J\\L\7H+1@FV='BO*N7%5]F]N'7G#QW]S9ZN.?_/F]NHB_HQ, M;TOX4;S;U!K"V1UV&"4*^KBD$'P4;QU_F'6W[.A]$G^_D/G)''=,XS\ZL[=X ML7P6[T+_%WT)!\<'S96(VR,%';V*/V>ZU4,&O>KM<,_ M^3=WMFKYFY5S_-G(WMT#_U)&RDD%J215 MI)K4D%I21^I)`VDD3:0YH#"C\U8N;KER82EXY;F,9\NNRG;&GI21@++F)UHZT)V6DG%20 M2E)%JDD-J25UI)XTD$;21)H#"K,X;^7BEBL7EL)6B6?+KLJURC*6"S%C54XJ M2"6I(M6DAM22.E)/&D@C:2+-`87QG+>8<U)&RDD%J215I)K4 MD%I21^I)`VDD3:0YH#`+L\APQM.6*8].VH]DOG7?._N))KR[VU.5:Q50QJJ< M5)!*4D6J20VI)76DGC201M)$F@,*XXD7,YYY5>&JQ>U"?JN`]JS*2#FI()6D MBE23&E)+ZD@]:2"-I(DT!Q1DL;HX;R7C6!\VR\GTV/>Z)9K7[[RR4[LD+$M8 MGK`B867"JH35"6L2UB:L2UB?L"%A8\*FA,VA18F9.?*W/[NM+HYS:O^;$$[F M+K-7/$N=LWW"%`_J%`],\<`4#TSQP!0/3/'`%`],\<`4#TSQP!0/3/'`%(]O M43QFLNO'\^*+4587QWESF-QB>KKS>BU:S%28IS*OUV`*$Z8P80H3IC!A"A.F M,&$*$Z8P80H3IC!A"A.F,&$*$Z8P?8O"C-<0GGZI6EUPL>!DKJ\4SU+G3+T& M4SPPQ0-3/##%`U,\,,4#4SPPQ0-3/##%`U,\,,4#4SPPQ>-;%$^\?/#_T6M< M6EA=+!;V6K34J#!/95ZOP10F3&'"%"9,8<(4)DQAPA0F3&'"%"9,8<(4)DQA MPA0F3&'Z%H5YWF+#ZH*K#2=S?:5XECIGZC68XH$I'ICB@2D>F.*!*1Z8XH$I M'ICB@2D>F.*!*1Z8XH$I'M^B>,Y;?UA=<`'B9&%#16\3*;%EUR`QF!*#*3&8 M$H,I,9@2@RDQF!*#*3&8$H,I,9@2@RDQF!*#*3'?HL3.6Y)877!-XF3>3"MA M:JAE7U>G>&"*!Z9X8(H'IGA@B@>F>&"*!Z9X8(H'IGA@B@>F>&"*Q[9;E)A98S@G,5,?SY47<\]MB@>FAH(I'ICB@2D> MF.*!*1Z8XH$I'ICB@2D>F.*!*1Z8XH$I'ICB\2V,9Q4O9;S\;/`P5)2<-=T! M-_.ZBM[ZWJULU6I:HRQ-6)*Q,6)6P.F%-PMJ$=0GK$S8D;$S8E+`YM"A, M,\,^H]=6RXS<>^]I9I<[9/F&*!W6*!Z9X8(H'IGA@B@>F>&"*!Z9X M8(H'IGA@B@)+>:: M1_'`U%`PQ0-3/##%`U,\,,4#4SPPQ0-3/##%`U,\,,4#4SPPQ0-3/+Y%\9B) M\3GQ+!/I()[%=`;CO4+%UT*LS!5*YK3$I:C$8$H,IL1@2@RFQ&!*#*;$8$H, MIL1@2@RFQ&!*#*;$8$H,IL1\BQ(S<^5S$EOFUD%BB[DHU%`PQ0-3/##%`U,\ M,,4#4SPPQ0-3/##%`U,\,,4#4SPPQ0-3/##%XUL4CYD8GQ//,I$.XEDL;*CX MBHF5N;83#0538C`E!E-B,"4&4V(P)0938C`E!E-B,"4&4V(P)0938C`EYEN4 MF)DKGY/8,K<.$EO,GUZM8&HHF.*!*1Z8XH$I'ICB@2D>F.*!*1Z8XH$I'ICB M@2D>F.*!*1[?HGC,Q/B<>):)=!#/8N$<*KZN0C^D>6PHEZ(2@RDQF!*#*3&8 M$H,I,9@2@RDQF!*#*3&8$H,I,9@2@RDQF!+S+4K,S)7/26R96P>)+>:BT"L4 M3/'`%`],\<`4#TSQP!0/3/'`%`],\<`4#TSQP!0/3/'`%`],\?@6QF-^KN^< M>`[UT:*$-=V*=\J'2R]'G"BH25":L25B>L25B;L"YA?<*& MA(T)FQ(VAQ8E9B;$9S24^4&]>`'0FM]0M/V*IGB6\=R^B@>F>&"*!Z9X8(H' MIGA@B@>F>&"*!Z9X8(H'IGA@BL>W*!XS^STGGF6V[#_?F9^^,I&%#87K*UR9 MUU"G7:TI,9@2@RDQF!*#*3&8$H,I,9@2@RDQF!*#*3&8$H,I,9@2\RU*S$R( MSTELF4`'B?F3Z@^OOO[P>K=:P]10,,4#4SPPQ0-3/##%`U,\,,4#4SPPQ0-3 M/##%`U,\,,4#4SR^1?&8V>\Y\2RSY2">Q<*&PD44ZU.9;1XE!E-B,"4&4V(P M)0938C`E!E-B,"4&4V(P)0938C`E!E-B,"7F6Y28F1"?D]@R@0X2\R?5MJ%@ MB@>F>&"*!Z9X8(H'IGA@B@>F>&"*!Z9X8(H'IGA@B@>F>&"*Q[> M9;8/UV/-B*9X4*=X8(H'IGA@B@>F>&"* M!Z9X8(H'IGA@B@>F>&"*!Z9X?(OB,;-?/YZ7O^=K/KR.D_73Y-J;7FUQ?87= MU9V7Z]GQM*OM/X4)4Y@PA0E3F#"%"5.8,(4)4Y@PA0E3F#"%"5.8,(4)4YB^ M16'J*2T(\YDK8LS'Q)'88D&OP10/3/'`%`],\<`4#TSQP!0/3/'`%`],\<`4 M#TSQP!0/3/'`%(]O83R;,]H4U/0C<>L46%U&X,ML\^Q4M2UB>L")A M9<*JA-4):Q+6)JQ+6)^P(6%CPJ:$S:%%B9FYLO_L^$Q#;9:YM?_B9F>&"*!Z9X8(H'IGA@B@>F>&"*!Z9X8(H'IGA\B^(Q$^-S MXEDFTD$\1PL_J;C%113FRR7T5*DRKZ%@2@RFQ&!*#*;$8$H,IL1@2@RFQ&!* M#*;$8$H,IL1@2@RFQ'R+$C-SY7,26^;606+^?'N97FU@:BB8XH$I'ICB@2D> MF.*!*1Z8XH$I'ICB@2D>F.*!*1Z8XH$I'M^B>,S$V(_GY6>#FV6.'22W6/CB MA>LK[*[NF5!AGG:U_:)^5-QVVLPQ0-3/##%`U,\,,4#4SPPQ0-3/##% M`U,\,,4#4SPPQ0-3/##%XUL4CYDSGQ//,L<.XCG-N_VS05Q?H4O>#^?Y_O2* MIL10I\1@2@RFQ&!*#*;$8$H,IL1@2@RFQ&!*#*;$8$H,IL1\BQ(ST^AS$ENF MW4%B_E3<-A1,#053/##%`U,\,,4#4SPPQ0-3/##%`U,\,,4#4SPPQ0-3/##% MXUL4CYD8GQ//,I$.XCE:=#:(ZRMTZ1_/!F%*#*;$8$H,IL1@2@RFQ&!*#*;$ M8$H,IL1@2@RFQ&!*#*;$?(L2,W/E-;&(^^G^VL>`[UT7J%-3T(O/4* M7%_ARNSIW7Y%RQ*6)ZQ(6)FP*F%UPIJ$M0GK$M8G;$C8F+`I87-H46)FKGQ& M0YGGN7@!T)H[^]ZM:(K'GY?R[N.O1C3`,Z?JE\<9MLY5 M;+N\6UE3/WN=A@LO7)G=55$NP[GS0T4)4Y0P10E3E#!%"5.4,$4)4Y0P10E3 ME#!%"5.4,$4)4Y2^15&:2;0?Y7.)+9/N(#%_(KZ\=%W"%`],\<`4#TSQP!0/ M3/'`%`],\<`4#TSQP!0/3/'`%`],\<`4CV]1/&9:[,=C^FJS^<[\-N+9S;9, ML8/H%@N;#1=E7)[*O&:#*4V8TH0I39C2A"E-F-*$*4V8TH0I39C2A"E-F-*$ M*4V8TO0M2M/,HOTTGVNV9=8=)+98\+(&4[/!%`],\<`4#TSQP!0/3/'`%`], M\<`4#TSQP!0/3/'`%`],\?@6Q6.FS.?$LTRQ@WB.9EX\O52KS&@JF MQ&!*#*;$8$H,IL1@2@RFQ&!*#*;$8$H,IL1@2@RFQ&!*S+Q9=8= M).;/Q.VK%TP-!5,\,,4#4SPPQ0-3/##%`U,\,,4#4SPPQ0-3/##%`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`E-^GQFK6.=/IM9ZUBGSV76.M9_ M=2:C>Y#LQL-I3+(;5SK6?W$.HV/]%VS$-G'K>TP[)9ST= MYF0?ZB`GN_!PLI+LPI6.[[OW77S]^>7CUZ>X738DO#DOP7X]O=!W_Q^/][X?WO/YV_Z@WP0[_ M_.WN_<]W^B#JQ7=:=?SE_O[1_@]%^^;/^Z]_/TR[?_Q?`0```/__`P!02P,$ M%``&``@````A`.LP5R/4!P``J",``!@```!X;"]W;W)K,(.U@)'MV=G] M^W2["KJK#.:R#[/#]'%QNB[GM,'//WW;;4=?B[HIJ_UB+*;!>%3LE]6JW+\M MQO_\_7DR'X^:-M^O\FVU+Q;C[T4S_NGEQQ^>/ZKZ2[,IBG9D(NR;Q7C3MH>G MV:Q9;HI=WDRK0[$W*^NJWN6M>5F_S9I#7>2K[J+==B:#()KM\G(_A@A/]2TQ MJO6Z7!:?JN7[KMBW$*0NMGEK^#>;\M`T.)L1KN2W; M[UW0\6BW?/KM;5_5^>O6[/N;T/GR&+M[T0N_*Y=UU53K=FK"S8!H?\_)+)F9 M2"_/J]+LP*9]5!?KQ?AG\92%>X2]&]9?#3>[Z-F4WW\4I>KW\M]8;)M MZF0K\%I57RSTMY7]D[EXUKOZ!/^O1JECG[]OVK^KCUZ)\V[2FW*'9D=W8 MT^K[IZ)9FHR:,%,9VDC+:FL(F)^C76E;PV0D_];]_U&NVLUBK*)I&`=*&/CH MM6C:SZ4-.1XMWYNVVOT'((&A((C$(,JPQW4YE?-0A-'U*#-@U&WP4][F+\]U M]3$R76/>LSGDM@?%DXE\W!GP..WUTE;-'FV0GVV4+I;916/J\_5%Z.!Y]M7D M=(F8%##Q>.0P%)$=$;84AMZ)H]DYYZA,#<]G_TC)7D0I*MO:']_V8BT/M68L!)&RF[/5H?FO%QDZ"X$Z:Z] MHI#1SG`9RSSWFH\2.^,-UW57@(H3X>!]E"((&(@XX)FCZU$<74B=U6>OT:QT MW,`05)TR=.^`*000IC#B@R#\Y0O#*:PPW\\.Y)RRXP/1A5Z,L8)![!H>.H^L MBRATZ[3"5J`]AL.#*D#.?6:)VSJF#3!8V-";1"0&ZY!6%;I]45Y6ESU>-]85 MU)SPX[IK3VUFK(_\$ND8(,&C)=A#C-L=I7>7&XB^'0C-&CY%$.3%O2UR\MU@ M(H4W+I37778@^GX@E&L4K"=5_(CE,\,@QT;T!ITR8XY@"QI=/<()T'4S$"<# M%YHQ2!%D^NH$Z@TKQ#D/H3SOL@AQQB,\I\8,^BXPT7(^[[4<0<@P2)P8$7;R M+J?HT,PI/"$`=@B"^AEK#9F59!0@PL`!*#=F%L-2(L^81,A,N5EA=J3DBN\+)KGC-EG*@&$.9,Z8D.3(0"(A[%K1\J,V<,59GU;Z+6: M!`R\;^15"F2$+(N+M*Q">PF[37LEZ+JOO3V-0PSF;2ZE2PP2A"`(""_:@[W= M?8!BWQX$;_>T"WWT!Z4#?N3+"$#+\-(16#*/N#&-H/1$\4*6IK0+;>Z1!A1O M$$*[\"[/D&<\(W1JA9KB>\8D,9)W.KUAG0D@3(0#4&[,-:Y,"*B\WX+".V`@ MMZ,56'N?"$]ID9J_[GR8TKK+).0YDW`;1EK$`I2:)ZSH&8;!V5")3)SJ$';V M_.L/QW#2.C07/&ZQ"`)=B2-6[XPL7QP(=9=!=&C&*W+U@*PA"'BQQ0P7(6%* M>B=5FBXKYG?+G0(+(+W&;2!%T`5Z$`'HR*H&.EHUBQ?&<4$>M+-]SJ+K?H MT'R(F7JD",)!$('YQ^R"(%0HO(]_:`;OL@MUQBXB=C1/$829DT(HS9H@0PB? M$VT@))EWW$CRS$U&S#BD&D"8IMZ-><;6+YBNMFK.7.3Z9]C=52R+ M_*.<%$&017-@9?.3X3IL0'LWZ#2##_F(/N,CGLZ"5B,("<9\`QE9-TZI MAMEIP3PG<4*B^W5C MGH@IS.,'P=2`UU75'E_8!PA.S]B\_`\``/__`P!02P,$%``&``@````A`&,= M]3)-!0``4A<``!@```!X;"]W;W)KUJDZ*;7)D!5WI MG[32OZU__VUY9N5K=:"TUD"AJ%;ZH:Y/KF%4Z8'F235F)UH`LF-EGM3P6NZ- MZE329-MTRH^&99J.D2=9H0L%MWQ$@^UV64I]EK[EM*B%2$F/20WCKP[9J;JH MY>DC8]P>QD_2BW;SHQR!EBH+=S7A@+`Y36RVT&,^"V:R7=K?3OQ(W)5#?6R\:@?S)ZKCI_ M:]6!G:,RV_Z1%13\'>N_V3FF MV?Y0PW)/849\8N[VTZ=5"HZ"S-AJAI&R(PP`?K4\XZ$!CB0?S?.<;>O#2I\X MX^G,G!"@:R^TJL.,2^I:^E;5+/]7D`@?U%7$:D7@V8H0>VS-IV3J/*$R:57@ MV:I8]L-#`&8S#WA>AK`8$]M\9@`PX4;#N6K\#R]FK0@\+[.PGAT(;,YF(/!L M-4!-O1:&6-(N12.4$?9R)SPCZ. M+7.B/LY4YL1]'.?*,<#GJ]FP`;IF]V_"BZ>.= ML'%XCPF.(XPSS?F"+-#D-X("OU?_44#[@XQ@D!$.,J)!1JQB2';"P8SMM._> M<9?MQ3MA._'V$AQA)YG.+,="A]%&,&"D=]T<9`2#C'"0$0TR8A5#5X-A-<")L(["+TS8*6E_1-5!@H5HV4G2-[W:5S(+KK&N6 M^NCC9&P2"BA/]VE4SB'Q.='$-M$B=C MD]`1[PE.:X1ID]D8+3 M'VH*S%=@@0(+%5BDP.)^3/*&0-KQ>(@U;.P.VDU>2^JW1P()0?>&+\'HJ`M4 M8"B!-\*1!(\F!(5]+./=RU^VB^>LG1WY6.9&1*8KI6X3-`*O)=VQ32CT@KZJ M9Z`"0Q482>"(V"AEBN_CLF4\"7[>,I$ZRY:AR\TC@M3KRD8%^BHPD,#1!,T[ M5,.1!*,0CB6P*RU;QI/ACF7JXH[8V3-+;1G M`Y5T.-0[DGI;^$"(47_GWH),&6B5._6,:=3EE!#C:>WS[NG,B&9>=0 M1'B\3@:7J`@9VX*BEV.BT6]:CBK1&*8$PY1PF!(-4WBID4^I?[C"3U%*%#6B MG)9[NJ''8Z6E[(V7"6>0O5];10DSAA*FQ2L0J-TC+M0G;MLWQ(4RQ6V[3URH M5MRV!\2%HL5M>TA6%U5#+;/X\0.V:0F7%'`-YQUA]>>'_X%H-7_\'``#__P,` M4$L#!!0`!@`(````(0!2H:FB:`,``%<*```8````>&PO=V]R:W-H965T&ULG%;;CMHP$'VOU'^(\@Z)$Q(N`E8+8=N56JFJ>GDVB0%KDSBR MS;+[]QW')-BF759]@=ASYF3.S#CC^=U+57K/A`O*ZH6/AJ'OD3IG!:WW"__G MCX?!Q/>$Q'6!2U:3A?]*A'^W_/AA?F+\21P(D1XPU&+A'Z1L9D$@\@.IL!BR MAM1@V3%>80E+O@]$PPDN6J>J#*(P3(,*T]K7##/^'@ZVV]&<9"P_5J26FH23 M$DN(7QQH(SJV*G\/787YT[$9Y*QJ@&)+2RI?6U+?J_+9X[YF'&]+T/V"1CCO MN-O%%7U%<\X$V\DAT`4ZT&O-TV`:`--R7E!0H-+N<;);^/=HMIGXP7+>YN<7 M)2=A/'OBP$Z?."V^T)I`LJ%,J@!;QIX4]+%06^`<7'D_M`7XQKV"[/"QE-_9 MZ3.A^X.$:B<@2.F:%:\9$3DD%&B&4:*8A,I4FB,PEXG$E0-(PF"4K2VRR!CJ@5 MF&&)EW/.3AXT#;Q3-%BU()H!8E0-`^> M(:?Y&;/2F+'O]9CQU(:L.XC*H.+-NHV+#[)=-AU"E0\D];H@6ZZN&.K^]XIU M,I23+2,.[?>MKB&.SO4U8N*09-<0AV1SC3!(+*'Q_PA53M"$1BT0BAVE&C,R M,(F-6-]$9#<1F[<0EDX(Q"SHVX54X(4/2>Q[#84C._J5QDS:;ATEH=N+IGD0 MIV/;.[/,48J<$F],.PJC2>]NB8(39XI2I^]VERHG1QQRQ6G,J!4W<,[,VC2Z M9<],XR"^Q-T>R(UE-7-JR4IM66_72H%=.4ZGK30F[6KE1+76YK/:.'&2D9G> M@R@=.>X;TWT:7;PM3?#A?.*&M32,*G2;+ M3&N$G`[>F%:47)K`DJ5N*,[W_[8LY>3*<@[(2F/.QPO.EZUZ;9H'HZN26>9H MXAX_&/8J`LT^'E\^75J;'N1ZSE6$[\F:E*7P4X7`,O<#US4`O)&O:4;)E$B9Z^WB` M"QR!L18.`;QC3'8+-;SZ*^'R#P```/__`P!02P,$%``&``@````A`.2IK]&5 M"```=2@``!D```!X;"]W;W)K&ULK)I=9=]XT/E4U6NU5O6\\R_E1,&X_8Y&\/KJ[[U!L'\_>YSE1OW]JC=V>:\<_0/[L[V]!&+Q&%9*K)@W%/G>KW2HI/3T<6^G@O>[>3]$J^+`\_^T8D;N;U"/6,>/P:^"%>QI1DJGH3::T#T[4 M`/J_=/99:-"(['[&?S_\0W1\+-=;E6:[5M?(O/3BA9'I,\ER:?\>1L'Y?XF1 MEDHE(GHJ0G]3$;U6T1JUUAX[W7ZD*%K@J&B^(A'72ZX`.6:7Q1T38O2A>\WQ0T!45TNAV/ M%+OX6FTZCPYV(6JKZ)VFUHQ]B]56D_B*PW6PBW9/#[?@HT1K`"F$UQU;431# MIR'C@9I(B-#]+'(I9)G*,Y-Y+%/G*2A#FFX_GNK=[D/U!TV1?6K30QLM;]'G M%FP^,-F!"H8J,%4P4H&E@K$*)BJ8JL!6P4P%F77L9.Z<7DHH31/S MN=[N*#-:&/%B`R!#(":0$1`+R!C(!,@4B`UD!F0.9`'$`;($L@*R!N("V0#9 M9DG.IS0'O^!39IWW:4(:\9M)G#_U@0R`#(&80$9`+"!C(!,@4R`VD!F0.9`% M$`?($L@*R!J("V0#9)LE.0=2_IMS8)),5]B;3W3T]]][0?+.=F>RUBEI3E)I M)I+W:T+HA89/PSZ004+8BUUF/BL9^%`8<2$3R`B(!60,9`)D"L0&,@,R![(` MX@!9`ED!60-Q@6R`;!.2#'W.U6RC!M^;ONAJ)I)W=4)TF6#W@0Q20E$H7=VI MY9?NH3`2K@:A$1!+E,I**ZG@6!AQZ0D(38'8HE166LDS9L*(2\]!:`'$$:6R MTO7\@"R%$9=>@=`:B"M*9:4;>>F-,.+2VZQ0+FQH1R,7-G=6`IK#?"E@UOGX M2(A&:8'PO5Y7']O"B+=G($BFF*:&3&*D4]N%=KVF]-442EQ[!,021`KI:FWC MU(AU]L=3HZ8W-"7.)D*&5S4%8@M24-4L,2KNV%PH\=H60!Q!"FI;ID:?=VPE M9'A5:R"N(`55;92J&MV&,J&V0H:JR@6B1KM.7XC$V#P?BBEBNV8B7O2&$E1] M:<4[.T`T3%&C(1YQ)EJ-$%D291H!L<:MVG&P:9T:_$XP?Q%)$M M44%UL]2*>B.M8";-I18?F04B!]&2H\][L^(FLC=K1*Y$LITP43?J#[@4M60$ M]%.4?*Y)]X63@GI7Q,DPM6K3NB:6HWI'V:,RI14/L!$B"]$8T031%)&-:(9H MCFB!R$&T1+1"M$;D(MH@VJ8H&?M\!+"-J?\_`M+M+>GN'OM>0UE/2_JVCVB0 MHC8M&!EW*ZOZ4%IQ=YNH-4)DR8)9>25#&4LK+C]!K2DB6Q;,RBL/[YFTXO)S MU%H@0P3!'9$A54-TNMBCLXEUK<=7'$3 MV<$U(E>B@NHVW"JMKM&E3^GY&;'E)G%U^?ADFW9?B,]TCT^VN\>^_K/(HV@3 M"Y;>4J9\7UKQ\1T@&J:H^(W&Q((C1!:B,4?)*XS6[=Y)ET5O>#NGO)3,X6U$ MLQ05-WV.!1>('$1+CCYO^HJ;R':N$;F(-APEVG2@!H9ERTUB[7P`L4W#+P10 MLL>82X031-N[F0!2]WWZ;/VC,,ML`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`\9J'W6&7E.YO M'[=T!:+:6X?\Z:[]Q1ZM'*_=O;\M*^C?V_S]V/C>.KX4[_YA^QAM]SG5-N5) M9.!K47P3IN&C0.3]9F8'TT'K,G];?7T^KXCW(M\\O)TIWCZY(7-CH\=7N[:SDV[]34_GF9;(=5N M;;X?3\7N/]6/MI2HG!WI3)_2V>UW>C>6:U-9EXJX4H0^I8AM=YQ!S^[UAG7\J+IDXMT.I[3NQF4@7]29%]Z4AVQYX7!4HM-C<& M\86+O?1JN3G8JCW8%UXM-PC1<[C82Z^6FX1-7Z2OK'XKU%HS-E^/BV%F.]/1)R/(14W:`> M5#X:4V@P$2I?A,Q=FZZ$AHTC#80_[IW!X+;[@P:OC;1Y0!M;MQBSA1BIA.S$ M!%,3S$S@FR`P06B"N0D6)HA,$)M@:8+$!*D),A.L&J!+Z:ES1#WI[\B1D!$Y MXMI]8-!(FI$0MF"7B0FF)IB9P#=!8(+0!',3+$P0F2`VP=($B0E2$V0F6#6` MEA`:G_Z.A`B9NS;];72:H9Z!!VE#0U-MU---QK5)G24@4R`S(#Z0`$@(9`YD M`20"$@-9`DF`I$`R(*LFT9)&$\/?D30A0TFC\;Y.B#.T])0\2*//LE:;U%D# M,@4R`^(#"8"$0.9`%D`B(#&0)9`$2`HD`[)J$BUK5(5:ULXO;7D:$M9E_41NPV`3(%,@/B`PF`A$#F0!9`(B`QD"60!$@*)`.R:A(M%]3F MK\B%L-9S(\16A;2FW[W%%Z,B#R402FHT:'<75.\JT M-F*W&1`?2``D!#*71`6T`!+57HT0K;X>8EP;<8A+(`F0%$@&9"5)&:*6'G'> MH.6GVDEVQ%[V]++=?'LHJ$YIBW-F!G=IQRCWD4)%SULI3)Z-Q$G4S!PC45J] M!;6,+>A467'%S!#YB`)$(:(YHT8"$46,/@TU5E8G]L1(J<>,9.S6C>M9`T-]B>H)^RGUE*W4ACEC-"Q'17=H6[V>8^SD5FQ4 M5K*>>NJ,_V_JA82Q0JN0T5N-D\RQN+UB]M8*>;394MW<'!>GTM$;E-=L=6R8 M"4#9ESX4$K>S@&4^+2QDJ^9,X%K&Y#275N*N3R-P8Q!>8!`1RW\:1,Q6>A#& M92\O"B+!(%)&-`\WHC>N,>,@JJ9F=2QH9LUJUYN9.,DP1QB[IY:0?Q5O'^T% MFHL.>2#2'&4J1*,,YW4LDB#:57-(`3255C3#L^,,'7U$`:(0M>9HM4`4(8I1 M:XE6":(4489:*\U*SY$XX3!S=-%T+1R-`:!"V@#@FNUE+.YXF@,`H*FTTJ9K ML/)1*T`4HM8H)^RGU%%'&B&,_/TLWU?6,BT.6_RWCU?&,MDV3)S;-I;1K&0N2L5U9T7#! MP^,$T93133D3VY9EV^:MKQG;*"4?48`HE(@ZOIJ57,O83\[1<8$H0A1?)+]$ MQP11BBAC5%6-:]N>;2R`5FQ2UHR6<#%P8L*O6I&7$GI?ETCKZZYE;&K'TJK9 MU]E1K6JGC*I5K>W2QG!@I&:&2CZ[J>DZ8*3$0XEZ>A,UY.H12RGUF)&,_?PHC^H)JJ>,AO7E9!*YEMR+#09]VS-J9J6IZZD7QV`P MRE_7Z:N3M.9P[U3(Z/3FR8FTTCI]Y=BC,Y6ZS3BP%Y../8_W8OKQT`R%?161 M:@B7E!6JLE1$N!53)2HKQS:W8AA$Q/*?7G#,5OJL9&[%+@HBP2!2B5RJD(]K M/6,KKG5S:;U2Y5,=ZZU,G)&9K>SZK9A3';5I+:U"S3N9TJJ!)HBFB&:(?$0! MHA#1'-$"480H1K1$E"!*$66(5AK2EEP'*I03\XO%K`L8O M]/[`E_*VI\$?Z+V"CSH3`'] M$3V]#4?9.3ZQK9&X$7O&@WX1]SWQ%[K# M.!(W$?$7ND-(:N=^H3M\(W$3#WWH#AV54_[2K2N1WK%X6S_G\?KPO-T?6Z_Y M$S4*>K:;.O2A>DNC^N_ M+M\VJ_7+I]/1V<7IR?+E?OVP>OG^Z?2?_PC_]N'T9+.]>WFX>UJ_+#^=_K[< MG/[]\U__\O'G^NV7S>-RN3V1#"^;3Z>/V^WKS?GYYOYQ^7RW.5N_+E]DR;?U MV_/=5O[Y]OU\\_JVO'O8-7I^.A]?7%R>/]^M7DZ[##=OA^18?_NVNE\NUO<_ MGIO)\?Y-\?UF_W7U]DOW^;32]NS>Y=_]`^N?5_=MZL_ZV/9-TY]V&EM\^G7X9W;33R]/SSQ]W!^A?J^7/S>#O)YO']<_H;?60 MKUZ63/\T*#]Q4 MZ3&[394_=*V;R9^FV?$'>"3GQ6[E(UNG0P_QR%1'_>5/ M;((4M]N$0:T./'0C4RWU%[,)AQR\D2F7^HMI>.A*3<%&MF)_<,S.N\ZQZVN+ MN^W=YX]OZY\G<@&3TW_S>J]5K0_IJP8)("$D@L20!))",D@. M*2`EI(+4D`;2#L6IFAQ"IVKO]R@5O2N..:BW6IP;T=2_S?1!IMD"$D!"2`2) M(0DDA620'%)`2D@%J2$-I!V*4PLYYX^HA8IV:Z'%WG#FD`4D@(20"!)#$D@* MR2`YI("4D`I20QI(.Q3GP,O9>\2!5]'N@=?B=@+_UMX']9T`$D!"2`2)(0DD MA620'%)`2D@%J2$-I!V*4PMY)#ZB%BK:K866#_U3UQRR@`20$!)!8D@"22$9 M)(<4D!)206I(`VF'XAQX&54><>!5M'O@.[F4_/V3U&0Z<6_<\SZH[P20`!)" M(D@,22`I)(/DD`)20BI(#6D@[5"<6JA!^A'%V(6[U3`TZ`>D!2D@A:2(%),2 M4DK*2#FI()6DBE23&E+KD%L+-4KT1^SC\9G9= MTPP->Y&.LK1@5$`*21$I)B6DE)214`!HT)21(I)"2DE9:2<5)!*4D6J20VI=<@MCQH@'E$> M/9X3/?#S$6A!"D@A*2+%I(24DC)23BI():DBU:2&U#KDUD(-$(^HA1Y/ M#FNAR>TJE_Y=I8^R=Q50H*9PW`X5DB)23$I(*2DCY:2"5)(J4DUJ2*U#;GG4 M,/*(\NA1Y[`\FH9=!;10'W"X!SX@A:2(%),24DK*2#FI()6DBE23&E+KD%L+ M-8P\HA9ZU#FLA2:WJUSY7:6/LET%%*A/EMR*A:2(%),24DK*2#FI()6DBE23 M&E+KD%L>.:K'E$>%>\,83<.N`EJHS]'<`Q^00E)$BDD)*25EI)Q4D$I21:I) M#:EUR*V%&FP>T56ZL:DS5M$D!WLPPO<^=)R/^BC;54`!HT)21(I)"2DE9:2< M5)!*4D6J20VI=<@IS_BX$?\NW.TJFJ:[ESQVG^;.20M20`I)$2DF):24E)%R M4D$J216I)C6DUB&W%GM'_!/UULO)]G%U_\OM6CJ`!.T93T[DL_CN$_HQ1_N: MU&/XH`=Y'TG.3=2XGR98:-IM0/]Y_\S[5"RP4:;KA6QLE$G?.KG<,^"XF8,Q9PXT MR8#8K&Y.6FBZG/11`2EDPX@4LV%"2MDP(^6FX;3?KH)4LF%%JMFP(;5.0[<6 M:OA^^(UKK$?[@V<\36K$9;O=S)]DLU&F8@M28&BV>^=F>G4A+[=Y_3`T,?;H M1:38DMVJ\BH\8?N'9^SD3?AD=HT9K,S4DXJ;&;3L&141:I)#7.U3I1; M4#4M<$1!]2S"L*`=J7'!H*#>D9F/^RBS@PM2H&DJP3;7A7=RA&P8D6)2*Q1T];#"O=D===_8'#N(\R M^[W0-+[NBQ]HFLC#E>VN,^\1*K2Y;-2>2F.-L6UH-B+1)!<(5>G9V;7W7)2R M34;*287-;%96,JHBU:2&N5HGRJVTFJCX\Y76TQW#2G?D]NE+[YXV'_=19K\7 MFB;V<2DPI)ZHI8>-+N1&BSHC4\3D,2G1U-]6_6M%RC89*2<5;N;1V=2[E91L M4Y%J2\,SV#N2C8GJGD;D8>1J^L'K5ZV)V5U!W=-`39O@-)!7RG5__\?Z=3?, M.:+SZXF8X2G1D=OY+[T^-%=7;G69MPT7FN3!T)PE@2%]2ES(F_T\)9`I8O*8 ME&C2_7QR=ND-4%*VR4@YJ7`SC\XFWBVG9)N*5),:0U>[/G)Y-;J^8OV'!\2M MOYJ70?UG]H)O3H`]XURYC?0#73V]8VMW*U=L54YG+@*T8%1`"DD1*28EI)24 MD7)202I)%:DF-:36(:=&$W]>2-V4Q\?.1>RRN--%FBY59^^G%/QS?FZB;&T7 MANQKAH$A)Q>&12;*YHI(L2&;/C'DIODOO?F#TD39 M]!6I-F33-X:<]#,O?6NB=NG=,\"?C7J_-ZHG(S47;K?S5I-[5\;XUT:9Z^V" M%!CJ[CCR#3WYS_VP)#0A]I$](L66[/DG-WDW5Z*CY#K7/6;[)VAJTYBMSD@Y MJ;"93<.2416I)C7,U3I1;CV/FUN21R+4LR/WECKSA[^ZX?"62@HT_<'PEPTC M4DQ*#DJ?LF%&RDF%36^+V!\<0Q4;UJ2&N5HGRBWB<9-2$TY*:?(ZI?=D,+=1 M9F\6I$"3>AH87,N]!\_0-K11'!39*+/&F)38-?ZW?MGM\6#T]#!\WZ3[I))^?RV\]#V>,^F7F/Z7/=T.FN74-Y M.#"'(C#IG>$O9JN8*R+%I$33^U>#E`TS4DXJ;'JS0R6C*E)-:IBK=:+#YJ`UMC:7'&CWI%#3/^CP?V;X*[T>)T@_QV1W M98+AKV[H=/ZNX7#XJZ.F,I)Z[P3IUVC.K(CI8U)BTK][_J5LF)%R4G%0^I(- M*U)-:@Y*WSH-W;-!327A;#AZ,#SI9J1D/>;HWVH:#H9)"U)`"DD1*28EI)24 MD7)202I)%:DF-:36(;=&:BK#K]'_]"J^O!^,GJK)?8C"4W4?9>J[,+GL.TH! M*21%I)B4D%)21LI)!:DD5:2:U)!:A]S*J=F?8>7^8!#;318YO4B3/F/76Q4 MWU5(`2DD1:28E)!24D;*206I)%6DFM206H?<\APWWS/E?(^A05A]9S&V5[ MDD!2D@ MA:2(%),24DK*2#FI()6DBE23&E+KD%L+-8]Q^,U?S3YXPVQ#;E?QIU!LE.TJ M.IQ!2D@A:2(%),24DK*2#FI()6DBE23&I+ZD45[<+KR=#^:V/V0 MV_/R[?MROGQZVIS]AR426[%[YQ9*I M+-E];H8E,UFR^]5%++F4);OI!G_)^/I&?;(L%T-_R>3J1@VS]RWY($MV_1AM M))L,*O:TF5[(%NR^=N"WF:J?K-S]P*._9"3[(]^QVY-M)/O3382AC6RU?-EH M7QO9:OGJR[XELM7RK8L]2\:RU?(=@#U+I,G>%B-I(;\3L*?%2/93OH>^;XF< M!=U+X-@;.0ODFP#[VLA9T'UPXK617P#]LO>,4JO?ETE6OC=>5KUOS5^F-U_V MGTKJO-RW`JGBWB)*#?>>DE+!O064^NTKGWSQX49]K8$'2;ZS<)/L72)?-[A1 M7R9@&_FFP(WZ'@"7R(OXLIY]ATI>JY?U[%LB+\G+>O8MD5?>93V[)>=]!>67 M4E_OOB^+N[?OJY?-R=/RFUPX+G;OVKQUO[7:_6.K7[KZNM[*;Z3NWK]ZE-_$ M7&ULK%IK;^+( M$OU^I?L?$-\WT&WS5))5\`.,=J75:O?>SPXXP1K`"#N3F7^_5>Z'N[H($T:K MD89P7%WVJ57U7 MG8HC''FISH>\@:_GUT%].A?YMEUTV`_D<#@>'/+RV%<>YN?/^*A>7LI-$5>; MMT-Q;)23<['/&[C^>E>>:N/ML/F,NT-^_O)V^F53'4[@XKG^?BY:'_).;K0/0'C_=M@/Y7%N^U\W>OWE7ORW.Y_:T\%A!MR!-FX+FJOJ!I MMD4(%@_8ZK3-P!_GWK9XR=_VS9_5^ZHH7W<-I'L$C)#8?/L]+NH-1!3MI4>[@`^+]W*+$T("+YMX>^A!.7VV;WT`_&=Z/),!!@WGLNZB8MT66_MWFK MF^KP?V74,K).`NT$/K43$=S)Z4B,QNCERLI0KX1/O5)V9[^R#KRVEPV?>MWT MAU\WL900`VU9\0_ M/G>Q`U44;8W%>9,_WI^K]QXT+J2]/N4X!L0`KU/5&VRRXC:`6D;'`(D:WL0\D/I#ZP-('5CZ0^<#: M`080%AL;Z)A_(S;H!F-C6"T,T`5+>H$P%F9)[`.)#Z0^L/2!E0]D/K!V`!(( MZ'H6B`"*Y?((,C6!JV#8N#4AAI3H0MM`D]O"&5&3R)K88#`D84C*D"5#5@S) M&+)V$1(3F&6N$.!N:$4,B1F2,"1ER)(A*X9D#%F[""$*4_\&HFA-B2I$ M0!$Y2?:G@#4RT8@MTBV3_GQ)M-&HW9+D=!;.:/&DU@OX):Q0/KL;X_7216O* M2B'2+5TQ]N>\,A)CF^.8(8E&)BT%(<;>IIFZ*P@#T!4W,$!KRD`A(4Q`)R_> MIAXI(TB>S0M#$HVH)(03Z44A=5<0!BA("`6E3NXFT'3-KMQ\651P:;!]7TA. M`/'2V@2]4&JM8Y#$;G8",:&U$6DK-SUFX:,B<8OOYW@K70-[B\G-0BC(ZS6O)Z+.RBR,-12`0K#%(%FW&2N,_=='.0DG MWJQ.B6O*&<7'-/<@VW(#;92L,0T@IR)ZE@4,RAA$,IAY8<6G$HX]": M0#06J#IX+&X6%T*K%QC=-FO!S"OSA;'"IC+JW1^_G4U7$JXT:CLMX58IAY8< M6G$HX]":0#1@J$#\@$FXT;P]9%K+N$VC(*I"I#>&(^PIF#).E<4<2CB4'MAHA>! MA5F4$C^4(*H7E^`/DJK$#F%B]8_+Q+L!B82U,A<5=U"W4/(-02]46[\(Q=1K MF[3S`ZXI.10V-Y!3.HB0L]*HN\9`>EM2)*Q51XY!B;%2,BR01U%"/Y4 MH[5>Z,S1$':`!A9U5I:WAJ2CTXQ[HM.DK],Z7]T9/^;]K^@TR76:AJCV MEKY.TU8P]#O>VI<[F7A;FC,JG1;.9M)[+I,2UZ28)4HGMYC]7'].I[5NO&0K M4889Z)(=>%<6Z850$AUIM9!4R072VDIUL`S@GZ?1B6M*^I(@D_`$'':[ZS-7 M6@EF+G>A(9KFG;APQNYX(TM`( MIJ-3H_Y^J:V<1,7&%Q2A77BA1O49/[Z!(JXI9]06/F<9=C?+IC%OR*^2*R2_ M6L'0)O7W5*FL2'X5A#UV+0#:2@=@/)ZR`>VZI@%`L>$'0(QX`'[0L4JS$-(* M6'%IQ*./0FD`T%JA@_%A@U]V0?"6"2!RT+G)S&`1>6T:H M+#S=JR$HWO;!P-!_AIMT!F9,IMS-DD.K;J'V[/5BUAD8SVOBAH8-58\;MA^4 MBA)))$07=%,0>.HJ@BG7ALC=N2UTM3^TE0KD!&:B)PI2[GK)H54'73E;9JS4 MV<93=KNR-A9\>\'?AVX(96M.]8"&R+8>!-X&%W56)K]Q!UTAEQ@KI0=FTZ&W M`Z?&H%,:2PZM.NC*R3)C94XFO+2MC0&_>\`'B[<$DJO)U@-Y-!%Q*.90PJ&4 M0TL.K3B4<0C?FL`N4&-5]:%Z"T+]0GTHSJ]%5.SW=6]3O>$;#G"+]7AO8?7Z MQ6(\AY\F(/<^+N0<'['Q(T\BF#_!N?D1>!0&:X*+1T(XTE8Y.\\(CK0O7OA' MY&2.(_K">0+[SHBW)A;C.3X#X&MB.9WCF.1'8`;.< MMIOV6;WLHKXT^O'O<]7`2RKMD^`=O)14P&L"0WS.]U)5C?D"D1C8UYP>_P$` M`/__`P!02P,$%``&``@````A`.@>%RS!"0``Y"P``!D```!X;"]W;W)K&ULK)K;!^0$+B(,+VA,U)`@DD8G;W M&F/9)AJ0`W"[^^TG2U4IJ>K'#-[N&X,_,G^E*JNR#M+-GS]VV]KW]'#<9/O; MNMVPZK5TO\Z>-ON7V_I__AK_T:O7CJ?5_FFUS?;I;?UG>JS_>??O?]U\9(=O MQ]3F_]9O.X?DUWJV,C>TOW],MS=MBM3O3OX:5Y?#NDJZ?< M:;=MMBRKT]RM-ONZ5.@?KM'(GI\WZW28K=]WZ?XD10[I=G6B^(^OF[U9NW\'Y#? M;=:'[)@]GQHDUY2!XCU[3:])2GTVHFM0BZQ^ MY)\?FZ?3ZVW=L1INJ]WMV61?>TR/I_%&:-9KZ_?C*=O]3UK92DNJM)0*?;)* MI]'N6LY71!PE0I]*Q&OTVFVWT^M2)!>N[BI'^N2K5V[A@B/)YC=/G\K1MJZ[ M9$=Y=@O/*V.E<9=?DCZ_%JNG'.GSB[':U*EDCD7O4NEK=&W+<_ZA8>VB=]`7 MY7GE?=K<)<27K]VIS1U!?.%XK\R+S7U!?&'?Z^Z5.X,8/5^\5^X--GU1KG37 M%SJ>3?U&IJ3:@Y!==J'+.6G*(9]7D.'JM+J[.60?-2K+E-3CVTH4 M>;LOU+AVR*L7U>2S8D)51*C<"YG;.MT(E8DC5<#O=X[7OFE^IZJU5C8/:&/K M%@.V$"5*R`Y-,#+!V`03$_@F"$PP-<',!*$)(A/,3;`P06R"Q`3+"FA2>HH< M43_Z'3D2,B)'W+H/#,JDM8R$L`6[#$TP,L'8!!,3^"8(3#`UPEW)$3(T%Q;&32MGJ=GX$'94#TJ1I8QK@:%29$E(",@ M8R`3(#Z0`,@4R`Q(""0",@>R`!(#28`LJT1+&DT&OR-I0H:21E6^2$C+LXRL M*:-+62M,BJP!&0$9`YD`\8$$0*9`9D!"(!&0.9`%D!A(`F19)5K6J`FUK)U? MT_(T)*SSY'"C/BA",ULE76:9*XS8;0AD!&0,9`+$!Q(`F0*9`0F!1$#F0!9` M8B`)D&65:+F@/O^%7`AK/1>2N/EF)I_?!T"&0$9`QD`F0'P@`9`ID!F0$$@$ M9`YD`20&D@!95HG6\+2N^D+#"VN]X26A53CW[X$DK7(Q,%2$!F)EH#AZ71L5 M1BPT!C(!X@,)@$P5*0.:`0D+KTJ(5DLT&I M/$'DE^C"Q0)EU:(14+D78_

<70^"$-^?E[+L%J4 M5AQ$7*(+021E$*+9>]VN/MZ6I0H)ZYU+[,G-\Q'';?QSWY*;>=HG<*P/XB2- MB@6=!%=B]8Q8!LJ*CI'8<8AHI)!;]I,Q6DT0^8@"U)JBU0Q1B"A"K3E:+1#% MB!+46FI6>J+$7MU,5$NL9JZ>@:EFF\5<(:,<&//K0%EIY4!JN?*X79QEC5A+ M5GW7[KANQUR]C%%JPGY.T2%\1J5ZP$BJ.U[+:?ZCFOU#/4YJB_8KU2/V:I7W$["R,NKHN/95KO=,O9H2S;*>[R>>K'E_\74 MJU.#WE]VPU;)@)I$Q%>5*& MQ*7!9YF+%PO8JCH3.)8Q.4V5%5VQ&KA1A&<81,CR%X.(V$H/PKCM^55!+#"( MF!$-O,^;/>$@9%>S&A9TLVJSZ]U,G%&8W.V5\&XDF12%29SB&BD4+:=`V.$W3T$06H M-46K&:(0481:<[1:((H1):BUU*ST1(FS#G,P7;=HEZS MM+2BSL.#92A*G3[*1HS4"OV361K\)NQ7JON(`D92_;-9&M1G[%>JAX@B1BKV M3V9I4%^P7ZD>(TH8<>SG9^FJNIYQ<7SR_V5<>!IC4R)C;!H+DH%XPFJ.34`C MMNKF,[%M6;9MGN>/V:8,GK"Q9.L# M>ZB0MB)76G)5:SNT,>P9J1FCTH25RNG:9U0NF0.%VM7=WIG,0Z`SUBKE0T:E M?'25_%Q956K>@K5*^9BMRF5$PDBND]R.9WN0^6KH>N;%6]VA57IT) MZ0UJ+$\'MCHG*D?J4*&V?%U)[L6D5;NESF$LA[9+QGIXC%(3A:CN\!SBHWK` M2*I_5N4AT!FJARQ5QAXQ4K%_4N5!?8'J,2.ON)U$(<=2>[%>KV.[1LLLE1'- M"-0,6NI%1?[%U.<2^J!7R!CTYLF)LJIT]J%";6UE`'LQMG)Y+Z8?#XU1>*)0 M9$E':3;[;&VSM[%ZXW4'^]N"ER\ M>WF?/_H9W^O0`$/FPVZ?'9]/CVH.6/?ZR?G^-#KC_+Q;]RP[_7IB<$9 M':]/9_[(8Z^?Y+Q9"-$[IF^KES1:'5XV^V-MFSY3DJQ\PWR0;ZG*?TYJX_R8 MG>CETGP/_4IO$Z=T:F:)D];G+#OQ/W3A9O%^\MW?````__\#`%!+`P04``8` M"````"$`TRSM#38)``!$*@``&0```'AL+W=O=M7S_O3Z M,/S7'\EOB^&@;K:GY^VA.I4/PQ]E/?S]\:]_N?^LSE_KM[)L!N#A5#\,WYKF M?34:U;NW\KBM[ZKW\@177JKS<=O`G^?74?U^+K?/[:#C812,Q[/1<;L_#;6' MU?D:']7+RWY71M7NXUB>&NWD7!ZV#-N^/V_/7C_;===7P' M%T_[P[[YT3H=#HZ[5?YZJL[;IP/$_5U-MCOKN_U#N#_N=^>JKEZ:.W`WTA.5 M,2]'RQ%X>KQ_WD,$F/;!N7QY&'Y1JR*<#4>/]VV"_KTO/VOOWX/ZK?I,S_OG MO^U/)60;ZH05>*JJKVB:/R."P2,Q.FDK\(_SX+E\V7XQN M.A^'"LP'3V7=)'MT.1SL/NJF.OY'&RGC2CL)C1/X-$X"Z*\+`R9F`'R:`=.[ MN1HOPSG<],(XN-K.%C[-.#5WL[TP<&8&PJ<9.+GJAG,S#CZOBPSB;F<(GS=% MMC3CX/.VR!2T3'M'_,?%.8YTZ=M.BK;-]O'^7'T.8'E"<>OW+2YVM4(OMH=T M/KNN^EE303>AER_HYF$(F8)^J6$E?'L,Q\O[T3?HWIVQ64L;12TVU@);%=U& M',0<)!RD'&0X8M&Z388-8&T(V%L572V=DAT6"Q((D@J2" M9(+D@A0^(;%#36^(':UI[(8LNHUC(T@D2"Q((D@J2"9(+DCA$Q(H5(<$BF=( M&-ZY\_SJ8P0]T208`D=JMT&$*F1;1&?4-8`@L2")(*D@F2"Y((5/2%Y@TB0O MEYL?K6GLAG@-($@D2"Q((D@J2"9(+DCA$Q(H")<;`D5K&J@AX-\K\H05N3/J MBBQ(+$@B2"I()D@N2.$3$CN*IAN";\UI]!9Y=98HDBB6*)$HE2B3*)>H((C& MC(K)5XV7.UMI@:4?A5IAMS9H"ING5W)^]#NKKN8.N8$!EQ6QL8+S&*5HL%A. MF!A-G!]P38-#%71#<%HTD>`TFL*&V06G9OS44IV5"TZ@V%BI>1N)4C.F#1+B MA@:"VN6&0(S4:1]8394T8E6:L86I.BL7B$"QL3(EFT!T[SM=U_7%>09FJRG#4/(FWE$,2+%CT\C4JA0S7E\G96+SR`GZF-EW,,T MNJ*':D%])<:*W#%0+J,T;I06_WO<1J#X<6O$ZLJ6R`;5+&S48.7B-LC?J0.Y M^LP=,?>P^N:3.=O+$^*:QHPJXU+,?U3O/ZLU?&O1%=N(%3]H7[^T+;%1`D42 MQ1(E$J4291+E$A4$T5R@LN"Y"(([2.^-3QFP??`SUR*_E&'`GL\VSLKU@*]W MVCS&TBJ1*)4HDRB7J""(9@@EB9^AGAW`[PHT9X>O0?[A*U"D!(HE2B1*)Z26*)(HE2B1*)<.QPW02=E0M. MH-A::6$Y681CIT+:73VQ%NW.02-!K7-#)$8:>5M0H!$K$]?_SLI%T@VT*#96 M^+.#EQ4133?06?U4>>'O'R3`7UMH1@?Y<6O$*L@59WM[4#EN8&10L.S$6&Q0 M2!1GP!6G\W5-W"B(_,+^6MQ&5KGIKP.-)M"'7HVXXC16T!6VN)%!H;\S!7)9 MFCMJQ3E9+KF028AKVLQ]*DO!;U)0JO;IXCK%&4B)91#NYR[HD$LL8T6*K7V1 M+ND)VECI%1R$\!][VB"N:=`H:'BA@Q!_)^Q[B@)LE34N,Z:A#*+%#=G&N#%6 MI+C:EX=B:Z4WV'`Q96LCL08]^RNJ$Q$3+/OKGQ%A>8G@-&)%9)G>F(&DB&:@ MOV*->WU:0G"\7OJZ]D+JA;^VB-C\)KWJ$;CU0D6005.XL]>C_+PT5EZA(NOK M\L*T5C]_%"2N:`WV[YPKR^OKA7LN8U:$87*3]3C95?7X/PO.\R)Q>I MM3()F,T6?(,FKFD"4-[PAO:+?MW.A'LG#UJC2?M^@7X6-E8>BB2*)4HD2B7* M),HE*@BBN4`%PW.!)_\-Q=.W!E8SP5Q0].&JL=/V^4'Y%"+))(BC6#INS8/ M0Z:N-F8@V2!Z!O:L#V.E]_LY[(E,%"32=2I1YI";IKA;;JWTW68+\;A26`MY MO(0HW6Y()9JSO58CF"Y&+,3.+$&3I>E$F4. M7;A9;JWLS10K6V$-VIO1GN0B\[_TI%23T)^86V^OVD@4211+E$B42I1)E$N$ M+WNY>>F8]P@!>3PMZK\SLBVO<&UQH"\HY3+EWQC#A MWOG"='MGJV"V\+M3SVP5W%H?O^S>4:!6^"V#'!.%X0HW8GD%=MD5;J3R"KRS M]Z4W)_`N7]\]UI#$7OL04MCG?[+Z`FTB;[R>K.`UBAX^7<$K!L!'7=SP#M_[ M]K7\^_;\NC_5@T/Y`JTT;G716;\%J/]HS%?E3U4#;^^UWYJ_P=N:);Q9-<8O MD5^JJK%_X`VZ]S\?_P0``/__`P!02P,$%``&``@````A`"[-BA]?*```;PH! M`!D```!X;"]W;W)K&ULK-U;<]M&NN[Q^U6UOH/+ M]RL628F27$E6623.9]3:>U]['"5Q36RE+&)A`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`Z/8/[Q M34]F9=,U_SCSZ:STBC@^FGMI/)W-RKX,S#^^\2G9_%?N!?!T/N:U?=PL]Q+8 M?..+;65?#.8?RP8^\Y3LRV'E7@_/O.!6]G5@_O%42F^./?'0L??OO[[_\?LO M#W^^TN%263W^_MXYCR&+(8RAB*&.H8JAC:&)H8^AB MZ&,88AACF&*8/7BC>$X9J4_\.S(RS9B,[-Z]L^!"6T>!V`J[RCZ&+(8\AB*& M,H8JACJ&)H8VABZ&/H8AAC&&*8;9@R`0'7(0R*4.$>GSH.TC9BV=\;P^LKK9 MA#O\;JE16Z>.=!66[$XEIU`@&22'%)`24D%J2`-I(1VDAPR0$3)!9E^"C'2, M1T;F>'[F@-.76MULPV3W)V*[&I[2`;) M(06DA%20&M)`6D@'Z2$#9(1,D-F7("9UAR"FIP]\ICK,8I&;T[EH!]E#,D@. M*2`EI(+4D`;20CI(#QD@(V2"S+X$.UY76,&.-Y=K+^H?IJ$PDT7"_G$=]8]3 MT:E_0#)(#BD@):2"U)`&TD(Z2`\9("-D@LR^!#%I)P8Q/=T_3'68Q2)>_X#L M(1DDAQ20$E)!:D@#:2$=I(<,D!$R069?@AVO\6VPXTW_V&R^KJ'',K#-"QY?82T)V6DG%202E)%JDD-J25UI)XTD$;21)H#"K,PX\YX#N!E MG<9,_42]QE+8;:*Y@9VK.O4;4D;*206I)%6DFM206E)'ZDD#:21-I#F@,#HS M0O6C>Z8;'0>T&LW8O7QG9MY,8GXW`NU9E9%R4D$J216I)C6DEM21>M)`&DD3 M:0XHS,(,1?TL7GQM9J8TXUZT4-"+;B^BDX]=T86Y)V6DG%202E)%JDD-J25U MI)XTD$;21)H#"I,SPU$_N6=ZT3)Z]7O10F['[\PD<]BQ]J2,E),*4DFJ2#6I M(;6DCM23!M)(FDAZE\K;.6$69LSI9_'R7K2,7OV83@-:[Q+N%K/0IRI[E-R; MB:,PS(R4DPI22:I(-:DAM:2.U),&TDB:2'-`87)FT.HG]TPO6L:X?CS^L/?P M!L#.O'D2[O@]*2/EI()4DBI236I(+:DC]:2!-)(FTAQ0F(49F?I9O'P<9-Z, MBD]&IW&OWXWB]P[LBNZ8N"=EI)Q4D$I21:I)#:DE=:2>-)!&TD2:`PJC,V-; M/[IGNI$ICT9&"[D=OS/O[,7=")2Q*B<5I))4D6I20VI)':DG#:21-)'F@,(L MS/C5S^+E)Z-E).P?[4Z#8[\716\([5:G*G-&D]9K3"Y9T-'.S8%5&RDD%J215I)K4D%I21^I)`VDD3:0Y MH#"+>'KAZ>N"-><0+(5=);Z]P%6YKG*:?+"4L2HG%:225)%J4D-J21VI)PVD MD321YH#">,R(UK]4>":>90#L70^L_3'QY^2ZZMK84]J'X+@)793O,GI21-^MERJU?[H` MQS7%J<:FMG>K6>R9:XIE M7L"_IEA(?T[AK&ZC"'?K4Y7-8D_*2#FI()6DBE23&E)+ZD@]:2"-I(DT!Q3$ MLSEOCN%0'LXQ6/).5Z0]*2/EI()4DBI236I(+:DC]:2!-)(FTAQ0F$4\Q_!T M5]EP(L&2#E5>5XGO4W!5IZY"RD@YJ2"5I(I4DQI22^I(/6D@C:2)-`<4QA-/ M))@K\A>KGCHEN1H7Y-+X\9-KYO,G&:MR4D$J216I M)C6DEM21>M)`&DD3:0XH#/*\68@-9R$L^:I:W;T\TK&:MR4D$J M216I)C6DEM21>M)`&DD3:0XHC.>\68@-9R$L^:/-IR'L!3VHOA.!E?E3D:YA5R7V>E&U4.5 MHSTI(^6D@E22*E)-:D@MJ2/UI($TDB;2'%"8A1GBGY'%,B/@325L%M+^/XV/ MUA?Q[0JNRG65TXJ6,E;EI()4DBI236I(+:DC]:2!-)(FTAQ0$,_E>5,)A_*P MJUAR_6)'VI,R4DXJ2"6I(M6DAM22.E)/&D@C:2+-`859G#>5<,FI!$MA5XGO M27!5ME_L21DI)Q6DDE21:E)#:DD=J2<-I)$TD>:`PGCBJ82GSRJ7IQD#NY?O M%M(KP-*.M"=EI)Q4D$I21:I)#:DE=:2>-)!&TD2:`PJS.&\VX)*S`0OI4Q4N MBV.51_NERKSCZYU[HG<9,E=EV\I)!:DD5:1Z(6^[&E+K5O0W-7J#N'-5=E-[ MTD`:21-I7NBXJ6%B\03!<2+N\`')K[]^_/#WNPB%O4QM2ZU;T-S5ZZZ1S5793 M>])`&DD3:5XH%61J=F%U=6Z0G%@P]TGH,MS;.SO2?B&]?VR^ZT<3#]'9+7,% M=L?D;*8@E6[%I>7H$K-R!;;EFLTTI-:MF-[FSA78EGLV,Y!&MV)ZFR=78%N> M@V;"/GK>[(.^\"T>-RUD/F7C=;/XO0Q793=J[\A;<17-KV>VZNH0_NKB]O(Z M&C+GMN3R=%PO2*6C)QZNLE7VX3:WF^C55ML2]W`-J77TQ,-UMNKX<)O5Y29^ M@Z&W)>[A!M+HZ(F'FVR5?3AUI>AX.-N2P\.%+Y5XR7R4Q+U4 M5O$\HJMR+Y73BI8R6W5]>%UGU-I6N*8; M4DOJ+!V;7ND[8=91`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` M83SG3:==<3K-DCMQ[$A[4D;*206I)%6DFM206E)'ZDD#:21-I#F@,(MX!LP< M\E[VE9-7G!VSI`2];A1-:^UM&2ULNX(Q5.:D@E:2*5),:4DOJ2#UI((VD MB30'%$2W3<]QG?WIPD,[ARMIZ=THZ[=RW>6PM-5%.'.5=D5]Z2,E),* M4DFJ2#6I(;6DCM23!M)(FDAS0&$\NN(,QI'/Q&/*PP'C=B%W--N1]J2,E),* M4DFJ2#6I(;6DCM23!M)(FDAS0&$6\8R-.5V]Z![T+2=S+(5GJVA`OG-5KAREIR33#@90T?SPW7:ITF'M=.)"D*<:%R0H-)!&TD2:`PJ#-+,%?I#/'/.6R05_`+50>$J*(MQM3U5V MQ^])&2DG%:225)%J4D-J21VI)PVDD321YH"">*[CB8JGXSF4AU<,EMPW#NQ( M>U)&RDD%J215I)K4D%I21^I)`VDD3:0YH#"+>*[AY?-]UYR'L*1CUND8IWO" MPHOSG:LZ=2-21LI)!:DD5:2:U)!:4D?J20-I)$VD.:`PNG@>XH6GJ^O3!(4? M4G3KQIVM>NITY6IDJBG#GJEP\IQ4M9:S*206I)%6DFM206E)'ZDD#:21-I#F@ M,!XS"?#M5Q/7RYR!=S5AR1M!D?:DC)23"E))JD@UJ2&UI([4DP;22)I(--]G?G@PFH>P%)ZMHGLO=J[*=ID]*2/EI()4DBI236I(+:DC M]:2!-)(FTAQ0F-QY\Q#7G(>PY/2_B%,7U0D$OVL2W2K@JUXM.*UK*6)63"E))JD@UJ2&UI([4 MDP;22)I(!]M>@C)23"E))JD@UJ2&UI([4 MDP;22)I(:`@N1NSIN`.)2'OU)&RDD%J215I)K4 MD%I21^I)`VDD3:0YH#"+U`3$BZ[H;CC_8"GL1?%]$*[JU(M(&2DG%:225)%J M4D-J21VI)PVDD321YH#"Y.+YAZ?/13>G:0:[E^\L^;UHJ7*T9U5&RDD%J215 MI)K4D%I21^I)`VDD3:0YH#"+\Z80;CB%8"GL*O'-#J[*AK@G9:2<5)!*4D6J M20VI)76DGC201M)$F@,*XSEO"N&&4PB67+_8D?:DC)23"E))JD@UJ2&UI([4 MDP;22)I(M)`&DD3:0XHC.>\>8(;SA,LY'^+&&E/RD@YJ2"5I(I4DQI22^I(/6D@ MC:2)-`<49I&:)SC[JXQN.$>PD/]51@OIQU-LW]A;4J_QQD#1>^29J[(KYI9< M6P6IM!0V'[W'6[DJVWQMR37?D%I+8?/1>U^=J[+-]Y8.S8=YZ(@3C#B?.729 M\FC<W%Y=Q)\+ZFT) M/Z)XDYI#.+^'W579Y]Q^TT9T=B.6 MYWQ]O5Y'':]M6QIP MN7V*H&W5\OG)FT2/9ML%J;0-/?EPE:W2!;#;J/@84KOFO2H$[:KLKEN>LG.//C/9!VV'0J?D,OT=_VV=&;SF9L9!_74/:DS)23BI():DBU:2& MU)(Z4D\:2"-I(LT!A1F9209_YO;I\^BM*8]ZW4+!F>RA?RN`MK?@C)23BI():DBU:2&U)(Z M4D\:2"-I(LT!A5F<-W-QRYF+AJ7%>#+CF9,^9RUN%_*["FC/JHR4DPI22:I(-:DA MM:2.U),&TDB:2'-`819F@N&,PY8ICPY;"X5GE6A0O[L]5=E^L2=EI)Q4D$I2 M1:I)#:DE=:2>-)!&TD2:`PKCB6&"*!Z9X8(H'IGA@B@>F>&"*!Z9X8(H'IGA@B@>F>'R+XHDG!EY\ M2]?J@I,&)PO[6C2)J+ZVK.I"4I@PA0E3F#"%"5.8,(4)4Y@PA0E3F#"%"5.8 M,(4)4Y@PA0E3F+Y%89XWC;"ZX#S"R5P4BF>IF>&"*!Z9X M8(H'IGA@B@>F>&"*!Z9X8(H'IGA\B^(Y;V9A=<&IA9.%'2IZ`TB)+:L&B<&4 M&$R)P9083(G!E!A,B<&4&$R)P9083(G!E!A,B<&4&$R)^18E9B8!OOVJ?76Q M3!IXM[6>S!M#)4P=BA,."5,\J%,\,,4#4SPPQ0-3/##%`U,\,,4#4SPPQ0-3 M/##%XUL4SWGS#ZL+3D"<+!A6745O[:E#+:NZ%)483!T*IL1@2@RFQ&!*#*;$ M8$H,IL1@2@RFQ&!*#*;$8$H,IL1\BQ([;TIB=<$YB9.Y8YOB6>J<*1Z8XH$I M'ICB@2D>F.*!*1Z8XH$I'ICB@2D>F.*!*1Z8XH$I'M^B>,SL@7^\^_^X&EPF M(H)#X6+!R>LJ>E-;89[*O)$73&'"%"9,8<(4)DQAPA0F3&'"%"9,8<(4)DQA MPA0F3&'"%*9O49C:S4&8SXV\3'T\5E[,'?84#TQ]#:9X8(H'IGA@B@>F>&"* M!Z9X8(H'IGA@B@>F>&"*!Z9X8(K'MS">53S+\4P\A_HH'FMZ%#=]?A7=@+1; MN3+7H6A9HBY/6)&P,F%5PNJ$-0EK$]8EK$_8D+`Q85/"YM"BQ,PPVC\Z/I?8 M,NSV#X&KQ?P.1=NO:(H'ZRH>F.*!*1Z8XH$I'ICB@2D>F.*!*1Z8XH$I'MB4 M,,7CUT7QF('Q.?$L`^D@GL5T5/4Z5'R7PTJW<1X.E2Y%)0938C`E!E-B,"4& M4V(P)0938C`E!E-B,"4&4V(P)0938C`EYEN4F!DKGY/8,K8.$EO,1:'C'4SQ MP!0/3/'`%`],\<`4#TSQP!0/3/'`%`],\<`4#TSQP!0/3/'X%L5C!L;GQ+,, MI(-X%@L[5'POQ,KN/5R*2@RFQ&!*#*;$8$H,IL1@2@RFQ&!*#*;$8$H, MIL1@2@RFQ&!*S+Q96P=)+:8&TJI0\$4#TSQP!0/3/'`%`],\<`4 M#TSQP!0/3/'`%`],\<`4#TSQP!2/;U$\9F!\3CS+0#J(9['PDB^^8V)E;H,V M'/OPH^7J4##%`U,\,,4#4SPPQ0-3/##%`U,\,,4#4SPPQ0-3 M/##%`U,\,,7C6Q2/&?V>$\\R6@[B62SL4/%]%?HMWD2'@BDQF!*#*3&8$H,I M,9@2@RDQF!*#*3&8$H,I,9@2@RDQF!+S+4K,#(C/2Q=RQ31T*I@X% M4SPPQ0-3/##%`U,\,,4#4SPPQ0-3/##%`U,\,,4#4SPPQ>-;&(_YQ<]SXCG4 M1_%8TZ-X8ZCH8V`[_2(W.Q0M2]3E"2L25B:L2EB=L"9A;<*ZA/4)&Q(V)FQ* MV!Q:E)@9$)_1HF.*!*1Z8XH$I'ICB@2D> MF.*!*1Z8XH$I'ICB\2V*QXQ^SXEG&2T'\2P6GJ%P$\7Z5&8[BA*#*3&8$H,I M,9@2@RDQF!*#*3&8$H,I,9@2@RDQF!*#*3&8$O,M2LP,B,]);!E`!XDMYCJ/ MSE`PQ0-3/##%`U,\,,4#4SPPQ0-3/##%`U,\,,4#4SPPQ0-3/##%XUL4CQG] M^O&\_#W?]3*0#I([#:Z]D]<6]U?85=TUO<(\K6K[G\*$*4R8PH0I3)C"A"E, MF,*$*4R8PH0I3)C"A"E,F,*$*4S?HC#-6-D/\YFWJ/3E$[P:7"SH:S#%`U,\ M,,4#4SPPQ0-3/##%`U,\,,4#4SPPQ0-3/##%`U,\,,7C6Q2/&1B?$\\RD`XZ MU&+ZXX976]Q$8;XBPEPTNA25&$R)P9083(G!E!A,B<&4&$R)P9083(G!E!A, MB<&4&$R)P928;U%B9JQ\3F++V#I(;#$7A4Y>,,4#4SPPQ0-3/##%`U,\,,4# M4SPPQ0-3/##%`U,\,,4#4SPPQ>-;&(^^CN.L>`[UT7S%8N%G$+>XB<*5V;/1 M?D7+$I8GK$A8F;`J877"FH2U">L2UB=L2-B8L"EA#FV78'23F#\67 MJ0Q;%\2#.L4#4SPPQ0-3/##%`U,\,,4#4SPPQ0-3/##%`U,\,,4#4SR^1?&8 M,?,Y\2QC["">T[C;[U"XOV)S*K.=1QT*IL1@2@RFQ&!*#*;$8$H,IL1@2@RF MQ&!*#*;$8$H,IL1@2LRW*#$SC#XGL678'23F#\5MAX(I'ICB@2D>F.*!*1Z8 MXH$I'ICB@2D>F.*!*1Z8XH$I'ICB@2D>WZ)XS,#XG'B6@700S]&BJT'<7V%^ M?5?#*^_[)Y083(G!E!A,B<&4&$R)P9083(G!E!A,B<&4&$R)P9083(G!E)AO M46)FK'Q.8LO8.DC,'V_;#@53/##%`U,\,,4#4SPPQ0-3/##%`U,\,,4#4SPP MQ0-3/##%`U,\OD7QF('Q.?$L`^D@GM/@VC]#X?X*351@OH*FQ%"GQ&!*#*;$ M8$H,IL1@2@RFQ&!*#*;$8$H,IL1@2@RFQ'R+$C-CY7,26\;606+^>-MV*)@Z M%$SQP!0/3/'`%`],\<`4#TSQP!0/3/'`%`],\<`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`57R6=ZI1?<5?(%=Z477/)QWFWTXKE*[@,MF=.7"1NED+Y(,-=J;IBZV-GFGZ4FNC9YJ^T+K4*S%]V;K65JM76NU0K(G:C\6[U]E][W>OA$_9T)..7FT)#P=SH\ M)SO%G1),'IR57^JPM+_\.0T`'W_\_O?WO]QW[[_\\O'SXZO?[G_6@/SB\`;` ME^/;;,?_^/KP^^$=M[\]?-5;<(=__GK__J?[+Z9:4S0_/SQ\M?^A9-_\^?#E M[X=!_X__*P````#__P,`4$L#!!0`!@`(````(0`BWG'4#PP``*%#```9```` M>&PO=V]R:W-H965TIFN]`\7X#!K)1 MG=SJ@/=]G6>:D(3J$%)`;]]^CFS)LO2GN6&F[\--^N>CX^58LBU#/OW]<_/: M^[[:[=?;M[N^<3'L]U9OR^WC^NWYKE\6UE\W_=[^L'A[7+QNWU9W_5^K??_O M^W__Z]./[>[K_F6U.O0HP]O^KO]R.+Q/!X/]\F6U6>POMN^K-UKRM-UM%@?Z MY^YYL'_?K1:/=:/-ZV`T'%X--HOU6[_),-U]),?VZ6F]7,VWRV^;U=NA2;); MO2X.M/W[E_7[7F3;+#^2;K/8??WV_M=RNWFG%%_6K^O#KSIIO[=93MWGM^UN M\>65]ONG,5DL1>[Z'Y!^LU[NMOOMT^&"T@V:#<5]OAW<#BC3_:?'->T!.^R] MW>KIKO_9F%:CV_[@_E-]@*KUZL>^\WMO_[+]8>_6C\'Z;45'F^K$*O!EN_W* M0MU'1M1X`*VMN@+)KO>X>EI\>SUDVQ_.:OW\L1V;/OZ:K_9+.J*4 MYF)TR3(MMZ^T`?3_WF;-3@TZ(HN?]<\?Z\?#RUU_/+PP)L,KBNY]6>T/UIIE M[/>6W_:'[>8_38S!,S4Y1CP'_10YKBXNKX=C@R4YT7#,&])/WG`TNK@VAK?C MZ],-)[PA1?&&DXO)Z/+ZYI_6>,4;7K<-/[A&ZB_U<:*?YZWQEC>DG[RA<74Q MNKDT+NM#?.+H&'0R-+6APW_>\3%$20QY:#]XA`QQ;-E9=.9:Q=$UZ)?SCI)! M!6GV55;FP\=)U,:0Q_B#51V)0\Q^.6^+1Z+GL%]XTX]N\4B4A_WRH6,\:+IM M/0K,%X?%_:?=]D>/AE9:^?Y]P09J8\JRB?[?G%?MB/"[`8%&`I;E,TMSUZ=C M3YU]3Z/8]_OQ]?#3X#N-/$L>\X`QAAHQ$Q%LF&%IYSJ8.E@ZV#HX.K@Z>#KX M.@0ZA#I$.L0Z)#JD.F0ZY#H4.I0Z5!T84(G;.E-I_T2=61I69U&A!P&R\".M MJ")"-)GK8.I@Z6#KX.C@ZN#IX.L0Z!#J$.D0ZY#HD.J0Z9#K4.A0ZE!U0"DJ M#MO#+[5"MR%MI4%,$`O$!G%`7!`/Q`<)0$*0 M""0&24!2D`PD!RE`2I"J*TKQZ3K[)XK/TE#QZ8K;%G9\K?7A!QYTJOIM2%M] M$!/$`K%!'!`7Q`/Q00*0$"0"B4$2D!0D`\E!"I`2I.J*4GTJA5+]X_?KXO+, MHNLBB^(\<%&OV&.M1[=!HMD0@!4@)4G5%J2D5XXR:LFBUIEPZG1)D#F*"6"`V MB`/B@G@@/D@`$H)$(#%(`I*"9"`Y2`%2@E1=40I(#_5G%)!%JP7D0OD[G5*_ M]VV#VDX)8H)8(#:(`^*">"`^2``2@D0@,4@"DH)D(#E(`5*"5%U1:LJFMLXH M:AVN5E50IU\BS9%,)`O)1G*07"0/R4<*D$*D""E&2I!2I`PI1RJ02J1*(;6N M;/JB.QUU^K;6:&8[Z.%%=+L'06IWO=*NH3)*-)PCF4@6DHWD(+E('I*/%""% M2!%2C)0@I4@94HY4()5(E4)JJ=FDQAFE;N9`E%)SZG9AH#F;RF8CNHPRD2PD M&\E!Z79B3VH6O M]2[<1LDN#&2R]Q=J]2TD&\E!8D.^>,O3]2*S9',I$L)!O)07*1/"0?*4`*D2*D&"E!2I$R MI!RI0"J1*H74NK(9BC/JRBD)82#:2@^0B M>4@^4H`4(D5(,5*"E")E2#E2@50B50JII69S&6>4FD]]=$O=T*3^F$']UF[& M7M]2Q3HT1S*1+"0;R4%RD3PD'RE`"I$BI!@I04J1,J0Z=R M=VC.B7U\H_/0?*OV?U-&B5P6DHWD(+E('I*/%""%2!%2C)0@I4@94HY4()5( M%:?FV*MG`(V]?^`,8%FT)^>&1O(E\,P`F@NBH4">`3?:1P),&27/`,AEBRBY M1D>0FEY[:>G**)'>$R1S^4B!(#6]]E8LE%$B?21(IH^1$D%J>NWM2RJC1/I, MD$R?(Q6"U/3:/'(IHT3Z2E"=7CV;V%1,=SPY,FY0;V\'#CYSTQTX&F)W'>T) M,1K#+4$;)39JSCZ5PX87I:$!9U(3-:*SITT_'FK[;,E<(KV-Y$B2N4;Z&ET1 MQ?;Z^_UD.)H8VOGGB9!).UCZ2(&D$ZL+>=3I'8QD+K&#,5(BZ<0:4Q'U^QW, M1(C)D'IUROG)/G]UQOE9AZO#&B=V26U/H-%$ M.\UF,DH?.3(YR?Y-2Y69HAS9%,3E?RQLO"*!O)07(QEX=1/E*`%&*N"*-BI`0I MQ5P91N5(!5*)N2HE2JTKFR3L7M[^I]ME]OE)[6:)TY4\<:*`1'67.J?F< M=WWK;7*ZIG&M'8[&-]IK)TM&B5PVDH/D(GE(/E*`%")%2#%2@I0B94@Y4H%4 M(E6PUP^4B`;=M-K5^]01HGT$>:*D1+94*8W1MH[G51& MB?09YLJ1"ME0IA_?:+>.I8P2Z2LEEWHVL4G,[MET^G9YQ,*UVY&&E-N1\8VV MSS/>4!E+CC2$JZ#)&YZ^IEN8WD9R),GC!VMT151SW1W?#"^'VLV_)T)D[_&1 M`DDG5A?RJ-,[&,EL;YR:=@Y78_L*D=>"J[TKK\3$:)XSM',CF=?K2QL*&- MY""Y@IH'"^/V]LCMPP=((:?3FQYAPQ@I04H%_7[3,Q$BMS-' M*I!*04UN^MH=')9*A!QYWJ+'I'-.(!:N#7`-T21QYRS7)XAFHS9*%&:.9")9 M2#:2@^0B>4@^4H`4(D5(,5*"E")E2#E2@50B50JI8X4^E?P/US*<,Z:IPKKZ MRMS,C?Y"5T;)4K<-!9D892'92`Z2B^0A^4@!4H@4(<5("5**E"'E2`52B50I MI)::S;V><5EHIFJ[G\E@`R'KZ)T7NDAS)!/)0K*1'"07R4/RD0*D$"E"BI$2 MI!0I0\J1"J02J5)(K2N;'#VCKLU7V&_OV]GA"_J2$2VA:\61-J-K6E*_ M.8`V-[2D'A%@R:WX=KN^A!;43\RZ&T/:LOI=,RRA;\K3Q\V.;)DQHB7UO!FT M&=.2\=$V$UI2W_=H;>@+^9^/YZ(&QS+1RH_&TZJ/K?GSA/(?W77:HF,;]$!5 M/%I$JM310E&=CI:)JG2L2#05-65S*7A@:=9BRN8D<`E-.$S9=`(NH;F"*9L) MP"7TF#]E#_&XA)[0:0N.+:$7S5/V6A3;T`O(*7N]B$OHW>&4O1G$)?3:;\I> MZN$2>F,W9>_C<`F];*,MJ)<,VC.%_D#"^^)Y%2YVS^NW?>]U]41=<%B_?-\U M?V*A^<=A^UZ_A/^R/=#?1JA_?:$_A;&BKSX/+^B1Y&F[/8A_T*H'[1_7N/\O M````__\#`%!+`P04``8`"````"$`#%):/F`,```^.P``&0```'AL+W=O'UKNW<=-NM[>OF\+A[_7+7_L]OP2^C=NMT7K\^KE\.K]N[]A_;4_O7^W__ MZ_;'X?CU]+S=GEND\'JZ:S^?SV^33N>T>=[NUZ>;P]OVE:X\'8[[]9G^/'[I MG-Z.V_5C66C_TG&[W4%GO]Z]MK7"Y/@>CSNQVG[S'KG]^OCUV]LOF\/^C20^[UYVYS]*T79KOYG$7UX/Q_7G%^KW M[TYOO6'M\@^0W^\VQ\/I\'2^(;F.;BCV>=P9=TCI_O9Q1SU0P]XZ;I_NVI^< M2>&.VIW[VW*`_KO;_C@UOK=.SXMS3:Y"?E@<^'PU=E&C\J1(4[ M4#HH/;`ZMAZW3^MO+^?B\"/:[KX\G\G=?>J1ZMCD\0]_>]K0B)+,C=M72IO# M"S6`_F_M=VIJT(BL?[]KNU3Q[O'\?-?V!C?]8==SR+SU>7LZ!SLEV6YMOIW. MA_W_M)%326D1KQ*ASTK$\6Z&3G?L#4GD2L%>59`^JX*NJ?Q*.5(M6TV?5;GQ MS:C?[PU&?U/AH"I(GW6%[JCO]`>JNU=J'%8%Z?-C7:1`*YM*GW6-]?A>J7!< ME://CW71H3E4UJB^U%6^JY,.SP;UY6/==&@"Z5H;,^FFY_:'HW(F7>FIP]-' M?3&UOJ_%/(.1"I<3+7OF;8.3R/UI1[B]WC5X7FDOE0EWSEU'9Y) MZDM=Z;6N=G2LETN'OSZO[V^/AQ\M6H_)NZ>WM5K=G8E2XT5#.ZE>1OYJ%:'E M0ZE\4C)W;>H(+1`G6OJ^WWMC][;SG9:K367S@#:.;3%E"[4V*5E?@ID$@02A M!)$$L02)!',)4@DR"182+"5829!+4#1`A]Q3^XC"Z/_A(R6C?,2C^\#`.$VX M;,H67,278"9!($$H021!+$$BP5R"5(),@H4$2PE6$N02%`U@.806)W!(CY:. MRW=:CA%5BNZIC1AQ1IX=`0^5#6G5@=2W3::U2>T4(#,@`9`02`0D!I(`F0-) M@61`%D"60%9`8V&T/+:]8A2UJ5S>%`?-.E1 MNE/'C]OMB0BJC;B8#V0&)``2`HF`Q$`2(',@*9`,R`+($L@*2`ZD:!++%S3G M/^`+96W[0A/R!0_S%(@/9`8D`!("B8#$0!(@=%SW*Z( MV(`M3`-"1!&BF)&6]D;N4-PF$[8PTG-$*:*,D99VG-'`%0Y8L(G17B):(U"'QQBU(MJFQHI#U$((D0Q(ZT\Z@_$W$_8P"C/$:6(,D9:V76'73'Z"[8PTDM$*T0YHTIZ M.)"M+MBBE+8=JW;]3C,*NF!YXG5OV"+4L?VMSI9D/YV/?7P\=+>J)FTJ9(B:=/(;9[LC&"M MUD9TNV9_^NK(3Z\%C&:,]!QVU%,>,5X!FQBA$%&$*&94:0_ZWE"L.PF;&.TY MHA11QDAK]\:COB>6C`6;&.TEHA6BG!%K#WJNF/@%FY3:MJ/5289TM-/_X(Y8 M)5G2Z1JI*5:G7_+(?%J5(R/VL,_(3.19A5Q*U6HIUQ$''@$7;%;HRJ0D-%9< M8\3(U!A?KE&$3\(%K]8X-U9<8\K(U)A=KE',[047O%KCTEAQC2M&IL;\[2G$Q_D[3K8QHKKZM.;II)^TC,YJEZZ&JO"SZB&2,.9P_N MT@&;F)`+$46(8D:5=G_D]<1.*F$3HSU'E"+*&%7A/!STQR)O6;")T5XB6B'* M&;%V?R#SQH)-+BP5ZGRFZ=V?RP'T*8_E].K@ISG'1B*\I^H!MW)Z$["%T0D118R,=,Q(2SN#D=PG)&QAI.>(4D9&.F.DI>D',"[< M'*#W2RYD:ELQ,M(Y(RW=&W?E"4/!%J6.'<[J(.>?.UP?!UD.KTZ(K"@779XZ MM1&O8GZ%7-K6-6X$(O)F;*4.;.D09]3K]L6J%J!VB"ABH:O5Q6Q553?L.S*% M2U![CBAEH:O596REJ^M[='HH[DL+U%XB6K'0U>IRMJJJHP153OO"TK8FD,KX MKDZ@WPYO?W76-RZ']B*,OLZ@N5*;VSJP$(4D:VO$A/,F/%\@M&I;SM#]*R_'%]2ZG.I^3`:V0=1+B>V%E/JX+- M[85!YE[EPB-#MM+'Y3W:^-^UQ5)^()-<%=!S])MC_[4-K)4$?>HZL2IN:MP MY;Y\6A6D M.`E(C'RSZ>#H>F2XS^F[&I%Q(ZH^#X>N*P)G85I`VG;HRM.@GW,T'A+1@JF" MW(IH1VZ9I\:*.^U7R*,TY9JCJQJK+<_H4D37+6#M$*N+WE5=S%;-TP]7KB&) MD6\V'1P-[4I9_FJ?,[:J^DQ^EMN\A6D!.%H=3N`6PIPAOW.;I\\XF@<%:IFS M$\HI(A_1#%&`*$04(8H1)8CFB%)$&:(%HB6B%:(:".7.K'IQ[I7QK(A]ZDN-2@A_ZD*%_[ M$T/E#R?T`TWL0#JX/YK03P,OV(\F^27NCR?T"S>TC\83^HT:\G0\H5^9 M(5^-)WG).W4'Z.W%M_67;;8^?MF]GEHOVR>:CMURS3CJ]Q_U'^?JB.CSX4SO M+9:G1<_TGNJ67C'JJKWMT^%PYC^HXD[]YNO]GP```/__`P!02P,$%``&``@` M```A`)!_%OXQ`0``0`(``!$`"`%D;V-07B^CV+5Z3KY!.=5 M8TI$LAPE8$0CE:E*]+1=I]O&0(EZ\&C%+B\*8:EH'#RXQH(+"GP2 M2<9384NT#\%2C+W8@^8^BPT3PUWC-`_QZ"ILN7CG%>!9GE]A#8%+'C@^`%,[ M$=&(E&)"V@]7#P`I,-2@P02/24;P=S>`T_[/"T-RUM0J]#;.-.J>LZ4XAE.[ M\VHJMFV;M?-!(_H3_+*Y?QQ&394Y[$H`8H?]U-R'35SE3H&\Z5GWYNK$^WV! M?V>%%(,=%0YX`)G$]^C1[I0\SV_OMFO$9CE9I(2D)-^2)5TL*2&O!3ZUQOML M`NI1X-_$$X`-WC__G'T!``#__P,`4$L#!!0`!@`(````(0`D>)U`M@(``/T( M```0``@!9&]C4')O<',O87!P+GAM;""B!`$HH``!```````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````)Q676^;,!1]G[3_@'AOR5>[J2)4%.C*ED`60ZH] M62XXC55BD.U&Z7[]+J%IR>8P-6_7OA_GW'.-+O;U=ET8&RHD*_G8[)_W3(/R MK,P9?QR;:7)[]M4TI"(\)T7)Z=A\H=*\=CY_LF>BK*A0C$H#2G`Y-E=*55>6 M);,571-Y#FX.GF4IUD3!43Q:Y7+),NJ7V?.:KU+BVX5Y3G-SZJW@F93 M\6JC3BV:EUG-3RZ2EPH(.[9;507+B((NG2G+1"G+I3*";48+VVH[;6"':/8L MF'IQ>K;5/MHH(P7UH+"S)(6DMO5^8=]14HLV(TQ(Q]ZHJPW-5"D,R7Z#;`/3 M>""2UG3&YH8(1K@"6G58<]C91265<.Y+\217E"II6Q#07.[,=FS;9B-GV-]% M@'4865=HF(#CD&/"5$%EO)P1H324A_TVYQV+AG%#:#]%#&\#!UR!7CCDS;19 MV6;^UH,71WX0H<#'8*%X$OIN`H<;=^)&7G!"2M/SJT#_@T$)H$T_!/.:<@K, MX"/MO.(,M3E]'+E).@]P?(MO4A1&`4+8C6K=4(BT*0-\ZWKA)$Q^8=?[F88H M3$)07!L[Q%%P#V%>G$9)&'W#0";RW;FO#Q_AP)U'$(?P+)AC=.?.]9)>X#!: M!"B9!E$")OX>AV`LX`2]Z&M?`G;L_8"^=D]D.H/'XM;,M<2_0)/A'"_<21K@ M:>`BJ%N#Z6MWJZB?<'>.?L(Z?7!"'N!+TW;1+9.>UU&==D!:F*-B'4_I[GZH MA>G.&9V0.7H#CXZP[TO;?G:)_-<>?P%&8 M[I0#F(,]\]=FF3#^)-,J*7VBZ'YU'E[::$4$S6&I[/WO%_8=;$U1U$6\%>&/ M--_'_.NH%_VB^9MQ^J/SWK`'.[QU9UOO_RW.'P```/__`P!02P$"+0`4``8` M"````"$`P?KF)\\!``"6%```$P``````````````````````6T-O;G1E;G1? M5'EP97-=+GAM;%!+`0(M`!0`!@`(````(0"U53`C]0```$P"```+```````` M``````````@$``!?&PO=V]R:W-H965T&UL M4$L!`BT`%``&``@````A``N3F[FL`@````<``!D`````````````````2!4` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`"GEX%TS!```6`\``!D`````````````````31\``'AL+W=O\#``!G#@``&0````````````````!S M,```>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`//"#;:A!@``?!P``!@````````` M````````US@``'AL+W=O&PO&PO&UL4$L!`BT`%``&``@````A`"D\C?]\ M`@``T04``!D`````````````````P*0``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`%\(XFAA!```S@X``!D`````````````````8*L``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%:!R=EH`P``F0L` M`!@`````````````````K+P``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&,=]3)-!0``4A<``!@````````````````` MPO```'AL+W=O&PO=V]R:W-H965T=7R@H``.0S```9`````````````````*\"`0!X;"]W;W)K&UL4$L!`BT`%``&``@````A`!X\YX+Z#@``JE<``!D` M````````````````L`T!`'AL+W=O\;I7L(```K)0``&0````````````````#A'`$`>&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-,L[0TV"0``1"H``!D````````````````` MBR\!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A``Q26CY@#```/CL``!D`````````````````U&T!`'AL+W=O@$`9&]C4')O<',O8V]R92YX;6Q02P$"+0`4``8` M"````"$`)'B=0+8"``#]"```$`````````````````#3?`$`9&]C4')O<',O =87!P+GAM;%!+!08`````*``H`,H*``"_@`$````` ` end XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8

5. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) (USD $)
In Thousands, unless otherwise specified
9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Equity Method Investments and Joint Ventures [Abstract]

Beginning balance $ 28,949

Equity contributions in existing joint ventures 1,161

Equity earnings in these joint ventures 4,722 4,481

Distribution of earnings (7,358) (5,624)

Ending balance $ 27,474

X

- Definition

This item represents disclosure of the amount of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporation; these investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13

-Article 5

+ Details

Name: us-gaap_EquityMethodInvestmentDividendsOrDistributions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.12)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 11

-Article 7

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireInterestInJointVenture

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 15 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8

2. FACILITY ACQUISITIONS
9 Months Ended

Sep. 30, 2014

Business Combinations [Abstract]

FACILITY ACQUISITIONS

On September 1, 2014 we completed our acquisition of Hematology Oncology Consultants located in Van Nuys, CA for cash consideration of $553,000. We have made a preliminary fair value determination of the acquired assets and approximately $15,000 of fixed assets, $163,000 of medical supplies inventory, $39,000 of other assets, $100,000 covenant not to compete intangible asset, and $235,000 of goodwill were recorded with respect to this transaction.

On September 1, 2014 we completed our acquisition of Imaging Centers of Pasadena consisting of a single multi-modality imaging center located in Pasadena, CA for cash consideration of $1.8 million. The facility provides MRI, PET/CT, Ultrasound and X-ray services. We have made a preliminary fair value determination of the acquired assets and approximately $1.7 million of fixed assets and $105,000 of a covenant not to compete intangible asset were recorded with respect to this transaction.

On July 3, 2014 we completed our acquisition of certain imaging center equipment from Healthcare Partners for which we agreed to pay $2.1 million. We paid cash of $300,000 and a promissory note in the amount of $1.8 million.

On July 1, 2014 we completed our acquisition of Moreno Valley Imaging consisting of a single multi-modality imaging center located in Moreno Valley, CA for cash consideration of $700,000. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a preliminary fair value determination of the acquired assets and approximately $285,000 of fixed assets, $3,000 of other assets, $50,000 for a non compete covenant and $362,000 of goodwill were recorded with respect to this transaction.

On July 1, 2014 we completed our acquisition of Liberty Pacific Imaging Long Beach consisting of a single multi-modality imaging center located in Signal Hill, CA for cash consideration of $1.9 million and assumed liabilities of $65,000. The facility provides MRI, CT, Ultrasound and X-ray services. We have made a preliminary fair value determination of the acquired assets and assumed liabilities and $577,000 of fixed assets, $100,000 for a covenant not to compete and $1.3 million of goodwill were recorded with respect to this transaction. We also assumed capital lease debt of $65,000.

On July 1, 2014 we completed our acquisition of Medical Imaging of Manhattan consisting of a single modality mammography center located in New York, New York for cash consideration of $2.4 million. We have made a preliminary fair value determination of the acquired assets and approximately $672,000 of fixed assets, $139,000 of other assets, a covenant not to compete of $150,000 and $1.4 million of goodwill were recorded with respect to this transaction.



On April 1, 2014, we acquired the diagnostic imaging practice of Sidney Friedman, M.D. located in Westchester, CA for $1.4 million. We have made a fair value determination of the assets acquired and have allocated $600,000 to Imaging equipment, $470,000 to accounts receivable, a covenant not to compete of $100,000 and $231,000 to goodwill.

On January 2, 2014, we acquired the diagnostic imaging practice of Leslie A. Saint-Louis, MD located in New York, New York for $360,000. Upon acquisition, we relocated the practice to a nearby existing center in New York, New York. We have made a fair value determination of the assets acquired and have allocated $310,000 to goodwill and $50,000 to other intangible assets related to a covenant not to compete contract with Dr. Saint-Louis.

X

- Definition

Custom Element.

+ References

No definition available.

+ Details

Name: rdnt_FacilityAcquisitionsTextBlock

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

EXCEL 16 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]C8CDY96,V-E]E,CEC7S0Q-&1?.6(Y.%\Y,6)F M83'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5- M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/C%?3D%455)%7T]&7T)54TE.15-37T%.1%]"05-)4SPO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/C)?1D%#24Q)5%E?04-154E3251) M3TY3/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K M#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C5?24Y615-4345.5%]) M3E]*3TE.5%]614Y455)%4SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C9?4U1/0TM"05-%1%]#3TU014Y3051)3TX\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/C%?3D%455)%7T]&7T)54TE. M15-37T%.1%]"05-)4S(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/C5?24Y615-4345.5%])3E]*3TE.5%]614Y4 M55)%4S(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/C9?4U1/0TM"05-%1%]#3TU014Y3051)3TY?1&5T83PO>#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/C9?4U1/0TM"05-%1%]#3TU0 M14Y3051)3TY?1&5T83$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\ M>#I0#I%>&-E;%=O7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO'0^)U)A9$YE="P@26YC+CQS<&%N/CPO2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)S`P,#`W.3`U M,C8\'0^4V5P(#,P+`T*"0DR,#$T/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO2!A(%9O;'5N=&%R>2!&:6QE M'0^)TYO/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)S(P,30\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C8CDY96,V M-E]E,CEC7S0Q-&1?.6(Y.%\Y,6)F83'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4L(&%C8W)U960@97AP96YS97,@86YD(&]T:&5R/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#`L.3,Q/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XQ-3,L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!E>'1I;F=U:7-H;65N M="!O9B!396YI;W(@3F]T97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M)SQS<&%N/CPO3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C8CDY96,V-E]E,CEC7S0Q-&1?.6(Y M.%\Y,6)F83'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C M8CDY96,V-E]E,CEC7S0Q-&1?.6(Y.%\Y,6)F83'0O:'1M;#L@8VAA&-E<'0@4VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!O<&5R871I;F<@ M86-T:79I=&EE'0^)SQS<&%N/CPO6%B;&4L(&%C8W)U960@ M97AP96YS97,@86YD(&]T:&5R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M/B@X+#(R-2D\2!O<&5R M871I;F<@86-T:79I=&EE'0^)SQS<&%N/CPO2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M/B@S,RPX.34I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S&ES=&EN9R!J;VEN="!V96YT=7)E'0^)SQS<&%N/CPO6UE;G1S(&]N(&YO=&5S(&%N9"!L96%S97,@<&%Y86)L93PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S6UE;G1S*2!O;B!R M979O;'9I;F<@8W)E9&ET(&9A8VEL:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XR-2PQ,#`\&5R8VES92!O9B!O<'1I;VYS+W=A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!E<75I<&UE;G0\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0M86QI9VXZ(&IU'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&(^)B,Q-C`[ M/"]B/CPO<#X-"@T*/'`@'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^5V4@<')O=FED92!D:6%G;F]S M=&EC(&EM86=I;F<-"G-E2`H0U0I M+"!P;W-I=')O;B!E;6ES2P-"E)H;V1E($ES;&%N9"!A;F0@3F5W(%EO6QE M/3-$)V9O;G0Z(#AP="!4:6UE'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5&AE(&-O;F1E M;G-E9"!C;VYS;VQI9&%T960-"F9I;F%N8VEA;"!S=&%T96UE;G1S(&EN8VQU M9&4@=&AE(&%C8V]U;G1S(&]F(%)A9&YE="!-86YA9V5M96YT+"!);F,N("AO M"P@26YC+BP@4F%D;F5T($UA;F%G960@26UA9VEN9R!397)V:6-E2!O=VYE9"!S=6)S:61I87)I97,@;V8@4F%D;F5T($UA;F%G96UE;G0N M)B,Q-C`[)B,Q-C`[06QL(&]F('1H97-E(&%F9FEL:6%T960@96YT:71I97,@ M87)E(')E9F5R2!A28C,30X.R!I;B!T:&ES M(')E<&]R="X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^06-C;W5N=&EN9R!3=&%N9&%R9',@0V]D:69I8V%T M:6]N#0HH)B,Q-#<[05-#)B,Q-#@[*2!396-T:6]N(#@Q,"TQ,"TQ-2TQ-"!S M=&EP=6QA=&5S('1H870@9V5N97)A;&QY(&%N>2!E;G1I='D@=VET:"!A*2!I M;G-U9F9I8VEE;G0@97%U:71Y('1O(&9I;F%N8V4@:71S(&%C=&EV:71I97,- M"G=I=&AO=70@861D:71I;VYA;"!S=6)O2!H M;VQD97)S('1H870L(&%S(&$@9W)O=7`L(&QA8VL@=&AE(&-H87)A8W1E2!V;W1I;F<@:6YT97)E2!B96YE9FEC:6%R>3H@*#$I M('1H92!P;W=E2!I;7!A8W0@=&AE(%9)128C,30V M.W,-"F5C;VYO;6EC('!E7-I2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^2&]W87)D($2P- M"CDY)2!O9B!T:&4@97%U:71Y(&EN=&5R97-T7-I8VEA;B!G7-I8VEA;B!G2!-961I8V%L($=R;W5P+"!);F,N+"!E M86-H(&]F('=H:6-H(&ES(#DY)2!O6QE/3-$)V9O;G0Z(#AP="!4:6UE2!H97)E:6YA9G1E6QE/3-$ M)V9O;G0Z(#AP="!4:6UE'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^4F%D3F5T('!R;W9I M9&5S(&YO;BUM961I8V%L+`T*=&5C:&YI8V%L(&%N9"!A9&UI;FES=')A=&EV M92!S97)V:6-E2!O=F5R(&%L;"!N;VXM;65D M:6-A;"!D96-I2X@5&AR;W5G:"!T:&5S92!M86YA9V5M96YT(&%G3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE2P@86YD("0R,RXV(&UI;&QI;VX@86YD M("0R-"XW(&UI;&QI;VX@;V8@;W!E2X@4F%D3F5T+"!);F,N(')E8V]G;FEZ960@:6X@ M:71S(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#AP="!4:6UE2P@;V8@=VAI8V@@)#(Q,RXY(&UI;&QI;VX@86YD M("0Q.3@N-"!M:6QL:6]N('=A6QE/3-$)V9O;G0Z(#AP="!4:6UE6EN9R!C;VYS;VQI9&%T960@2`D.#`N,R!M:6QL M:6]N(&%N9"`D-C4N,B!M:6QL:6]N+"!R97-P96-T:79E;'DL(&]F(&%C8V]U M;G1S(')E8V5I=F%B;&4@86YD(&%P<')O>&EM871E;'D-"B0Y+C0@;6EL;&EO M;B!A;F0@)#$Q+CD@;6EL;&EO;BP@6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^5&AE(&-R961I=&]R'!O2!O M<&5R871I;F<@97AP96YS97,@:6X@97AC97-S(&]F(&]P97)A=&EN9R!R979E M;G5E6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^07-I9&4@9G)O;2!C97)T86EN(&-E;G1E2P@9F]R('1H90T*<')O=FES:6]N M(&]F('!R;V9E7-I8VEA;B!S97)V:6-E M2!R861I M;VQO9WD@<')A8W1I8V5S('!R;W9I9&4@<')O9F5S7!I8V%L;'D@-#`@>65A'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2!F;W(@ M82!F86ER('!R97-E;G1A=&EO;@T*;V8@=&AE(&9I;F%N8VEA;"!P;W-I=&EO M;BP@2!I;G1E65A3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\:3XF(S$V,#L\+VD^ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/&D^4VEG;FEF:6-A;G0@06-C;W5N=&EN9R!0;VQI8VEE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^1'5R:6YG('1H92!P97)I;V0@8V]V97)E9`T*:6X@=&AI'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&D^4F5V96YU97,\+VD^/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE3L@ M=&5X="UI;F1E;G0Z(#(T+C5P="<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY397)V:6-E(&9E92!R979E;G5E+"!N970-"F]F(&-O;G1R86-T=6%L M(&%L;&]W86YC97,@86YD(&1I2!U<&]N(&5S M=&%B;&ES:&5D(&-O;G1R86-T=6%L(&)I;&QI;F<@2!"4DU'(&%N9"!T:&4@0B8C,S@[0R!%;G1I=&EE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^4V5R=FEC92!F964@0T*<&%Y97)S M+B!4:&ER9"UP87)T>2!P87EE65R6UE;G0@ M=&5R;7,@6UE;G0@=&5R;7,@:6X@;6%N86=E M9"!C87)E(&%G0T*8F%S960@=7!O;B!P M'!E6UE;G0@86YD(&1E9'5C=&EB;&4@86UO=6YT'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY5;F1EF5D(&EN('1H92!P97)I;V0@:6X@=VAI8V@@ M=V4@87)E(&]B;&EG871E9`T*=&\@<')O=FED92!S97)V:6-E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE M/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q)2<^ M)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[('1E>'0M86QI M9VXZ(')I9VAT)SXQ,#DL-#6QE/3-$)W=I9'1H.B`Q)2<^ M)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[('1E>'0M86QI M9VXZ(')I9VAT)SXQ,#,L.3,T/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^ M)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[('1E>'0M86QI M9VXZ(')I9VAT)SXS,30L,S`P/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^ M)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[('1E>'0M86QI M9VXZ(')I9VAT)SXS,3`L,30W/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXT,2PR,#,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T* M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^,S@L,C6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXX+#6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXR-BPS,S<\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\='(@'0M M:6YD96YT.B`M,3!P="<^4V5R=FEC92!F964@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXQ-S$L,#DX/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXT.38L-#(T/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXQ-3@L,S0P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT M)SXQ-BPX-#@\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@6QE/3-$ M)V)O6QE/3-$)V)O6QE/3-$)W9E'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&D^4')O=FES:6]N(&9O'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY792!P7!E(&]F('!A>65R(&]V97(@86X@,3@M;6]N=&@-"FQO;VLM8F%C M:R!P97)I;V0L(&%N9"!O=&AE2X@5&AE2!C:&%N9V4@86YD(&-A;B!H879E(&%N(&EM<&%C="!O;B!C;VQL M96-T:6]N('1R96YD3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#AP="!4:6UE'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SY);F-O;64@=&%X(&5X<&5N"!R871E"!R97!O2P@8GD@=&AE(&%M;W5N="!O M9B!A;GD@=&%X(&)E;F5F:70@=&AA="P@8F%S960-"F]N(&%V86EL86)L92!E M=FED96YC92P@:7,@;F]T(&5X<&5C=&5D('1O(&)E(')E86QI>F5D+B!7:&5N M(&ET(&%P<&5A"!AF%B;&4@=F%L=64N($9O M"!P M;&%N;FEN9R!S=')A=&5G:65S+"!I;B!D971EF5D+CPO<#X-"@T*/'`@'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/&D^1&5F97)R960@1FEN86YC:6YG($-O6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^0V]S=',@;V8@9FEN86YC:6YG(&%R92!D969E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O M;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\:3XF(S$V,#L\ M+VD^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY5;F1E2!T;R!I;7!R;W9E('!A=&EE;G0@8V%R92X@3W5R('-O9G1W87)E M(&1E=F5L;W!M96YT('1E86T@:6X@0V%N861A(&5S=&%B;&ES:&5D(&%N#0IO M8FIE8W1I=F4@=&\@8G5I;&0@82!2861I;VQO9WD@26YF;W)M871I;VX@4WES M=&5M("A225,I('-O9G1W87)E('!L871F;W)M('1H870@:&%S(&)E96X@87=A M2!H879E(&1E;6]N2!-961I8V%R92P@<&%Y;65N=',@=VEL;"!B90T*;6%D92!I;B!F;W5R M('1O(&5I9VAT('=E96MS('1O('1H92!S86UE('1A>'!A>65R(&ED96YT:69I M8V%T:6]N(&YU;6)E2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP M="!4:6UE'0M86QI9VXZ(&IU2!A;F0@0V%P:71A;"!297-O=7)C97,\+VD^/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#AP="!4:6UE2P@86YD M(&YE="`H;&]S'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SY792!O<&5R871E(&EN(&$@8V%P:71A;`T*:6YT96YS:79E+"!H:6=H(&9I M>&5D+6-O3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#AP="!4:6UE2!N965D2!T;R!M965T(&]U6QE/3-$ M)V9O;G0Z(#AP="!4:6UE'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^3VX@82!C;VYT:6YU M:6YG(&)A6UE;G1S(&)U="!T:&4@9V5N97)A;"!T:6UI;FF4@;W(-"G-U8V-E2!F=71U2!W:71H(&-A6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^5V4@86YD(&]U3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP M('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE M/3-$)W1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`U,B4G/C(P,30@1FER M6QE/3-$ M)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H M.B`Q)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT M)SXH,BPW-S(\+W1D/@T*("`@(#QT9#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXU-S(L,C0X/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X\+W1R/@T*/"]T86)L93X-"CQP('-T>6QE/3-$)V9O;G0Z(#AP M="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^3W5R(')E=F]L=FEN9R!C'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE(&9O;&QO=VEN9R!D97-C6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU2!!9W)E96UE;G0\+W4^.CPO<#X-"@T*/'`@'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY/;B!-87)C:"`R-2P@ M,C`Q-"P@4F%D;F5T#0I-86YA9V5M96YT('-I;75L=&%N96]U6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE2P@=&AE M(%)E9FEN86YC92!!9W)E96UE;G0F(S$T.#LI+`T*8GD@96YT97)I;F<@:6YT M;R!A('-E8V]N9"!A;65N9&UE;G0@=&\@=&AE(%)E9FEN86YC92!!9W)E96UE M;G0@*'1H92`F(S$T-SLR,#$T($%M96YD;65N="8C,30X.RD@=&\@<')O=FED M92!F;W(L(&%M;VYG(&]T:&5R('1H:6YG6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP M="!4:6UE2!T:&4@97AP96YS97,- M"G)E;&%T960@=&\@=&AE('1R86YS86-T:6]N(&%N9"!F;W(@9V5N97)A;"!C M;W)P;W)A=&4@<'5R<&]S97,N/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\:3XF M(S$V,#L\+VD^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\:3Y2979O;'9I;F<@ M0W)E9&ET($9A8VEL:71Y+@T*/"]I/E1H92`D,3`Q+C(U(&UI;&QI;VX@'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY4:&4@,C`Q-"!!;65N9&UE;G0@<')O M=FED97,-"F9O'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^/&D^)B,Q-C`[/"]I/CPO<#X-"@T*/'`@'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&D^26YT M97)E6%B;&4@;VX@=&AE M(#(P,30@1FER6%B;&4@=6YD97(@=&AE(%)E9FEN86YC M92!!9W)E96UE;G0L(&%S(&%M96YD960-"F)Y('1H92`R,#$S($%M96YD;65N M="P@=VAI8V@@87)E("AA*2!T:&4@061J=7-T960@175R;V1O;&QA3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE6UE;G1S+B`\+VD^5&AE('-C:&5D=6QE9`T*86UOF%T:6]N(&]F M('1H92!T97)M(&QO86YS('5N9&5R('1H92!2969I;F%N8V4@06=R965M96YT M(&AA2!P87EM96YT6UE;G1S(&]F("0U+C(@;6EL M;&EO;B!W:&EC:"!S=&%R=&5D(&EN($IU;F4@,C`Q-"P@=VET:"!T:&4@2X\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M5&AE(&]T:&5R(&UA=&5R:6%L('1E65A M3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\:3XF(S$V,#L\ M+VD^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\:3Y087EM96YTF%T:6]N(&]F('1H92!P6%B;&4@;VX@=&AE('1E6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP M="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\:3Y297-T6UE;G1S M+CPO<#X-"@T*/'`@'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SX\:3Y&:6YA;F-I86P@0V]V96YA;G1S+@T*/"]I/E1H92!396-O M;F0@3&EE;B!#'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SX\:3Y%=F5N=',@;V8@1&5F875L="X@/"]I/DEN#0IA9&1I M=&EO;B!T;R!C97)T86EN(&-U2!E=F5N=',@;V8@9&5F875L="P@ M979E;G1S(&]F(&1E9F%U;'0@=6YD97(@=&AE(%-E8V]N9"!,:65N($-R961I M="!!9W)E96UE;G0@:6YC;'5D92!F86EL=7)E('1O('!A>0T*<')I;F-I<&%L M(&]F(&%N>2!L;V%N2!I;G1E3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE'0M86QI9VXZ(&IU M6QE/3-$ M)V9O;G0Z(#AP="!4:6UE'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^3VX@07!R:6P@-BP@ M,C`Q,"P@=V4@:7-S=65D#0IA;F0@2!2861.970L($EN8RXL(&%N9"!A;&P@;V8@4F%D;F5T($UA M;F%G96UE;G0F(S$T-CMS(&-U3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE2!T:6UE(&]N(&]R(&%F=&5R($%P2!T M:&4@26YD96YT=7)E(&%N9"!A8V-R=65D(&%N9"!U;G!A:60@:6YT97)E2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY2861N970@36%N86=E;65N="!C M;VUP;&5T960-"G1H92!R971I3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#AP="!4:6UE6UE;G0@1&5A M9&QI;F4L(%)A9&YE="!-86YA9V5M96YT(&AA9"!R96-E:79E9"!T96YD97)S M(&%N9"!C;VYS96YT6UE;G0@9&%T92!P6EN9R!A;6]U;G0@:6YC M;'5D:6YG(&1I'1I;F=U:7-H M;65N="!O9B!D96)T(&]F("0Q-2XU(&UI;&QI;VX@=V%S(')E8V]R9&5D(&EN M('1H92!F:7)S="!Q=6%R=&5R(&]F(#(P,30N/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE M&-L=61I;F<@=&AE M(%)E9&5M<'1I;VX@1&%T92XF(S$V,#L@07,@;V8@=&AA="!D871E+`T*4F%D M;F5T($UA;F%G96UE;G0@8V]M<&QE=&5D('1H92!S871I'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/'4^0V%P:71A;"!,96%S92!);G9E6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^1'5R:6YG('1H92!N:6YE(&UO;G1H2`D,3(N-B!M:6QL:6]N(')E;&%T:6YG('1O(')A9&EO;&]G>2!E M<75I<&UE;G0N/"]P/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPO6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@ M3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#AP="<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@F4Z(#AP="<^3VX-"E-E<'1E;6)E&EM871E;'D@)#$N-R!M:6QL:6]N(&]F M(&9I>&5D(&%S6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P+C5I;B<^ M/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M2`Q+"`R M,#$T('=E(&-O;7!L971E9"!O=7(@86-Q=6ES:71I;VX@;V8@36]R96YO(%9A M;&QE>2!);6%G:6YG(&-O;G-I&EM871E;'D@)#(X-2PP,#`@;V8@9FEX960@87-S971S+"`D M,RPP,#`@;V8@;W1H97(-"F%S6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M2`Q+"`R,#$T('=E(&-O;7!L971E9"!O=7(@86-Q=6ES:71I;VX@;V8@ M3&EB97)T>2!086-I9FEC($EM86=I;F<@3&]N9R!"96%C:"!C;VYS:7-T:6YG M(&]F(&$@2!F86ER('9A;'5E(&1E=&5R;6EN871I;VX@;V8@=&AE(&%C M<75I&5D(&%S6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&9O M;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@&5D(&%S3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-C`[ M)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M2`R+"`R,#$T+"!W92!A8W%U:7)E9"!T:&4@ M9&EA9VYO2!E>&ES=&EN9R!C96YT97(@:6X@3F5W M(%EO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2<^/&(^3D]412`S("8C,34P.R!.15<@04-#3U5.5$E.1R!3 M5$%.1$%21%,\+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\8CXF(S$V,#L\ M+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY);B!-87D@,C`Q-"P@=&AE($9I M;F%N8VEA;`T*06-C;W5N=&EN9R!3=&%N9&%R9"!";V%R9"!I2!E=F%L=6%T:6YG('1H92!I;7!A8W0@;V8@=&AE($=!05`@=7!D871E M(&]N(&]U'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^)SQP('-T>6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^16%R;FEN9W,@<&5R('-H87)E M(&ES(&)A&-E M<'0@6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)V)O6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$ M)W9E'0M M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`T-"4[('!A9&1I;F6QE/3-$)W=I9'1H.B`Q)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)#PO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[('1E>'0M86QI9VXZ(')I M9VAT)SXH-#8W/"]T9#X-"B`@("`\=&0@'0M:6YD96YT.B`M,3!P="<^0D%324,@3D54($E. M0T]-12`H3$]34RD@4$52(%-(05)%($%45%))0E5404),12!43R!2041.150L M($E.0RXG4R!#3TU-3TX@4U1/0TM(3TQ$15)3/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXT,2PV-#0L-C`V/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI M9VXZ(')I9VAT)SXS.2PR,S4L.#8S/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXT M,"PW,S0L,#@S/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)V)O'0M:6YD96YT.B`M,3!P="<^0F%S:6,@;F5T(&EN8V]M92`H;&]S6QE/3-$)W!A9&1I M;F'0M86QI9VXZ(')I9VAT M)SXH,"XP-SPO=&0^#0H@("`@/'1D/BD\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=P861D:6YG+6QE9G0Z(#$P<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)V)O6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\='(@'0M M:6YD96YT.B`M,3!P="<^1$E,551%1"!.150@24Y#3TU%("A,3U-3*2!015(@ M4TA!4D4@05144DE"551!0DQ%(%1/(%)!1$Y%5"P@24Y#+B=3($-/34U/3B!3 M5$]#2TA/3$1%4E,\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E'0M:6YD96YT M.B`M,3!P="<^5V5I9VAT960@879E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXT,2PV-#0L-C`V/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXS.2PQ,#4L-3(R/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$U,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H="<^)B,Q-3`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W!A9&1I;F&5R8VES92!O9B!S=&]C:R!O<'1I;VYS(&%N9"!W87)R M86YT6QE M/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXF(S$U,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P M861D:6YG+6QE9G0Z(#$P<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$ M)W!A9&1I;F'0M86QI9VXZ M(')I9VAT)SXH,"XP-SPO=&0^#0H@("`@/'1D/BD\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=P861D:6YG+6QE9G0Z(#$P<'0G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]C8CDY96,V-E]E,CEC7S0Q-&1?.6(Y.%\Y,6)F83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0M86QI9VXZ(&IU'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY792!H879E(&YI;F4@=6YC;VYS;VQI9&%T960-"FIO M:6YT('9E;G1U7-T M96US(&]R(')A9&EO;&]G>2!P'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SY4:&4@9F]L;&]W:6YG('1A8FQE(&ES(&$-"G)O M;&P@9F]R=V%R9"!O9B!O=7(@:6YV97-T;65N="!I;B!J;VEN="!V96YT=7)E M6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$ M)W=I9'1H.B`X,B4[('1E>'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@:G5S=&EF M>2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M M86QI9VXZ(')I9VAT)SXR."PY-#D\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@,24[('1E>'0M86QI9VXZ(&IU6QE/3-$)W!A9&1I M;F2<^17%U:71Y(&-O M;G1R:6)U=&EO;G,@:6X@97AI6QE/3-$)W!A9&1I;F2<^17%U:71Y(&5A2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$)W9E'0M86QI9VXZ(&IU6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE M/3-$)W1E>'0M86QI9VXZ(&IU2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY792!E87)N960@;6%N M86=E;65N="!S97)V:6-E#0IF965S(&9R;VT@=&AE(&-E;G1E6EN9R!T:&5S92!J;VEN="!V96YT=7)E3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#AP="!4:6UE2!O9B!K97D@ M9FEN86YC:6%L(&1A=&$@9F]R('1H97-E(&IO:6YT('9E;G1U6QE M/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI M9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q)2<^)#PO=&0^#0H@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`Q,"4[('1E>'0M86QI9VXZ(')I9VAT)SXQ-"PQ M.#$\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B8C,38P.SPO M=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXH-2PV M,C,\+W1D/@T*("`@(#QT9#XI/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E M6QE/3-$)V)O6QE/3-$ M)V)O'0M86QI M9VXZ(')I9VAT)SXT.2PY,C`\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXR,RPR,S(\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\ M='(@6QE/3-$)W!A9&1I;F&-E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXS+#@U-SPO=&0^#0H@("`@/'1D M/B8C,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B M;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q)2<^)#PO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT M)SXW,RPX-3D\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q M-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0Z(#AP="!4:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2<^/&(^3D]412`V("8C,34P.R!35$]#2RU"05-%1"!#3TU014Y3051) M3TX@/"]B/CPO<#X-"@T*/'`@'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^/&(^)B,Q-C`[/"]B/CPO M<#X-"@T*/'`@'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#AP="!4:6UE'0M M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^5V4@:&%V92!T=V\@;&]N9RUT97)M(&EN8V5N=&EV90T* M<&QA;G,@=VAI8V@@=V4@"!R96=U;&%T:6]N2!A;'-O(&ES2!V97-T(&]V97(@='=O('1O(&9I M=F4@>65A3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^ M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE2`Y-BXY)2P@;V8@=&AE(#(L M,3`R+#4P.2!O=71S=&%N9&EN9R!S=&]C:R!O<'1I;VYS(&%N9"!W87)R86YT M2!V97-T M960N)B,Q-C`[1'5R:6YG('1H92!N:6YE(&UO;G1H'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY792!H879E(&ES65E3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#AP="!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B M;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI M9VXZ(&-E;G1E6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L6QE/3-$ M)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$ M)W=I9'1H.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SXF(S$U,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T* M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXU+CDQ/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE M/3-$)V)O6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXQ+C0T/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXW+#`Q-RPT.#@\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^ M#0H\='(@&5R8VES86)L92!A="!3 M97!T96UB97(@,S`L(#(P,30\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@ M9&]U8FQE)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H M="<^,BPP,S6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXV+#'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`T-"4[(&)O'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E M'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q)3L@8F]R M9&5R+6)O='1O;3H@8FQA8VL@,7!T('-O;&ED.R!T97AT+6%L:6=N.B!C96YT M97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[ M(&)O6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@8V5N=&5R)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&)O'0M86QI9VXZ(&-E M;G1E6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@8V5N M=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[ M('1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$U M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-3`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/CPO='(^#0H\='(@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXH M,C`P+#`P,#PO=&0^#0H@("`@/'1D/BD\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^,BXV,CPO=&0^#0H@("`@/'1D/B8C,38P.SPO M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^ M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@ M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X\+W1R M/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$U,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9#XD/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$ M)V)O'0M86QI M9VXZ(')I9VAT)SXF(S$U,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T* M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-3`[/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$U,#L\+W1D/@T* M("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/@T*/'`@'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY!9V=R96=A=&4@:6YT65E(&%W87)D2`R+C$@>65A M3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`R-"XU<'0G/B8C,38P.SPO<#X-"@T* M/'`@'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^5&AE(#(P,#8@4&QA;B!P97)M:71S('1H90T*87=A M2`R+"`R,#$T+"!W M92!G65A'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY!="!397!T96UB97(@,S`L(#(P M,30L('1H90T*=&]T86P@=6YR96-O9VYI>F5D(&9A:7(@=F%L=64@;V8@86QL M(')EF5D(&]V97(@=&AE M#0IR96UA:6YI;F<@=F5S=&EN9R!P97)I;V0@;V8@,BXU,"!Y96%R6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO2<^/&(^3D]412`W("8C,34P.R!&04E2(%9! M3%5%($U%05-54D5-14Y44SPO8CX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^1D%)4B!604Q512!-14%355)% M345.5%,-"B8C,34P.R!!2X@5&AE M#0IF86ER('9A;'5E(&AI97)A2!R86YK2!A;F0@ M3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE2!O8G-E6EE;&0@8W5R=F5S('1H M870@8V%N(&)E(&-O2!O8G-E'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SY,979E;"8C,38P.S,F(S$U,3M&86ER#0IV86QU92!I'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY4:&4@=&%B;&4@8F5L;W<@'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P M/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)V)O M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE M/3-$)W=I9'1H.B`Q)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT)SXT,#(L-#$Q/"]T9#X-"B`@("`\ M=&0@6QE M/3-$)W=I9'1H.B`Q)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT)SXT,#0L.30R/"]T9#X-"B`@("`\ M=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXS.#`L-3`X/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)#PO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXS-#DL,3(U/"]T9#X-"B`@("`\=&0^ M)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0Z M(#AP="!4:6UE6EN9R!V86QU92!O9B!O=7(-"G)E=F]L=FEN9R!C'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY792!C;VYS:61E M&EM871E('1H96ER(&9A M:7(@=F%L=64-"F)E8V%UF%T:6]N(&]R M('!A>6UE;G0N#0I!9&1I=&EO;F%L;'DL('=E(&-O;G-I9&5R('1H92!C87)R M>6EN9R!A;6]U;G0@;V8@;W5R(&-A<&ET86P@;&5A3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]C8CDY96,V-E]E,CEC7S0Q-&1?.6(Y.%\Y,6)F83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^5V4@<')O=FED92!D:6%G;F]S=&EC(&EM86=I;F<-"G-E2`H0U0I+"!P;W-I=')O;B!E;6ES2P-"E)H;V1E($ES;&%N9"!A M;F0@3F5W(%EO6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^5&AE(&-O;F1E;G-E9"!C;VYS;VQI9&%T960-"F9I M;F%N8VEA;"!S=&%T96UE;G1S(&EN8VQU9&4@=&AE(&%C8V]U;G1S(&]F(%)A M9&YE="!-86YA9V5M96YT+"!);F,N("AO"P@26YC+BP@4F%D;F5T($UA;F%G M960@26UA9VEN9R!397)V:6-E2!O=VYE9"!S=6)S:61I87)I M97,@;V8@4F%D;F5T($UA;F%G96UE;G0N)B,Q-C`[)B,Q-C`[06QL(&]F('1H M97-E(&%F9FEL:6%T960@96YT:71I97,@87)E(')E9F5R2!A28C,30X.R!I;B!T:&ES(')E<&]R="X\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^06-C;W5N M=&EN9R!3=&%N9&%R9',@0V]D:69I8V%T:6]N#0HH)B,Q-#<[05-#)B,Q-#@[ M*2!396-T:6]N(#@Q,"TQ,"TQ-2TQ-"!S=&EP=6QA=&5S('1H870@9V5N97)A M;&QY(&%N>2!E;G1I='D@=VET:"!A*2!I;G-U9F9I8VEE;G0@97%U:71Y('1O M(&9I;F%N8V4@:71S(&%C=&EV:71I97,-"G=I=&AO=70@861D:71I;VYA;"!S M=6)O2!H;VQD97)S('1H870L(&%S(&$@9W)O M=7`L(&QA8VL@=&AE(&-H87)A8W1E2!V;W1I;F<@:6YT97)E M2!B96YE9FEC:6%R>3H@*#$I('1H92!P;W=E2!I;7!A8W0@=&AE(%9)128C,30V.W,-"F5C;VYO;6EC('!E7-I2X\ M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^2&]W87)D($2P-"CDY)2!O9B!T:&4@97%U:71Y(&EN M=&5R97-T7-I8VEA;B!G7-I8VEA;B!G2!-961I8V%L($=R;W5P+"!);F,N+"!E86-H(&]F('=H:6-H(&ES(#DY)2!O M3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#AP="!4:6UE2!H97)E:6YA9G1E M6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^4F%D3F5T('!R;W9I9&5S(&YO;BUM961I8V%L+`T*=&5C M:&YI8V%L(&%N9"!A9&UI;FES=')A=&EV92!S97)V:6-E2!O=F5R(&%L;"!N;VXM;65D:6-A;"!D96-I2X@5&AR;W5G:"!T:&5S M92!M86YA9V5M96YT(&%G6QE/3-$)V9O;G0Z(#AP="!4:6UE2P@86YD("0R,RXV(&UI;&QI;VX@86YD("0R-"XW(&UI;&QI;VX@;V8@;W!E M2X@4F%D M3F5T+"!);F,N(')E8V]G;FEZ960@:6X@:71S(&-O;F1E;G-E9"!C;VYS;VQI M9&%T960@3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V M,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE2P@;V8@ M=VAI8V@@)#(Q,RXY(&UI;&QI;VX@86YD("0Q.3@N-"!M:6QL:6]N('=A3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O M;G0Z(#AP="!4:6UE6EN9R!C;VYS;VQI M9&%T960@2`D.#`N,R!M:6QL:6]N(&%N9"`D-C4N,B!M:6QL:6]N M+"!R97-P96-T:79E;'DL(&]F(&%C8V]U;G1S(')E8V5I=F%B;&4@86YD(&%P M<')O>&EM871E;'D-"B0Y+C0@;6EL;&EO;B!A;F0@)#$Q+CD@;6EL;&EO;BP@ M6QE/3-$)V9O;G0Z M(#AP="!4:6UE'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^5&AE(&-R961I=&]R'!O2!O<&5R871I;F<@97AP96YS97,@:6X@ M97AC97-S(&]F(&]P97)A=&EN9R!R979E;G5E6QE M/3-$)V9O;G0Z(#AP="!4:6UE'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^07-I9&4@9G)O M;2!C97)T86EN(&-E;G1E2P@9F]R('1H90T*<')O=FES:6]N(&]F('!R;V9E7-I8VEA;B!S97)V:6-E2!R861I;VQO9WD@<')A8W1I8V5S('!R;W9I M9&4@<')O9F5S7!I8V%L;'D@-#`@>65A'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SY4:&4@86-C;VUP86YY:6YG('5N875D:71E9`T* M8V]N9&5N2!F;W(@82!F86ER('!R97-E;G1A=&EO;@T* M;V8@=&AE(&9I;F%N8VEA;"!P;W-I=&EO;BP@2!I;G1E65A'0^)SQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SY$=7)I;F<@=&AE('!E'!L86EN960L(&EN(&]U65A2<^/&D^ M4F5V96YU97,\+VD^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#(T+C5P="<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SY397)V:6-E(&9E92!R979E;G5E+"!N970- M"F]F(&-O;G1R86-T=6%L(&%L;&]W86YC97,@86YD(&1I2!U<&]N(&5S=&%B;&ES:&5D(&-O;G1R86-T=6%L(&)I;&QI;F<@ M2!"4DU'(&%N9"!T:&4@0B8C,S@[0R!%;G1I M=&EE6QE/3-$)V9O M;G0Z(#AP="!4:6UE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^4V5R=FEC92!F964@0T*<&%Y97)S+B!4:&ER9"UP87)T>2!P87EE65R6UE;G0@=&5R;7,@6UE;G0@ M=&5R;7,@:6X@;6%N86=E9"!C87)E(&%G0T*8F%S960@=7!O;B!P'!E6UE;G0@86YD(&1E9'5C=&EB;&4@ M86UO=6YT'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY5;F1EF5D(&EN('1H92!P M97)I;V0@:6X@=VAI8V@@=V4@87)E(&]B;&EG871E9`T*=&\@<')O=FED92!S M97)V:6-E6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O M6QE M/3-$)W=I9'1H.B`Q)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT)SXQ,#DL-#6QE M/3-$)W=I9'1H.B`Q)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT)SXQ,#,L.3,T/"]T9#X-"B`@("`\ M=&0@6QE M/3-$)W=I9'1H.B`Q)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT)SXS,30L,S`P/"]T9#X-"B`@("`\ M=&0@6QE M/3-$)W=I9'1H.B`Q)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT)SXS,3`L,30W/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXT,2PR,#,\+W1D/@T*("`@(#QT M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^,S@L,C6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXX+#6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT)SXR-BPS,S<\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\ M='(@'0M:6YD96YT.B`M,3!P="<^4V5R=FEC92!F964@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXQ M-S$L,#DX/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXT.38L-#(T/"]T9#X-"B`@("`\=&0^ M)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O M6QE/3-$)W9E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXQ-3@L,S0P/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXQ-BPX-#@\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)V)O6QE M/3-$)V)O6QE/3-$)W9E2<^/&D^4')O M=FES:6]N(&9O'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY792!P7!E(&]F('!A>65R(&]V97(@86X@ M,3@M;6]N=&@-"FQO;VLM8F%C:R!P97)I;V0L(&%N9"!O=&AE2!T M;R!P87D-"FYO2X@5&AE2!C:&%N9V4@86YD(&-A;B!H879E M(&%N(&EM<&%C="!O;B!C;VQL96-T:6]N('1R96YD'0^)SQP('-T>6QE/3-$)V9O;G0Z M(#AP="!4:6UE'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SY);F-O;64@=&%X(&5X<&5N"!R871E"!R97!O2P@8GD@=&AE(&%M;W5N="!O9B!A;GD@ M=&%X(&)E;F5F:70@=&AA="P@8F%S960-"F]N(&%V86EL86)L92!E=FED96YC M92P@:7,@;F]T(&5X<&5C=&5D('1O(&)E(')E86QI>F5D+B!7:&5N(&ET(&%P M<&5A"!AF5D+CPO<#X\'0^)SQP('-T>6QE/3-$ M)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY#;W-TF5D(&]N(&$@&EM871E'0^)SQP('-T>6QE/3-$)V9O;G0Z(#AP M="!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\:3XF(S$V,#L\+VD^/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SY5;F1E2!T;R!I;7!R;W9E('!A=&EE;G0@8V%R92X@3W5R('-O9G1W87)E(&1E=F5L M;W!M96YT('1E86T@:6X@0V%N861A(&5S=&%B;&ES:&5D(&%N#0IO8FIE8W1I M=F4@=&\@8G5I;&0@82!2861I;VQO9WD@26YF;W)M871I;VX@4WES=&5M("A2 M25,I('-O9G1W87)E('!L871F;W)M('1H870@:&%S(&)E96X@87=A2!H879E(&1E;6]N2!- M961I8V%R92P@<&%Y;65N=',@=VEL;"!B90T*;6%D92!I;B!F;W5R('1O(&5I M9VAT('=E96MS('1O('1H92!S86UE('1A>'!A>65R(&ED96YT:69I8V%T:6]N M(&YU;6)E2X\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0M86QI9VXZ(&IU2!A M;F0@0V%P:71A;"!297-O=7)C97,\+VD^/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE2P@86YD(&YE="`H;&]S'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY792!O<&5R871E(&EN(&$@ M8V%P:71A;`T*:6YT96YS:79E+"!H:6=H(&9I>&5D+6-O3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE2!N965D2!T M;R!M965T(&]U6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^3VX@82!C;VYT:6YU:6YG(&)A6UE M;G1S(&)U="!T:&4@9V5N97)A;"!T:6UI;FF4@;W(-"G-U8V-E2!F=71U2!W:71H M(&-A6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5V4@ M86YD(&]U3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP M="!4:6UE'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M86QI M9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E'0M M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`U,B4G/C(P,30@1FER6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXH,BPW-S(\+W1D/@T*("`@ M(#QT9#XI/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^3W5R(')E=F]L=FEN9R!C M'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^5&AE M(&9O;&QO=VEN9R!D97-C6QE/3-$)V9O;G0Z(#AP="!4 M:6UE'0M86QI9VXZ(&IU2!!9W)E96UE M;G0\+W4^.CPO<#X-"@T*/'`@'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY/;B!-87)C:"`R-2P@,C`Q-"P@4F%D;F5T#0I-86YA M9V5M96YT('-I;75L=&%N96]U6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE2P@=&AE(%)E9FEN86YC92!!9W)E96UE M;G0F(S$T.#LI+`T*8GD@96YT97)I;F<@:6YT;R!A('-E8V]N9"!A;65N9&UE M;G0@=&\@=&AE(%)E9FEN86YC92!!9W)E96UE;G0@*'1H92`F(S$T-SLR,#$T M($%M96YD;65N="8C,30X.RD@=&\@<')O=FED92!F;W(L(&%M;VYG(&]T:&5R M('1H:6YG6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE2!T:&4@97AP96YS97,-"G)E;&%T960@=&\@=&AE('1R M86YS86-T:6]N(&%N9"!F;W(@9V5N97)A;"!C;W)P;W)A=&4@<'5R<&]S97,N M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\:3XF(S$V,#L\+VD^/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SX\:3Y2979O;'9I;F<@0W)E9&ET($9A8VEL:71Y+@T* M/"]I/E1H92`D,3`Q+C(U(&UI;&QI;VX@'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY4:&4@,C`Q-"!!;65N9&UE;G0@<')O=FED97,-"F9O'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^/&D^)B,Q-C`[/"]I/CPO M<#X-"@T*/'`@'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^/&D^26YT97)E6%B;&4@;VX@=&AE(#(P,30@1FER6%B;&4@=6YD97(@=&AE(%)E9FEN86YC92!!9W)E96UE;G0L(&%S(&%M M96YD960-"F)Y('1H92`R,#$S($%M96YD;65N="P@=VAI8V@@87)E("AA*2!T M:&4@061J=7-T960@175R;V1O;&QA3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V M,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6UE;G1S+B`\+VD^5&AE M('-C:&5D=6QE9`T*86UOF%T:6]N(&]F('1H92!T97)M(&QO86YS('5N M9&5R('1H92!2969I;F%N8V4@06=R965M96YT(&AA2!P87EM96YT6UE;G1S(&]F("0U+C(@;6EL;&EO;B!W:&EC:"!S=&%R=&5D M(&EN($IU;F4@,C`Q-"P@=VET:"!T:&4@6QE/3-$)V9O;G0Z M(#AP="!4:6UE'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^5&AE(&]T:&5R(&UA=&5R:6%L M('1E65A3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF M(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SX\:3XF(S$V,#L\+VD^/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SX\:3Y087EM96YTF%T:6]N(&]F('1H92!P6%B;&4@;VX@=&AE('1E6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SX\:3Y297-T6UE;G1S+CPO<#X-"@T*/'`@'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\:3Y&:6YA;F-I M86P@0V]V96YA;G1S+@T*/"]I/E1H92!396-O;F0@3&EE;B!#'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^3VX@07!R:6P@-BP@,C`Q,"P@=V4@:7-S=65D#0IA M;F0@2!2861.970L M($EN8RXL(&%N9"!A;&P@;V8@4F%D;F5T($UA;F%G96UE;G0F(S$T-CMS(&-U M3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4 M:6UE2!T:6UE(&]N(&]R(&%F=&5R M($%P2!T:&4@26YD96YT=7)E(&%N9"!A M8V-R=65D(&%N9"!U;G!A:60@:6YT97)E2X\+W`^#0H-"CQP M('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SY2861N970@36%N86=E;65N="!C;VUP;&5T960-"G1H92!R971I M3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF M(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE6UE;G0@1&5A9&QI;F4L(%)A9&YE="!-86YA M9V5M96YT(&AA9"!R96-E:79E9"!T96YD97)S(&%N9"!C;VYS96YT2!T96YD97)E9`T*86YD(&YO="!W:71H M9')A=VX@870@;W(@<')I;W(@=&\@=&AE($-O;G-E;G0@4&%Y;65N="!$96%D M;&EN92!A;F0@86-C97!T960@9F]R('!U6UE;G0@ M9&%T92!P'1I;F=U:7-H;65N="!O9B!D96)T(&]F("0Q M-2XU(&UI;&QI;VX@=V%S(')E8V]R9&5D(&EN('1H92!F:7)S="!Q=6%R=&5R M(&]F(#(P,30N/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE&-L=61I;F<@=&AE(%)E9&5M<'1I;VX@1&%T92XF M(S$V,#L@07,@;V8@=&AA="!D871E+`T*4F%D;F5T($UA;F%G96UE;G0@8V]M M<&QE=&5D('1H92!S871I'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/'4^0V%P:71A M;"!,96%S92!);G9E6QE/3-$)V9O M;G0Z(#AP="!4:6UE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^1'5R:6YG('1H92!N:6YE M(&UO;G1H2`D,3(N-B!M:6QL M:6]N(')E;&%T:6YG('1O(')A9&EO;&]G>2!E<75I<&UE;G0N/"]P/CQS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAAF5D(&EN('1H92!F;VQL;W=I;F<@=&%B;&4-"BAI;B!T:&]U'0M:6YD96YT.B`P+C5I;B<^ M)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D M:6YG/3-$,"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`T-"4G M/D-O;6UE6QE M/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W9E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXQ,3@L-C(W/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXQ."PS M-3@\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXR-RPV-C8\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/CPO='(^#0H\='(@'0M86QI9VXZ(')I9VAT)SXV+#,U-#PO=&0^#0H@("`@ M/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D M('-T>6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE M/3-$)W9E6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXQ-C4L,S6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXH,C`L M.#$P/"]T9#X-"B`@("`\=&0^*3PO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXT-S8L-3DQ/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O M6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT)SXU-2PT,C8\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$ M)V)O'0M86QI M9VXZ(')I9VAT)SXU,S(L,#$W/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXU,C0L-C0X/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X\+W1R/@T*/"]T86)L93X-"CQP('-T>6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W=I9'1H.B`R)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W=I9'1H.B`R)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W=I9'1H.B`Q)2<^*3PO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W=I9'1H.B`R)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXQ.#`L,#`P/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXU.#0L.30R/"]T9#X-"B`@("`\=&0^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)V)O'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQP('-T>6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M:6YD96YT M.B`M,3!P="<^3F5T(&EN8V]M92`H;&]S6QE/3-$)W=I9'1H.B`Q)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I M9'1H.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT)SXT+#0U,3PO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W=I9'1H.B`Q)2<^*3PO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W=I9'1H.B`Q)2<^*3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H M.B`Q)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W!A M9&1I;F6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M M86QI9VXZ(')I9VAT)SXS.2PQ,#4L-3(R/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T* M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXS.2PR,S4L.#8S/"]T M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXQ+#`P,2PQ.3`\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H="<^)B,Q-3`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXS,3$L-#$Y/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E'0M:6YD96YT.B`M,3!P="<^061D M(&%D9&ET:6]N86P@'0M86QI9VXZ(')I9VAT)SXQ M+#,X-RPW.#0\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=P861D:6YG+6QE9G0Z(#$P<'0G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O M'0M:6YD96YT.B`M,3!P="<^5V5I9VAT960@879E'0M86QI9VXZ(')I9VAT M)SXT-"PP,S,L-3@P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@'0M86QI9VXZ(')I9VAT)SXS.2PR,S4L.#8S M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXT,"PW,S0L,#@S/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V)O M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE M/3-$)W!A9&1I;F'1087)T7V-B.3EE8S8V7V4R.6-?-#$T9%\Y8CDX7SDQ8F9A-SDV8C1C M,@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]C8CDY96,V-E]E,CEC M7S0Q-&1?.6(Y.%\Y,6)F83'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!- M971H;V0@26YV97-T;65N=',@86YD($IO:6YT(%9E;G1U6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)W=I9'1H.B`W-24G/D)A;&%N8V4@87,@;V8@ M1&5C96UB97(@,S$L(#(P,3,\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T M:#H@,R4G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q M)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`R,"4[('1E>'0M M86QI9VXZ(')I9VAT)SXR."PY-#D\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@,24G/B8C,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXR-RPT-S0\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/@T*/'`@2!O9B!K97D@9FEN86YC:6%L#0ID M871A(&9O6QE/3-$)V9O;G0Z(#AP M="!4:6UE6QE/3-$)W9E M6QE/3-$)W=I9'1H.B`X-R4G/D-U M6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXT."PS,#8\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/CPO='(^#0H\='(@6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V)O M6QE/3-$)W9E6QE/3-$)W9E2!P'0M M86QI9VXZ(')I9VAT)SXS.#4\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)W!A M9&1I;F6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E M6QE/3-$)W=I9'1H M.B`W,B4G/DYE="!R979E;G5E/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q M)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[('1E>'0M M86QI9VXZ(')I9VAT)SXV."PY,3(\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@,24G/B8C,38P.SPO=&0^/"]T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXY+#@Q.3PO=&0^#0H@("`@/'1D M/B8C,38P.SPO=&0^/"]T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0M:6YD96YT.B`P+C5I;B<^5&AE(&9O;&QO=VEN9R!S=6UM M87)I>F5S(&%L;"!O9B!O=7(@;W!T:6]N(&%N9`T*=V%R6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O'0M86QI9VXZ M(&-E;G1E6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=T97AT M+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO M=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q M)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[('1E>'0M M86QI9VXZ(')I9VAT)SXS+C$U/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q,24[ M('1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=W:61T:#H@,24G/B8C,38P.SPO=&0^/"]T6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W9E&5R8VES960\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^*#(L,C@S+#6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W9E6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXS M+C4W/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)V)O6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXQ+C,V/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W=I M9'1H.B`Q)3L@=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&)O'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA M;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@,24[('1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI M9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q)3L@8F]R9&5R+6)O='1O;3H@8FQA8VL@ M,7!T('-O;&ED.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[(&)O6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@8V5N M=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[ M(&)O'0M86QI M9VXZ(&-E;G1E'0M86QI9VXZ M(&-E;G1E6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXR,#`L,#`P/"]T9#X- M"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXR+C8R/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\='(@ M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXF(S$U,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SXR+C8R/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\='(@'!I'0M86QI9VXZ(')I9VAT)SXF(S$U,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-3`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V)O M6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$U,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-3`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T M9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5&AE M('1A8FQE(&)E;&]W('-U;6UA6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&-E;G1E M6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q)2<^)#PO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,24[('1E>'0M86QI9VXZ(')I9VAT M)SXF(S$U,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q M-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XD/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXQ.#`L,#`P/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^ M)#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXQ M.#`L,#`P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SXF(S$U,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XD/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXQ.3DL,#`P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SXQ.3DL,#`P/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[)B,Q-C`[/"]P/CQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA6EN9R!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`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`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!C;VYT2!E87)N:6YG'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!F:6YA;F-I86P@ M9&%T82D@*%531"`D*3QB2!F:6YA;F-I86P@9&%T82!F;W(@:F]I;G0@=F5N M='5R97,\+W-T'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'1087)T7V-B.3EE8S8V7V4R.6-?-#$T9%\Y8CDX7SDQ8F9A-SDV8C1C,@T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]C8CDY96,V-E]E,CEC7S0Q M-&1?.6(Y.%\Y,6)F83'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&-E<'0@4VAA'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO&5R8VES86)L93PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO&5R8VES M960\+W1D/@T*("`@("`@("`\=&0@8VQA&5R8VES86)L92!A="!T M:&4@96YD/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#`S-RPU M,#D\&5R8VES92!P'!I'0^)S$@>65A M7,\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C M8CDY96,V-E]E,CEC7S0Q-&1?.6(Y.%\Y,6)F83'0O:'1M;#L@8VAAF5D('-T;V-K+6)A'!E;G-E(')E;&%T960@=&\@;F]N+79E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R M8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPOF5D('-T;V-K M+6)A'!E;G-E(')E;&%T960@=&\@;F]N+79E M'0^)SQS<&%N/CPO'0^)S(@>65A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C8CDY96,V-E]E M,CEC7S0Q-&1?.6(Y.%\Y,6)F83'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C8CDY96,V-E]E,CEC7S0Q M-&1?.6(Y.%\Y,6)F83'0O:'1M M;#L@8VAA&UL;G,Z;STS1")U&UL/@T*+2TM+2TM/5].97AT4&%R=%]C8CDY96,V-E]E >,CEC7S0Q-&1?.6(Y.%\Y,6)F83 ZIP 17 0001019687-14-004145-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001019687-14-004145-xbrl.zip M4$L#!!0````(`/-U:D6DS+(;LJD``&KW!0`1`!P`2-(%5T]8E:,ZKCVKBGOE_#]>]L^O3Y9.+NB_"%K!L"]>;?*E M$I+N13PSK=&YP''\^?_>W?8&8SQ1:\2P'=48X$J02R?&7W'Y>$51SMG3(.E2 M2EIY4(=X3A\_J?:\9`IP3?HE)/!46J6,[-@][$I/),`W#G<3CTASKW'F;XG-(5(-4V"*#6;[- MF18S``;Z%.7UE(%I./C5043[4KFQS$F`C>,=T_NL MU.;US[)APR'.V^S7V>]$HT^&!`P40XD7R`N4[*KSG\I7VFD;"E<7Y,_GT6[9]\.#Y=:S3TX,2<&37$D2:[Q`.\K!DN0+4"A)PJ&3).R`)/'0NYM8 M9'?S;;\8LOV'2=B"[1>SV'ZQ2-N_>HS]8^#:CCGYX]YU:,/2V<+]U`''WH8O M/U3+@L:VOQD:MIPQIG[7@ZX:\`@^SAYI`.9U MJI,!<3RL2".0TILE^>[>!96$>OJM5V)7OE*?YF([0CZ?Q]8=QGT>#_PH?8_- M^MB/6`ZZ/5L$TBGW1HC?]Z4IC]*\R.G?*@Y4]#U4$/57O2FAN56&SY MKF-,@:];_(QU_CA48B;:Y=OLXV]0CVH-QF],4$]9EM(O4W'DRN!/BT_*4'9E MV,7ZQ3IE$$[*$*'B'2N#>%*&"!7O1!GZIJ/J,QK>EQ8PSS*.@"-O^W7^XFE4 M*-&HL._)PVE4*-&HL$ME.(T*Y1H5=CEQ/*T]'$P;Y1D<\8$Y.1(_-*E:)>7CI&(K5*QQ7&=M&Z7D60SQ?!SGVM+S MO*]S;4?M>24TDZ7PQ$IN$B-3-:!R8AKO3U66Y#[R"5K0WBA8]]Z,/)(]F[1[)OBW!:"#FXA9!]G6T)=(:-GV-3U[!E>VRR MPZ'O2D_6MK9W4J*1JM.?CDB=]**\^[,,U.:UTE&JE8\_:T,,&,:VN MZ6#?40^""-T0RW9N"3;ZV)KJQ=PP6A3PZ!N7AYE<_`@BC&NU%"EU]@P)\385.UF7J+UQA4X--;--L2'Q$9E32;0[3I*8[!5R\J!^LI"OG"QIJ(&RNEPK M(,-(TU1X10YACM:8"5(.;$I"@Q-E3D@#+9YO%D=H&Z78,!C6X[IT&AB[DF.K M(?^`I,QG2#X(63-ZF`#]TJ=;NFROL M(AMPZ'L.-6I"P'ZH-%'+T()2[X?ANO(939KUQ>E?`4#+P\56(]([8RKW4>VX M^=I^9'P?_&PYNKX/DG(9H=\'5=N,\GNPZ&OGZ)$(-RPBX:^6:6?H9'%A@C:O M*'`\WVC6$ZXHK$2['YFSK*!P4A'RKAHO;R'MC6EA,C*N7,O"QN"M;ZF@00-? MA=@WW5.HF2I>XB'DZ:NON?A[-7%QX;<@K.6B9!NW[_UQE=,.P[M4M.V]P/?% MTY;>X/LB*Q>O\'U1MLW^XWX,&/,U+I?\2[H[-F('ZR_?YDD>U#=V6)6Z(K[# M&=JOZ+KL`.*:_9+"M^)X3JAS2F1/)4_I]D)?3N]/V+PGU>!XX._8Z%M_MO<( ME>I7IA`=PYM-I)K=[&C//$<=BQ$V;S[;KU-BL3RS>DK&I\A'C@/E+W&!7?<' M#&9C\/];S]A21SA8V7B`V2_>R7`2.D&\Q.Q9O5%(UU\G=(FXSGWL6RV3WQ]X'^O MWRG7$?;W3T.AK1/2D-*WCG3'"O0@.U`3,6PR8*>1=F6:HLME#8YO M2-%;!44)F4S9ERMZVFP!%ROB]T6GW."51AR=A4A9T#`Z=ZK8JNL:1X"C>G1N MLJFJ/*`E&@VVP%38_,J;K]^8EO\33<"]T/89QU+>C)V+Y2=1UKEV\! M/#^AO=]628XSD=@+.W&SA[,RUN[2I!!VS8[[)H$W(2Q,S`P*N_9P3?A@P5:2 M,J\PV"7U$X'Q>;1=N_6L$IUN0X']9J>S"C"?8E-6)+GN>Z<)<23`'A^.(B>3 M+RBR0"-7):D_JE&_855WQE=0\+TU4F'D9\,#N[7P"!,-(Z<=-T&2(]N2FRO. M!VKZ[2Y9%!M[@0I,-E*Q*HN1J\@[)+61BM1F0\C**=/J'Z;U%[;LL`LSA>_T M;F;'^-.UWO+14@`96EK>6.GV$--K9T.6Y9U"3*V5C:;`[YK$E-I8S\3A>MU] ML/"$N),\K28/3";IX(M5YP4WM6[R3;&>Q,@7`S>]]12D_:%-K;-U\$PRHV5Z M'I_A#FMDH%HY*2S?E'U#GZ#*+=&EUT]>5'AY1^A2JZ/$P]Q]=]2ETSZQ"0-/ M6G"!IG8,V[7H.@M=F"$V?:L%]4MO,,XG&IG(2]$C2FNJW!)=:JT3>1"CL2-T MJ;6.YQ0I$H^X4.[2J1W/B8HH947'EA&P1M^3T_??DY-YGZ#>$*+#14SQVR'8 M\N5>&TZKU3F!VS?^U:^!VA3)71!2D[_X:J9OACHQ+8-PAWJQ68KZWG`#L=]4B_IEV%A"ES=[JU!HXY!G^O\3."\;&]TZ;[GRP1[Y+ MG8_+XKT5)0PU,YY"!4OM[=2;T1V,<@J6VE$2Q(-IL70^EL"W*E[BT:>RC34_;>QO5G:0N0KT[!-G6@TJN:5:EEOQ!BU)G1R MTK)MO/:TQH8-$"ZZ8)8-0'%B)#HA*=>3C85%BW$+J8G.#JQD;A(E6=]*!*)@ M>1*U#<\G&Q-2"<06G^^P2N_*#UW]FTVC*<+TG3SCQ*=0D\PA_67N%34MG8M7&]T\Z&0612`8TLF-.[V\2HH9H0ZU1D+E.7X6&$H6S:@Z0Z^Q2\#9N MMZTW]<2! M]/JP*>94,9C6Z\JJ4)BRPBN*WYNW@E0XX6L4BMD0):XI;N!T,Z("!N"4&;!,G4"B9;D M,@N6K&\LM9@@UIMR_JKH7T>AK]49_.T2:S9UZ!C_-HGA?(>';FY'E^3%=X4G MK'QAZ&0WJRY-\R]V/^]^R,ZSAE,_J)9C8"LH*OMT49"#`]79*EZ&[>=\5#4# M.^&L.8!M2`TI`G9S=4O7]5@D_COLC$VMPRZT>3NW&K9T.FOTGG>,+MYV>41L MUARYDXG* M8N[=$$,U!H2>S1V:UH1->O-8?ZG)BB0E`)\821Z">:^&R&5]J5:7!7%K^98! MY2'FEMU5@FFRO+5H:3IN(I*VE`I<_B:?5X.E$>Z;86%5IP4R4SPP)U/5>'NP MS"%QZ")VUW3:.IE`972$GRR=Z,E\C+-93V1T4Z-;/K4X>P,+0%UA.,&4WP^O MR3/1L*'9]^"]T(G%D\LFO+G(JS2YQ?;='M=N)$V];*:4@29E#T:47U]G" M&"TN[$SDTU(-4$UE[K^LJ6X;6*EIE9L*+Z2"%?!_IQJJ=_N;GIO-\\J*'%WU MCZTJ,Y[4'#6B"[?YXLEPSJ%H?E(>4,B$IXM?6@-V2I*^[=(R#?@X\"*UMPSM M:DQC"]@=(YR&P,@TU;'=!\27>HHUNJ\_Z\ZG*;*=-QU_J0PATP5J3AW4)Q/H M1X`$/9H3U:AZ/U11#UMD^`G!F#@BQ@7B/B%:2PW&C!%\I5--,GRK_#QR/M&" MG^B'[GV_C43TLSJ9?OJ)KT.6;OL':EU=W7_K]CO=7U&OW^I>MQZO>S3+^5.0 M^7S*/OW$B_X_!2#U?R0PUZ#E<6=U8BRB]V'+W*<2H>L8Z$Y]0[0=JP@FHVCF MG#`L<\U`/;H,H%H:NC3IOX2]1Q6IZ-=6ZP&Y4[HQZ+>,*'T*5'\(^H*N_&C9 M-GHASAA=L=.CV+)GJ<]0?TSLA9(LS.;R-E(-!@2S34CDF/#$#WT"G[Q*7L;8 M0,1!#GT5VQ`*1E.HEMWB'IFF9B/30K87=\6F)0P"`(@84#Y2/=_(&:L.E#G4 M,8-*OT&AF(73L!D(2(Y?!ZS7(/#<&%]+-<0(`[W8G$LT,2T,O=M1B0X(M5EP M((8-&W0)'[DVA6<.617#A2:Q'2C2FY5">I?.;=D*#4L*WA245/5%@A:E'M8( MT<>TYUOT?8Q`(Q0#C$](2%1\\01%-U](95D.4CK8A05Y!,H/(I/<4-]4Q9^!JO`J`WG.47](1! MI0TFP!`RHFL\8.>+$5^O,@B@MO(9^@%2T-4ESX76WQ!^5G579>534@BXG@,G M8#,,V320Z;+P+K.][3G;:&K:;(.E"GAM5W=8@YB`V-O!I=0Q%'/ZSN;]>6ZI M\S#"2S,"_XV:#]ABZW2EM=92V%JW6X]=,-,]]-!^1+W?6H_M$EG"B'G>)Y2@ M=6GO0#9M7]JY6.!W!L:=@N)277[QUV^1ZBW@(L.+5P1ZRK(QC1VP,$N`G:H' MZ^[A'ZA5@N["[(DY7^RM(@,[2[G'6*>=F(%P8'X'9NL-C(T-W5UGYN,CH2X/]#7UEXOBF,[2O@XSO0.LZS88#"#A2P6\,OI]JFI: M\#TMLA>B.>,+!%/(#Y_0DVF!O:X-@"YU:N,+%'RJS.%0)%90#;2K0\`D!JKS M9#I@@^>IJ55@.;08&?T?%],%)8<5DIZ8P58<3?%%`&J@R/A2D2N;B@NL07]L M88SN@+6QC=K0.EJD[Q<&=C_R=HFQ(W'91VMK_0ER^+I>\U*"XDZ=?7/M]YH` MT9.N@BWBJ66AH_:B;8UKBQY8(<]Q$+GJ8:O=85"1DTHF)2H]H4)NA%*?*@F/ M!R*+>$2RG-IEFPX)S@K`'%DP*=&HPV):%^BG-ONS;OCPW1U)`F\G&$IT/'2H M!S1U(MY9C?[&2NN"MTG8:C/Z"--AF/RICK>*S)PRF.D^JAHDJJ*.,3C[I[W@ ME_JO@-]LQ`)?[$-J,[Z8\W^29^`_++:O13UV5HA4E>K\[C#O6=J/DMQ(6_$O MAR:C4&T*RK%+V6RD;LA"C=++F#AXG4E*888N6[W.%>JV^ZC3O;J_:Z./M_>] MWB_S!0O4ZOACFZRZ53X- ME.="TFZ1Y[E\LV/.;T]FM`?3B1V'*C_F#6L/GJV*S46TTI?SD M?V_;('E:@Q.'!\3ACK:2)!D<+V6?-CM/IROQ#,JEEP:)@0#AP-6]*V2:%P\I MO`TUVW]ZIP8RM1'2^EX7R]; MXM.!@.P'`@[`>)>4O-.!@-.!@-(<"#AGMF[AI_WG-==^EC5=<7ME7\59SJ;`F' M%1U=QF4P5$BBL1@CM.;9C(+&G!C.)A5X^:K_$QZH,`^AN8CEA]1`+Z:K:_`( MJG,(RTR><6RXB96A(1+&NKR>!20I;5")>CBH1*?[O=WKW[6[=.\;_?N^`Q^^ MP[=OC^W>O(_,;\Z=8DSX4V(TAMFPUR-<(QP"A8'YD\8E0\]!'#06`,9\,V_: MW+:2I`M_?R/>_X#HZW-'CH#8!'>>,S,1LFQWJ\>V/)9/>_K3!$06)1R#`!L@ M++-__7Z)+Y-OOTQ3JE3!DSMD?I6$QWI+(7S M20@[B3\,0*U\F#D31*4A.!_RI@(I"#@S1O06*1HF63*)V?T*5"L,'`G>0D:] M_Q#%L$0#)QC[-`.NO$QKUB;IOQ"W4%`38X7"H_"$_"F-EYOGDK<34@U0(N,5P?Q M[MPV%3;("O.O=;?E`%KV"X0N-@ M-3W6;U9KJG*0YI(Q-E&A=7GGXM=M4&M:I,JHR8V>VV]M4E&[Z?2>R5GM%XFS:'M?5J/KMKJ5+\*A/%VG9T&`Z8Z"!A3\L0:!5HF" M1,U(P*ADD)/G25J>F6Z#4F[K`6O[DTD2?P>3=2K"F?.B46LZXR`,4;JA_N$/ M'A6*ZKSKS9P+HD%;'&AWHX[JTE\O.K6^?B=]T*W5]0?*>E_+E#$O!NHGC#L; MSFK/OCU'Q"E+;T`Z6W"W&N_MT8:QE17?9<0CV<\%3@LV=-G`@-W>%-_4 MZJXOM+J]ENOU*H(FV[?:3D&!.!JLN=[KKFY%AE#/;6Y7Y[)_QK6Y-#1]HHYE MZ2[:;J>Q(JUG'V;"NHQ6Z9(=5>+01GF][EU][DKZG"_*U]!E9#;:Z](#SI*+E==[*0+,+"ZW6$? MFE&`367&?D!!:'B&SP&E(EI=1^ZEAIZBAOZ#72C-7ON43E:CD;M6#B;`CNG. M6>72.[;36-BSO`2,LZEQ M#R_RQ:SK2*N`1<]`^S\:T'ZWP=X7!-"7/=U6"Y:CPA/OHN:W,6KZ]D0_\W0[ M/;?OK1$=/QKGFBZV>68;K>_V5A5=5(U]L`NME0$>5'O]PO\N*IHH)I*OG1]> MS"PWC]R.KL$4$E%*]M$G$:*Q@Q9K2KGIK["EW4=_1B\^VG3SCIUN3@AIEZ^N M[MZ\1M"TCV\^W%U]OKG]X!3NC9^^Y6PAL$,8&*#^8"/7;\+Y".9N>DQ+=O"@ M;6&GX(\`_[BU8$*^V#`A@5ZGGW7%5M8R3)]B)XS!*`3%;HR7%C,;$31!AL.; M;O"(!3Z)&&$>>XSA;%2]L3\[,:4N%8)/.O0)E3)8#SSA3V``=/I@A1#UX1UE M9%8^<$T0=23.O81HP%]2BL4W3OW')^Q*5'3CT2^0AD7)1DX4:RP9L!MT'1)5 M0=BE2IRJCQGDFG9NW'NUX,TN+@PM)-9H)-]DRC\!VZ!ORN3^ZVF!HN/"R_'_ M%W0DKL0OR>!+&,\QB\:6/A:PA^.:?&?#$:(:KH_?7 MR0/L\#MULNS4_P[S>9"U5VD-A!"1H!!\:-9C?\8=K1&;ZY('"30H5QET3RGI MG',#+(VDJO_&-^H)N80N$4<1YJO$DBVP^H7RYD+4LJMB%B*66 MTDSQ'(98"64UYVXQ"!%MB(A$XH?AC)#&'.#0A(X3LC8N,3=QQI^)[Y,`ZVWP M4YPE<#I_29/GMLHC/@CG7!R+E))31T3PR6NX]6;7;=?[+E7\Y/*P^IU:_Q=7 M95XU7*_>P"=SAWT)H^;/FI0'DF$1P@2)&&5JZX5=R_-ZL^H2.DK#``'NICQL MJ:0J(>3,*277&1WOPCG%/0^&HB!W>$6_^4D09W`=S28RG0]_^&":Q5M2B+NQ MY]O9JW>;3O9786BVCP$B!EW=AYB>G>L)18B%"1>U<7,CRV;XPG"G\ M9^H/6&YO6%]X[NA>8<"@*J_VK75RRLQ+Y_<259;S=:7=4*5_?R]IHV1Z_"A1 M"(U6=R71ZM[DKZ6/L%G7?-G<:1"Z'W'>GW3>Q+4LDL?[^%TP$I1%3F;'RQ]E M]EB=!X6S_BDJ;.YZTDF1[#!"H,PS9KWI*LM..9;+7[?"HS M.(6Y5R1^E@;?_\*^NP,*[W5NNQ/L07#RE!^4HF.@?/^W.WZD3*NC.6(7#;?1 M:[K=UO;XHHKJ<>;J4'^+*ND;5.`0K/DYDK+""LW54]0P73:^- M$>\3.:#M6O_`:7//S>:G2_EA+CUMOVX"95/)V9HO@ZCVE0OK(530_-38J5G; MKBCN.6GV:JO*AX\F3[?KUKVNVZJL5*;RVU3JIQ3'\J<_TX&5^3"GQOS-6F>K M.N+G/;#-DVO&VG&[7M_MGHOY?X9:.S\/%T?>^[J3CD9NR[F@7T!&\2R#ZOI-;B^Y$0LRL8)ZO]G;]O^#/AS!/=, M^?EX[?$".\(([CH7UM&$A\X7UNE0?H@+Z\>/WY[\37*ZE)]/[#F@6TE\Z.1/ MPIGR_=OBNQ%\B,OV9PWOG@_!F?)G/,='$^P]7+F]]F0'VI--8`9$BFP;S*%G M_SXF""#9J9GQD::$JPL?(9Q.X17.!4$=!*.12`0"!=V+Z1.B*V"!.0+!&8`2 M#E]AV*H4!T6#+^6!&%QGG(738!(&!C3J#"XQ65H+F;P35O_Z@Y,&H;*=/IJFZY<1`-UYK+:?Q5Z;#F+(:28 M4;((UC)^B`B]@[;^\AZQ_A`:2L,!HGD)?R.O$2Z@`DMB&!JB0Z&,*/@/)/U% MLT^84Q+,*TCI/0/Y@GM\G1Z:<(Q\YTE%YWP93YW`88J'\RW/&C6/@V\_(YA$ M/O:%?Q#FW">#+\4@4E>\%Q>2PE;WMT]W5^H?G=]2]6=/.KF.`[FNT:JUE^!> M/M,N?\Z!+DP05HXE+A]#U0>\B/%5V$-I(,MMX-7!R!A*G32/[:$F@X%:&`1RM:0RGP[D=R>YPEIB6Z&36@"8DANGY&2;-832FS@5Q]'DHNESPL$U[3 M4<(Y2(B\ULX M)92X8MY[O'C+71MO^>W5S2?G[U?O?G_CO']S=??[IS?OWWSX?/?LZL11BL]% MBT6$F#6]HBYIQ+!6&SLXH_=_P/U.F)]&JHZ%C^S"((((QYH(V5"*M>TA$HDN$E'WKP$'XRI8F@:].9T0=&`:2OAE;>I,,\2-3 M'GPH&(;7QN8#TV0PB!,\K>',E?W@BC,E,@8@`]">]*<$N,ENL MH)"DP`4P\(!@VN+\2EO[=`I-=0]&RCM<1T./I\Z!]QL*1]1#<'L1.II>/I!XWD$T"+.A*+P0 MMSP-0*T$2Z-\PTOX!'XS_Y95C*-\=T&4?UO-D6J"6HT!`OH18K2D>/H($IL% M*?P>%U0VL-.8TT`%V3CQ4(1X-8!J3)C;W"X+Y/54&/5I%HAPZ`PRT-?D@N*( M*$7C)(GOXX1[W-F+J:PG;#9^/@"+#T!SRP.@V3J+K$5'!D)PYN*^V)OA_)ZJ M&RL5ZG5!]"T.<7>M*TC[!Z3B@!SX1S9\P"OHO*4%)P_[UN\%W.Y%.%9R>,,; MQK0;>8,6?0JFI<%0W&./6ZE(I%0K`$KSK, MR`5N^()UM/_`][**OPIJ.G9YQ1Z@.DE$.]XZJ_RC+T+CO`BALU;/P!]W$3B( MB=K)YL51/^YJ#,2>5V,+,;T;_&FS_HLLR/):SML@`3/@72`BYS.J)N]BU=!K MZ0R/"@-TG;R2J@E_YBFWZ@VWY2W!@_K!YGO>XI]@OBVWWSJACJIW8A"#U;RV M[*S<%#G*3/VMLWR]WBG5!Y]N%N9IK?,.U&XA`P[A03CMXWVF_$SYZ5"^;S6@ M`MMUTV6JJO32^#&[%?LQRQ%(#NG&W-(^_O&<&&BQ%_5\W:]KUT\-':Q4'.5R M$L]9?Q8I7S#]-<+"22Y84EM(E/ACN,"F7!_DIX^TW/0'%E?`6@HJ(N>"=.1\ M^`NZL=G8SCG0>2K0DR5*II.DTP6BD2J.EX79R<"%NY?.L]XPC5+-2+E M:@B<"U_X(7+9TX*5P=-7-\N:H-YVV1 M]>&Y/&==<#**DW$6RC<6J5+EU9Z+2W-6EC'=47;?Q4-WYE- M?\\5(,/;Z)/`X8$V>.!#C.62_,]7?AJDGY&?CJ/XZYPQFQOUG#&[P--\SI@] M<>_1V9_\V?X]S%W_6',@SY6?*#Q[*/V?,GC-F3]*)E_<@U)XS9D^')W_:!,[S@A^8[!\P8[8DS>VJJLRU8F[!1 M#+-0W(X,,+H-G4[-2VX9MOT*,UJ#Z>Q9<^'*T]X,2+1)>J.^!C*WC8'G-?2J MA+)WIO"?*<+`8O[CAJV!SFEP%:;!564^W)J^`\ZMU0GJB^I=\/M\*P39XZE> MIW^M8W`\IX%$QS2MDLKGG,T7U6/J2N80O\GU,',^PF9=BF>&M;^Y6J^8<(J)6MX/&$04Z; MNCT%,XZ.O/U;L(7LE5:+TU=TD^SRJ,E2A?TY$W^6Y/&XW;KG-MI+3(9CF$"% MF4O-FK?$;7(\DZUVGT]E!J*Q^!5.UY%S\I2?TT#VXI]6 MIM71'+&+AMOH-=UN:TD2,7[T\E@(;M2:!XZ6/#=GGB[EA[BRKE$U#K$)'55L M8W^_ZA:EJD2J+6QVZX@VO?9J]_K1'-!VK;]"EOQH;'ZZE!_FTM/VZX+JY?T= MU4:MT8;C-8RS^U!46[K M_(FN6_>Z;JNWE09SB-M4ZJ?<>'/;#U9O/LD!!SWIF/5651?&E:[IV#ID]B&.+BE8;4>X552;UG?-)%GM M[EL\YC;.P^UGN*7C\W!Q]+VOW$^]#_O(`#COV"%WS-!ALABLSXKY#-97FV4V MG'=UG[NZ4T[&KHMY8%_`!K'LPVIZ.R2S/H-%V3A!_?_L;=N?`7^.X)XI/Q^O M/5Y@1QC!7>?".IKPT/G".AW*#W%A_?CQVY._24Z7\O.)/0=T*XD/G?Q).%.^ M?UM\-X(/<=G^K.'=\R$X4_Z,Y[C:8"_\KU>?E&H+A=+UW0O+BZ7JUW$Z?2^F MC_'P)OHFTBGUS'DMTD$2T&N.M2*=H]Q!ZOA.`A]B0YPG/QG:[:@"/2$GB)P_ MX@#^^`;_PK8VF]:EG[NU["_DOW[]7+>=JY_#;CH+H0>7B@D%BG^X2K)&?6%= M4:/G]EM+\I2.J:9(O4KRU64H1E.,E4GI]>:?&;9[0U&1!/<90P7`R1'?@W2* MYRU_"H_E?O!T5"W,O#\O^\N#\"&V<-L;]#YFK7;76WFM,1*:IK MJY5*'TV&0,Q_B=G;((*]#OSPM3_U;Z*_H1C[NY1B1PV19"FDC)8T0V;]*F;. M2$V)MF`(\T)MM51.2Q9'[!SYR'K:*8/M>,VSFKK?IH)*$MT]"C%UD$5_K4#X M[`/0Z/G;"NZFZO>ZK.9>YYK,5J,D5ZO9>XLU>Z_E>KV*FOGL6P/"CS[$T6#- M]3ZPWMASF_6M2@P.HZ%D%9H[2Z1@G/!+5'?]C4JQ;?;??.%13H2JL3[4MK^+XJ^DJ_.9,D'@53)]%XCO`,GX-_2]$.)#E, M'=COI8:>HH;^@UTHS=Z1`K67[VRCD;M6#B;`CNG.J=29(GTP@^_5'WK^-VSB7"Q^>(N8G@:A#.W12$/D5X7UMNM54^LPI8=`\N MF]V=-$`>)-%>L?F;5J,3]E%S:^B./()3+?3<_O> M"76.1L8*2&P]LXW6=WOU`P-Z[4*KMQ6$R]ZOW]6QL,U#6HO[B+R1`>>/(E&9 M7\'@*AJ^#L(,S)YGC8S)3?LC2Z?!:+90+5%3<"9P"Z<%Y4J7PO@0OB#*ZN4$#I9^1;3Y@]((4$]XH_)7[0("I#FHK!AV=V&![N.3; M*O[Z481#.)E$Q#2A_B\S%R-Q'-Q+\T$U\@_@34@SP)'-?#"V=PZZ5:WK;>L2 MV;KQ8F?POL>9\K*L$4RK75'& MRPG,]J+561)J*Q]X"7##<[&&WE,<9NE8NC5U=W-M?/A MS6?GYL/U[?LWSL6[V[N[E\['-Y^?7KC7'W^_.GFU>^?KUZ]>^-\OG4^ M7;V&QUU\OO9O=P[\Z/WM!^?N\^WU?_WU]MWK-Y_N#GCWK%/:]]/A`IPI/SSE MA],W-CC<7Q9[RY0V(9UF%L:M5?TX$4D0'PRAI4Q]JCQ[8N'JS6LKGMMIM=S. M=KFEZ^[=`2;XC&O8[+N-9MOM=2H`?/Q9U[!5=[O-EEOOG=(:'BKKJ>]Z];;; M/JG"P:7J&,9N*!*1MPU-'*%**[&232KDRBQ@K8HR<=8_-O6:5T$@<]\'YD@7 M[Z)>6Q4&7L.(^PD7;45R[;$LVOZ3XV`M3B[5>Z%4_M&,E3/E9\I/6DUZ??/N M]\]O7I_]5C\4HYTI/]G#_6/ZK:K9H"H=28>EO$KWS8'7O$*GR<'7_,=R:5P- MATX4$](+G&BL`TJ"`?[)&99I=O^'&$R=.`IGZ,](1?(-VU#A\]C7Z$BVQ7/K M=<_U^@=N%5/9]?#3(7,^ZQGV/+=566[Z\]_'>(3Q::R_]4-U^09IFI$7DK*S MA>HBAZG8=+)CQAJE/.@GNW%B)2M_4CY\SVWVNFZW5R$??E(!#O9; MO=ETV[T*]+^?5?J_7\Y+XG!"P?4+`"0CO M(UV\S\Y>'6\:'=A[YQQ$(8262VE M=8#_HH4`4I*Q$\)2.$-8"^="ELAGD3^.X4;\%SPR#-(!7(!3JKQ_X35J7?6^ MERX1<9_$7P6\('Z*G/L9O\U_2`1C\RPJI3^7RE=9*E^4)<]>ZEQ=J>!;?R"< MOR,,&8V[HF"PBDD*!/C; M($FGSKL`9"M>6`[>6.M7A#8.6%G76%P16F^Y_59%0$TG,-\+A!G>>+KKUTL> MQRR;_;9;7X:F?$PUD_@1Z'V@3*U_EO;@'ME6]U[I%?%Z:S2,WT=H]#DG?=%P MN]T5YL:24W5*4_6Z7;?1J`J&=`_]#^A*/J3+:?^V;+NWXMHZZ)DZ\.0OO(;; MZ6_2N^#TYPQVLMMH'2?6[YI@@ZL]'(L1!C\F030()G[X.8%[T1]07LWZ1MX1[,!9;@Q$19_?'LR,%;FZY[@('Z*QCF!X# MZ5LA^U6J=NS+I[7+JE7;ANU8>.'@<'M[YY/]K=H9N^V,J7=2 MCS&[&)2XFRC-$@IPK53WCPI#S*OWW=8RET355#_[?)MNO[G$2OS!YMOT6FYS MF9OMAYMOW?5:)X*+AQ^]%T-X2Q4)K)NN_L*JP$;]]*K3>FZC>W)UC)[7I^TVNR=GE+?ZH-@T3TZQ:?4[;JOQG`VP5^@('\M3`GXP`7K1!>8Y MJERY@\RYWEQQSG^X.3<\M]]J_VR3KKN]576?N4GO6RO`C[#W4SI_U1^+8/8Z MS5,TE+UVSVUN5_S]K-=@M^.V^R?G2VEUVVYG.Q?@86YOF9_HP"]$X@S\23`E MCYI#4%0/5'[XH]WE(.U:_0/JKT:_C]@[I_C^JR;?;H$L?4&0?U>1;?5#G MGE,4+;WMN281K?C*[OECRHWW>BVWWCY@!.NH)@^WH'W+WY\/GJ\\WM!UI1DTZYEVJ-_`P6EW"H617V^SBH^R*X MOF8HG&'@/T0Q/#YP@K'_@!#/2(XTAU.$N0HS`G2';^'2A.>`C^((O=WJ%\[% M^T\W+UW$MIH0/A8/,^?B^C-\,XG38)H@+.TX2,F%9S_R\0T^$V6# M4/B),\8L%F!CABL9^V/UH.MDX33Q4[SI79OPQ!\&!\I!`66#R`SAG,)&:/AT?DC#J*I`Z=SBF^%EW2:>G4X^S=UX+S1Z$'D7,-&C>(D M"GS7>>\GL]#'*;T%Y248PD>O@`B%DXH'@GU!A^HHP$W%I-Y$3!!. M!DB?9`EL'2S3L[-LF=Q\)E(^/XH%:#]$BUG'%(0MV[7R&`FJ-O,'!J'GDS]$ M3?2]'_EL`C-0G',!&R*GW.K^-O>4^JKWVTOB@E=P,23`CI_422!*.!\L=/X" M/#IQ;FYN7-AYX/V1H#,(WTS\9!H!>ST&$^?"C/?JT_N_6$.4\M;B57#*5H`( M\L,TUDLQ-RGGAB?OEGVEOBLC1E?);X4776]$,?Y9JH M=YDCN.`1VH'71AS-C2:WU*SO:[B_S/*ZVT+@3I%$Z/:]^B?_7OO1:0'LP M0=!AH'?ZZ$^=!P%,[B-'PKXP!\V/0Q5@]+CB>4R4DG8@#+9:J`88G0J3CW1C[BO.%UL_;B M[S=O1N=1RF#IGR_+%E\M6]` M0\W!ZVCA.T&NXGO18_0HI:-5\XW?+!R-:,DM<9`N6I)?G0OO)7\9/\&P/%B=,5PP MTV,ZX:SP;K[,$6 M=/-4@L0)07>.I[B5*!:(E'MA4X[OTGMR$RGZ<$D1)%$Q!>G7ZMP0TX)J+K[A M"T8P;4ZC&03)(!MC0RFZ1+4E\BN-,!0X+%^=R/AEJ\L30-[6GZJTG53/#;>? M-'22!-.8?P0B"31YZUW6%LPS&N\*=N`0K)8_QD_X0Q"7\+T3B0`"1(LP,_7J$7*7V-0_8;.7VJ@02<2$&.1:\)"2_:D.O'0(R< M-]_%(",A=XLW(/X,Q+)0B/[XLU+&M?NP&9#3>.U"(_,6[HUYW6B M9N^0?@Y$T&G30Q(9_?XOFH_XVM6\C]R'%D.-_E-=VBD=:_F3G-$QEF:)]C'X M+.?TQ2;G`I(`M%=B?6DZ2V%LF<\RG(BWHK85#)HI';9,'B8QGH3Q#([1(T@@ M6&XPB./$D@?T,)[L.$NEOP`99B*(:ZR?Z6W1'[&^D=)9EGZ5M69-I^MPT2 MEV!OT5G+EW5,SH50JH=F+%MJPDB/P7W`0=\'F$(ZE2(Y`6T/M9X)[@1F8<": M*#=0S8%#BN:M5.V`Y;)0K]H`[C3!?AUT<8`=JU7-'&.CC0P+0??.O0@#>"%? M:E+)46CM]V(*7`VB,LT2^41A6?$,:[T4OD8J2G=-,2OQ9B02ON_2J69,_&4D MQ)!%@_@.^NC4-SV:0%GF]DTQ`>F@Q48N&^$8$FDD<)8=5(>QEL!+/CI;;QLU\W1T3*W^+' MR/F[?5*/(9Y3&Z&NL+5O.=_Q>%/H0;H:S,QIDVA8NFD*)I:Z M5-3A&>$PZ@1**6M94OR>-]*W81NX4G62PFVE)$ZQE\/\O2/%['L_`DDP1:1L M9-DDCK^&L\C5SE<<#>2')7"63(V4M:=XR:P^_$.]IF1FTD3;:'9QI">GIV)1 M;]TTUCZA195?7RF6A*,))&+>V*ZEG#L)+AD!AM1H*I*(V(!.HM#,+[@UDG8*M=<`;M` MXEUM:=D.6$Z$8*I,Q#2O;(V$<#%,D&;&^B,R5*RE3#%+T5YGI8*OI=*'.'"3 M);GKG:].,N0+][N6*WC)$PF//LQ8?`>S,26/1`97*BN8WZ35:2T>*.8#RBZ_ M'/M?\;RJ"4B+-HX>8OSX7L98[<"*E')EBUDX(6C46?X6=@Q$$1:1W&?#!RXM M6;DQM37VCI:(5@`4+6,LLF'#I,-L_#05X#7C M!U$Y!BX3$1FY3WEO*+,&UU^Q_^L[5F03HY8R,/($J8QDU2C'A[G;5D\#;12T M:>YI_O>80H$2,(:#A,"1+QK-6H<#U+);![[M1:-E^FT@#<6B,>O$6`GGJ>D3 M5<"W7`/6DHA`,"D73\]$W;VN)`C(=):2:&2!6M3*:*CEFE_9RP_:^_/D\_#SG.)97*N=7'KV?%Y"Z0O25YE1D.@.#_S MP5JK5L6BG&6M161K3^13&IT^W,BMMVQ/JI<(NV$T8@-;QFK9\GW@.1VEI')"D'Y$YB MR:E").EXX490T&>IM#S#*:=@J[W52[U0]PNLOF@JVXD2.S@D47:L:`0SGJVH M83H+.4[D2U0_M=008^7'LMYZ+T3DB!`,ETCEVYEQX3'[_3>Z>=MRU9-0=I=K>++`]`S( M66I;KCJJM/!T#6,GBJ?,6WAW94E*,0MD8&D@RW>KS4G8\(IB&5VR2^WLF#[< MN!AKR/#^)SI4ID`$A^G1#T=K>B5TI.9>#/PLU>'SG`-'ZA=C'ZU`^.J?62#= M@LJ?F4^^4,E`%&,BQPV(@1)M`8ZY^#X@SXRM3U!OJ;,,&*X)Y-CP;ZZE7Q3%$M2SS'Z12KU@:5^ M;A<%M44F<[PDU@AE.]/#">/HX9*::A;"P%;@EYV9.CHEO?7JN7"F.6CR"7$7&#PA(0[,!;] M72+;7Y8)MM]([<2\WP?E(\.@"*LW1;]O:3D%[1D*52-_@A)-ONRW9SV@H([F M#+0L\N%DJE2K#>H[+-,++AVXT]CPXHTF?A(/&>N/SMWE_SC%PRSY1I65^&0Q4E+L5-V%HSB>PC,8 M+16H(6($`L6AS$P8E5&(FN9^5'=&EI.\@QC="HM>*4I>F&,9;8V*>E596-_**0P+AV6YA#-"N-(&VFJ)QM01NV0*BF^648, MOU(N!&HYJ$A(9<[DB0?C3>JBG/213#`RA7SEK/@CB[@^0Q^:U2]2#A%EJ#/# MTT$A72#B9#`E*&74F6MK\#97Q_"_]';@].0>*%>'H]P<0$/(6L![/P%MP>O* MRDF^<(&<,?WR",0M#!:4R-W@D*6X>4KNK(1YJY+G(VSP`-TG!R?O%.ZJUQE) M)]*@^-R2.\!D!5NU8O*"L"XE4''03Y:0AO.(JGZJ?,]V^8(MDN5NH!X.NCT' M,F1*R22DL^3F#Y,\?HL/U"A(4<%<=JXXRU6>'1)E]F5V+T!>8E:$5O/CB)WH MZ"4)A=9X62U.,3TV(Z?LNF=^4Q*?G2T.SZ'YLRPQ&9[_T#9:M?82D(EGVIY% M$+I*;U@'1M=5&@O=YQ@(DHG/9.B8R4JS;LB.+97*/_%G(E$ITC)?&CA]G(KP MFW15LT6+'@PX3-D$<0I21``)TD>^PS6)&(PBPQ6K)%TG1'>C1?;(JBB@&1E5 MJN9*:OEF`A6GM!)Q_YH[F?$K+E[_E,BBY"E.FLM/R4[,C'6- MEIV0.))*8&K4.A,>+G>&:L^#+$S0)OJJ:1B7C#^.T2Z@_=$4N,9;I0]N"')A M09;IA)ID1")T@>'BKU^%F-"KHYS-8S93G2I.!.,$8C0>EY\94>\47 M'QV%5`R0;?&*9Q?/1!N`%"14D#C6P.2T%%RQ;`V!S)X,90J;/R3@,43,<*7? M3*&DR$;%XUB6,YLBQ)_Q7MSD#J!8L>1K7&LX)L,Y_8X%!TMZX_9,M%MT*%V1 M)+&I,@WH&),D`2ZFL.8PDV$.ZUTJCSU(AI?D?&>!0]<$JESZU]7G^54&4)\9.^4ZL2C?K;J8MGF!%J\Y)I2L8644K"GCS"W$) M5\.EDLCT$#F+J;:1F8U14"PL<806FX)%;\+A%SQL/GT.G@9I/XU9[AE!13'( M)$#$@)?V79;CMT&L%H%SJ\E]2Q%WR:I(B/X%5ZQ_TQLU4,>%;!Y8.KFI5F7' M=(YQST+((N7WI;BS.H:DM,;<*JA@$2U@;70*/GH0- M,*GQNCK4HA=I=8IT+JBCM9?QN=CQ.`VC6RIL6=A3A/4++<-=8PTY4NLHZX50 M2-#%)S?*B4-F2;,QRKQ_V8X5&RZ#H!&="_H`OXD%;\ZZB\#.TN4'%6' M=--7?E5WZL_$/^^9;=X0VQ3P"P^#,+H%Z1^0X6W*=R.\!!UTFTTM=A]2$*=> MN62J?-5V;5>>%QK'P@N5SNHH^&1_JU9IZ_K6\W)`I7-I_D!S.>_+`=M:J)=) MQ:#5XJ;JU\:`OU$&_)+%.\9V\EZ][[:Z2[I054WUL\^WZ?:7M2SXP>;;]%IN ML[ZD-\\/-]^ZZ[660.-O0G5%@F5IDPKE1#R@$%_>7LAS&_63Z\38[+F-[NDU MSO)Z;N>0W7.K(AMDJ'?$/::5+_Y8%JSC-@[9'ZD:HMMNKW/`YC(5L2;(@>UZ MHSTSU*79];#3<;OWDI%JCZW:V6^O#7%VWF(Y1W2(<19>X#DBW`\KDHYI[S^T> M4L$[JKECHZZC:=%V\,D#US>WVOE]W^G%`$4H1M-?J6]9(1!WJ7N9+=(%YECBF\:.7/]ZLT3]%0]MH]M]E:L=?'1W:KVW';_9/SI;2Z;;>SG0OP,+?W6KF< M/YBX`VG7ZA]0?SVJR7L=MW=(]_]13;[=!EWZ@"+[J";?ZH,Z]YRB:.EM_YE` M-]&*K^R>7[I;D'O:'QO!YX\F(UNW3L6K^NA)X]> MU^VNFQ*A\V=*L,]]]#R)_OLM[<][5%[YB(6`119$S1F?8[YMA`;P))P=X_S,EF#%G)#U4$E":%4:OH[:/)CW*6B/(#$E MH40#7VLPH7_1L/1[J@Y4CW$]MR8\CW7'I5NRW*YL&O/U+JD.AR@)X_CK)5[-LA2+:XVY[#K7"S7&*L^K'$B)!9&-E)37`N6`!N)+ MC0*0KSZ4^/)/0D+%<;&L*4-D,$R9Q`ITA%CS\\#U8M.I&$^F5@]Q^[VRYM&, MJRMQ%[R<>80[`L)>\+:RUT%6V9<,6/X\5C$AGA.R(.+8IJJ7A%4$+`\.`:LS MRO&,2S:YU#-"#DZL+Q#0,8+1'1P)Q_`PO'"$_4KLQ/K<9]UH#%1Q`, M?B$-C$0U!GF1);HSCYZ&H9^+C?&B1FRLD8$/=%%@T!W*)=,X6C2C7\J6XR3[ M7!:N?"E%5@FU0+TBPJM`RG:]]BR3^%)'R*POCP*;>2`X/L+\.N,8Y&P8?$7H M?>J-BK\F.6O3CS!?`36$F]JODVAVI"A(=YQ6#61==2+!=BW]9'YA\`%L,&(` M*N:UD+<(HRJF9VY`N^"*LP"8$8P)I$0^J MAZ\"5,"OGAX%Z1_8@^$4:CZ9/?+Z_B3">2(`@F`.U MGXC\H9^#X9,`*?']'TK)@MLF"T*$\S'=PV\LM,R[60KZDG/QZ>;NI1D.;L(I M/L.S?83U(H!0'[[$J[S`R=@>@^QNZAP$^C4;0JC.R:_@-S"`D_)@B,VIULQ@ MO\49X[$54.QETU-)/`$<$E%JC1E<3A%."LH]KGSP@#894:(`/XRJ5+;/U%N! MG(>LJC#\/9F1^B$#%&@88IRAPP;L[E3J3##43'4''<<1*Q,LF<=FX:S6+_E% MPAXMU)9SBA!&RF)FU@6N0+4*E6\:D/<0[7Z%EWT_T^!:KJ%6+@O3@*:I:AL. M,Q5X+SA/0GPU:*\^*\#LFT&MTNRO$V4$!L#JLFYUR[]!TS4282HA#8/$&81^ M,+8`%A5&$\-0?Q'*1R116<@"R*V167L#]O,7;!-P338S@HO!E..A"+$S0JC@ MFZ_NKIU6NW[9K.?-"WQ0-S^6IQ%M\R`B($#3$T>IB`O)(519;C1@X,QH&]+B M!FETM7]FV#(&=SK'H#F<0L,TU+D@-SRMF-:H"SVSO%I/][6R@.+6`;>1JV&C M)Q*`KIPK(;ZERBXA\I5I,_9@E7KX&SL<&)V`X:O`RX,`7C6[+ MK=?K-LYFSCV-SWCMMMU#MZRWGCI5-^RPXZWS/8DD"&L#277*! M[=!>HM1+@ON,P:5THU393!11&Q%:=!H/OC[&X5#A^F[7,9>FV:JU<[.\>-'J M='Y9T6$5R)9V2:IM&Y^0DY.22P.:)J:\8$M?:=N7%4Z_5>JKR)V.K+ZIZ`.9M:!B#&M M#S`R@UC)9'^I=9:=\KCYF5H3N7:R"9IJF2=;/IDP*)L:[!3/>6MD\B+UH.0# M;0-1REXFJN?=&26YT`IT*D1'5!5_@]'O0L\4W%3Q7W%!D!M8& MM'6(SX'9&3^PJY?VQ'Q['R<)H3PJGJ*V<%$@>RRGV",(47NYRZC%_]HX!=,' M#($I79!C(=CL#;7:%PDQ3-G^EVYK\YW-??I]A//.N@!'0YE57H>+!',BZ5%89\5TXT)`33) M1<%'C>;(@5DXY=@8*##;,K7ZKKG./4:5J*&`S@20,53"C)Z9OMW*T+P7LUA& M1V77-C#T1PK,E4+@4E>AN+X!R]^-XQ4-]#C+Z.7RWU?TI_P;J77QCFB1+W'$M:!W%@IYAS0F]HJA]J*T\82% M8P!2@(I\SXI#K+VN>4@OV"&PNP$>AB%_%.0 MBC-;Y'-1L*6$[L:G.P;*E"^KV9_R?*2/>(1B:>:TGSE4_(:QM?R$C8XB;_"Y@^Q]2YL-KU-MV]`SSCCA*=G M?/#]X8-7`25=5BUGP["N\XH]H+Z^]8'1_X[J!XV[`ONUBDD^^6+DC*'_<(%MQN_R"I($.!O@R2=.N\"D*V?44R_`\&ZI-RS\*K& M`4%6&PM!5EOUEMMO'0(T^#CF>]%W^XV-I[L$L^`H9]GLM]UZHR*HX(H.V=(" MQCOTM@S7/TN;KO$:-:3;EG*M+AKNU3&BLOMD3FG2%PVWNPR+?,6I.J6I>MVN MVV@\)^;G"I@"NI+WO-:'+HWLK;BV#GJF#CSY"Z_A=OHKBM'W?;@.O>'=QK;( MRR6'[(>MA5W5N2P.OU&0).*`"3!-$@F&!@ M149EC5,*70CQJ,3%\3-ZCVC8S[GF:T.!;6SOT1D+NS#&>#MFV6".H8JML']7 M=Z+=H^OEN!<.7YQI`^L*^]6/900<'?F?!*^8<*Z4_TK'*FP5\IKY&S_^2^8G M?C2=6;_`"=$@/^,R+XM,O?>3P:/3:*N4LD_^4'5]?V\:=:?!.`OAZ`NN#B4; MG9RBN$E/L=T9EB.?'!4R?2PQ>J5S+9QAD&!HQ61`RWZ6)'^T;_((MBH\YE($ M35WAX'"Z"-%3]W[>#:8SW@,?W M0(,S;>YG^3>-R'WB:U+YMU=PTX1.DQ.]G`OD%Y5,UJ4&4V9RZO/>;R^="U6# MS-EUBX2%^86FB?B7$ZRQKRMZWF.J5UHM>TK(:Y639W5E'<6)FVO8CKG>#U8V MDHD``G7SNX(._F;=R@5'+B=,_?7OM.(&S_^0R"D[".OPIK,F7WJ]`F/*PZ39D:@H9<2Z!*&\A_JV/\25D=:GC`S)DMU.3`&8:EZA,-P43Q%1O%E23+75RE]#G%/ M,+AOZD`>A4\*L3TM>L\'?(^9C"MA);ARD>O:4YFAI#N14P:RB=32C#"S:DEV MU/&,^L9^T)21/U5MI"=6,B1@H1?Z%5_?`1-5L/6=&40FK7?4F]9QMKDHJ M9LE`D),<,/>FL-4J_S[^QBD*B1@C0`\%_L&8/L?K;5(^J^-OU"%56$G$J&QB M;:F=ELRBC#!F0WXCT^H6OM(6#LD<&<1[& MV1CSR#`S9^1XM?HO#J-:J&I,2]-;NC(LWI8.6IZK@E*I7FLV?SD+F++S\%%F M-1;/0SJ`ZR`+%0P"I^QHVW>3G3,USP8#BE2@?\+-`B_ALS'6-5[];IO*RD"/ MT$\0$;FGVE;N$9\&JJA@)OY;%@GI")!5`$+>-YRXRAE.#!\R\8,ALL[8GV(N MVKDFIW@/L3J-E;$)^C@H:5KE:RW:S&EK`BL?143%<=R'9\&;RVX MH1.$!".RHMC5A5U0QE=4:!D[K/9C$+^\S.5?,U6=]:5"\0'X%$EO*3,&`0EG@PR.A(7P0O<]&2AL<5 MW1=!P`*$WJ^U*C,($5(<*'TD75XEW2LXW2++4%D-/&@4Q66WDJNAX>YG5)X5 MRNH35CO.2?XK?43I-`D8M>@Z_B9`.P/Q4?`/Y4N;=6AC`(,`35*>2]Q?JR]*55V_A'1NY,942<.:>,<][J4.9"OEFE4E*) M('GV3%Q4LY)=PP?$?B=M8TIYUUAZG"!,$QUU+B-F7F#L8[05B)2R2MSS;I;M MYIMOREQ^+49^%N;4TQN)7+)4!@C]AB&_P9W_:$VA+K<>@9J#D`!$#?QU3D'! M\C%V*_BR-CDR]](3PJT.L?%G_C7T*PV?2`PCRX4(&WY&G<34S:$2@>3M1"24 M3\*ZZ22RU0B%ZM"?I1*OBBC+F#I#E#4-`A^8,8KX>*+J*_%;=2I4S:AQD[MV M4;<_F83!@*[1AP0+5AC!G=;FSQSHP>KS?*$USMK8[/<)P:!)JD!2PBK!+SZ]Q!W(-5SS(I!I*3H$!>S8''`X#S%_"\`"@T&2<0B2^8#B3@)/%/MZ@O$81N$: MPZ**(@ODQ7>1#%"3(4YAQ5;."!=W>(:1F/,PI(+EM"H03H1B7[6)OD*Z`_X( M$%%ZBFPO$=P&5F&Q^(ZU^%S<6709K>(81$LL3^9S9;S4H9`I"C@\B0'YK)AQ M0NN.^AFW-Y_!EHO\ZI2SGW!9EF6<<;9/ASBL3L@66)%NP0:GH*:?^[]HH+T6:2J92E<3T()WMM>LMW/I\D8+0R*UDV,H+4Y9/SP*%@(22\0LBX>BEI;IA>P/C(A:EQ'(M@ MDCG[0D."L=HO@T%S:1EV2PN%3T,"G=$+AF!G$I31$Q@$./931#CG;('`GW;] M>W%)/A>60$H&VD"%Q,CF"Z,RV`E>$P0@,'31[WK[D.CTOUX0G:P( MTSMU.Y&L\4D,L>$-NJ`*-I]!B]9<[I;D4;'*MS`5*8CHK)(>'K!>[)*@P\X, M"$+!RBCKU6H#58RGY:KN.XDFDP5DZB"@'D/!9O.$UIR/"1(![&$S1:ML`A@K M)B`;5ENG=FZ53G)<\0^MX0E@LOV1AL# M(Z*GY*B<]:,R4LID`\*4*_!N/L?3P'1W09=?3EF"PY3;'"W4&RT+8-.4JDBT M,?U.2F-#8%FRM.7@,DMG&J0C3DW4VAI"D3S"9#5,N"5`/N?3&5,P93E94J8Z MYF?"=HI%.8/.Y^(B1Q!8/1YFL8(@"\Z?2C3`@=2\JCC.$6A,22[#(SBJM52V9?#(2`#[9J))N+Z304>X@R,FZIC$8ZK^'UQ.R&-[SL'PY=9*7!L'.U(7=_A4$ MPL?:>]""D>G^$2=?G6N"3R2L*KWU#1M[O4#XM5P_33B<74Q[S>5G7VG#:-'C M97N%T,&RN<%04J\:$=)+4AGG4)B_G&C>;[JMCD3.7E*D6&:G:<\=LEN_4^LV MM1ZQB!%E2RFVL3BD1WJS[G)`+3DDGTM1%S.^'&/YL9,0GR(=_85'E)?1F]O, M;W#XA^%,;ZH6M`A4AZ=AF/A/!)U,+4'DAB_;`:74S)-->AL2UN[4>KTBYTI8 M%WLZI*OHW:H"A9%*S399;.A73:6A2P^$)ET`2<:NU M:\%=\2O)>\0N4MZC%&:3;FBN_Z9U^]^+Z1,F%JYD&UFL$"2%#$9;%B.RJ"E& MLF!H+0^!XN::\X7\AH2#KOO#YOB'RF'NA%=FH/";AGCW4J2T+>AV/`NZK87NU(=9RS*;DMOX_)PE MSCOK(%&Y#C(JW)ZE2DBQ.C6GA<`YEV?:LANEV`ZHN8%*7RUB*N:D`QXY)1:' M^0.[G/\M#95J-&3F;,Z,Y+=K7J]7>FFN_EN-9U:WS:;Z/YV)0TZW)[_2:M)%Q+Z"9?<&-E$ MRW+QW4ZV*.ROY5[5JI3/8GV18KC8)'.6FV-ERX4'1((YDX:1WS0^.JK-I]ER MF^IJQ7G'M"F9$^9.7I`KTT8+\U:7=84R.2YK$L^"O.#%49U]WA&V](U)+#I[ M9\I(>5W:T8JUC`7-5RC`!>H1`C7+Q0YIL17?%AMHV0U3[&Y8B6Z=9[6>T`OR M[W_.TLL'WY_\^DK"?[^F:XE$S54T?(5AI-O11RM_X3/,\548#[[^Y____R&F MSK_K-\P_"V^X,UTZKKAQ$!#VD6QKD>IW41(3_..3&/W'G]Z">HQK<%GWX/^F M,?_=OVS6__2?!]VW+T*7.\^W\I"Z`'4,L/.LX%N0:O`7=)K%IHD@O0>^K"NZQH2% M.(D"WT6=;A;Z.*6W89P$0_CH-=#Y1-T"<>?_!C\6,WG_/<:P:3=I2#8L_+]R M9Y2V74'$(PMQ'?J!+%-7%LB[<1U15?3Q2#\U+C7OMV)C7 M1(M91VPU*,N55O^7!7D`^J_%J^"4K8#T M'J6Q7HIY5>Y&1:I+OE+?E9&B9AU\+WW!T+F1)_%.2C4[7*[.FG[HHUP3]2YS M!!<\P@VZC#B:&TUNJ5G?US=W=QEI@O9&.`G`^,8BS6 M(Z2L4KMZE$=G&6218E0.YPZM$#\9ILXU>NAE&AP;TV9UK^ZN;:%Q)\,)/:]^ MB?_7OO1:0'LPR4+93AS,+HFR$7)2+'&0RCI]F>_.)=LPZ+Y`@BPI`^;&OM%@ M2@V%;>=8AG"(%&+(B8UL0J6<4DD94R3'!?FD487M:]M\*')6:^JK^1"%U([$Z%.OX=ZH= MW.3H_3N<5_)*JDH^YPVOF[47?[]YDY.N,D_&DJ'DL(''4DX+8&<[R@4*X_\1 M8WVQ\RV637&M)%7].^H_I7ZH8`6X-PNV38H$;AW\37TCAX+K@H3T8.@!BH_@`GX/DJ@A=+1\EYLRF5+%RW)K\Z%QZ5/D_B)`W\2 MV8VO?74:%`F\>%@RCGB(5ML_;F#NRQ]:[-+Y35I7JC$7*'?4-SR2;<,N&DR` M!2"'X;W[-$[NR7U`H[M*^A*XJ-U:FV^FZ=2)F*K!D+2G7PO<@T+I8^0 M]N0F4O2QNS'13$'ZM6[RA$P+JKGXAB]`YXT,?@7)(!NCDV60RRW\E7/E!0ZK MHT&EJ^O.^[]HDVD(-;='ZCQO,*?X1Y$_E?GW\ULPSV@R0,=I?TC.8_SDF-PR MJPT-B4^,IE(;&KZ"34\F+F6BSFGX%CXJ4NKQ?Z,7D)(2\]Q")T$FF>-7CO3_ M\M\\"1;@YVO4(N6O,:A^0^ECD6+3Z27AQY^?'0(S0 MDS_(2,C=X@V(/P.Q+%1B.O[L58SOQ8(9$@"QC.<&F(I.'E^N(\!MT0(D),4O M<1UE76KF-@:G.^\B\9HU[Y>2/DFY/KF+\6F=UXF:/><,`!%TVO201$:_KYW= M\MK5O(_/IBDW.Q.GA)TUFYPXWYK+N= MCZW,!UTI1(%%P.B3]E M9#NL*I($4QA7_]1V=ZC[W39(N+]7HD*LA:(D,Y8M-6&DQ^">B\3\!ZSLFTJ1 MK$'<<"=DJKIR`]6E:3:R?YZS%%AS@8M90"0Y=S?EGQ#&N]U.?&FZ6[IIB5>#,2"=]WZ50S)OZ2 M^HK*BA4,J%LE+*`L9X(XLL"['(S?(X!RFEW1@_`5#T,8G!*M2&;L[/H,SF5XC0,P5EZJOZ MGLBPGBGW7)2_396=\8T(-)$\2F0&+-G+8".8'2^UC9_]NCDB4OX6/T;.WYWK M)",'!?I7\.J3>@SQG-H(=86M?;0@_2U6!%R'"3:%BZ:0HF5@[G!*LD M"2Y<$B*EK&5)\7O>2-^&;>!*U4D*MY62.$6P@?E[1XK9]WX$DF#J$?ZC4E,[/2C-:>71SIR>FI6-1;-XVU M3VA1Y==79\!H`HF8-[9K*>=.P@H2,*0H#]_V.4F#RW(X\I_-WF_7>C2[DN2Y M3\L1'5SVR!DM*XJC2[GG$C]9#!XC8@$ZBT/$XDFG"5OEFBM@%TB\JRTMVP'+ MB1#HU+`TKVR-A*!6GMA#55E_1(:*M90I9E3[RTH%7TNE#^D&I/;USEY23G!'BEW.F+ONB)Q%T35M]X6GV:[.HU(7<6YM^S*%*J:W:.;Q6BP\0W MFDL9_IX(66^-T0/IRL>,CKW`:^::3.=_9B(B(_M+N` M@74E(%DURO%A[K;5TXBY2?GXGN;/5:>810,'"1-U7C2:M0X'J%6?F`@_;9FN MLTB#(MJ1/6NM$Z/,"8050!DCY;K"8P*C2ZB$"F=1,H4N8V3L0IF4*_'_F:"F ME3Y12J*1!6I1*Z.AEBM`M9>YQ#(YU[JX]>QT-W8EZ]@AJC0$BO/+/,YU5JV*13G+6HN4E5NILH67"J-. MNWC*V[U\2^WM!5&DPD);'@&F9S6%2^30CB18@G]W>63K3R23&MW^G(AM=ZR/ M*I=(.^^($4@-KVFE_!+Q'HC4UCHB23D@=Q)+3A4B2<<+K23$LU3:-<,IIV"K MO=5+O5#WTT5/,CJ+V4Z4V,$AB;)C12.8\7))X*&,]\J7*,SMU!!CU].2WDH0 MX;IT<<@X/6I<`B4P[[]A!.D<70K6.WT4I%J60M"2Q2DAI(F.)L,!-$EYE7:7 M*O_*I[3VZD9GT=+1*MJ9.ZPZ88Q-<(TRE7LO$?&B7U0P/,\<\&6OMM&K5"9_ MSB*TS.'U+BUU7YU/5O%D$=Y4G.0M5QU56GBZAC%5Y1!OX=V5)2G%+)"!=4,< MTV]E2M"^>"2C6,'5(3K;@SQS5DP?;ER,-61X_Q,=*E,@@L/TZ(>C-;T2.E)S M+P9^ENKP>$6"UL)9*5,IT9'LK74C\1PSV9'`OVU:WD MFZ)8DGJ.T2]2J0\L]7,S6(HADSE>$FN$LIWIX81Q]'!)[2<*86`K\,O.3!V= MDMYZ=;DEPK2G6W.2"`7.."I)];<2X5W53*'D*;F(G&25Y%*,#;%8&L4]#3,"P:/` M!WM:92Q\P4:JR5"^$"N^5@3F26Y9<<.,P]$$?.?74`=7IK,)<@M:O7TR M51IE'@$_T@6+8!T".3I5+1JJU-XQRD;TH&564X:B.]8IN&*5[S7BJ!C&Z5GE MDB+[GDI")8Y7?J6+>6JYC=8VJ&%:I<3#/E#5.::OX'P7KZ/FQ2^<#TFI8$N6 M6UVK+M^'L`C"U9'4A$,+['RU5&(230F4K>FC\[A8-1Y#X9#J'#,9<6 MLO%@$M8*MC@;3+DNI]R49_\[>[=+@N%?K!A)%.T9"E4C?X(23;[LMV<]H*". MY@RT+/+A9*I4JPWJ.RS3"RX=Q!D<+JI'1H&29`,-QJZZ]?PWB;1/68@'\[+N M*>?I)_&0L?[HW%W^CU,\S))O5%F)3Q8C)<5:+2/CJ2QK%Z@A8@2"D&-8&.91 MC$?6_*AN#2TG>88Q.I46O-(4O3#&,EN;E/2JLN4)/=$*82G@#=\D\ M*:JHN72IF4\>E:XMCV8\@1M*NM(RVV'#T!\^-6SAK9*)2)24.X+%@Z5"0838 MF!03M!Y=N5[:Z9X[JGK=G+763%U-)&Z"L0:F7NG#(:Z3:0@2)(5QZ;`C MB>&='T?:2%,]V8`R:H=42?'-,F+XE7(A4,M!14(J.5'0`H9 MBR_K<$ZC#+;1*MK+EK3(>1?(Q-94YGHO*JC27AY9\`28E MV"H4D[>#=2.!?J,A[+F17*H.(/>CH(@DMM'O2B5/,C94X%Y5TR9LGL>QL M;W>*/[$A\(E#,CA=^LGL&`^PI/7Y3VJC56M/IL=V5._F@S04=E2:@G*U(#/Z M6(.E_?D:%R5UE8Y"-SB&?F2J,YDV9K(:KHQ<62IY?^+/%(">SI`&]AZG(OPF MG=-LPZ+/`DY0AD!"-@RN32*&G\A4]0DY+T0'HT7VR*HAH!D9Y8G0`"EQ3M94 MQCDGFY5Z;7+:UG"6D:0KBX1)#3@U&.U('+UV436"T5J,I\C$(W5X]'ZV3G(5 M"DO4-&5]G(1/4PB-T@--CK[4CB9@6;`))2HIKPQ?XP[)532"A(H*:8AVO<-R M-_7N?$EF4+L5IO M0DSHU5'.RC&;J4X5IWYQRC":"SFGF)JCTFQCJK;BVXZ.0BH&R+9XK[-39Z)- M/@H+*L`7:V!R4PJN4;:&8(`DF;3F#T&UF`8I@0VRITSAHI!,`3:+90&S*3L\ M^Q66WP$4'99\+<&HAG-*'0L.EO3&T9EH1^A0.A])8E,M&M`Q)DFB>OI@YPN- M0YDKD"%W^R6YVUG@T#6!>I;^7%T=NL64&%)8#7].II8#`BA-9VPPJ&S$G.V54TC`7 MKQ&Y;^24.6I>?IDR;0N'I24U*ZF51B6SN6)VKD!>">W?Y5090G MQD[R3JS:-NMNIBV>8`VKSD*5?6_1^RD5!4%MF2[A:KA4$ID>(O)$,X^Q^"C:\"8!?W"ND0RMA#IX&:3^-6>X90451QR1`C("7]EV6X[=! MK!:!LZG)84LQ=LFJ#+PJ?\$UZM_T1@W4<2%#!_O9\:9:M1S3.<8]"R&+%`[O M,,H8WPM6C,=$C936F#N76L?PD=\N180><:&VCG.+*=%(9D=1Q8#_S0]"RJ(H MB4C8E1>H#^$XG,LLWVTW-"LGNN9(TT,^N6!J3CX[4$4=6,+:>!)X]"10@$F& MU_6@%KU(JU.DX::\B16H/OU*8\#=L%@AL?XF7@#])Q:^. M^NM/AARD)%'#D!()]X;B#[#$IO'8/(T.$/K%L&2.\L/MGD/28!VB__A31T_: MYE0V`K17XYY#0<@_[YEMWA#;F#9+NY.T3](_(,/;E.]&./V9[+RIZA>2`2_Y M2>"F=%5MJIYH7$LO%#IK(Z"3_:W:HW*5HW@ MN9^5`RJ=2_,'FLMY7W8YD'"M`YF8IQ,-\6J/DU^=__.&_F>93)>*0:OU"SUU M;0SX&V7`+UF\_$N\7]:^#LI_^6+]'WB_Y/>!\+_H)5Z][[:ZC<-1_>SS;;K] M9NNGF6_3:[G->OTGFF_=]5K=:JBN2+"`X3T5BU0`Y40\H!`O4:_-`K8\MU%O M'HZ::JAN]MQ&MW-J5'M>S^TTEC#KL9(-,M3;:K7W?U6;,Q4,CV7!.FZCU3NU M76Z[O4[_U(B&`]7PEMSN1TMUL[T5@QSBAOH2)U]%DOX;=4.ENH(@CO[\D2*_ MI/G^D26S8UG*KMMK>*>V_SVWW3FYRZO1<+OUDY-JC:[;V6ZM#W-UW6(Z1G6+ ML-PXWUAAW\36MZ^_9ON`,OFHYMYSNX=4\(YJ[HV6V^D=4$(G&+3ZG?<5F.K"^LP.L+'\I2`'TR`7G2!>98XIO&CES_>G.O-%>?\ MAYMSPW/[K?;/-NFZV_.6N.7G)KUOK0`_^E".M74L@MGK-$_14/;:/;?96K'7 MQT=VJ]MQV_V3\Z6TNFVWLYT+\#"W]UJYG#^8N`-IU^H?4'\]JLE[';=W2/?_ M44V^W09=^H`B^Z@FW^J#.O>3A%O2.QO=VX,F#V>C6O6/QNAYZ\NAUW>ZZ*1$Z M?Z8$>_S(5/JOK-DO%OG_E4I#KOU$W"8/?A3\B_2=5_[P-;HM^,?'6_:?][8` MU0Z13:MY!NPH:2*AX3P)=J`'KB6;3L5X,K4ZBMOOE?609EQ=I;O@YV>S_!O$B< M7E5")S=:G@-LYT?-@(D4JP9UFH@(2]:)W?U4(]O(^BWN$8S-5!2]4S!Q$`^S7A_/)X,:).*"SG$^XA2EB;B&K+^22SPK2D^:$\CR(,IAF.),4 M2S2P,M+F9JM[0LDCJN`)"!\Q34L1:;:X=M3-E0Q!JKV6G^3GNVDE-GPE=28Q&#&1,8\A:=(4S"T/Q"UPX2W+'`D.1SQM'DJ_0SDCV MQ6)<`Q![<8*0?,,`1DM$-#"'WB##,CGZF.\G1$A:V00!%V4$G1Q<@TUCA;-Z)>RZS@)/)D7V<<@W`-@Z^(OD_M4?'7)%QM M^A'L*Z"><%/[=1+0CK0#Z9_3^H`LM$XDWJZEE,PO##Z`/48,8L6\ZO$6D53% MM&Q9B0J[:;JP82!&&74KA\=E6W+<8QOC!5^$)=D$8DRH+>)!M?%5"`OXU=.C M(*6#>]/F*>&%D/VV$K%@6?-[84T#+V[=\W&#AKN/T;`LL M((77Q@"KHGQ-S!G1T@8$`XBC?TEUBM@4S=G+$.M[N>N1QA,/@Y%&YO0-:'(8 M(]6L\5CM,1B2R@AGC6M,;:=9*)?J#B5\F-,-W@L?S\TH"W]/!=PNV&KNFSA> MSC7T.D"PHRD^)L95M!8X^#BHTYCQSM68X+`B!QT@P)8SS<>?1!!]$XP"YUP- MZ*IKU.M]EV%H$!6(&BN)R.?["Z\BW=#57.&!VAT)%<-/*,,`U'Z\61&(=H8J MLP4`2?K)-$`1[`A4H),X"@8*FD-"XA#@.2-SX]4TQM<;]"4L1:HY"%F1QJ/I M$Y_7;R*,)Q+6!^9`;2(B?^CGP/,DK$E\_X?2A.!*R((007A,E^\;"]CR;I:" M4N-VF&@^MJBL_P;!]AO0C+TX6\DE@JIZ;DU,FMO('K^@G#^UV3- M(B083#D>BA`[&(0*9OGJ[MIIM>L@VO,V`#ZHFQ3+TXA6QK MR,-YK76M:[ZHP[X+_ID%0S`;7VLLWF-4"329=)RN*0\AA#LLA;,Y.`*4VZ-4 M::E'LL2PUV#VV'0$+#D-+P;<]J+1;;GU>MU&PLPYB?$9K]VV^]J6]9MS&0]0 M-LI:."R]SNK?:%3K14,WA3*=[R,L24"+5/HO+K!%V4N4<$EPGS'\DVY>*AM\(JXB@G]. MX<`]QN%0(>]NU\66IMFJM7.SO'C1ZG1Q@U^6=#U%O&@8D/KDJZ-(A!"P;0IKYCJ/H$^!@OE=8`8(M>\9PHN3&2N'LN=> MF@>_EZ"4U(J3SSY9EDL^?0O"$E1#H@V_=R(]H"F#PB\ MC;M;)-/+;"+##\;\(%#PIS*81=,ZS)46`&I$,#PW)"&OHR06!S2-QOC`EKY3 M-Y,JG?XKU>L0NP]9/4U0WS+K0,28C@08'T$T8[*UU#K+[G7V*^O8^3A'`8%4]1 MJ[8HD'V/4^S;@[BZW/G3XG]MB(*9`TK_E"[(L1!LXH9:[8N$&*9LZTL_LOG. MYC[]/D)B9UV`8Y+,JJ[F68JMP.^YL2#%GU4P%F>NFY7&"48R@+!)EF`'4DF% M%2'5Y!9U#Y8(YL72>K#/BNF0A!"7Y([@HT9SY/`HG')LUA.8;9E:O=!9JU`XXR7- M45,PCG.B2YUP%4%&5Y0TKZ,8?:(22)I8\ZE#G&+0-K0:IM?=*E=`1'A?MS':S1%2=C\4[Z M""S#&I=,;B$H\.B1M6[@,,V>LCE5#M;?W'H$)HL>23Z2VBKX(P:=P?D&<]!M M#+$MZ6S"4:4<8@*D?D>*@I`2JTX'J>N9' M,K2'J.(!>EYK1,87(4.)YB(&:N0,[56TVM:3C%XNWXWP$.8P";JI*? MX/I1C5F8Z=EQACE%Z),*.*[*+883Z6!,XY`[+B5"MK$`\?GHI]1J%(X$_M=0 MB#'^`A^A5@$SW:DXFV*'U:&Z3FGGX$FYE[3WO-D!(N*#]4Z^MD@\Q%..>L'# MP'R1ZNIJGUN.N@MF*$P7H(=1R#\%J3BS13XY!)L^Z`YYNHN?3+RR&O`IST?Z MB'?X`M,6=OE%NVO;P)24ECO0U,L8@Y9\7B]D+7T6F5BH*9Y7/B6O87PM+V&# MD_@K;/X0V^'"9M/;=(,%]((SDG=Z1O#>'X)W%6#/J^"NUWG%'G!9W_K`Z']' M]8/&78'.6L4DCG,=7LMS^'.O`A<+7:NLOMMPX!ZWL<\[WHN_W&QM-= M@BIPE+-L]MMNO5$1F&]%AVQIB>$=>EN&ZY^E3==XC2K/;8NM5I?U]NH84=E] M,JU[K0Q> M_(77<#O]%>7B^SY&I605)O-F.M='^F%-( M.%`Q[?`PW.M+F?Y=\T(O>)KTGEWU[!31,Z34[T M:)N)?3J;&SJOH>8^IUFBU M["DAKU5.GM4W=10G;JZE.N9U/UC92"8""-3-[PHZ^)MU*Q^TD+%$JQJB%-2Q M@[24T'+WE2'Z"&[OTSARY3_TXH;//]#(J?L(*S#F\Z: M?.GU"HPI#Y-F1Z*BE"47>(`L=J3Z8IU+H,L5RG^H8_]+6!UI><+,F"S5];D8 MA*5*$0[#1?$4&<67-<)<2Z7T.40?P>"^J?EX%#XIQ/:TZ#T?\#UF,JX$=^"J M0RXT3V6&DNX53AG()E)+,\+,JB794<=S)H[[Q'[2EI`\56^E)50S)F*@%/D7 M7MT#$U6S]9P91>6G=H6;U'.VN2JI<"4#04YRP-R;PE:K_/OX&Z[1.4UQY=DY?I7/@O MN61WB$L`Q_)-EL1##/XG<-.AA`VSU&F"%/@%TV,N[OEQS/[E[R]@Q"%28DZ_ M)BQ_\[[D=Z'3ZQ>^TA8.RAX9!%X89V/,(\/,G)'CU>J_.`PSH2HO+4UOZ%LZ:'FN"DJE>JW9_.4L8,K.PT>9U5@\#^D`KH,L5!`&G+*C;=]-=L[4-QLD M)E*!_@DW"[R$S\98UWCUNVTJ*P,]0C]!1.2>:ENY1WP:J**"F?AO622D(T!6 M`0AYWW#B*F:G.(]Q.HT5L$FZ..@I&F5K[5HRWFQ M$=N.8+"&#@D9I7O*)#2)*\10/2@6WF))O%>__"]=+3,*T@$\,A-PQMFBMRNJ MB`JNJC)B\[Q_A?TKL<3R+D@#SW#6*@ZN52RR`=>^VKMTIY;=[/1U![ZFRYKO M\BTO[,64LB*P]E5,5!S+=7P:O+7@ADX0HXO(BF)S6SME-[6)@,D/%FWE%>AE MYF%553.4U1D%SF5D+8-3B%9AT<%PWN0UJ?ML%K.PS^Q<-5^3]:U%]0+Q$4A4 M*#\)`P9#C([T1?`R%RUI>%S1?1$$+$#H_5JK,H,0(<6!TD?2Y572O0*U M+;(,E=7`@T917'8KN1JK[7Y&Y5FAK#YAM>.U690MY;K"]+7UJUC7]D MY,Y41L29<\HXYZT.92[DFU4J)94(DF?/Q$4U*]DU?$#L=](VII1WC:7'"4(R MT5'G,F+F!48@1EN!2"FKQ#WO9MENOOFFS.778N1G84X]O9'()4ME@-!O&/(; MW/F/UA3JK#[/ M%UKCK(W-?I\0Y)FD"B0EK!(\)Y7$!!3SA'S\?+[X_!IW(-=PQ8-,JJ'D%!BP M9W,@Y\IL87,%@]Q/4''A?!?)`#49XA16;.6,<'&'9QB) M.0]#*EA.JP+A1"CV59OH*U0[X(\`(9ZGR/82K6U@%1:+[UB+S\6=19?1*HY! M9,3R9#Y7QDL="IFB@,.3&)#/BADGM.ZHGW%[\QELND6Y&\*>JKSHE'/915X=:?YY]XO*DB?1:I:EL+U))3@?3W"GT!3 MG.5KOU?K].J_%!,/[$A_+OO%+!0Y?="JMWSG\TD"1BNSDF4C(TA=/CD/'`H6 M0L(KA(RKEY+FAND%C&U_%Y?D`EM[RX M&3?J83M3BPQ8AG^&Q9V;(@LFN10ICY^XQ35"GR'-7JX_9KK0'JH)SLPW9/4]00`"0Q?]KK M%:M\"U.1@HC.*NGA`>O%+@DZ;)6`(!2LC+)>K390Q7A:KNJ!DV@R64"F#@+J M,>QK-D]HS?F8(!'`'C93M,HF@+%B`K)AM75JYU;I),,/(&,KJS"Z$9*Z&95V\9MU1&(YW7\/JYFH3YZ1`:OJ_,#[*] M"5D,[WE8OIPZR4N#8&?JPF[_"@+A8^T]:,'(=/^(DZ_.-<$G$E:5WOJ&C;-> M(/Q:KI\F',XNIKWF\K.OM&&TZ/&RO4+H8-G(8"BI5^T`Z26IC',HS%].-.\W MW59'(F8W./S#<*8W50M:!*K#TS!,_">"3J;V'W+# ME^V`4FKFR2:]#0EK=VJ]7I%S):R+/9TYQI7YE#R50(%EF<.G^'0]8AW^0S8B\=A%;'.6,$G]WR<'?"*S-0^$V'NGLI4MH6 M=#N>!=W"0K?.PZQEF4W)+7M^SA+GG760J%P'&15NSU(EI%B=FM-"X)S+,VW9 MC5)L!]3<0*6O%C$5<](!CYP2B\/\@5W._Y:&2C4:,G,V9\9R9LBHH(>77;K6 MVA04A9KS^X0J46P%+O]"EA0JS%]R$<*YQX50EK*6?GS'+#6\VS6OURN]-->Y M@8L#7\0LVML>WCM&T*M[?YUWOB2T^P$>6!.04/E5Z9PUPJ&]?&>:3JUOFTUT M?[N2!AUNS_^DU:0+"?V$2VZ,;*)EN?AN)UL4]M=RKVI5RF>QOD@Q7&R2.\.*HSC[O"%OZQB06G;TS9:2\+NU>Q5K&@N8K%.`"]0B!FN5BA[38 MBF^+S;+LABEVYZM$M\FS6D_H!3'=*9=UF"IVH[KS0Y%^X@;F'\1TW094<(0# M?NCWN]=_PDP#(#],_^-/E\T__6>["4]VX2`:D@K#;$%%TZ*BN185#3`5>Q53 M`?/O;K067J]5;_>K7XON1FOA==MP=Z]#!?4UDQ]3Z(+E`UXN5W:'D$KXI-UJ M=(BH-4>M@,B-V:C5KS=;!R9R8RYKU%O]YN%7=R02,6R?Z7&?-=^ M(FZ3!S^2F?H??6I->L<-/^1;WXDT_8BU.=BY\&VR3\K7?SF2:Y\0GMHGIY6G/<^%QVZ\WFDJW<-M0N&W(&RE?R[B#(@K+%/ MPE:RYF+"O/J>5VPYURW;2V]CRKY0WWHQO.*JK`^4OW\[DD_S4+>6^WQC[EM` M;:O>!6VNUS0$;TC)'B:RG%D73*39[_70YCBFB2QG[D4[TH*+O-T[JHDL/PP+ M=Z0!\^A4QUK%H_3*3X/!531\!HE<&+H"2O)O40N[F5%]R+!5U"Z M@,GGN)M>M-XH.8 MWD2(5/$.0[-56(>7C5XC'R+)C;$Q`1L;>+UNM\+A-[;06JVV5^WT-[.Q+EN= M#>9OA8AOHBO=%/7.*AE3A5+P5S3\&Y:[_9T3$/+T7J6WH[7]=]U6-V^"[T3' MWB?5O/0:ETUOQ:1Z_59_GY-2>XB<\8;ZQKX7T\=X:`U3442DT2C,8XVA*Z-W MP>5B^4W"E;3># MH0A^?1--X9>?Q`,^X$?3#P@AN^8J_Z==*/KO?U[TNOGAKH&XQ`\QI^K[?XG9 MVN.A7[[;K[<;'7NTPMOLX5Y+U(C/L\GZL_+JE__-[[=_7O;:CX2$\0947\Q, M7/?]YN_\*+FWV<-IX-VWH;^VI^,_1\`N@D?(O`+R(,_RN*GZ([X:=Q)(8W5'J\]K`?8IL!%KQM?MB_QV$63?UD M]C8(,;=SN^$*;REA;UZ'3P0L"BK@W=2?9NN/]@^1YMB[]&WSHQ(UU[#<#W&R M_I&Z4O!F8#/2&^RA::"7%`P+::Y@,C:Y7[W3SIWS) M8&5GD[F0S]1;^&S]]?_O9OY)Z<>Y. M;W<207H0)-(GRH#'LAK0!Z3`VIH'O7:[[N55RV7C[$K36DSG-9OM?G]KFEZ+ MD8`OAI_][V!ZB&GZEP34Y)T7JM/IY_ELZ3@[$[7N2C6\[8GZF`BL`7C#G5V` M(6\14(1_M[U4:S>Z^85:-LRN)*UGMGIU;WN2^-.=^:??;11LY]R+-QYU/0;I M=IJMUOJC?DSBB4BFLX\AV!.P+&]4WG8QL7KU9SV^,>N:ZP;T+6CAP#D*[,)3/V- M*@;:>[O9*Y3`Y-^[^:CK3;_3KF\PZHYS[+9Z;:_L$EY_G+5FU84KK]M99QRI MUWYD8%*X=:ZX1/-=X-]CJ[=`[*YYU.O]9KF*O\:P%5.\WH55[S2]3E44O\[$ MYUB')G9>3=(D;88M>_W6-*RGO'3:[2UHD'*E+-MQ,TVV4*56>/$6XZYI[+3* M!>6"<0F02?++[MI[NQ#'*'G[E@2L)R>]>G/3\K=]@Y457D/-;UV MP5NQ6GA7>:MXO6:OO^'X\TQ5@3KJ]1L+U/BR878E:=W35%B;34AZ%T3B=B1! MNK=W'%$M4&Y[S&LW'7*M6:\[5AP]8'<`6^9N+R;:[7Y!A2A[_[8TK&?F=AN= M3G]C&A:(C@I.1+==J)E8.50EM*VG;76[_=UH(^>B)6LJ6#`PF_)B??$8NU&S MGKW3+A1EKD^-]=`.9EV[7U]XLVPXXIH&7KU9J+I=,J(53MTM8EB(%Q9>N\VP M:\UVLV&O-+#:1S\8WD0*L&7KV[+;]5H%^[5\B!TH6=.;WNP4\L;6I60PR,99 MB)%_.AH(5IN(1Q&EP3=ANUNBR`9FPX[A[(7FMA+PM.H!W) M_B2XJ8U*GK=>!UH-(JMNO\!>M]/JY47OZN&J(7"]I40F+5AIFQ-X9S5?XWRW M&X6,]1$S8^+H:LHY;J@G?(Y1O@/!21R&$CJD+J#*94_9=60<[A)KK=3O?H! M)OD^B.*$WK7CGC3JK3Q7%=^\SU2O_QJK&JH&U; MG_.FM%DW^T<_N4TP^TT,Z9)7]4=K+]V2BK&Z7>"TQI@5D5FZBHYRJ:/ MP+?_*E2,+5S%!:21\5A?I)(5A]J1JOE%.PQ5-]R>9Y=U:C6ZH*3;]8D+1MF! MF+67!U3H7M_K=W8G9F7>9W7+LZ0<=E.RJERHI62EH!)6B@32:O>:!;^N/^]&ND^^_,@HV1^1H-^?/]HYKL"GNDTP!^D#><[7.T%61NT4=47T^WGXPWT>L@I60(>.AV5)*2L'7]JMO5R@S MK6Q--L4OZQ2++]:GI&*>SR2LB9G.6J1>+ M`"I=F0VEC%=O;[$R`Q%A,[NW0LC'*E*'BVI[R4A;$K,QS^R%BHV995]KL1F7 M;$9%>3SD)LJ!P]CX(Q_]9!J)!),3N,O/7$[-UAPUAR]2#7&'F_+F)ML<1,FI M37ES*Q"VN'_24]X<>G;7#WP"OK^OBG<_#;O''H%-P4]W)6^:KUX7K\02,SWRW4HU1/TL9'J=%LEHFA MBI=I4S6J5W:\5]+T,8GATPHAQ#N%SF=F@,V&WOQRJ#=ZE8Q<,NG_75`/\YXZ M#*]M855*T>I:DL-1MR'.>KO@7]R!1S8$RN^-^^BJ)S4YUN0+?R@]1(_W@^T(EODTO[0 MZ[&Y>&@^PWJ4#%"M'&AT6L4BFH4C[DCRWY@#.-@3:=M8``=Q,G,4G,13C277]1B^]_G*4J@6#5TCS+NFYAZ>V MXKO-*QC51S*ARB^QXYC7[A?5<_5>XHKLX4/9OF^YK53XF\;<@A1^^C9/7<78_'66A:C]65>"QE=?OE@VY M*WF;%U;5>_.IR2O)HQ)=NV=,Y5"+G7;3%$HO&FEKVG=6WKO>)[+!J^.Y"H1/C>AN*SZ7KVI MV@2V>;"'=<:NBMY=?,K;T+D4,;0:3-!U\4GG4"DWIVU[4);M*"28\E>@B@[1 M7@9CN3HEJ%$O]&TK'VM[BK90%PO*['H4W42LK2NM_292&N4G,1#!M\JPN%J- M7B]_<-<9NBIR-U_.=KT_5\A9`;GDOM'`C!6"2;>Z[;DBSS7&KH[B+;(BZ_NA M!B1\,E>(E"TJO(O:=5;CFW3FXPBTHV=]\MG`F[V5&ZF%Z9$^5X(U6)Z]Z M+1]T=Q(W7MQVH0'P9@3.[\2R?MY;V_8K3^2*9M];D;D%KD81075G,M=I;%\- MI_8:C574KT/,_J:TN=AH%ZV(:J8$6O&UGSZ2VVLHAJ]FOX,R`Y>"O@\&T^`; M=XV.YQ$MJL$Q;M4+,"2[$;7_*6Z.OBX;/N]KBK#C!`SR.;X:@/V8"'CO,,-7 MB`JOXGZKB*:P:MA*Z-S\%NA[>Z#3F.APL*IU:C2;O0)>]?H$5$OZYKC?_4;? MJXKT)!X(,23DFQ+/2.7+7H21V6#\BDG?G,7GPQ:;DDXNU/G?2;C1M_Y`WAB5 MN4#6'K`2"C?G9-5ZLRHZ;21@%8>K%M9WS3&KHG-S`[_36KJD2ZE=*$^JAM_S MO,X*";8$>FM3ZC;7PWN%)@^;4+=`R^!?'$:[NVPU^UYK'=UG3:KV/\GWI9;6!^`$<4*L;4;7/2ZZ#;/C[@;;9O?B6VOT-QA-6DLZ]5J M1W%ZSU;*NE;*AMB-FZTCT4AJ*SBB._',?LMNG*,48PCM! M/5ZODL2/'@2^2RTN/690+:IQ077F.F-60-K!YKNY^=TLMJKCMZ\WWPB-+QDS\5MQ$.0'I4^HA.AF]@VE6'C)Z?SB8$ M5$W\[OAGNU!?_A27J!8C`17%4+QB+_@-2*B:_,T7OX`*OPOQRC6!53+5^'L; MS4(;27N(38??PBW3\8HQR/GA6;'-$N#5%*X`[3^$57R'JX1)[3?C"4@6TI)2 MT'G_(>@-;^.D(B-4:18[T;*W"6WNRR'`NVHG),W7=\S`]S!V2`&DS_$G?QC$ M8?PPJ]9K[C5RN[+)^.NE:EFJ]ZN9>43:6%1[?\NUDF^^BV00I!CL_)!A045N M@E>@=YI)_>]M-DVG/BGW\N?PCR\^#C9EU6;Z*,!.Z*#^`E^AR8!_SI5JL#)D M+\O-A[>8'-;LMNO]5+Q_^+T<,;K M3K'5:[8:_9;<^944Y.B5?O,9.2TYJ3#]#.2]"N/!UW49\S__;SC];>*DTUDH M_N-/(_C1KXY7GTR=S\$83/H/XLGY%(_]R.4/7.<.!/SH-V?L)P]!]*N#C]9_ M)E&OQ+_.KT)E-ZY#8BPN[$9$K;YGBN@TOD/.'-.9Z$8BJ&3IPECF^6VHE' MSE_%V)_2@71NHP'_`5I?FH53W#\'-@*+'YT@I_[;,]#_;*=(A@$=U?81/OKHI\#RD<\'A-S[^+'OI/`7<,P83EAP.8Z' M/@I`)Y!O&-`;B`SKZ*F7+3EZ^/(77JWGC('7D'^#YNIW+<_I8!)S37/&D#T,A\.!'Y\^((K6>M966M=(?X^3D04@YH3AF*F1?HVXEMI M340#\$;NS:MD>))%).Q'=C=ZY=H7'):<0D4DZ._:?(YP`7PX M/)$6X%JPDQ+5[#342\X*U`]][-X%]YB2!H)Z$(R"@3YX&)%W7@E_\+C9&20* M\N<0Y?,=3!`L@+\"(ZW6HOI:*2&^3],,+`@GM-*W\;E.>\E!)3(V/*R5*5E, M,&N1%M%TLMK=[H)CJ^P=/IN+%"UZB5=KVGK;DB-*1"P[ICAY/TQCO9D`WRD9H(TT.`FMKO[:EQ5*\J90);TK#X5ED;UH-#WU.G483I^[3Y:G_^9' M&.^"[O)WG]E(XW=YO%>AK0^#A$3;V MZALH-@]"/?0Q`@/)EO[X`+[8DD@`H MD0+4YB&V9,QP[A@,!N!/?W]>1,XCI`P1_/'H[/CTR($X("'"]Q^/;OU.U^^Y M[I'#8H!#$!$,/QYA$;^ZHS``EXZ MGR"&%,2$_M7Y`J*E^(9.I\L:0!?<5$08AC_OM=\5`SB)7M]U.GS:?8O M!?\I0OC;I?CO#C#H<+U@=OG,T,>C%0:?+HX)O3\Y/ST]._G7S=`/YG`!.@@+ M_03P*(<26,K@SCY\^'"2_#4?6ACY?$>C_!D7)SDYKYCY7Y%D_`HE#%VRA+PA M"4"=B[/C9Q8>Y<)/)$A)!"=PYHB?W$Q>GYJJ MEAO&XD3\Z82K9[F`..[B<(!C%+\(7=%%0BHG/\$UIW#V\8B&..X(U0N#$`_\ MHPYL_/+`G84A8>M'SLE6-/8(9B1"(3>^\`I$0K+^',*8J0A4`K9*W1A0+IPY MC%$`HJU)+<72$-TAQ`R&JX\6W@F%3IDW\QY$Y.*ZU)%S751[X4"$6`KG?`QZ MA"X/Z`NX,RL2G.WSY,W\F`3?YB0*^9PQ^'7)G:X/9RA`\6Z,:2#>C\8`FU]' MY&EWDRM@:H+^$9^[*/1F5TN&,&2,1[XKP!!_W)A"QA^L%3?K86F"[FL0H(BK MM!MPS3*DY=0RF$9D"9^Z04"6?.;`]WZ26=%0294)_$(1CGO<)VU&*20G8!'5)R.B(5"0449&[HY;Y*\": ML7=$DP3S!@+&V4YB@MK@)4#[BQYC'LT"I%;Q=MCVQ\<4W$5-<;&.JPTOUZ-6 M#M6JQ^L1J`G>HO?KT:D%W%HDT*-1`W1_WM2',4`1ZTS@(\1+>$4A^!:2IX9R M#17V_?/I0XP(]6'`8<(1B9N*)&K\>^=U!*A8'#TJ,XW=L+81-;-GU0V;&V"M MQLU^'C9_ARC3#``0)1'\1@9U:J$.Z#&VW3KXVHN1GN:G.2R@7G M+>.D(,PMVWM(ED?<(;\*0C22S29PM\^CMGYJHFEM9M<,2#JP;=.H+=M:2&14 M!R`*EE&BF"'_O`8!GV.(0QCF>`3Y.Q6-^=<"0U;IS3NIK38G_WO-&_<'('_3%;[XW=/O=*?]PU1UV1[V!XW\>#*9^ M7H?/B8](L$9P)#8""%W7>D9O4NV?`7:7E/R7K',/P,.)L(83&,4L_R:QC\[I M65;Y_V/V]2]=QC@OO245)>/\`1&X@U'RV%^R<1O#3LP1+(ITW(C$#U%S?`21 ML.UNW.-F_<)C7V+VU8QH@F\RN&).71HXA(:0?CPZ.SW-GP1HL&9&Q8V8;,0) M6RY2D^T@;B4Y_(R2A4SBF73)-LRL:H93<>0\070_CSG]1C69%>78!`:0T\X7 M22,8JRU1"J6GMW/#>M/AW#IU\07#`T#AX%E,U9";G1?/(4W9K5:7'$I/71>& MU:7#N77JZL,9Y$R%4_"<4OJ)$J8.]`HP/86],ZPP+=ZMTYC*E>HY3?MS4U5P M*U60;<(>4_(`:?PRYAE=DI3R^?-!Y&P\$LNBF0S*ELFG,HRI6;9.3Y\("9]0 M%%7KY&V$+;-)A?PW6;%.UBZ.`;Y'/!U)^>!V,7@.HJ4H*:CUH`=MRP12H:,Z M(K!.?_FTE];F8(\PS@#!01J*I8%-`U1/<^]-:4Z;>>O4]E:H9"[NSF8H0B"& MS%_>,10B0!%DG',2)-_RN%U:2"[SQYW0ZJG[!W..VH#0K#.%/GP@#,5,E0IN MCM-3UH_F?+.,+0NE7[9L>`LB=5=-JY!Z&OJ+Z>BI8MTZG0T1N!,]9]S?E6O; MLK$6U+_&X$64@'B0XM_0)0SK\%0+B?F58S5K%26R&L*QSC;[2S@EKW.3NO12 M/MS\JE);:5*&[5-/%O.R#A9U='\=:'ZAJ:^2;7UEJ M*T7"K'6*>3,@'/?X3Z3>HI&`F%]$;N$Y%8Q;IZH>>$`QB(80,.C=1>@^/3^C MU)<*SOQ24%MI>B*P3G,K_&FEKY:E#L=99]Y5!6)6[:0>X@UGP8 M>K.47)F[K(ZR*F6K])V030&*'1Q%E@J`//I;ZL:50C*/L4&P7(AY`_3]L62 M2RF&8LL'QMYL"IZE.P[U$)E/O=LUA.T$:YV!3,3Q$`S#_.3="E\;UWH4;4(' MUGS2WZH9Z(O/.LT7Y5(G3;%S[J[04L,F8)LF;Q`F-&%*E6X61]HX7U=HL8I- MZ_2QLL3IXK".GZDAS7N=+G?59>%ZBC-:0*W#H62@E-&?3C;Y'/+/>S[76'Y[ MW-HAQXMM#CDZWZUA_K[-$YNUKY9;8^^='GO^E/^X&8PX:]ZUXXT'D^[4Y0,, MGN;\#$$4SWM!"+*,3)E' M;`PS'P`J!5[8R2CASSKSZ<,'"L7AG^1&(7%IOI`D#KL+4>7Y;>W:F=+C-1K0 MYD.`KL[J2,,Z57X""(L"NH?[B"7GB#BUWDQU1$H!9GY30E=Y6OQ;F`SQ"$%? M3V*>29*AS8'F-PIT55/!HW4N],K/VW:4QG2Z.MBB^:G(PZ96*A(C2VN,^HQ5 MFZ5UWI_LA&JD;NO#S-Y]D&PE9,2(I4HUV:6#+7"1,J$7+SBHXM.ZL,4=@J]1 MT".\AC"C5Z:3DL$6>+>63BKYM$XGY1NB+N:!]BU^K1ZV'P,:8TA%BQ^%(80+ M><-P4_@MR.\T--^L-*TS%I&Z,L$"Y-GKX%E,74O$YNG;8^0A5@/4@CQ10\7: M,K!T$N>61M8S%&4H5L&9[R?749P>]TUJK:*.*2S(PR*K]6;N`MQS4GI0A(JJ M^J4,P'QWN%3V*O)M=96W:'W-^>T1\:ZA97(3=[[5?`5GA&;]@%/P#-EF$TL7 MA^M8TLZ!&QC/2;ARW8TT!=H?$>;370,RKUJ0E2S=+%UM6B"T4O^WSJ/'E,Q0 M+"^5K(XQ[P]%BHOKC+WKWK:4])6WS`*O((8S66MS)8!Y7]94>"6S]CG=VKI' MLDA<'V;>]4KI+EZ_NJDMVYQCC8W=CK-M@>9#NX99E"6XKNDFC MG42YS3!?7Z4','=+F&KVH'KC#[+:QYL]`ZXTNP.RJM:LZ%"R1>-6\S^9?7JS MXNFIS0.T:RGH#S534)&!^E.O]_-G;]@?3/P_.X-_WKK3?SO?]0?7;L^=&CR9 M)-[D=1V1IXJ#23]NE6UW_<_.]=#[:O)@DGB_%>52KQE3Y9WL6S M993?2R[U60F4^;Z4MKQ8*2KK]-OH=NN.&Z5MMJFTHO%=MX$,[S24$]Q'0D(X M9![M(Y9FU_($I"X>\[TOK5C#=N)L_PS@ZOVVBNE:C*\>;KYOIEF]R;FU-&"O M$NG-TC=]B>X@8=M+;X[)MGU^U0]+ORF2#)"\<4+M!RH>NWI:!Z M2O]P,$K7Y]S2"/UV6#'MWUQ[Y^SK"V>K=:X+KUT,.3#-UY.??>Y>UN">\Z3> M1=:#UM3]P57"ZLC./LW[B?)YT/`(7Y&B1K)N[B]+[K^O:@AT_3/@ZN5+:;?.VSEYSLA-@: MC?4J.$W]'T[)39/O@TD(M-^?J@&JJ>R#*\-I2^T`]*WS2N9M4D(Y/DW+.)S" MWH[RL-1DVTBX"79[)Z2 M;O#K$E%Q:VVX%/1"56ZL`6IMVU=-E6\VC.@*S3X7*"/]K4C+P[9&G;L.#FM; MPYJW`+D8+30%2@((PZ0%IJ1@KVD+=9!8VS^VHS'4%V3[N]=%HE:O8LH[[*MN M8=&&MK9!;$N5UF+>TG2V$)RT.@+E4-:V?C4--T1 MO;5+SMV\N%'AVQW+APA#<6"<`6+L<;2Z2EPK)NI!1/O777 MZ_WPXAVTI6V$HD@F/Y+:T!.L702W,?UOKP+K;$RVU%L[FE=UC\CG]#Z.[1;3 M]9Y@[6I[-QMK6@76V9@06;(X8G-1K'\$D4C;QI`B<29TO=NAVH[J83%YU&$V M@T'LS0;/P5RD%!,00P^7DU_-;CTLYI?:VRAY\YS#%H*S]3KM!L314'O)#@)J MZH[UQU M?3>Y(6L\&?B#T;0[=;U1:W=_93LJ+\DF6=KN57'+UX=-%LZ/G>MNSQV*2\JZ MO7_>NKXK2/5;HW4$G[)F1&XI?@QP"&A83NW9Z2:U%US@@Z^;9+Z[M@9="YJSRZ MMD;UQ2;5/QRGM^UUN+LE%]7=C`\VZ?U1 M.)L[<;YTA[<#YV;0];EPD\OTVG,WK7@W)A$*4)6UO-\Q[CG?Y?C;N_Y0C\^I M:'ZNX/*'G;E,L;?'XV8DDG'SHU8\:I_FRL`D([XPT2K"4_ML5,0I&1.%J582 MK=IGH#1L2<@_+\R]U<&K?>KUO+L/8X`BULF.OUSQO/9;2)[*9Y/SPHQ=V]^S MYW'0[(G.7?Y(DR\;^`Q!%,][/$!X]![@[*Z/,?^?"\J']!$%4'FNJA82HT>) MN/;2G9;%`C%Q3:"PCFLH/R\D`3)?!]E"@84#0$JIM+_G7,[�Q1L))&;VP^ MJX#,EV5VT(X.@Y868"NX3J\,VC::;$";KRCM[GEUY+2'.]((_08I6TU9'OAG M@D'DXO\LZ4N%%VK`F:]N[>B(VK(Y$%],SGQOZ8GKL.9W[]ORPS(9'5IM,L]R MTXZEI$\0ANN-2VMY;J'6LT.>FS[3R1[J)$^U).L?`2J*SH_E];GS0NUH:RF\ M/FA_"_WLT>6<%:I,%2O]#(F!I7YNL>K"Y'FAU*1<^:\A=QXS[`:Y_!F^9+LC M(.J#&)0S6J@V:3/*\3NS_`%.R)]@CEF%TQ6*4+I,[L/)TI).H=_DW_P74$L#!!0````(`/-U M:D43#IC'1Q(```\"`0`5`!P`&UL550)``-: M%F%46A9A5'5X"P`!!"4.```$.0$``.U=6W/:2!9^WZK]#UI/;6WF`0.VDTP\ MR4YA$`DS&#P(.SM/+EEJ;&V$VM,2ONROW^Y&(@BI+Q(2W7BV MOR"_P+[G`V1TX?S>!Q'`#Y85GQHGAT>VT6A(%'L%`A>BR\E@5>Q=%-V?-IN/ MCX^'`7RP'R'Z%AXZ4*XX"RZ0`U9E(=L-0'3=;OWYSZ->Z\-QJWUR^#3#(O3L M"#\^PM_Q@W:;/IT>'9^>G)RVWDI6%=G1(EQ5U7IJQ?^6V3_Z7O#ME/RYL4-@ M8%Z"\/0I]#X=K`GX>'P(T6WSJ-5J-_]S/K2<.S"W&UY`^''`09*+E)*7K_WA MPX9 MO-'S/6Y7H4>:Q8'1+(6Q"X,0^IZ+[=0]LWVB6>L.@"@4`11FK!7=A8VPS#\7N-'UP,QSO&@[P20*W@UC=GC7 M]^'C]B:7*:D*_"/KBZ"P1"7+&4WRQ62A6X^[;C M^9C2CH.9#3VI1LW+4XDNP6/'<>`"]QS!K44'8<@5HN+GJ@*7::,`EQU>`&3= M8>(Q':$:A)FK`(==1D-,A1QB5?$S5'* M_`79JK%W#]&QZ#FP0RPV]0EB@^=DVIWWN,#>S/'$%)0PRB1=7>MJ01'3M&%OV^)Y.CW"#_$J`2`PVJRB[?AFE^2E83&T]NZ1#DLE; M-T9IW18JA(?:1DX"/"_Q.@K&"G2R$$Z6GM]2<'>X".0L;D##]>9D48Q,Y.** MUC6S*@6WW29.VHS3-',+J!_WJK*&"^>V5Q!T-O<.$-.:&G,POP&H(-QTUOJQ MVKY?#"'-4#^N`$:=HM"2/#NU23"S%WY4VBB3[&G,^&$?R8EQ-N`;:-A)+G6/^(>SE@68:3*J`>W>#LH!?H((UVM*.// MW?&H9XXLLT<^6>/AH->9XB]GG6%GU#4-ZXMI3JV=8\_?'TH)FL*?[OW!QAR<9]8WQA3CK3`4Z@3"[>1E)*P+=E!.R.SR\F MYA><;G!E&H,1_FX:;X9CRU+$I,P.4TKL=P7%)E);TW'WMR_C8<^<6/\RS-\O M!],_C#<]LS_H#J8_)CODB>`^=%+2^F2+'J)<[TV][LP.;ZCK782-6]N^;Y)Q M6A/X49C\0D=NC58[WI/_(?[Y>B4(5C$8X(\K8_;M&^#3NJ_CQ'EIFQI`ITM? M$K#C=)N0OYM9!R7@XZY+?)D;"T_ M6Z4H MM??L7+=S9*B*H&1DOZTOW)9!*B2+Q&.U)&*HETY=^FY M-X,7?BN!8LQZ.KN.ZU*]V?Z%[;F#H&O?>Y'MBUCA9JNA>55.D5@`)E]J"9N0 M9<4`N,F.C8BI_/37>5Y<,XHXR)E]D^+&Y#B+^<(GLZHQGI:CG`FDL&')%G&= MY\(U8["8,,R^2BVIV4GQ%$IX2&ZVZQ/]R1,+P"+L1"UA(QB001=6"R[Z=H"' M7PB$D8@O7J[KM_K3)<3/8NNMXN9%CAN$:[NIG":UF?3Z)S6\R*]7Y"+6]%G)O^5.1#9HXDU',Q",,%<'L+A.WF`B`/NDMSH@_C,P?F$T".%WY?_V5P M5:BL_>"RN$C,`8:.7-/S!-50S2YJ7YD62,0:O]WL3PA%4XA8_Y)33AS MZ)9LX\8"QILTL=B\"7KEE6EO+'7)S!PYZ>@WEDYP@L=^R'/H]AY.UGFTD?L9 MP9"[T5"F/.V-8@NQ6+R_TY%WZA*KHYU?W+ZR+B$5B_3W2DD_]P*(Z#F>Y;RN M!QP$L!?K8PU-@`OFHOY`L@#MB2TB!XO*G[2ELN<1T[Q94!FF,']._V4YB2G' M=9$:]MH8"@O*LI8/2JV%M6XZQ/ZJ#Q'P;H/N`B$0.,]39./AC!./9^@W?SFZ M68V+SL`,DCMQ3VSCJ:E"[6VI3KF9"SYJ=V$O$)QYT9`[//B>1GL&-Z#*[-]] M;&Y(@>OXINBP828:0NJLW?M21PP[UA>C/QQ_K>T,9<%`"2F1?B+GC+V0'-#" M9>`O[4-CU)E>3DR"_>S2&HQ,RS(Z(W+PU1I0B2XFIH6EHP=#ZY*)&U8A)<&' M30F.#HU^ISL8DD.-G>[OEP-K4.L15D&LA76P[=8FV&.L;O,KQMD=7XZF@]%G M8CVC7F?2JPTO,Q)#"FE[$^G)H6%V)B,,T3(NS(EA?>E,S+HPB@,SI,`>;8)] M>V@,1E>F-:5'7@F6E',AA3HXTW0[PZ7)W,;N*51GW)^ M@;U+SGUM%E8CFDQ'B[I<,S MWB3EUW9"O%2PAY20[[86K,:]78U[LU9@>N,$]6XAQT$NKW/LP M>6GUO@3#EDZW(T!II"1PL.AZ!3N'FOLO'%WS2,F*JMV]E^JXT?GVR];\Z7SK M9=FOT^Y<>'IX,ZFB6R_"9@+%L/7T=4,8W$8`S8F$4UP9O]?)3ZUWO\.34+<# MCYM81;Z-E5Y-K\/5-)\4S7N=:GC1NIQLD"GRRW7?0R&>"H!@BG$, MH1V$)`VS-R%Y>%D4]2J"1@#EP5?MS1AJQU-Q&+@I'%R=,].KNAHIKW$^=&9? MKOB\_'*IA$C'&U.M$JFZ?R4_F]_`RM*[3G.2R\">0Q1Y_\.XO9#N2LI.3G*R M:D^1G`1Z#GYC\R)>81I[!6&[64^L/3DLS!+]Q>[.A&P9+3BU_IS9T2V]_KRJ M:&<[<)MA/5."9?9^&5MP<2&[WX/C!QQ.R9+9`!9NR:4*-Q[BTM4)R0Q%G)(S MLPF1-D4+0@RC!P6`UZU1V*H M/CM\LK\/GR[Q(`U%=^"HU7I'`.-'^&.+?.02LUVAJL)YB7FK0"ZFQ],@<$UF MC-TADMU2%W/V_#W)A?U,-[3)7=-8#VN:F4#?[T-$'G)&<[74=_U.]Y6<^L36 MJJWF)]$1&R_BHV54XSS$G07CLR\^G>B]]SDK22^AQ93F5_&:.K274LJU0; M%6Q[:6G+(\MV=0_W,E6]6N0VBF/98]GP4HSEBJ_`N[V+@-MY`,B^!8FGOD"> M`RYHR`L2JY[`[]R$$;*=O*,`I*3B!>D[N=Q"'A9M:@-$5=@D>'K9R5R2!V#G M)K6]I=0V=13JB66J:@-@"340%IJIU&2NU8%X^29;L:Y89JLV$M?66D@$56VY MA7"\&F]Q=?%.*>RW`6_W>O3:9$S-2%<2P,LWV@KU MQ+35LDN.L+7*38PEARO0FQ)*S)QPD-$0N)1P)7(QZ@#JX(!G[ MRO$[FBB/V0`4OSN@2A6M^6D]&T!Y@*\-8%OE,1M`Q:OV1H]&BG(JX4J@?5A<`B9OBL_HE>UV1C!8.H3EBSJ_1UF0 M.LU78ZWZVTOMTC-M3>WAOMQVLCQL,Y[1:!"8(1!V;=\'[MESHL@X(>=$\I8% MZV\Q50C(-(JRRQPESC*5.+6D,3E2T)EJ5SO!R[6H%/K5PY49<0;5I8K382K/ M)$RB`4K)Q^2_[,RK1+-+D/%Z9I%N,F7L`WOEA&)25O$4)JY];4*5[.&E7KRS M21(_U][0(B$&BXCCBF\+2ZZ6EM\Q)+GWAI@"XC`)TF#KI,P`.S.NIF\&&"0&C%WM&4$P1-@T!:P]<88*\QP.ID:=DED,8%`](C\(." M";+I'25,2F;=@AQL8!5%L6(D5Q-$3$[A4$8`YNQ4[?N/%[.$'7C MJ62JPE36Z@J@0%ZFQU#;ZU:RA=]AQ4C6)ULR-99U.I.HVJS@V=0Y.EA[?*3X!O;QW37J@KGWO1;:_ MO,V%>R>`'H#;AZB_("^O(;$:[8!W>[UP4=+,KI(@]7>DL&H-I"K&; MW]7M3YG:7[P52BN!.2]6NX4XO_?A,P`6'A)X#LC7Q@C2=P*"Y3)!2"5MA"+Q7O%EW&2*"SQ<5(\+IR$ MBY!_'9K>.Q/ETY<;>?@L#JH.$)`+1G0%2I!K'_6?!L^<"E>\"IF/I?-@>S[9 M1\!.F48<+D1#)O<^TI$O!).6M26*W1TV[]L>HK.%'1K\SF!A7G>&E:9R;'>MR8I+7;EMK[X'7X-1OAL'78^6OQ\HK8&G5A,Z> M5Q^_>`!AW'?/0_``?/[NKVQ^O?>%BVE!MP7:7#>8E4.TL5FP[S0698M!< M1%':;52KH%OG;>[=F<1.]\?ITL$:/,XN>5Y21:_?+M?$H%@6S5WO(+C'\T=J M;6W1`3A.)E6W$K:B35(LF;F#)A0>E:'P2.W)U+HH/-+_`&H>[.,R%,:9KO-\ M^1Y3N"X6L_O2BD+.^P/SY5R]0Z*MR(-*SQ:YP%GL5#RVL$#@0=3W4(CA@H"$ M%QA".V^P2)(S4BM3M8P&H23\JH<57(5;`(]M76F-9Y/OE\I9^)F]B.*#)1!% M$0;:`S?12E[>49"\]/O`D(0`S%Y"*45#&-Q.Y1G*3;Y'!''PL_@YT6T9GA_Q MY;A=8CU^/>`+E3:6E/PAT<#Q+_\'4$L#!!0````(`/-U:D7E3BNA3DH``%`* M!``5`!P`&UL550)``-:%F%46A9A5'5X"P`! M!"4.```$.0$``.U]>W/C.)+G_Q=QWP'7#^BJ\@]GX3KZ">>S'HRC`"_P M&K%F_IB^;`ED$Y\B[IOL;X\Q7HN5">+X#>5_$^(',N`>_=`/]$/O_D`_]+OL MSU/G'@??($I)@"AMUP\561G3&]/*WN+8C[QQV$_K.KSK^-H(_MRUB.1^/=_!/>%%-YKY$,2=2MD,4[8H1H=>,'/UL==KE-]V!D5XF3H%THX MZ-#W-P++W7WB>[X3OTR29(=CI3F0$9LT#&J%RR9"3&D=-%KJU?&S)T:<^B@6 MI#^,/NZ!O_)#]4PV\5BZ3 MR--L0AEZ+2Q@L*>G9QU\9<+!X!9[8[ M>ACH`"JQ=F19IU\J(3('H=R>M?,8LUBZZA!!I5<<#HT&4")2O\]KQ8W;9/@FWQ)Q-\1,.WBG-A9+#)%@T5"]#1T$. M!DCM.C:=Z(0$O0,&IHN7XI^??!R3WGQ\89HJS(XNLQ6(:35(B#8E)SS@Z:A; MQV`K,WB+][ZSQ7L/Q>*][V;QWI^`Q7NO8?'>PP73A\Y@^@`%3!^Z@>G#"8#I M@P:8/ASIV,]"DPJEY$=],9VQX[U*S>)(+R*R/O!MFM6'FY$B2LLC3&$8D05. MTMAW4^PMT\C]36D^)+0F#8=2W;+)$!):QXR.=G7<[&D1(X9VJO<\G_JWG>#6 M\;U)>.EL?0)T)9!:>(R>^G74KW@!5`Q@`*:C9<-+4/`@RG0^"5'&!@-I-#X? M;W"8CO^Y\],7^DHA"LE_)HJ#70N/T4`I'?4K\5(J!C!(T]&R<=G+2-&>%M0A M;>2ZN\TNH%''\_01QU3-&#_B,/&?R.[.C3;B[50/?J.6KFNS*E9/EQD,+KMJ MW+"&>W[$!*"*!,1%H%?3*$F^@P%^ MZZ?']!$L'/HBB)@SOBIG7VQQ&*B9S'H/=!I0=26H.*QCII.:8B?#@KV2I4L4 MRK9:`^%HL+AA,K`IZ0$B^F$2IICTG3I.0,UB.&:X5?E:Q+"4WCK6.B@IB$0I ML:"<1X4PR"O%>Z-C\83C^ZAXS]AER7@O]1)QHXT)R2D8:S'!UU%=J MKPGK&378KW_O;+8_B?[W=^^^_\-/20>#?DKC^<'H>*:EQ\1]1O/#X:-YT,@> ML.6[]N,DG?HX7.%X,XV<,*$T\MV>FM[81D]'[0)N*F+K2ZZNAG5L40+$^!!E M1)03,59@%P+3*'P@$VQSA>_3EF@_,:G)W9Q*V?*N041G'4H:RC7NG&NDQPT] M7V(R!%X%YW)+HR`V9F9:%2YLC)32.BJTU&N\9V;TO2S+Z5S.@=DT=E.WF;+" M]\Y]KK-`;Q1@+.7,=_T8!1[9+_/=*=OAJG-2J'G,WKAJ MJ%^]<54P6#?L7;14^07YR>3;!)4%?6OI1'D4MQHXHZ&EK::'#8IMP*$?Q;,H M;+L M)R:S#H-VW9H1Z)08C5XCQG#..&!8C8M=XH$D[)2D,!U2:I/VHT7E MLA&1D%J'D)Y^=1CEU*A$?ER;4TQYI8&EN`YIK13ZP=0IC`RM6K1C8ZL\P!E:H4_-BX>T?$*4\TI!> M12[?CX0>S[=),:=&:!(5&SBHP:$2!HB#638",C1HP:$7(;Z,AM M(+T8%32K^K,I+(B4RB%0_@W$R`L4:O@>,A*6CL;F*!>5,VCI&$5;:G2FQUVH M9AT`%2)02!!I)H4$)T:$FM7SL8&.$5'$H\I40:KQH%O5G[&0?"7,/H2+K&31"'V>`4`Z49(2F]V.]FB=G5;*2$& M`2(=#>M(FB1YL0\'4<[SWR@KRGFS(@[V,/4Y"G9AZL0OK`*?J`:,A,XLAB1J M5K%3(P*$&;%F*JP4'(BQ6#RS+,Y;3A-GTO?$//C_O7Y&^BA4Q!:]H'(U6W[H=I$()`4IMV4G],=N[*W#*, MQ3YJZ"E0#S,E2CN(::@JQDM!!A`M==W:L,+.Z(,C98"D8?/UM1\ZH>N3&1!E M(2WBV^=NK%92B&DT1IA)3,%G'7L]E&W$J.2L*%JC@AGEW.B7G!](:.PH27": MM,"P3F0T9YA0P+Q7BV0I!0<^DDCZ/0H_^/O@1Z<@*6>3&]=.+XA>SQ6:)A2=LU M>8UFANO2G$JV.!U&,*CKHFT#A82)59)SZ3_PGAT&($>N&^V(-@OL8J+9?8!G M.,WFEVP.*ED,9\AL5;[VBE5*#P9L&DH*'J@R%A07/&ROG MF9OOCW&4)&J,M?"8?66DH7[UP9&"`0S,=+247>\R]SC9GI--NY>)0:GSC!PF M"`;J;F.\=7QO_+S%88*)]68OMWE3)5VB9C%:05-#^4I%304]&,1I*-G(G,!9 M$.8\O"1KQ)[@NQD6(6&NLCO5V<%:/`.T[OW-)OBBS]VGNAM_Y9MYB,"XC:,M MCM,7&G;/(O;)-G!+_1YD:9?.%A6+66/4KGS5&,GI`1FC5B4;QF@QOQTO5G]# MH]D5&O_7W>3VAAPOS]!LO(*!LI(];7%(""E-8DJA:AE*`C(P")+KUJ@MOOHT M7H!R0WR,(N^+'\B:MO_9)";J2I6!D/\&9O1K"M6'//\9QG!/PI0HYY-C(<#+ M*"%M(V/.]VSRW9`&GPV?0&LS1'X!*1,8].EJVDQ3DCD#UOPJ+WQ`+N5ESBCJ M+7"K#@08F)R$3SA)Z=XOF82C]=H/?"?%R7)WG_B>[\0^3L@DC%SV5[)5_'-$ M)M=G0KXC_2Z=OP?)-&M/!VA^U=`>(!#,'!BB%8T@TT(FL<_H5\J!GC(6&'-! M[!7S\M;*M\A;FSK1&91 M)E*PBJDR!2`$"=1JXH43[3VN,&"AA(,-&,B'W\*P:[I1E?Y32,>%J>_TU><$8FXX*-Q+>3487D^ED-1DOF=MUN9I? M_N73?'HU7BR_94[8U=_`054O*$S%8`F.&N%AD@$XC\)=YAK]G$EF`2+0DV0G6V)^Q+1&]_0J=2M;>Q$A&*2IM&ML]'<8I1%R"@\'$.!DY]4% M?L*A-"2V067#S5!34>15R$C@`$2HE]1G$',R&,A@*=,S&ZHV*$)*LZ5'I:I6 M2R,TR,`@1:Z;1G!@R++;9XL5#/3LD1^FE^3_^RW!S@IZ.[9&HK;8ZM2(P:"J M3<,N@:=#9V8XY'$'J^\TQ4Z"Y_>!_\"2L;;LT-N8S#[GT&E`]1V'B@,,WK34 MU`!=M.=%N]"C8:A<,@JH:"![)^W3H>U#H-Y9S_*1KM6GJGU\J\:G!GLV<+#9 M7R?I.[%$/);`)%=?@JLF`QC3I:-EPVLZGWT\7XT7-_!<6LV57_MR6F M=ZDLH@<#,`TE%0?#,(5]C3SU0SQ?\W9)9UB9Q*S):BI7M5#[W\'@1:!4'1\+ M_!0%3RS\BY&AM>-2&S9HPJS#"E[3FKGELZVLL4)2TP6O9!@1JY< MLSA%R6<`V[9(3A6M"YH&'X!3GWII:V4"@SU=31MQU.JS'FQHLB!PX=91TDLJ M!N,/@Y2*-]X'":G!P*]517'\?AB%YZ=P4FP_M5@[!;:<^<`Z$93>`W!8Z!R4 M!24,JUO@U0F$6G4.KH(;3%5*HJK,B-0@,[IODBA9V2;5:,"`1:)8PP?.<](F ME`Z=H__]^NW;M^_([CQ&3Y3K#)&OG;WE_XL2GK+6V:6/4>S_"WL_H>_?G_W; MVP]G?WC[_HR%IGQ/*/_]A[-W/_PAI_9I(G^/QZWL<]TB)T5+TO^L'AWZ\)9^ MZ-WWC.H*N]E?W[&_?CA#1,X6NZG_A`,@1\R1Y[$,ADYPZ_C>),PVH;+((!FU MT8@LM9I4LA$W,;X$8<) M0?DD=*,-GM)W'SB=KU?.LZPCNDHQ'`+8IXFU,,`N(N``M)?>@G#`7$J>%*E#2_PFO?E?IF=1A-8E:_(668MG.!0::VJBHP M>IP2!O::VV(RP?A+^EONLAFE:>S?[U+J<5Q%](`>A2GI*:+*PR1,,>EC_<-, M/^%V#SZ'=(CZD-1',JR#^:!M$I_I%XY'+/T9(H)??YOPS7;VQ6]9QM#T!;W* MYM1W,";5C1^2+3[M"^7T:)*9!+I,R3)DZS1@#+%$,4$M[Q+<:-H/1@UDW6]. M'NU99MLFZMDW,'"1JB8V.2(;`P,R;0\&V_VG$C9(3SQ;7--"'EC+HJ:VK4YL MYM*!B\:2F^S6B>2 MHI4Z]'`1UEZP4@RSZ#BE*@])[$<=Z46-L9:X!"FUV61\2I6K:?:$I&!PI=:O MF1J/4J-]03AHI=^RI])MF;6;9&:O)\1*5B\CJC1@`"-1K.'Q&J_08OQY/+L; MPT#&)^P$Z>,EL8'S^,$)_7^QH-%;\G\)CIOO."8JL4U['=G:7"90 MV[$)%)&:+-;W+MWT%+S6I(R51TXLX853XH5A?)=.@)-,7WFQB`:5T9MDL8J5 M:^0J"2QC)59.?(]'-[6@N/N0L))-&3&; M."]F"@-\2V+KXZ*0V#O9QK-.9737+E:QLFNODH`Q7&*]FD[IC(I79(,!C,9& M47=#:7E[KK4MAW6LDZDG/MA%.7616!X88/9OY-K:6Z:T`IJFJD+8[,F``J>A M8.,*?W8YOQFCZ\7\!F5'NOD,R%&.O;+4=0J(:8UGP=%R!H@(P2Q-*NW$1;(S M#+$*ZZ!\`?DSG*PUU"DOC7L14!HND"Q3M58/N4X&!CARW9IQ0YPR7ZB@H,4E MNV__"5]CG+5!'B75I#0<<293M19M5B<#A!:9;G6TW&"'OFI>[P*T2S#RD;F(;V2FJ\G&^>!?/P2T]8);YI5 MU,9NF-M5+FZ6Y:10/%1Z:M8!0QD*WQ2!BL^9D,NY8!A;JF1"IP5.YN'XF9YP M=G[R2+UF\[5B>Z?!9]HSJM6,NG=4R00%?UT5EGE)B>$*7L@6L<9) M/5G)*/2J4O@>\@:GCQ'YY8F0B.(%K6A@_GF7T:YM/ADS\GDP1R/S;9;XQ5]- MY\OE=^AB?#U?C'-'YVKT5S@>SJP#,L-U@4.\EB;FDU*;GTY2E9O0;Y!"VUVH MU:PCZU7EI<1WZ)Y3(]I+U+E%7U2F%-$P$$:T)=HI+NW*!"9QU%2L#)W]K[!V M&0V]1"\E*\8'!@PJ3JD#=FWF14_95\J':#321;AV0H]6)9/I%JK\4.CU6HQN;A;C2ZF9.,U1XO1%2$ZHU2O M$2&\F<]0N20"#!CEB7CS!%873N*[9$=ZY0>[5)J&IY7+)-0TFU`&7PL+&"NG MIV<=FQ>CY>02-1%Z.UZ@Y:<1.1Y\'5CMAE$0V.R`2>A85&/P:C*]6XVOOD(4 M_HS]AT?2\!&->'W`LQVM%C)?-Y(;M82!=1=C$K=]&UD&=%<98)#>4_'Z%/AY M//GXB?Q8O1QS%&_1/.[U7(UFEU-9A]/"]%L]3FPSS(9$+%<:5X?(#,! M)X?BLM:-G03]#31(LU5(-]E?9RD`@-K61`VHRD1`!VN+WHU-!R>'`=@BU]Q\ MS4^39-\N*,336LZPHQ2S:>U[-;&:\[Z3"#"`[:=WX]E4D8\P6J,*.\HR%NKE M*83@O'X/9FP$2IV([UI5K>LZBHF1#"]9U5[W914[84)PP9\1L_\*>$H6[]<= MOS%LJ=YVK(\9#^,X6HEU2''%7BM>#=2(K3HR5[#5?E0+,FB!42^YA^(61`2EW M4*@U]4,\(?^4A;"("*V@HZ&H$"$%%3R4U%53((62(D8+!2Z:[GW+#GPM%[U= M)_P6QW[DD;&.4]5JI^MQO\`/?DC#`M"]$]#\3V=9N1Y+WLK>A5;->B]U1T&N MI\9`L`J#0.8O;0@O+7:UB^E.B7<`@PK[<;YECR7&SSAV_40:U--'D/%"O[T: MVL!G)RF`EIN>JC>>M1`9+*$<*VM2*@BVV](7MQDWS^+*!+[YPA**I\D9Q,)T MDGYAQ4,'F``J.0#PW]Y,#?C+A4!'?ZOF0X(?D-G?7P@DJVCD>2SSJ!/<.KXW M"7D1@8!9AGN']`4]89/CM9-=+.1]-%^7>T[2\4?YDLF)<\2N*D^M(WP&S.0[ M7MN:1R5"\?!W2.>59!SQ;=0?">YLL`'#7:Z[N/NMDP:ZE?3>L M`]I1U7,'7&$WQF0=HFD#%MC#&^4N29O;))P[-JD,8$U6,)#MIF^C;B%1Y='A MVW[@][&JAE[Y";\>HTV578]]XDZO'OW833P4H/?I%-V9T$7V24R5'@UJ1HH_ M^1X.O01MR?%`\=H;QGP:-CJ/9Z0Q%1A:^MKI1H8VNNQXH:'%I\#,Q>.VKQ$" M\4BK0M)\L.YNLZ/<3YCFG]&)&(4>(__!Z)@^X?@^2K#JADF@FRA#QJN`4'R7 M!8?9NMKK=[EJXV)O'"JS,,F5;.1&9C^?^MVJ6=3K#8%H=BPGG(>] MBY>[!'N3L"C@,R*K_I.?^JT%JC>VLW54.W%G2 MR\J!O@-FDAVQ!2/7C7;R!-!J%L.I05N5KYTEI?1@H*VA9,.W7^=W]MJ9NZN*8_[I=8V49IHH-1XPG857NYY7/&9 M2[JJJQ"CB?1Z-;"27Z^3!##&M)?:S>N.$@W/WVVDP-857N,XQMZ"?*9[!C@R6C>2<5)^`KQU M!7P!D<%QA[P=YH?C3`Y$VT=+T9&EG)VD;F.\\7<;K1DJY+-G!17-D)M"`1-0 M>RC7M,THWD>AAQSRORF.-QR<7B8(R#F#5DJD9ZF\8"I>L\BK%*4'G-DIHH;DUPCDS#*2* MRGCFC6])WZ7':O3TVZ$QE3.O!A\TA';0^?3KL>ZGXQ6;2CY?0D9)@M/D7>L< M%C/9L9^J!HCMIH@#&AJUM)55J%YF%:JSLM;H$E*%ZKR@2/4IG"ID24!L/+N& M5.%&%%B#$EKLG5)+4T\.)>=E'H29E&\;&>)'H3?UG7L_8#>`S!QG/[AD^2=' MJBH!^6VWH9>6^=N%4GRH[)[-G=IM=&MQ\#?Y<>M',ULM%D=&QZ-C)`&F6244,'(7C74#(-V MAXB9[0)2U2`U)$6<\$&IT+H.2T::/1Y),_L*%9>W,:9OTG(W=U:IF:Q(K!$= M<:HGS"YNNS18C6,=2?!QW:$58IQ#PG?>"J:9;O7W-B:3>-5K0!F7:@[K.^-. M:DIC!0#5?6_.H'T`Q!,.=_J;S`:?7<,H:8;:!M:8H#D]=!56!*DP,JC0RS?` MM\X+W?P2JTW^$N]P^3S9>=NM%@;C&*338+V#D4H2?#AW:(7T\+3EO&?(X:P( M<]O,7081-=@P\*__4N@R"LD?=N1OV8_R,-1#A<)\*Z;J@'[OQD028=5,&*0M MHO?H6N]30$\1'LH[P+-)I2``4T&CH1KP5T@!LZ'NK7K;L\G)[/-X"?+9)%GD M\GR;W%E-&N_M:#NQTE&AP6?T%99N,RI/L=J8H'D:=!56Y1WSLYOLM>-F>QE+ MR2@,9(TSFSE$8[/95?&6!'*`\\>)H+H/4Z/I>EM"#;L(L&UIU`UK,SEB[E.P M/4K-5=C=9KSL-`0L[)"TR\788X\-!1&6.M#M(L'P6^6N3:L]7=9E![.EZZZS MX&$SD\`?W2590-A@H)6$[S3USD+0KHMUNQYDG_EKTGQ_4M_]=V.UB#)E8Q1`$_)!Q9I*63VX59X0@]]" MMN=J4+-8W2:V9&90T8/?"FKG86`'EN(5.\W*\.PSSPK(E`SZ[J##?>/:0F$Z M!`_TC6M*/`G?>+>V2'WCNX3'A_JYN%/QBQ>/R0_UBRL%`9@&&@W5@+Y"BO5] MQ\&JM_G%KR>ST>P2HE]\@;?9*C=?3Z/P887C#7W'1@Z,>2$J[.YB531`-Q$F M`=VG<64H=^&'MGGIH7MS+^T3V&^=`.6BZ%.QD+Y)Y)'^U*5;Q`#`P'/Y])#7 MRN$O,S4<)W4&6SXKL>(R%U65&HPQ;551?72[C^(X^D(SF1W+,Y!/CY`_MF5O M;84'4C&AN5._2M']&5]$91T,K:HU0%"R-/`>0>>Q?7Q'@%E2E_F7D"6[GV*6 M?GU$JYL^L#39.>H9V3ZUJ62^#"3;1L3Q(-TA"DP^2#"T%7G(1DF#3@=.4C7\ MHCSU0TRV))=$66E4O8+>UI(L5%NV(E>(K=M@70U%1_1MOB:_RK>`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`T9Z"K(.]2&T5SW:+)Z\[8/9*\T>_"; MRR[=HUG[[-`=F&&`M8?&S7T*$\'AR$K.HCB3PHI!Y7*@O3*>QP].F!4.NHS" M)`I\CV_A0^^6=#+=X5>*LSG!DOR%S[*6;[R/(Y`3JW]#R;.DN!_#<9#D3;^,-O=D4JI*<^BQV`"N2GD11$7TX,"H M4+(.NYP%E7D&M*>2C726J."%O>3EM9$2F2W483"V5=92O-@;*ZFMPT9;Q3IH MKD>7D^ED]37S!>VY4,$&8QFK-.DVCD+R3S?;NH9>40FH3,/>X058:K&& M%6TV!FZXSJA&PATNU_H,.$)CZE-E,;XDFSQB5R_G=S/FOEVNR#9PM+@"\D!Y M[,0T6H!&E+"`V98-GYS<:$!;B]*5X#4)+1CTM2C8"$K+R!&A1XP!W&FYWJ(V MLZJ@MXDJI0&4$H/%59NI&H\6,V*@ENAVO$#+3Z/%&`B:6,Z?&YP^THBW(D,0 ML#E.UHQ):MYI=_.;\8+<=7Z')^+0%=.ET[?LSBXO>-;ULMU"PFL:RC M?!FH*GHP*-10LG%_0%@0XT$E)G#65]2R-MO:PF,;;4J[J&0`C;?V"ZO)`GT> M3>_&Z&8\HH\/;MH>L!F\1V\&"]!T!/Y#Z*]]EU8+V#N2H\!W_784'B;2Z#W\ M`(VOW-,?(`]:0I@!VG+Z428'S0.(B.^/;8`H5AGJ@X!:8B[?'>?L,+"951Y> M8#8L!@MK_N@B153WY"'6#T_221@)B( M(T5KY8DO5\XS+PW)E12%$DE)C<5GM2A;!&9)Z*R#14,Y:6)20HXX/0SS1D&I M9[Z$E&;3[$I5K2;-;9!91TR[;E+`%,]5N0/]2/;C!CLT"&&]"^X27&3G4P.C M"Z,QV]*I(86ET>*RCJ+.JM9!M>=%A!D5W#!,T=3_Y\[W_/1%_T9=S6+2..DH M7[92*GKK0.N@9!UB!0N+Z,B?:RXRQ8`L>DOW$7L[7ATTJ^VQBITPH=D.HS#) M#B"M3HZN4HQZ._HUL>+VZ"8"#&K[Z=UPA.#XR7D.P7EPJO#96S5U6]"L>2VLU@'5#<]FP!B93L2SHE2PHH"PLM> MK4.S@_4@5.H"=T>A=^4'NY0>&I&?"W?SS%(Q?).0M)/7!]QL_"1A5B7TKK&T3+.2PVPJX5;5JYF%I>36 M]T7Z.C;R^1%"6J")[((*YB/MP,57^S?8\UWR-]%.KXW#V!Y;3_5B4ZTFMXX6 M?1V;]U?\9QBV1]R$VQAO_-TF\S)W"C.IL]J/_1$WICW8I\IG'7$]E!5#SS^X MJH/$./TSMB4)P@B+[0 M[3//I>'Y"0O>5[H180SZ%"=)$2U['<5YM.V!8)")-0R2'ON17JT1E?A,NL4P M'--[Z@0XC[P@F@E=H5420,,DTZS>Y2MJ#]C$^)R%6E#R,T09T"^4!C64%PX!HER05>1S%>.<]#S2>)<-`& M4=DA!YE'H60PD!^T.8W;5B=T'EAEA]R'F2!:==3WZ$N:"-5-*^3)5)[\^69_ MM*''0QZYU:E_VX79GRRZ#6Z?'&V2@$\&3?5;]PT.S\.4D*7#Q?X3_=!I`KX4 MH3A01U8D0H:^H.F'X+\D[F0G0;,-+3,!E:;"UGD98AYT2H?Q3A0?(B6UG/+B M71EF*CHH]ST:.@Z1SP*F]Q+.I_>!06<2VE]7>O#5:*U'B8R]4.: M1)W`QA>.2/EW>)-$J%TS(TK(BB*XC`S&QBW+RS+%3H+G]X'_P.O/$@.ZHTFG M),UMY3+Z\EFO"97WSFH6,%-;3\^&DRG+M1-0-N073YPMS>P93OF)GY[W1:-1 M(0!D6,5ZB<*K?$:&7@6$\#ODI&GLW^]2NBVE/HJ%XQ&B,[HK>?UM@@CI)@I1 M0I\_/D:!AV,@WE]QUH=NY25K/#:K`0K55U4$K#"`0:&.EHWCTF@YN42S,2U* M=3F_&:-7T_ER^=T^%0<:K5:+R<7=:G0Q':/5'"U&5X3\C-*__G9)G]7>S&>( MO;3]-)]>C1?*9WY''-6?L?_P2$Z,([(*.P]XMMOA*'W$:(MC/U(^ M>3$^L8ML-/I3NV"!-\RZ"C=F.J5CD:;5-8@,&!_2DUV-*JOOZ,GQ`_9&.;ID M"B]+^F9]U+)2'2#/;/WO`YLMW5EU$09F]3NT!8V`O,GT;C6^,K@VFILQPJ4B MZY;&>C'R?MWQ8T&7A4='FLG9_8;`\+_(MU((USCAXUUM=)U@(\\#X41\XVP4)R8/Q(MTU$*58>Q0EX4R9)LJ/KW=TV"L?/-#U&0M,IE1,G MA=[/3AP[82-\8`B!QFZN!FEX<;]UD#3K(!^L"2+(.X7LD'*W7?N`[*4Z6N_O$ M]WPG]G$R2I+(97\EQJ^2>U,T[`<)-`P.OGU>IDZ.C> M"8;(PS7,-KXHGQV-W'_N_+@(+ZKF795TE3:WRZJNR=^YSHWLU&+3I,$(Z&:TF[Z2 MP<39ZD;',7W$9,\)8A#%K;GR:4N'(^"JP(JY&*+DX2 MBO'["N(=?FOIG2;F8^P$=(O#+EW=:+-UPI?;.%K[*;W$FT7I./`W9/M#`XLV MBN3#`\J',$=Z=XO.W.DL'/R^;#6US5)BCVZVL%:QB3[D1MTZ!541V MD0`(FSW4%J.TNC^)J*P:4K=_3%B;WLX5GIM=$B"H+K**8_2CKW M6!\S6IOFJ!U621!YE"^!F6E';5ZC\&GIH7K&_]7-/_X:\/B]G7_G1&==M9N. M-.'X1R"^&CM6(X7OR.ATNX#TC.S0UG]D+Z`GX2WK[(]Q*:GAP/TL_-(I33E% M5PTYZ02?^6J6.'G;ZK.-46);.=I8)@*:I`![5RP+#%>8OT(]SN= MI.=*L$7[IE"RGHJN&M)R"SX";3D=K M8C-M,AG6`'LHBFE9-GK9;\N8GN96UT:*A)8GC<=KI.29XU>UU/`>27*W6MT%HC2\JCJR>,OSNJOG])BTK%+C[2C4WWZ*W=I:C3]*W%T)IU\3\>8 MX$-J`&J2#]^UG2;Z<)^'EA+1?--[^%E/:([G+;8ZS3LJ<5(SO5<'#SK9.VE@ M?5MNM=FG[H!O[Y.&,]3.?.^HQHG-^%Z=//"<[Z3#US3K^S3\O\55`-3CY-=] M;:#5]/]FEPD6?$7:7P>UU`S;I4>ZC@"SL)B^I.B_H;1R=;'(G]1>TBS:CION MG&#JK^LSKANKK4N*ML;(;B9D?-9W0#V4;;V#*/A120"B$@`M*??UN<@CI4:[ M]#%B:9E8+H=2X-0M:712F6P+.G=+:VXV535ZJRTE`.T-X=H=[+VYO`A.9J]Z:_:UVEO#NX/JSOK(@7? MA-:C"1/?91D=1%LZ*:FYVHIJ9?=5$\5TUO&GH5RCTF%.C0IRQ.@!K4/#N)>4 M`#3PO5-RE[1VVY&\GQ;GDVEO9\?9F66OV?,#FI^-E:[9(??M/J)JA[SKM+0. M\T'[N[DA.ZY]@S;$UX#.T6.VM6V2XKV`(VVJRI;K3*EYO*"G!D'1Y]K\:60P^U-=/ZY$ELWCMTWB#[=XWO?35O M9/7;VKAKRA:%?%]@+4#F**848$B*ML['K;]YQ$6Q>TPEI?I/4]ZK#M4#B(+3P5U;CMMQ"(I*VVUD-/ MZP#2U5#_\2;C`FPS*ZTK?BRF@LS?U%.6=?NHV]Q6J]@FZ&0.4YH-D9^P^/-D MH@)*AGB7W,,TYCK+SD)]!(`PGM*&:5G3!C=\\RI366IOGYH>(#(U?0!\N MS!FA4SF&:#=$!V%6(=W8=JWBP@ MS++[)500BC-FM(YBY&>,IY]"P&0VX0]@$'*\MM4QQ%"((LX&-"[V@([XC!.Z MDH3>^'F+7?+/543_9*J`C?[G3^)PT+-3AYRUNM_^:J9RQP:KY_<3$_9U3.U& MMBU6H];(ZQ2]3Y_2E.[2F4=(ZJ'\[EENV+,&;[9!](+QDE>I%'?>+`JY36+]E+!FEG^_C))T%J5_H\6&W>@AI.\]):-S MQ.^9G,E'[[;R]#W:Q\#,V6.W4#Q1=V%<$/+SV3E[)H/:(X,^%HB<<(P=]J3LV.37$.GP+3&N@TR8Q,M9M\JJ, MO209CEG1R1A^6#OJH-AS9*X^OB"@AV'2@LO>1F8Y,K(])3F`+I)=(G_VILMD M[MVD;@/VKRC;.*P;JTYJ-EY8.H+9)2A2*MX,G!,31Z;"VTM`&Z=OR8^6XN7HI_?O+)SBQV'U^F^(E\^-D7;GCT..%M M<#KJ71]6RL.3(YVA@@W]0GG^#N.86[1J$F[)RBBIL]=*;?+@V**R$'954K`H M$ZK9`-5HLD"?1].[,;H9CY9WB_'->+9:'FDE6N+0C^)K/T[2J8]#&I@RC9Q0 M9`*EI,96FA9EBY5%0@=C)5$KU[CV8M2(D2-*ST)G$>4X*B*6Y+0>>GJ0$-$: MQH1'[M+"`T@LI,;'9FT>5PM6[ M0A&E=1QIJ2<'TB[&'C003:/P8:6)(0FM20@IU2TC2$@(!D`J[23XF44I!G*S M,_5#G,S7EP3._E[]*S]Q@RC9-1ZKZ;,919)F(RJ@:N&!@R\]1>M0HVST(L%E M?(;/R(.D`_8BU]@`D&^Q!Q3L.D>TXU`K.4A:X&.-0Q9L/,5.@JF16M![9Y\8 MK6CA>'X41`\O]!W)EK:_,3A=F&&-6`_-F]79F`@44!G((T+XI3U]YI)&*,[E M()P+LC*^CS00*9F$\RV.F7*C),',ZS;UG7L_8$EL9CB=K[,?7*)NS*(+2P3D M-]*AWB2\)4/Q2!J\BITP(2=OZHL3^16,?QP8OLRWO(%/K@+R0Q3E2B"'?8RY M3(/]9\Y0B%.Z'N0_9\K4Z>CO5!\J=\(FT9`TKQ0_\E:P&H3I(R82_T`;2GXB_WQ+_RD9O\/$P1K=0=JB*`C30Z@-A&1//I-Y MR*_WV.U>8^"%5+#&4Z4BP(W);1RY&'L)-?]+)\#S=7D1F(0I)KTDR(^DR0=L M;#HI71^MG)LO>PGAIZ[@RO)'7QES&5;&,G,US]?%G0QUD]-[E\/3QU7-P>TI"-AH']:*QO#GCGPRZ,55%??\YR*17Y*)PBA%+V2W MM"5BZ!B2RS1TS^?PBKO;LOCFSVUE@#;.VOLVW87P7NZ.M9(#Q9["C?0$.!92+8>*^#S6:+`GPQ=1]!N+`IFO69[.\@I^Z\1I MB&/YKJ6S!%CCUU=]<:*%>R*HE`R%RJKM9K9GR;W":]_U4]4PJ#@`CHF&NN+YPQG/J)_R]>^=S?:G M_']_]^_OW_W;3PGB`E$FT=H(9L:"J!OB5.]TI\D'<#2UE1:/:6$.N0!(ISM5 M*9=;LO7EB5%IG@3I-6MW$;!&N+?^^B7$>(D*(@QE&6*7;94J#(VW*-7XU%^W MUGR3\8$>V1:E>U:`H!*0DR'#RI!&\6\X3LI9;[;DOZ.09K+[=1!VAE,E_;F1DA."FO<6O4\B:N'3/-KQ\T"J9OA*3I,L(:F@\8`!ZGAN$OH M&SC)\4]%#&M0-#0%.!A-SYTLPD%*"6L8VM0$.`;9K'UA#U$2EELPD4=P*:EA MC86.J@#'H_!IT\?D.8KH4S7YH+2SP!H9;7TE#OPD>VG/ZO:PO1A[A9>R#%!V M@^I&GL>0EI=Q855;B%IWVRC,S^3S-8#-8(*74$V/77L8^]C32FKOHSK*X6Z@:PBVD('8VJ MDW1Q]6=872S4#6`7"Z)@&_TLH('5V7(%&_X4C;(4-BX<.ETMP.I\#4WUKPL8 MEY7!&;C".*PATE)VH$KC%N]O#JK<#6O$.BE]I`K>AD;22#59R*.KK?[1JLH> M;7=QA+SWH$925]TCY+\W.V;#Y0(_@?&3*7U:.<$5#>Q?+>`$1J^N[.!5`VP< M$/(VRD>N$S>L<>RC>NM:B*LA2,5@VQKB/'4B3^ESN8OC6FH[(8'AA/L5O;,A M4NO5R#+(J,Y01F>UD^6]"ZY;6_K34C>64L(I`-ND`M2]"N6:V4E+F>GLXK>D M2DN/P^QJG3ZV62..OB[$<<(CRB>A&^SH=ON6)K&+PE&:QO[]CMWGK:(9$4F/ M55%`A#WD8<^B41E&,J`!';A!PGK@F?AOL^A^%O[//X&R;Z#R1VBP6_4S*/^. M_:E*-J#-+FN9OT(>0!C05E4QT]D&FY-;&B1QZK=;\G^)C<_*;&;O5V_CZ,E/ MR*_DW';A>#0N0&B##Q0):(B':DD=`5PNHH)16?(9RF2C3#C*GPX7XMFAF7P` ML2]8`@T-`IU&23(/K_QD&_$8GCQQK@@22@9``ZZG9WTX*1=Z1?F^0V2$2JPT M.)D,W1;'Z0NB-Y\I*E($G*'Q29V;.26WW.5GVHPV>2LKQ"L@@]KM`.WG/<^)L1IUN MW/X'Z\.@JZ'(H(E9+"XX"84#)J9Y_$Q1LO.31VI&Z0.2>^&IHY4)T$31UU4T M5@F?*YBO/U5VN@11`;;,&'WM3\XE4=429,95:-&4'(#&3%/1AIUC^0_*?(7! MRUA-V[Q*@Y1+?)D`VDBT+^VLXRTOZWRH5\YSIL<%#O':%]HO"2F@?F_3L#X" M&1X)U-R(_:N9>+N8H$Q:YZ\8)R-1V M5'@8#Z.E814=7_/VJ_96.GR`AK23NLT0E$M`>Q%@ M!I&YCVK50_6&4<0)>B"5"FL.)?>V[2]UK-K&9A-O8TS3I><;X\P=-0H]IG>7 MT=61!'JT.S5`<_0SF86;C]YED5E$[A\5U[H"_EG:/\%M/^$)\:(]L]TE6]2JO>N,UI96.0KUN8$/9(O2FB/*I)QQ/^%9 M$7QLTUG8:.LD?,))VJ@8I$,/>0A%:NH,6HD/UE++%1MRJ=64"&B4!VI(QZ6V M$`]VJ5V0PU]6G'`]C<('FKR!^K>)Z>*%LP*68U"Z1^_"#P@.O=1N%@O+A5"/ M,A5SSA)6\/N!_7]G$A$K,X?F]X'_X&3/MZE=SW_>?]$2%O(#)*]WCMGMX_Q+ MR++E3#&[2"Z54&/9!W.RD??KCML^$4@&$0P(/<.VIPZKXAR?B4>,\0R1+YRS M3Z#L&ZCTD3.4?R8GWW\)UFK$6S7D:J0I$1"`!FI(Q]6H$`]V-:+*,Q.+`-*23#:2T:Y:/0+%8Z8]+_;NBEW'[&WHV$X8R>FR=^2/.$?;99+>N?* M#W8I]E8LW%&%D9ZB`,'CT!8T+N,S>10." M[G%N)#W?,!%E5\49*DF!->7% ML265_.9\'_/29?;WE0H(#`,V1F439,$Z9XA]`!5)R/)OP+$/1:54[A"G-=[W M%V$W9.M#BQ_,PP4]MGYU[)R$_*^G'8A[T&4#3_9BMTXT"+3NT MJ.NB3)=]$K%OGNW7GM)W6303^_+)`K'(=#S;U5]2_=A7A-_V-AK;>Q3?Y_X@FPB];^_0^W:#4.U0X4O4%O?DN&DC0?0\4I;U<9%%V6D]Q<9*XIBQ)AM MID0YV%3/HI"#,4]BGJ0QJT@B+J=BXGO0K,NQFWD$^T(^?\Z_G^461R4-"JMC MK_BH``*;``@`5`!P`&UL550)``-:%F%46A9A5'5X"P`!!"4.```$.0$``.U=47/;.))^OZK[#[I< M7=WN@Y/8SLSLY';N2K;DB79LR2\)DQ]X`NV>C M<('_JS=V5NAC[V<4(N+$F/Q7[XL3;-AO\(T?(-*[QJMU@&)$_Y!\^&/OP]L+ MIW=V!ACV"PH]3#Y/1]MA'^-X_?'=NV_?OKT-\9/S#9/?H[/_CY?OS#V^?%Y2$@1/3/U_0?],_G)_SO\XO+C]^^/#Q M_7?`3\5.O(FVGWK__#[]7]+]KX$?_OZ1_>?!B5"/XA)&'Y\C_Z3R/\8\>G=8M>)N7A)/].K;,'^=98U.V._.CN_.+L\ M?_L<>6\RYG,.$AR@*5KTV/]3,=E^-8&6"L;J'?O3.PK/9H7"N!]ZPS#VXQ>& M%5GQJ=+I\[$>"5K\](9X87S&H&<"P3[X[Y"^\R"4H[:IW=O4,H&SZE!'H8`ML00]TC;^$QK1!7V%&I,B&%,_39/%+,;N M[X\X\.B>,?S'ABK=`"U\UX^;$088^#B(.='C38"_-1>Y@Y':F/^8[ET$3197 MF\@/4131E>_*B7SZN7N"(OIAT+JI-DH;\[YQ7#^@D/9=BFSD@Y1:U*<57J)O M?=?%&[ISA,L9MZR()YV5N%<;\QHZ)*1C1_>(S![IXBN;457[-N8R"I]0%#.) M'H5_PWX84[N/R8Z43=*.;8>KF>O+(:XWVO'HF#L/05M4[(^E0\MALQ7WTJKQL`D"NVO4 M?M@\09VUK02P.0*Z'D^;!BAV_"`ZFZ(G%&[0%4'.[Q[^UI*M(1O]^'3.4.AC M,D,N[>.-<=S62B(?_^BTCAW"#D=/4DNCV:@Z5LWT6ZK+9J&;UG4S`[P=\TDX MVE'H^`6]W/BA$[J^$PR M%_0Z?]\YZ6:_\CU3&>\D0O?P8Z;RSF0?8W9ML MP)SIF,@XQW[SFVBN_8GZ?._7^GO_HMF<,4+7WVZ3!F%RHE,Z=-RUL6)YJ7ASYQ M>YAXB%#$LC$=XNY)P>%]1-KBW9H[J<_<1S_8"M""X)4J*U.V80DA>>[2*1P= M@FM*"'&"$=679[I]BC`X:`H$X=P^%"JH-@%#1L><#EO._?T60*9?V,3T,AI- M\IH:[SZF%'CL$EC,]$)3(/1^*=4F8.C3V7AL1C>!LRQG?Z$)D.T?;&)[ M*94FV'V](8S$&S]RG>!7Y!"AX%>W!H+PG4T@R&@WM_%^14'P2XB_A3-J"N,0 M>:,HVB`BVH`KNP"1^=XF9$!<,`?/%QQL*`?)"X]PBD2P'#0%PO&#?7!44&W0 M/$WT=XK6F*37I/%&B$95#R`H?[$/%#$/S&'#9>2:+J9+3(0'AT)#(!(_VH=$ M*<4&E0.O5CCD_BKNBXYRKC:AB@C[@4]U]N$#88C)J,[>4?/.8,-,0C$BN,10/*X_C%:27H/'7=Z5>5TTN67FLZYX_]J)WUMN& MR]&?KR?CP7`\&P[83[/)[6C0G]-_7/5O^^/K86_V:3BIN+VMNL=)6)K`BYMVA_5NK$;UR>M'$85* M3DBQG2F7KA)?]W6I@I+V%[6F:*0F)!24@^;&/+UM@5/!`#LP8O&]=`EG_\?" ME9^<@%V+]>-KAY`7:KKP&[-JS(#=C3F.04#@.B39!&(:RAM-D8OHA!\"-$9Q M2JU`WX2]C'F;:T`&H=\.I`9H@>BTO+GSG!#X,\%1)(5*TLV8B[H&5B`.V`'6 M/4%KQ_>&SRP0`]$U81(_(I+,NAHK<2]CCNP:4$'HMP.I/:J`%H9!UW6=):Z, MPASSZ=P3O;I-J*Z<(9]>C&,GX"T-*QA>(Q*_W--S%C](TOUVS4PMNGR+%$S4 MRY@#O+FY"&&''?J66PCD=GUI8V,N\>8P"8BW`YV?,?:^^4%0#IOSBBN#I,(..P#,[-%D%4#7 M.**SQJ&;[+3"C0C0U9S/7!DZ,"/LP&T7RAZ-POYBX0<^7=&CV>8A\CW?(3Z* M*-G8Y;^EFVGI4X,RC6PTK#F??`U5;8&!=LA"^9ER)[RJ!^M\3RBBVAPAZAHL M8X,MH*V9O17)SM/%=E!`M'D[5``I(]$.]LO8KLIN;1X+.+LKV=S)P_&M[SRP MS!$^7WT/\XK(#U[P$:`@:W.%-#B.J?+)#O7+S1I\02;J`T50F]]#&89*%*V^ M+\NN&NZ=%W;/0$FEOR$;NK0<$""_>0$-`D56FZND(;(U.&8'U(,-FN.M82R_ MHREO#H5/FX>E(7Q"+E@"5+J[IVD7Y-;^MB'X7MI6<,HIMP,6G@XBU7JI]I0V MAL*CS7O2$!X!!^R`:"<_87Q-_]^71PT(ND#ATN;\:$V;*KAA!VC7SMIG)Q3D M1&CR$/C+)"6D%#E9/RA\VCP=#>&#\<4.#%6LQ09&X84V)TCKYOX)'MMWGC>E MLUU9-RC>VKPP[1S0JSEBAUH>[@`J3N3R7E#HM/E68/R7;86VNI%O_1!-%LD< M1>J5;P6%Y!C.$C`D981:`@$.EW-$5GES5P!%:6LH),?PV6`.2ZF]4F8.^:^6Y:4H#E MED4+(;I@S)UGX>6EVD!00#7Z+M2O+.OPR@Z@IRRE:8B\+%MTCIA"*9I#;"%] MH7!JC!51A!/.$3L0/"20REP20WW/TO!0/L:4:?7D81%N$'YTNJ*:4EBH/+*DGM9@B[K9`GJ M_6EOY#^_9@TZ@A^!LGQ"^(0]?L@N5J,3NA:J.W8`3.;T_^[&XZI\3*YZ4WNA]/^?$0;=$F_= M=NYR:Z6R@U&7'@_O!N3:.&QIV/20\/_`4U=.J!U+WR?D!/'C-25[0I9.Z/^1 ME(:E_Z64S1!Y\ETD?8.@-(AITZ,2#UR?IHXB>D_PDQ_1ORXPN7*\`7H0O9YM M/+!I,Z9]Y$4,5/<+_)CL;"%:LKW,O"]5@1&W*(JVS+AI69JJ!S=M9+4O43)& MFO//5]302^?]F5IC)+DD3IA/G'"Y7R>]4$$/TM%T$D@9OE`Z;-H?9DZ`HG32 MPE1`!PU-YWD$:EL%@5V_V4K/,^$RS5T)R5)7W<5TGD@U&UI*NQVJQ?)+3192 M<[G0S'1V1SESB^Z!$BKM`&"`*/-8=B>?%1A>!XCS,/3Z*W83_L=>$=K2K#R` MWJ:S/*K"I<(3.U#\V?%#%HLT"0=^M$Y]5I.%++N/I)OQK)"*N(&XT/U#QHRN M(V2;G.]<8(X4&YI/(:F(:`6I=BC=`3$*9H4-.2$5L:@D]V3,Q%U,)P#)?&/S M^1[K8GE(7/C^1X5K7T1T7:LEEF873I+YJ(17;^4-+8CY2-0 MPP3DVH*'2RGVG]`-0NDDA==AAXWMR`D)QJ.27#OP*`\R'H5C%.\6Z7SVW7N' MQ"$B[+T>7:(16HD?7+/29")>`L$=#6>$U)% M%<&LZ#[JG"UT!<'[5K9TEY7U,YY$4@5O&!-.!&R`!V"_F?&4D\I0GMJI?[?_ MWU#>7%,KP0\W5$QW07!7:(%)^M!S[CRCJ/ABJ!]Z^Z,DSQSN4/R(O5QA!5F8 MV9$F83R/IJ*]?FQX[#@';`E*&76%0K00O=:M[&`\$:8TB-V M+N;;&,_#J8+>(7%=WQ[V3HC-'EK7&,IX8D^E0W9=5MFQX.Y-'XBB!:DX:R-T M*AJ:Y7'('J!=.9'OTCU_X`>;6/1H2-K1>*Y.%6R!;+!#UXJ35<9*&2.S?BX9 M%39A\Q7YRT27ZGICZ2\;R?:M=M=5G5+:#Y2M(< MY708XUE":X-6#_L][ED-?+H:*;SC5![(>+I1O>#+.&C_T\^2W&;;R>^]`?VN MSAO0Z\G=_73XB;8;?1GV1F/Z[V'O3[>3V8$(7FS"IB^&^S(D31I3")!*9_RM(0/#^ODDXY107$M)N%M/4/F7X`JUV8K,E5:M,1AA[E#M(-%K/Z[IUCOE<\Q[!CS&P^ MN?[ET^1V,)S._K,W_-_/H_FOO3\-AC>CZ]'V)5A4!N^OGP+!M0 M2$2);1HX9`Z=_K,/`:2\6Q>Q*:>FU/[Q4=2"#\,$.Q!1B(^I'/^BW$@\.ZT4=`@0P MJ/D-UXCXF+GI2&S^!N1(-77T&Y%2'-LOO6(?D$E:_,&&,%=X,CLNOOR/DS5_ M(S1\1L3U(U&$:9VQK#%308)0BU&6K+OE\^>%1]K!6324-79L39CE;+(#Y5W0 M1#3'%:=>+K(/#K__6;&@:R<-OLAH2GWK*:4B1X&&CUEC,,LD12.K[9`EX8HW MI>8E\5U^<4B;];\YQ/N9"&/AZHYGC3W>:(N0,LQJT/GZUQ[FLN%,9Z5M9;OH M".+%M]X#Y!)$ERSVS'N*/+22;0/@`4PGKP6CJL@2^W$<^%$2V<*F7179\BDY MY=0#6NT+IM/AMB()=9AJAZBT&YZ;9(\X8K1T[H/&T_"")4DSS^T0+$U/(O1E M[@7#UV):AB=$'G"$+/#]-'#%_G9A0:[>^MY8-OU6W'C#T(*$*,V\L2I06N*' M.YB_)BQMBLME3PN=Z/$FP-\JBDK^4.M!87_VJ7=S._EJLJAD+JQS2Z-2L&U) M+[-Y4-B$>"DM"O[5RV<*ZBC$7`(^^P`NM44MTV3TVJ[ M03TB]'63TG8T\6DY@0.?<3'TH@G98!K\"/[LO/<*Z MWH+ZU[)^QN^/C:PX(AYV7U:R'/C[P>N2&)&2]L:+S1Y1-L0\,WDU5G&BN7YT MPB6*\K1R.>Z'WJWO//@!IYHOA.D?7+JGTGGO-Z!_VZP8R^XWQ'VD].=BV$1W M8&P.QYV"\5*[S6_&CL\TFXQHJK0\!#<+Q1V%F;.?JC;RG\1IS6"]S57F-8;M M@6,=S.3N[W2'U/)HW0+[582JO+^YBL+6BI6(T:
.R_,-F3Q5JY+-BC/W#I6N7@\MJ@6PZKKF"T98(9CO`=+U02`47DL"B=AZ"",#!JL2>RIG,NL0;^BILMR8>]3-S M=-3`*=.'77P#RR0E#QM1&<-XP6ZM*XF8<]U?4BB)+D(>CX8O"8CB3TWAY014]#9>\5L78$)N66JY@]YJB7L9+^*M;Y<]R8=7<':UXF8" MCPN5HV/G$5"7HW8X?*+^HNT;EQ;\1<*QH/)D?]J`^IRT8]>9HG6ZLDX6MSA< MSA%9L=!D5@(US2V,W`V1W*NHC0)%_]C>0@AHQ4)"ZMSK_BZ5-Z]83EKV:BH) M:(<=]HI]H/)P;*^BNCS(.:/K?)")83A#H8_)&,>E^LJMX_*V4!2.[;Q30$%` MG4UK;G9=GU"&^!O$R;P3PJ[6&"69'/%FNQ!S>2Q-P^&A\G!L M#YVZ5K;*[]-:OF_]$+&$?Y0(47B6H`M43([MF&NV>)?RQ8[5XP3S;U\>VP&H M+AP:$W1W]<:HU-9),N!^#BFM(_J+D%^HAE[Y>R7F\!9GGFKI"U`Y/+9?LRT+ MLS[7[5C3X.QIQ>\%'A>PT7"^3&D\7PV>6A:U-JD4U"QAA^ M8H\>V=7;DQ.(?>YJHT!EZ-B^4W49JL,].]:7\CDF-72*H:W5N*N-`L7]V#Y. M==SK<*_K*T4YS7W*44)>*/-XY25543GH#I41^SVA2OPZC9*FQQ`1A9H)'^QW MCX));D5,["B9L5FO`^Y7S&LW]5E#(])6<5.1T\5'0(D3(GI*R:(HV6,C9IJR8CZCU9HN3TF=FS&.?T5< M>&]V@Q?ORFH/!X59F^NS-:!P&^S0"GIZUWZ;'$0>XBD*>!3''$\=S\W6L_M([Z^U80_]Q_K8W[L\_3X>L8-75Y]EH/)S->OWQH'?5GXUX&:O[ MZ7`V',_[\]%D;+"0U80LG3!-2+JKXI44H,@3OLU;[`2[`E_R7:ZEX0U:`)D\ M#%#D$G^=SKU$-.94W*[H1'ZOYD:=L0R7QFI5/@H60'W6&E\MTH#]%QY#G"14 MK*AQ]V-Q;;AXV[OI7X]N1_-?>_WK__T\FHW8&F"RFET&Q#5>/5`493GP"O"5 M]VIS6R[CMDC=6"=)'\-J!>%X?DL%<<"X5HS1MS2;`]WM9ZQRJ4.\ST?CGUG=Q_&@/QW44XT*62J?HR3CHZR3T1O/W-3N"0[I MCVZZ_(;>-K%"OHU/EVEZZ/QE^%LSLH5TQ][?YN, MZ`]?Z+_H:="DC5=1:XPN9WMT`K1*=2#KZH_EW!@0[5,8P[0ZUL,85%%,Q#3C M:LMKK)\]5*8QWU/:RZ+2?O^6FIJ3ZU_.KOI)[?&[^^%X9MHSLYOB9)$GBGO3 M&)U1'/%5E).=O5:0ZV_3<4V^=X!._2H_=8".-Q[8L.*W(RO%UP[M<-OXXG#C M^(0'!-PAAU&S_]1[;VGX4%P:?F#.FM&T]Z5_^WG8NQOV9W0;9WN[R:U\2]!N MJ@"]%_^ZU>9S=\UO"_I_2D; M_\^O5R<67YTTP.[NOR9J*EXM M"Y*V8'R=DE1;9HSFG^`IRUFU+#KY[1[T`H`3S%3=UE:W!+_"Z M!)J08IN4EDD/6"E+&P/QTQ:4KE/I!-S1I%1WR&$W,8M-\)G58$A?^LH18IV! M?8&`:0M)UZ9P2KRS0_UN_7]L?,^/7Y1N/L2]@/AJBS[7J9`0?G7$$S-G154J M_##?-_;#)*._>F$L]L+,W$?D;9+TT#Q(Q0GR95%2ZQ]R,E8=Z(1]+369JFDW M3Q*4\0R!U`Y$9'6+G9`9%;*M'-+Q)!T=4.(M6>H/`F<$B_H/H$`N&Y;N$XGH MVJT%Q>FQ[=BE8CKP@TW,3FB4XTH+K>*`IL-/U*+!&O*M95>U)7%F(LT^>&8D MB3:S0L?_&A.J&>Z&D"3?PAB')/LG=^1"5PX=W^IP^&3K'._TN@&[)1B@V/&#Z"QU7%X1 MY/SNX6_E+R@N#MX**M\;I-^C7=,O]AZR3[Y>)EA\F3`**>))48/5RH\BONF& MW@T2%?41=CKA2P(`LS1=")1'\=PASW=S#X`+1T]9)]-G36T7`3!NV7&37SY7 M2O[*WZS2M50UW*W8^Y2#'57XITDYOV+R.R)1_@RSIO_&H1.,PK]O2%5H&Z#? M248F`FFW7TLG\2,B-75TO^])!C,JT&\_UO?TOXC=,9,GWT5U%^;R04XY%+(& M-[N>(5Z!9)X2F=F1"TRRF.Q6A*I\X),,X6R+.76%S[8J;@J,N$51M&7&3:MLA]3>9J^G5>$RK)[)KP?5OGL*H\**0C$%IMN8VU&:QPKMEAQFQC8).*G,DVO\L0Z'&AG4R-#R2_765N MB_/E:ER@=>NI?&\'5'0Q0"/ZH\"0*FMK&+(*YHH1R$U_ZT8TBP*SH48AE9\- MKT+P[`M0*&O;(13*II_SVEL#PMA9H0%>.7X(A2+?PPY`JL5*"$J>D-W5E\E% MBF_D?/^^0ZL'5%;@))/!PZ:F[XQD MT4Z<:V0XPJ;ZE'.P^1Y09@?+]XV(SZ&SPB3V_Z!3I0=6EAT+:J66=C6](H'Q M`;.A^W+AY29=MO;'K=4]6Z,E*[Y>8<.X0X+!-+N7/S(.MW;>?F M]D.OD:H61ZI^<8C/SA99;=EA&//Z2)2X+,=TB)?+)1UOY/AM">BRZ.0 MVAQH0FYQ%%VA!6895IY;U.R*\4\R7+=E'MDO5SO.(>^:VH8O[''9BAV(DI=H MJG(D'^^4PW^;\;B;L.P->LHAPRUP^ZA95L\KO*B5K4\R#%=(<5T_ MDG7%"([E1^ID["O,]=11Z*UP&G&E'L+.GB\(`9)OQFX9B!LK4UU]^ ME7!0);`BPVHZR&N*U1:*W,>)>X`Y!ZKG7FAF.C&B6CK44AKMV.+*\[,JBU*A MFVDO=\/BY:5,L`.OK\A?/M)S;Y]NG\X2C3MHVJ5=1PB`W.@^['M;3/^)&B<\WQEF^8G2 M1(J/.*``12GI\C6^P9"FO=A-]N6K%3$'/==RENRC?797W&J MY0D\@'&G="NBH\@O.PS0W89[0[E2P0C1D@'J;MQ+W=+:H,`K.^`MG^3`?_(] M:FM$$T+W?WHR?MCP8Y+J[E@]CG&/="N`U^->]U]BVFA?_'9A@?/:O(G!V-"* MD3$,BX)FV0&F6**N_`QS4$T=?(:AX_<6V0=Z'OW"ZSFFJ>>SB-D-)M#IEU4E MK.[>[;.&&JWVVQ.SS6I%UZT_D+`&Z^/)79;5A5 MA!NXM[$PE290*E&H'Z4KC']/9\*+_.4G7;8"71VF:0*1 M[@EI%BAV%2F[?V%=A#V@P-CE.9.29=-V";H\IM2PD$75V]DVQH:*@)4>LO:8 M:_Q1M.Q>3))Q]8>Z]V%V9%CMV#58.T3?.:&3U*=C5>JE96LKFG?[2DQ,FR6Z MR4.0SZZ<"'GYHMC9C7(NO%SP[F!/7?]25-?OW_9F\\GU+V=7_=EPT+N>W-T/ MQ[/]9,CY#_5P\J4>_6?O6_HMDQJ\HV:RR#-IB@*>%0Q3XXA'8S\P-F8Q"R M.RDEC'+(/Y?;G;/L7EO*1=S,=(5\N'WL'<2#IFAPB MA[:7L[.]N$\]?D24[N_9).F?Z(_OV8]"7)H.:CH*6HY:.VRSP\.2I1'9-\YS MU;^O7G9-4CNE3TUF+Z4\QXLI#H(;3-@?!0:`IN]UIG245GZ?G$PE+Y*/(D[9 MITSO&IHE1)LX[D-U&J_YFK+G9[XEC,)[3M3/1)@34,O'3#\BZY0T"^"R9&5E MOC26N0-Y@PVA/$EFFB1JR.?NR#)ZB';B&F.9MLV.*TVUF=W]QVQ-&3U\7OLD MRZ";\$W?PE?Z,=//WCJU\`G@>I5ED^:HP@-.;=GG.B7)I1QLQ20]?/O905E. MMRKF:-4MRR6?,IT^KU.27`F563FN<"46,HEE)M$]\5U$-Y0T&Y4DL3L;JIN3 M,!H9?CQA;Q^W[F?!;,RTC"^FY5UQ'F9#ZNV1^5KP=<08D=-^X/(P)KR*,S'[ M\,`F\:T%84<$^$2L:04/EJ9G$ETSJ%\]5A5N$#-R#IX`5,KUI$"Q1LH5`>N" M-VN*6"@85=MK''+6;9S@UE^4"5T)%-6]H1*C[Y*JCN-*Q@V+]M>'HA@GE[?] M3?R(>;X6'JV7N\ME87K1GIQ.F=@?1OP!>,(J15](UB4;)@B50CU96E2%JV2Q MLH&))ROZN>7<3M%O,D&HZ.O)=&.1Z#='65=9J"S?THA^U@\CW^7)!"IVWLK6 M4*#UY+RI";20(NL6G'8.1E*8VS^+U945/=<_,L"U'4FE`M;M(^C!2GG(I`?Y MB6:?2>>J6UP[WX0*J)XKFQH"JI7W5AX@2UYTR9]+*5<>O-#CX04B7#E[F[:F MZ\")HLDBG=R$3-E.#"H.*.\)14F/6U/$>JQ(R3_5#7[5ECC&8;+H9#D$HYAL M^#T$))I>ZU>ADJ;'M0B7M&/POOL!R?K6)(7+E@L]^97;6Y5.ZQJDE-IMO67D M;@A/$'WM!`'RKEXRWJ4-!:_&&@\,E1<][K^&\J+.04U^"L6[*=F-#1P6/1X+ M`"QR$JRW`_?FN_WC5F0$Q[N:PT%!/7YDJ8K20=EFVIZLH:H9+2*+3\;*DC&@ MN!\_R%)5JRL9]*KFV7`*1MCE\2,,VU1T6TRT*D5/YIMS(671$/P04J7:LEY0 M;(\??E>JS#`F',[M3C-\'9JR2;/A`Z' M7*B$>8>VA6LM&5#I$GY-U@B M7=1637_%V@EB<(\]#^-)ZHW+H1`@.X136)NGX![CE,MJ;]4Y1,,M8%')#>/AIS>.3_AQX@XY M+':/7PZE@:*E,:>7[XLQIS^\[=WT1]/>E_[MYV'O;MB??9X.[X;C^6P;,U!-2RZT6+0T"W\G3ULOWQDX\(9<+CRRUZ M0H'XRA?:OT-H04FR(SJT=/\YG+?L%EEQ&#O@5!/>*IAA%.NYG>9'^-Q,!'?4 MY4U-7V35$K^\O2?B@!WNB>WD1N&:'LBX7)W+(IN$G4S?!#4"#4*@[?!=U('O MPI900UWP770%OLLZ\%TJPJ?M$DP7?)<=@$_AW%CLT)6X'@G%%GI?9RCT,;GQ M242)0R%[\'N+G3)CD36O;&V-*5+!>`R@0:NC+_GJ#+DX],",+FMNC?T`Y70U MS7:L4K-'3.*83FV`'N(M=:)HC?+VUE@&8F`D5-B$S"T.EW,X,!7-K=GR0;@( M:;;:X2W.MG!Y7L/S;4>RA1/S@3,;)IHLKJGMX<CH=W7PY)W;L9&2)\F$BBZHHVSEYR4`D)*&F``4$;;F_ MO@M>="$IB)+MF*U\'A**V%WL[@E6ZO?:-::8 M(\'X]]H=_1D4%LTYG_VJ_^\U?WRKN>GPR_33_39^8?$=&ZMH0X MO:K=?[NUFV&7%YX]P5.D`>C4NRRM./+IN,+XN'I4J]6KO]QTK("N%!*>SUU" M'[+(ZV=G9]6@-29-4"$96HF"GE!/(&JOT3MBP;!*?%H- M&]=(22;IYY"4Q*0.3M!YV*Z,V6,5&JIR")1K]?)Q/2;WO?(8H=F"982\82`Z M:LAFX\&UG6F<`'>3K;.V" ME@SMN$.70(33"";A-*"4$PD"B8NGF(HVX],6'B'?!?K??>22$<%.21.(C[&0 M8]V;(1LK9<73!5'*8%9!"(G>R'>S&8%I`R_^="''U[GTYP"TUN0#!(XLR;*I M"C/.EQHVJ*-30<2SG'Y\&L@O:<2Y+"DI9(_0?]"G@T>$DD"Q:)+7M;(6LZ\^ M(NIHH2QM1=A%-2EF1;CO8<>D/P3/,XX]$!,P=>!%Q!B1;&"RD6O[[FX\2U4R M6:(7L:_W\'Z348^YQ(%`ZUPA5TYS:X*Q\$+7;VY6^_T(G"TC+XXJ:]577!]:'^Y?^[2$.%DZP(*#W%BS6:=7`'.\# MC/9IK8M_'"90#J8@SI_<;``((/L-*^E[DPQQ.@(8_8@%1[BG.BEL6IAN]T'_B:YDVOKW\%.N-. MUXPN_-:U3QW3LCXF7Q(5ST]+[UM\U_5^WQN";]JFEMXVF,?C`-FO&(6_2=ME3WKBZI%>C M]V6O>=FPOFKMCGE_B&&U"Y4TQ^;HRO<(Q9X'^?@5\@CXO+=B8PA33EHU1-_) ME!T*<)=Y(`Q^U"M:MS&X[>L2BZM;R^CJEJ4UNC)AL8P`(0B;%J`5K'T'B%$; MV<2%"-:P(9!Y9"4AR6Q1^_\LZ?^CBM9N-(V.#%J-)@0ORSC4'*.+GQJVS7PH M(ND8X@AU$'JGU<3_KXI*+IC7X7G&MID#%#O=/HZP?H78,^8D_(E="@ M/S%"Q1T\@HNB`;VY6>WOHZ2_3RN0S-[IUB#(AXRN]I-IP,,=_(*H?HCC.D@^ MRW([UI&U!:0V*ZOHID:UUX^37O]<"?/.,JR207YSTX-,YW"72,*##?T;C*2# M@KPQ7B.SFM3>/DEZ^XM<)(V^=M?HW.K:C=ZP8&@'&>0!.CM?'MB#1-XF<;39 MD4<-S^D+)W3(YA10UZJF]@1>@'G:N1;UK M0?`>\FK!CFU%;$WR(L>#Q'79,8>.24[G8\;U](B44L/[D:MM1N1U[8#GN="@OJ MJV1!'0]ITQ?R)+F\UV#.@@_0D&3<2XUS%%)H<3C>*>]EP/.(54N3DR4?*1J M6%);*3E@^;^<)?(_B/J.!:!N)V2DKJ[!4+8#'-!L%>-E8\%""(D^VH= MKLE^8!I77\-D%PUW-1E8L/N&MG:D_%8KRU?E^E'YN%Z9>\Y2TUV46+IA-R5BOCV44-Z?W*!%)H]\*"^9\_:OO(RI MZC^3L8I=X<5O7JA-^B+E_NH$LO;0)\<=TCPC996S&S+*H7(FATK]\PN5V4^1 M;5I$EU&#=$<&J]_2]1Q:UG.WU(%(,L'RLG#/112:X+$F'V_P=(AY*;#GLO1B M*<1UY>?!RY+@O@Q7\D+T.80QPIQ!$&T=GT?'\L+H&]X*/G?8%!%J"#R59.`M M?^A!E/,EZ35G_NRR%,HB0*+R0Y=1J="*(;'ZZY;FH'MW6P80K]V59'95_PUM MQ="YCYPN%@:UURX!91BPA?#=K6D3[HD.P72`^;3#$/5DD%HW9`O-N]M@89M1 M9TW!=0-4!.^N?0=[+L$6"!,=YI.$ZAM;WUWO-B?8F2;C:^KMN^LI@Z`,Z.MZ MIMZ^NYZJ/UW0`)D^5RU;D\-)DGO):/!ZR/PP]K.+9Q%X;"`MFPQOE-#Q=%IV,B\S;T%A88Z)Y98YDR3*+THP.AE?R#Q\8TQEGC^$:#*9\ MPZ*'B--FR\QJ?_ZBNB3,0-S`AA8>BCYV@P`&T1XYA+EL_+RP=1'N=N,I[%*1 M=1=\@.?BRF7VPR+KWT*T;W(M8AFOL6^2>=,ZN4IMHRKL(&U/(81:Y!_^WS1>S(0UA8*Y='&^J5G*!W.!HNV=`H2@UO9TQJL\QMXG,28,C9EDG"D.[7RID M7UC#SEX_2$->O19PDV,[/WWA1G#P>27X-F2.^L%1*F65F9]\JV'A)W_Q!Q>;6_YA),1+Q2R>/C5E,NY=H4)_-H@N'KV%DJ%.DDE0E#G71'WN+S-I*EG^- M>QL[ML(0J7:H%5<\U1\N]^_SD[VQ7N'F8.I^U MOK>8U;QW?O_&:?!B-S1Q7BNU6YIN?W^3+JKA$5AX_"]02P$"'@,4````"`#S M=6I%I,RR&[*I``!J]P4`$0`8```````!````I($``````L``00E#@``!#D!``!02P$"'@,4````"`#S=6I% M@3=3]\P2``"0\```%0`8```````!````I(']J0``&UL550%``-:%F%4=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`\W5J M11,.F,='$@``#P(!`!4`&````````0```*2!&+T``')D;G0M,C`Q-#`Y,S!? M9&5F+GAM;%54!0`#6A9A5'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/-U M:D7E3BNA3DH``%`*!``5`!@```````$```"D@:[/``!R9&YT+3(P,30P.3,P M7VQA8BYX;6Q55`4``UH6851U>`L``00E#@``!#D!``!02P$"'@,4````"`#S M=6I%B3&Z'OXJ``"FP`(`%0`8```````!````I(%+&@$`&UL550%``-:%F%4=7@+``$$)0X```0Y`0``4$L!`AX#%`````@` M\W5J1=UO>+E$#```J&D``!$`&````````0```*2!F$4!`')D;G0M,C`Q-#`Y M,S`N>'-D550%``-:%F%4=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(` '`"=2`0`````` ` end XML 18 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8

6. STOCK-BASED COMPENSATION (Details Narrative) (USD $)
In Thousands, except Share data, unless otherwise specified
9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Total intrinsic value of options and warrants $ 5,900 $ 2,300

Total unrecognized stock-based compensation expense related to non-vested employee awards 39,000

Expected period of recognition over a weighted average period 2 years 1 month 6 days

2006 Plan

Common stock reserved for issuance 11,000,000

Stock options outstanding 2,102,509

Stock options vested 2,037,509

Options, warrants and RSU's outstanding 4,834,294

Options, warrants and RSU's exercised 2,296,241

Options, warrants and RSU's available for grant 3,869,465

Restricted Stock [Member]

Total unrecognized stock-based compensation expense related to non-vested employee awards $ 1,100

Restricted Stock [Member]

Expected period of recognition over a weighted average period 2 years 9 months

Restricted stock awards granted 1,011,785

X

- Definition

Options, warrants and RSU's available for grant

+ References

No definition available.

+ Details

Name: rdnt_OptionsWarrantsAndRsusAvailableForGrant

Namespace Prefix: rdnt_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Options, warrants and RSU's exercised

+ References

No definition available.

+ Details

Name: rdnt_OptionsWarrantsAndRsusExercised

Namespace Prefix: rdnt_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Options, warrants and RSU's outstanding

+ References

No definition available.

+ Details

Name: rdnt_OptionsWarrantsAndRsusOutstanding

Namespace Prefix: rdnt_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate number of common shares reserved for future issuance.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockCapitalSharesReservedForFutureIssuance

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Unrecognized cost of unvested share-based compensation awards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Number of options outstanding, including both vested and non-vested options.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 19 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8

6. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) (USD $)
In Thousands, except Share data, unless otherwise specified
9 Months Ended

Sep. 30, 2014

Non-Plan Outstanding Warrants [Member]

Outstanding Warrants

Beginning balance 200,000

Warrants exercised (200,000)

Ending balance 0

Exercisable 0

Weighted Average Exercise Price

Beginning price per share $ 2.62

Weighted average exercise price warrants exercised $ 2.62

Ending price per share $ 0

Outstanding Options and Warrants [Member]

Outstanding Options

Begining Balance 4,701,250

Granted 0

Exercised (2,283,741)

Canceled or expired (315,000)

Ending Balance 2,102,509

Exercisable at the end 2,037,509

Weighted Average Exercise price Per Common Share

Begining Balance $ 3.15

Granted

Exercised $ 2.38

Canceled or expired $ 5.91

Ending Balance $ 3.57

Exercisable at the end $ 3.62

Weighted Average Remaining Contractual Life

Ending Balance 1 year 5 months 9 days

Exercisable at the end 1 year 4 months 10 days

Aggregate Intrinsic Value

Aggregate value outstanding $ 7,017,488

Aggregate value exercisable $ 6,719,788

X

- Details

Name: rdnt_AggregateIntrinsicValue

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: rdnt_OutstandingWarrants

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: rdnt_WeightedAverageExercisePrice

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: rdnt_WeightedAverageExercisePricePerCommonShareAbstract

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average exercise price warrants exercised

+ References

No definition available.

+ Details

Name: rdnt_WeightedAverageExercisePriceWarrantsExercised

Namespace Prefix: rdnt_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: rdnt_WeightedAverageRemainingContractualLife

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(4))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(2))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Subparagraph 2

-Article 4

+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Article 4

+ Details

Name: us-gaap_ClassOfWarrantOrRightOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of non-option equity instruments exercised by participants.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(4)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Gross number of share options (or share units) granted during the period.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Number of options outstanding, including both vested and non-vested options.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Weighted average price at which option holders acquired shares when converting their stock options into shares.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of share options (or share units) exercised during the current period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 20 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8

7. FAIR VALUE MEASUREMENTS (Details) (USD $)
In Thousands, unless otherwise specified

Sep. 30, 2014

Dec. 31, 2013

FAIR VALUE MEASUREMENTS

Senior First Lien Term Loan $ 404,942 $ 349,125

Senior Second Lien Term Loan 180,000 200,000

Total Fair Value

FAIR VALUE MEASUREMENTS

Senior First Lien Term Loan 402,411 380,508

Senior Second Lien Term Loan 180,000 199,000

Level 1

FAIR VALUE MEASUREMENTS

Senior First Lien Term Loan 0 0

Senior Second Lien Term Loan 0 0

Level 2

FAIR VALUE MEASUREMENTS

Senior First Lien Term Loan 402,411 380,508

Senior Second Lien Term Loan 180,000 199,000

Level 3

FAIR VALUE MEASUREMENTS

Senior First Lien Term Loan 0 0

Senior Second Lien Term Loan $ 0 $ 0

X

- Definition

Senior First Lien Term Loan

+ References

No definition available.

+ Details

Name: rdnt_SeniorFirstLienTermLoan

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Senior Second Lien Term Loan

+ References

No definition available.

+ Details

Name: rdnt_SeniorSecondLienTermLoan

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_FairValueInputsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 21 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8

7. FAIR VALUE MEASUREMENTS (Details Narrative) (USD $)
In Thousands, unless otherwise specified

Sep. 30, 2014

Dec. 31, 2013

Fair Value Disclosures [Abstract]

Line of credit $ 25,100 $ 0

X

- Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Line-of-Credit Arrangement

-URI http://asc.fasb.org/extlink&oid=6517033

+ Details

Name: us-gaap_LinesOfCreditFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 22 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION
9 Months Ended

Sep. 30, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NATURE OF BUSINESS AND BASIS OF PRESENTATION
NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION

We provide diagnostic imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. At September 30, 2014, we operated directly or indirectly through joint ventures, 263 imaging centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York. Our operations comprise a single segment for financial reporting purposes.

The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or “Radnet Management”) and Beverly Radiology Medical Group III, a professional partnership (“BRMG”). The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc., Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc. (“DIS”), all wholly owned subsidiaries of Radnet Management. All of these affiliated entities are referred to collectively as “RadNet”, “we”, “us”, “our” or the “Company” in this report.

Accounting Standards Codification (“ASC”) Section 810-10-15-14 stipulates that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics specified in the ASC which evidence a controlling financial interest, is considered a Variable Interest Entity (“VIE”). We consolidate all VIEs in which we own a majority voting interest and all VIEs for which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE’s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.

Howard G. Berger, M.D. is our President and Chief Executive Officer, a member of our Board of Directors and is deemed to be the beneficial owner, directly and indirectly, of approximately 13.1% of our outstanding common stock as of September 30, 2014. Dr. Berger also owns, indirectly, 99% of the equity interests in BRMG. BRMG provides all of the professional medical services at the majority of our facilities located in California under a management agreement with us, and employs physicians or contracts with various other independent physicians and physician groups to provide the professional medical services at most of our other California facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly or through subsidiaries, in order to comply with California’s prohibition against the corporate practice of medicine. However, as a result of our close relationship with Dr. Berger and BRMG, we believe that we are able to better ensure that medical service is provided at our California facilities in a manner consistent with our needs and expectations and those of our referring physicians, patients and payors than if we obtained these services from unaffiliated physician groups. BRMG is a partnership of ProNet Imaging Medical Group, Inc., Breastlink Medical Group, Inc. and Beverly Radiology Medical Group, Inc., each of which is 99% or 100% owned by Dr. Berger.

John V Crues, III, M.D. is our Medical Director, a member of our Board of Directors and a 1% owner of BRMG. Dr. Crues owns a controlling interest in four medical groups (“Crues Entities”) which provide professional medical services at some of our facilities in Manhattan and Brooklyn, New York while Dr. Berger owns a controlling interest in two medical groups (“NY Berger Entities”) which provide professional medical services at one of our Manhattan, New York facilities. The Crues Entities and the NY Berger Entities are collectively hereinafter referred to as the “B&C Entities.”

RadNet provides non-medical, technical and administrative services to BRMG and the B&C Entities for which it receives a management fee, pursuant to the related management agreements. Through these management agreements and our relationship with both Dr. Berger and Dr. Crues, we have exclusive authority over all non-medical decision-making related to the ongoing business operations of BRMG and the B&C Entities and we determine the annual budget of BRMG and the B&C Entities. BRMG and the B&C Entities both have insignificant operating assets and liabilities, and de minimis equity. Through these management agreements, we are paid the fair market value of our services, the result of which is that generally all net cash flows of both BRMG and the B&C Entities are transferred to us.

We have determined that BRMG and the B&C Entities are VIEs, and that we are the primary beneficiary, and consequently, we consolidate the revenue, expenses, assets and liabilities of each such entity. BRMG and the B&C Entities on a combined basis recognized $23.6 million and $24.7 million of revenue, net of management service fees to RadNet for the three months ended September 30, 2014 and 2013, respectively, and $23.6 million and $24.7 million of operating expenses for the three months ended September 30, 2014 and 2013, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $98.0 million and $98.3 million of total billed net service fee revenue relating to these VIE’s for the three months ended September 30, 2014 and 2013, respectively, of which $74.4 million and $73.6 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the three months ended September 30, 2014 and 2013, respectively.

BRMG and the B&C Entities on a combined basis recognized $65.6 million and $58.2 million of revenue, net of management service fees to RadNet for the nine months ended September 30, 2014 and 2013, respectively, and $65.6 million and $58.2 million of operating expenses for the nine months ended September 30, 2014 and 2013, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $279.6 million and $256.6 million of total billed net service fee revenue relating to these VIE’s for the nine months ended September 30, 2014 and 2013, respectively, of which $213.9 million and $198.4 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the nine months ended September 30, 2014 and 2013, respectively.

The cash flows of BRMG and the B&C Entities are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at September 30, 2014 and December 31, 2013, we have included approximately $80.3 million and $65.2 million, respectively, of accounts receivable and approximately $9.4 million and $11.9 million, respectively, of accounts payable and accrued liabilities, related to BRMG and the B&C Entities combined.

The creditors of both BRMG and the B&C Entities do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of BRMG and the B&C Entities. However, because of the relationship RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.

Aside from certain centers in California and all of our centers in New York City where we contract with BRMG and the B&C Entities, respectively, for the provision of professional medical services, at all of our other centers, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice group’s professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us. We have no financial controlling interest in the independent (non-BRMG or non-B&C Entities) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended September 30, 2014 and 2013 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December 31, 2013 filed on March 17, 2014, as amended.

Significant Accounting Policies

During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended.

Revenues

Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payers and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the B&C Entities, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the B&C Entities as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the B&C Entities. As it relates to non-BRMG and B&C Entity centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and B&C Entity centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.

Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payers.

Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2014 and 2013 is summarized in the following table (in thousands):

Three Months Ended Nine Months Ended

September 30, September 30,

2014 2013 2014 2013

Commercial Insurance $ 109,472 $ 103,934 $ 314,300 $ 310,147

Medicare 41,203 38,276 118,627 113,916

Medicaid 6,248 5,869 18,214 18,358

Workers' Compensation/Personal Injury 7,821 8,566 22,708 27,666

Other 6,354 8,727 24,688 26,337

Service fee revenue, net of contractual allowances and discounts 171,098 165,373 498,536 496,424

Provision for bad debts (7,532 ) (7,033 ) (21,945 ) (20,810 )

Net service fee revenue 163,566 158,340 476,591 475,614

Revenue under capitation arrangements 20,493 16,848 55,426 49,034

Total net revenue $ 184,059 $ 175,188 $ 532,017 $ 524,648

Provision for Bad Debts

We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patient’s ability to pay nor are revenues recognized based on an assessment of the patient’s ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.

Deferred Tax Assets

Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.

Deferred Financing Costs

Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.

Meaningful Use Incentive

Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a Radiology Information System (RIS) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $1.8 million during the nine months ended September 30, 2014 relating to this incentive. This amount was earned under a Medicare program to promote the use of electronic health record technology.

Liquidity and Capital Resources

We had cash and cash equivalents of $274,000 and accounts receivable of $155.0 million at September 30, 2014, compared to cash and cash equivalents of $8.4 million and accounts receivable of $133.6 million at December 31, 2013. We had a working capital balance of $65.7 million and $58.0 million at September 30, 2014 and December 31, 2013, respectively. We had net income (loss) attributable to RadNet, Inc. common stockholders for the three months ended September 30, 2014 and 2013 of $4.5 million and ($467,000) respectively, and net (loss) income attributable to RadNet, Inc. common stockholders for the nine months ended September 30, 2014 and 2013 of ($2.8 million) and $877,000, respectively. We also had stockholders’ equity of $2.6 million and $2.2 million at September 30, 2014 and December 31, 2013, respectively.

We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.

Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.

On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.

We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.

Included in our condensed consolidated balance sheet at September 30, 2014 are $572.2 million of senior secured term loan debt (net of unamortized discounts of $12.7 million), broken down by loan agreement as follows (in thousands):

Face Value Discount Total Carrying Value

2014 First Lien Term Loans $ 404,942 $ (9,922 ) $ 395,020

Second Lien Term Loans $ 180,000 $ (2,772 ) $ 177,228

Total $ 584,942 $ (12,694 ) $ 572,248

Our revolving credit facility has a $25.1 million aggregate principal amount outstanding as of September 30, 2014.

The following describes our most recent financing activities:

2014 Amendment to the Refinance Agreement and Second Lien Credit and Guaranty Agreement:

On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:

2014 Amendment of the Refinance Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012, by that certain first amendment dated April 3, 2013 (the “2013 Amendment”) (collectively, the Refinance Agreement”), by entering into a second amendment to the Refinance Agreement (the “2014 Amendment”) to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the “2014 First Lien Term Loans”).

Second Lien Credit and Guaranty Agreement. Radnet Management entered into a Second Lien Credit and Guaranty Agreement (the “Second Lien Credit Agreement”) to provide for, among other things, the borrowing by Radnet Management of $180.0 million of second lien term loans (the “Second Lien Term Loans”). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the senior notes, as more fully described below under the heading “Senior Notes”, to pay the expenses related to the transaction and for general corporate purposes.

Revolving Credit Facility. The $101.25 million revolving credit line established in the Credit and Guaranty Agreement dated October 10, 2012 was unaltered by the agreements above and remains in place.

The 2014 Amendment provides for the following:

Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates currently payable under the Refinance Agreement, as amended by the 2013 Amendment, which are (a) the Adjusted Eurodollar Rate plus 3.25% or (b) the Base Rate (as defined in the Refinance Agreement) plus 2.25%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on all of the term loans under the Refinance Agreement. The Adjusted Eurodollar Rate at September 30, 2014 was 0.33%.

Payments. The scheduled amortization of the term loans under the Refinance Agreement has been increased from quarterly payments of $975,000 to quarterly payments of $5.2 million which started in June 2014, with the remaining balance to be paid at maturity.

The other material terms of the Refinance Agreement remain unchanged as described in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended.

The Second Lien Credit Agreement provides for the following:

Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate plus 7.0% or (b) the Base Rate plus 6.0%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at September 30, 2014 was 0.33%.

Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. All principal will be due and payable on the termination date described below.

Termination. The termination date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by acceleration or otherwise.

Restrictive Covenants. In addition to certain customary covenants, the Second Lien Credit Agreement places restrictions on indebtedness, liens, and investments, and places limits on distributions to stockholders (including the repurchase of shares) and other junior payments.

Financial Covenants. The Second Lien Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.

Events of Default. In addition to certain customary events of default, events of default under the Second Lien Credit Agreement include failure to pay principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements, subject to applicable grace periods and/or notice requirements, or a material breach of any representation or warranty contained in the loan documents. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

These limitations are subject to a number of important qualifications and exceptions, as described in the Second Lien Credit Agreement. As of September 30, 2014, we were in compliance with all covenants.

Senior Notes

On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the “senior notes”). All payments of the senior notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Management’s current and future domestic wholly owned restricted subsidiaries. The senior notes were issued under an indenture dated April 6, 2010 (the “Indenture”), by and among Radnet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee.” We paid interest on the senior notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.

Optional Redemption. Under the Indenture, Radnet Management could redeem the senior notes, in whole or in part, at any time on or after April 1, 2014, at the redemption prices specified under the Indenture. Prior to April 1, 2014, Radnet Management was also permitted to redeem the senior notes, in whole or in part, at a redemption price equal to 100% of the principal amount redeemed, plus a make-whole premium established by the Indenture and accrued and unpaid interest, if any.

Senior Notes Tender Offer and Exercise of Optional Redemption

Radnet Management completed the retirement of its $200 million in Senior Notes on April 24, 2014 and following such retirement the Company completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:

Tender Offer and Exercise of Optional Redemption on March 7, 2014. On March 7, 2014, Radnet Management commenced a tender offer to purchase for cash any and all outstanding senior notes. In connection with the tender offer, Radnet Management also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014 (the “Initial Payment Date”), Radnet Management made a payment in cash for all senior notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the “Consent Payment Deadline”). As of the Consent Payment Deadline, Radnet Management had received tenders and consents in respect of $193,464,000 aggregate principal amount of the senior notes, representing 96.73% of the outstanding senior notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of senior notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88 (the “Total Consideration”), which amount included a consent payment (the “Consent Payment”) of $30.00 per $1,000 principal amount of senior notes. In addition, all senior notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional senior notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.

Tender Offer and Exercise on Optional Redemption of March 25, 2014. On March 25, 2014, Radnet Management called for redemption all of its remaining outstanding senior notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the “Redemption Date”). Upon redemption on April 24, 2014, the holders of the senior notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the senior notes being redeemed (or $1,051.88 per $1,000 in principal amount of the senior notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date. As of that date, Radnet Management completed the satisfaction and discharge of the Indenture in accordance with its terms and no senior notes remained outstanding. With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.

Capital Lease Investments

During the nine months ended September 30, 2014, we added capital lease debt of approximately $12.6 million relating to radiology equipment.

X

- Definition

The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).

+ References

No definition available.

+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified

Sep. 30, 2014

Dec. 31, 2013

CURRENT ASSETS

Cash and cash equivalents $ 274 $ 8,412

Accounts receivable, net 155,011 133,599

Current portion of deferred tax assets 16,692 13,321

Prepaid expenses and other current assets 25,272 21,012

Total current assets 197,249 176,344

PROPERTY AND EQUIPMENT, NET 225,597 218,547

OTHER ASSETS

Goodwill 200,304 196,395

Other intangible assets 48,392 50,042

Deferred financing costs, net of current portion 6,682 8,735

Investment in joint ventures 27,474 28,949

Deferred tax assets, net of current portion 39,004 39,914

Deposits and other 3,817 3,650

Total assets 748,519 722,576

LIABILITIES AND STOCKHOLDERS' EQUITY

Accounts payable, accrued expenses and other 100,931 106,316

Due to affiliates 1,120 2,655

Deferred revenue 1,948 1,344

Current portion of notes payable 19,558 3,103

Current portion of deferred rent 2,256 1,896

Current portion of obligations under capital leases 5,708 3,075

Total current liabilities 131,521 118,389

LONG-TERM LIABILITIES

Deferred rent, net of current portion 19,282 18,989

Revolving credit facility 25,100 0

Notes payable, net of current portion 555,920 572,669

Obligations under capital lease, net of current portion 7,573 2,779

Other non-current liabilities 6,505 7,540

Total liabilities 745,901 720,366

STOCKHOLDERS' EQUITY

Common stock - $.0001 par value, 200,000,000 shares authorized; 42,703,602, and 40,089,196 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively 4 4

Paid-in-capital 177,141 173,622

Accumulated other comprehensive loss (88) (50)

Accumulated deficit (176,485) (173,656)

Total RadNet, Inc.'s stockholders' equity (deficit) 572 (80)

Noncontrolling interests 2,046 2,290

Total stockholders' equity 2,618 2,210

Total liabilities and stockholders' equity $ 748,519 $ 722,576

X

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 9

-Article 5

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of capital lease obligation due within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

+ Details

Name: us-gaap_CapitalLeaseObligationsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

+ Details

Name: us-gaap_CapitalLeaseObligationsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Net amount of long-term deferred finance costs capitalized at the end of the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28555-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 17

-Article 5

+ Details

Name: us-gaap_DeferredFinanceCostsNoncurrentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

For a classified balance sheet, the cumulative difference as of the balance sheet date between the payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, within one year of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 25

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=7501430&loc=d3e39927-112707

+ Details

Name: us-gaap_DeferredRentCreditCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 25

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=7501430&loc=d3e39927-112707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.26(c))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DeferredRentCreditNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

+ Details

Name: us-gaap_DeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed within one year or operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31938-109318

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Asset

-URI http://asc.fasb.org/extlink&oid=6510090

+ Details

Name: us-gaap_DeferredTaxAssetsGrossCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed after one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Asset

-URI http://asc.fasb.org/extlink&oid=6510090

+ Details

Name: us-gaap_DeferredTaxAssetsGrossNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 17

-Article 5

+ Details

Name: us-gaap_DepositsAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph k

-Subparagraph 1

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 12

-Subparagraph 3

-Article 6

+ Details

Name: us-gaap_DueToAffiliateCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph ((a)(1),(b))

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 32

-Article 5

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesAndStockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 21

-Article 5

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

+ Details

Name: us-gaap_LongTermNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 27

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 7

+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20

-Article 5

+ Details

Name: us-gaap_NotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_OtherAssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.24)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 24

-Article 5

+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.

+ References

No definition available.

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568447-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4I

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4590271-111686

+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 24 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $)
In Thousands, except Share data

Common Stock

Additional Paid-In Capital

Accumulated Deficit

Accumulated Other Comprehensive Income (Loss)

Total Radnet, Inc.'s Stockholders' Deficit

Noncontrolling Interest

Total

Beginning balance, value at Dec. 31, 2013 $ 4 $ 173,622 $ (173,656) $ (50) $ (80) $ 2,290 $ 2,210

Beginning balance, shares at Dec. 31, 2013 40,089,196

Issuance of common stock upon exercise of options/warrants, shares issued 1,572,621

Issuance of common stock upon exercise of options/warrants, value 0 1,546 0 0 1,546 0 1,546

Stock-based compensation 0 1,854 0 0 1,854 0 1,854

Issuance of restricted stock, shares 1,041,785

Issuance of restricted stock, value 0 0 0 0 0 0 0

Purchase of non-controlling interests 0 119 0 0 119 (315) (196)

Dividends paid to noncontrolling interest 0 0 0 0 0 (148) (148)

Change in cumulative foreign currency translation adjustment 0 0 0 (38) (38) 0 (38)

Net (loss) income 0 0 (2,829) 0 (2,829) 219 (2,610)

Ending balance, value at Sep. 30, 2014 $ 4 $ 177,141 $ (176,485) $ (88) $ 572 $ 2,046 $ 2,618

Ending balance, shares at Sep. 30, 2014 42,703,602

X

- Definition

Changes in additional paid in capital related to exercise of share-based payments awards (such as stock options) and the amount of recognized equity-based compensation during the period (such as nonvested shares).

+ References

No definition available.

+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 23

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569655-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4616395-111683

+ Details

Name: us-gaap_MinorityInterestDecreaseFromRedemptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 35

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6939497&loc=d3e30304-110892

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-Subparagraph (b,d)

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Number of shares issued which are neither cancelled nor held in the treasury.

+ References

No definition available.

+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of share options (or share units) exercised during the current period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Aggregate value of stock related to Restricted Stock Awards issued during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Value of stock issued as a result of the exercise of stock options.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 25 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Senior Secured Notes) (USD $)
In Thousands, unless otherwise specified

Sep. 30, 2014

Face Value $ 584,942

Discount 12,694

Total Carrying Value 572,248

Senior Notes [Member] | 2014 First Lien Term Loans [Member]

Face Value 404,942

Discount (9,922)

Total Carrying Value 395,020

Senior Notes [Member] | Second Lien Term Loans [Member]

Face Value 180,000

Discount (2,772)

Total Carrying Value $ 177,228

X

- Definition

The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 16

-Article 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_SecuredDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

+ Details

Name: us-gaap_SecuredLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 26 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8

4. EARNINGS PER SHARE (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Earnings Per Share [Abstract]

Net income (loss) attributable to RadNet, Inc.'s common stockholders $ 4,451 $ (467) $ (2,829) $ 877

BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 41,644,606 39,235,863 40,734,083 39,105,522

Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders $ 0.11 $ (0.01) $ (0.07) $ 0.02

DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 41,644,606 39,235,863 40,734,083 39,105,522

Add nonvested restricted stock subject only to service vesting 1,001,190 311,419

Add additional shares issuable upon exercise of stock options and warrants 1,387,784 469,199

Weighted average number of common shares used in calculating diluted net income per share 44,033,580 39,235,863 40,734,083 39,886,140

Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders $ 0.10 $ (0.01) $ (0.07) $ 0.02

X

- Definition

Custom Element.

+ References

No definition available.

+ Details

Name: rdnt_AdditionalSharesIssuableUponExerciseOfStockOptionsAndWarrants

Namespace Prefix: rdnt_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_EarningsPerShareBasicAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e2646-109256

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesRestrictedStock

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 27 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 28 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

CASH FLOWS FROM OPERATING ACTIVITIES

Net (loss) income $ (2,610) $ 1,028

Adjustments to reconcile net (loss) income to net cash provided by operating activities:

Depreciation and amortization 45,193 44,050

Provision for bad debts 21,945 20,810

Equity in earnings of joint ventures (4,722) (4,481)

Distributions from joint ventures 7,358 5,624

Deferred rent amortization 653 2,893

Amortization of deferred financing costs 1,708 1,676

Write off of deferred loan costs due to refinance 665 0

Amortization of bond and term loan discounts 2,071 1,651

Loss on sale and disposal of equipment 1,581 357

Loss on early extinguishment of Senior Notes 15,927 0

Gain on Sale of Imaging Centers 0 (2,108)

Stock-based compensation 2,069 2,045

Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:

Accounts receivable (42,887) (25,096)

Other current assets (4,754) (1,504)

Other assets (72) 172

Deferred taxes (2,461) 575

Deferred revenue 604 175

Accounts payable, accrued expenses and other (8,225) (5,357)

Net cash provided by operating activities 34,043 42,510

CASH FLOWS FROM INVESTING ACTIVITIES

Purchase of imaging facilities (9,428) (5,918)

Purchase of noncontrolling interests (196) 0

Purchase of property and equipment (33,895) (39,291)

Proceeds from sale of equipment 766 510

Proceeds from sale of imaging facilities 0 3,290

Proceeds from sale of joint venture interests 0 2,640

Equity contributions in existing joint ventures (1,161) (1,803)

Net cash used in investing activities (43,914) (40,572)

CASH FLOWS FROM FINANCING ACTIVITIES

Principal payments on notes and leases payable (16,733) (7,476)

Proceeds from borrowings 210,000 35,122

Payments on Senior Notes (211,344) 0

Deferred financing costs (6,650) (432)

Net proceeds (payments) on revolving credit facility 25,100 (29,600)

Distributions to noncontrolling interests (148) (11)

Proceeds from issuance of common stock upon exercise of options/warrants 1,546 469

Net cash provided by (used in) financing activities 1,771 (1,928)

EFFECT OF EXCHANGE RATE CHANGES ON CASH (38) (104)

NET DECREASE IN CASH AND CASH EQUIVALENTS (8,138) (94)

CASH AND CASH EQUIVALENTS, beginning of period 8,412 362

CASH AND CASH EQUIVALENTS, end of period 274 268

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

Cash paid during the period for interest 32,389 26,614

SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES

Purchase of equipment and leasehold improvements not yet paid for 16,600 11,300

Capital lease debt relating to radiology equipment $ 12,600

X

- Definition

Capital lease debt relating to radiology equipment

+ References

No definition available.

+ Details

Name: rdnt_CapitalLeaseDebtRelatingToRadiologyEquipment

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: rdnt_ChangesInOperatingAssetsAndLiabilitiesNetOfAssetsAcquiredAndLiabilitiesAssumedInPurchaseTransactionsAbstract

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Deferred rent amortization

+ References

No definition available.

+ Details

Name: rdnt_DeferredRentAmortization

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Custom Element.

+ References

No definition available.

+ Details

Name: rdnt_PaymentsOnSeniorNotes

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Custom Element.

+ References

No definition available.

+ Details

Name: rdnt_ProceedsFromSaleOfImagingFacilities1

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Proceeds from sale of joint venture interests

+ References

No definition available.

+ Details

Name: rdnt_ProceedsFromSaleOfJointVentureInterests

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Purchase of equipment and leasehold improvements not yet paid for

+ References

No definition available.

+ Details

Name: rdnt_PurchaseOfEquipmentAndLeaseholdImprovementsNotYetPaidFor

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Write off of deferred loan costs due to refinance

+ References

No definition available.

+ Details

Name: rdnt_WriteOffOfDeferredLoanCostsDueToRefinance

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 5

+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of noncash expense included in interest expense to issue debt and obtain financing associated with the related debt instruments. Alternate captions include noncash interest expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 8

-Article 9

+ Details

Name: us-gaap_AmortizationOfFinancingCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of any adjustment recognized to the balance of unamortized issuance costs associated with a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, due, for example, to default by the share borrower.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 20

-Section 50

-Paragraph 2C

-URI http://asc.fasb.org/extlink&oid=7656903&loc=SL6757497-112611

+ Details

Name: us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (g),(h)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

+ Details

Name: us-gaap_DeferredOtherTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906

+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

This item represents disclosure of the amount of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporation; these investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13

-Article 5

+ Details

Name: us-gaap_EquityMethodInvestmentDividendsOrDistributions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6401765&loc=d3e13305-112630

+ Details

Name: us-gaap_ExtinguishmentOfDebtGainLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2443-110228

+ Details

Name: us-gaap_GainLossOnDispositionOfAssets1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_GainLossOnSaleOfPropertyPlantEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.12)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 11

-Article 7

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other assets used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets, other noncurrent assets, or a combination of other current and noncurrent assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of cash paid for interest during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 23

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569655-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4616395-111683

+ Details

Name: us-gaap_MinorityInterestDecreaseFromRedemptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

The cash outflow associated with the purchase of all investments (debt, security, other) during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireProductiveAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.

+ References

No definition available.

+ Details

Name: us-gaap_ProceedsFromIssuanceOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow associated with the amount received from holders to acquire the entity's shares under incentive and share awards other than stock option exercises. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.

+ References

No definition available.

+ Details

Name: us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph f

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585

+ Details

Name: us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.5)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 5

-Article 5

+ Details

Name: us-gaap_ProvisionForDoubtfulAccounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash outflow associated with security instruments that either represent a creditor or an ownership relationship with the holder of the investment security with a maturity of beyond one year or normal operating cycle, if longer. Includes repayments of (a) debt, (b) capital lease obligations, (c) mandatory redeemable capital securities, and (d) any combination of (a), (b), or (c).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585

+ Details

Name: us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)

Sep. 30, 2014

Dec. 31, 2013

Statement of Financial Position [Abstract]

Common stock - par value (in Dollars per share) $ 0.0001 $ 0.0001

Common stock - shares authorized 200,000,000 200,000,000

Common stock - shares issued 42,703,602 40,089,196

Common stock - shares outstanding 42,703,602 40,089,196

X

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 30 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8

4. EARNINGS PER SHARE (Tables)
9 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

EARNINGS PER SHARE
Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):

Three Months Ended Nine Months Ended

September 30, September 30,

2014 2013 2014 2013

Net income (loss) attributable to RadNet, Inc.'s common stockholders $ 4,451 $ (467 ) $ (2,829 ) $ 877

BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 41,644,606 39,235,863 40,734,083 39,105,522

Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders $ 0.11 $ (0.01 ) $ (0.07 ) $ 0.02

DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 41,644,606 39,235,863 40,734,083 39,105,522

Add nonvested restricted stock subject only to service vesting 1,001,190 – – 311,419

Add additional shares issuable upon exercise of stock options and warrants 1,387,784 – – 469,199

Weighted average number of common shares used in calculating diluted net income per share 44,033,580 39,235,863 40,734,083 39,886,140

Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders $ 0.10 $ (0.01 ) $ (0.07 ) $ 0.02

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8

Document and Entity Information
9 Months Ended

Sep. 30, 2014

Nov. 05, 2014

NonPlanOutstandingWarrantsMember

Entity Registrant Name RadNet, Inc.

Entity Central Index Key 0000790526

Document Type 10-Q

Document Period End Date Sep. 30, 2014

Amendment Flag false

Current Fiscal Year End Date --12-31

Is Entity a Well-known Seasoned Issuer No

Is Entity a Voluntary Filer No

Is Entity's Reporting Status Current Yes

Entity Filer Category Accelerated Filer

Entity Common Stock, Shares Outstanding 42,710,676

Document Fiscal Period Focus Q3

Document Fiscal Year Focus 2014

X

- Definition

If the value is true, then the document is an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

+ References

No definition available.

+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.

+ References

No definition available.

+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Details

Name: rdnt_DocumentAndEntityInformationAbstract

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8

5. INVESTMENT IN JOINT VENTURES (Tables)
9 Months Ended

Sep. 30, 2014

Equity Method Investments and Joint Ventures [Abstract]

Investment in joint ventures
The following table is a roll forward of our investment in joint ventures during the nine months ended September 30, 2014 (in thousands):

Balance as of December 31, 2013 $ 28,949

Equity contributions in existing joint ventures 1,161

Equity earnings in these joint ventures 4,722

Distribution of earnings (7,358 )

Balance as of September 30, 2014 $ 27,474

Key financial data in joint ventures
The following table is a summary of key financial data for these joint ventures as of and for the nine months ended September 30, 2014 and 2013 (in thousands):

Balance Sheet Data: September 30, 2014

Current assets $ 14,181

Noncurrent assets 48,306

Current liabilities (5,623 )

Noncurrent liabilities (6,944 )

Total net assets $ 49,920

Book value of Radnet joint venture interests $ 23,232

Cost in excess of book value of acquired joint venture interests 3,857

Elimination of intercompany profit remaining on Radnet's consolidated balance sheet 385

Total value of Radnet joint venture interests $ 27,474

Total book value of other joint venture partner interests $ 26,688

Income Statement Data for the nine months ended September 30, 2014 2013

Net revenue $ 73,859 $ 68,912

Net income $ 9,801 $ 9,819

X

- Definition

Key financial data in joint ventures

+ References

No definition available.

+ Details

Name: rdnt_KeyFinancialDataInJointVenturesTableTextBlock

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for investments accounted for under the cost-method. The carrying amount of such investments may be adjusted, for example, distributions in excess of cost (return of capital) or for other-than-temporary impairments. The cost method and lower-of-cost or market, an adaptation of the cost method, is generally followed for most investments in noncontrolled corporations, in some corporate joint ventures, and to a lesser extent in unconsolidated subsidiaries in which the entity does not have the ability to exercise significant influence.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596

+ Details

Name: us-gaap_CostMethodInvestmentsDescriptionTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 33 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

NET REVENUE

Service fee revenue, net of contractual allowances and discounts $ 171,098 $ 165,373 $ 498,536 $ 496,424

Provision for bad debts (7,532) (7,033) (21,945) (20,810)

Net service fee revenue 163,566 158,340 476,591 475,614

Revenue under capitation arrangements 20,493 16,848 55,426 49,034

Total net revenue 184,059 175,188 532,017 524,648

OPERATING EXPENSES

Cost of operations, excluding depreciation and amortization 153,000 151,770 445,838 450,030

Depreciation and amortization 14,423 14,762 45,193 44,050

Loss on sale and disposal of equipment 1,289 (5) 1,581 357

Severance costs 112 72 976 312

Total operating expenses 168,824 166,599 493,588 494,749

INCOME FROM OPERATIONS 15,235 8,589 38,429 29,899

OTHER INCOME AND EXPENSES

Interest expense 10,395 11,052 32,503 34,542

Meaningful use incentive 0 0 (1,762) 0

Equity in earnings of joint ventures (2,009) (1,617) (4,722) (4,481)

Gain on sale of imaging centers 0 0 0 (2,108)

Loss on early extinguishment of Senior Notes 0 0 15,927 0

Other expenses 6 4 4 152

Total other expenses 8,392 9,439 41,950 28,105

INCOME (LOSS) BEFORE INCOME TAXES 6,843 (850) (3,521) 1,794

(Provision for) benefit from income taxes (2,334) 483 911 (766)

NET INCOME (LOSS) 4,509 (367) (2,610) 1,028

Net income attributable to noncontrolling interests 58 100 219 151

NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS $ 4,451 $ (467) $ (2,829) $ 877

BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS $ 0.11 $ (0.01) $ (0.07) $ 0.02

DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS $ 0.10 $ (0.01) $ (0.07) $ 0.02

WEIGHTED AVERAGE SHARES OUTSTANDING

Basic 41,644,606 39,235,863 40,734,083 39,105,522

Diluted 44,033,580 39,235,863 40,734,083 39,886,140

X

- Definition

Custom Element.

+ References

No definition available.

+ Details

Name: rdnt_GainOnSaleOfImagingCenters

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Revenue under capitation arrangements

+ References

No definition available.

+ Details

Name: rdnt_RevenueUnderCapitationArrangements

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate cost of goods produced and sold and services rendered during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 2

-Article 5

+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

+ Details

Name: us-gaap_GainLossOnDispositionOfAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12317-112629

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6850294&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=35755891&loc=SL9156442-115640

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755891&loc=d3e8184-115640

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35755891&loc=d3e8195-115640

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=35755915&loc=SL9156464-115641

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=35755891&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=35755891&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of the provision for bad debts related to patient service revenue.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=35755891&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of expense for incentive rights held by the managing member or general partner, of limited liability company (LLC) or limited partnership (LP).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

+ Details

Name: us-gaap_IncentiveFeeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of the cost of borrowed funds accounted for as interest expense for debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 5

+ Details

Name: us-gaap_InterestExpenseDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of Net Income (Loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount after tax of income (loss) attributable to nonredeemable noncontrolling shareholder, unit holder, partner, or other equity holder of a joint venture.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.19)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This element represents a sum total of expenses not separately reflected on the income statement for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 7

-Article 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.7)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4,6)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_OtherExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RevenuesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 5.P.3)

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(10)

-URI http://asc.fasb.org/extlink&oid=35743120&loc=d3e1928-114920

+ Details

Name: us-gaap_SeveranceCosts1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 34 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8

5. INVESTMENT IN JOINT VENTURES
9 Months Ended

Sep. 30, 2014

Equity Method Investments and Joint Ventures [Abstract]

INVESTMENT IN JOINT VENTURES
NOTE 5 – INVESTMENT IN JOINT VENTURES

We have nine unconsolidated joint ventures with ownership interests ranging from 35% to 50%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture. Our investment in these joint ventures is accounted for under the equity method.

The following table is a roll forward of our investment in joint ventures during the nine months ended September 30, 2014 (in thousands):

Balance as of December 31, 2013 $ 28,949

Equity contributions in existing joint ventures 1,161

Equity earnings in these joint ventures 4,722

Distribution of earnings (7,358 )

Balance as of September 30, 2014 $ 27,474

We earned management service fees from the centers underlying these joint ventures of approximately $2.3 million in each of the three months ended September 30, 2014 and 2013, and $6.9 million and $7.0 million for the nine months ended September 30, 2014 and 2013, respectively.

The following table is a summary of key financial data for these joint ventures as of and for the nine months ended September 30, 2014 and 2013 (in thousands):

Balance Sheet Data: September 30, 2014

Current assets $ 14,181

Noncurrent assets 48,306

Current liabilities (5,623 )

Noncurrent liabilities (6,944 )

Total net assets $ 49,920

Book value of Radnet joint venture interests $ 23,232

Cost in excess of book value of acquired joint venture interests 3,857

Elimination of intercompany profit remaining on Radnet's consolidated balance sheet 385

Total value of Radnet joint venture interests $ 27,474

Total book value of other joint venture partner interests $ 26,688

Income Statement Data for the nine months ended September 30, 2014 2013

Net revenue $ 73,859 $ 68,912

Net income $ 9,801 $ 9,819

X

- Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 35

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=35687916&loc=d3e32787-111569

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 35

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=35687916&loc=d3e32847-111569

+ Details

Name: us-gaap_EquityMethodInvestmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8

4. EARNINGS PER SHARE
9 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

EARNINGS PER SHARE
NOTE 4 – EARNINGS PER SHARE

Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):

Three Months Ended Nine Months Ended

September 30, September 30,

2014 2013 2014 2013

Net income (loss) attributable to RadNet, Inc.'s common stockholders $ 4,451 $ (467 ) $ (2,829 ) $ 877

BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 41,644,606 39,235,863 40,734,083 39,105,522

Basic net income (loss) per share attributable to RadNet, Inc.'s common stockholders $ 0.11 $ (0.01 ) $ (0.07 ) $ 0.02

DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 41,644,606 39,235,863 40,734,083 39,105,522

Add nonvested restricted stock subject only to service vesting 1,001,190 – – 311,419

Add additional shares issuable upon exercise of stock options and warrants 1,387,784 – – 469,199

Weighted average number of common shares used in calculating diluted net income per share 44,033,580 39,235,863 40,734,083 39,886,140

Diluted net income (loss) per share attributable to RadNet, Inc.'s common stockholders $ 0.10 $ (0.01 ) $ (0.07 ) $ 0.02

For the three months ended September 30, 2013 and the nine months ended September 30, 2014 we excluded all outstanding options, warrants and restricted stock awards in the calculation of diluted earnings per share because their effect would be antidilutive.

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for earnings per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BRMG and B&C revenues $ 23,600 $ 24,700 $ 65,600 $ 58,200

BRMG and B&C operating expenses 23,600 24,700 65,600 58,200

Consolidated revenue 98,000 98,300 279,600 256,600

Management services provided to BRMG and B&C 74,400 73,600 213,900 198,400

BRMG and B&C accounts receivable 80,300 80,300 65,200

BRMG and B& C accounts payable 9,400 9,400 11,900

Meaningful Use Incentive 1,800

Senior secured term loan debt 572,248 572,248

Unamortized discounts (12,694) (12,694)

Line of credit 25,100 25,100 0

Capital lease investment $ 12,600

X

- Definition

Custom Element.

+ References

No definition available.

+ Details

Name: rdnt_MeaningfulUseIncentive1

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase during the period in capital lease obligations due to entering into new capital leases.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

+ Details

Name: us-gaap_CapitalLeaseObligationsIncurred

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

+ Details

Name: us-gaap_SecuredLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount of expense between the reporting entity and the Variable Interest Entity (VIE).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph d

-URI http://asc.fasb.org/extlink&oid=28200181&loc=d3e5747-111685

+ Details

Name: us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph d

-URI http://asc.fasb.org/extlink&oid=28200181&loc=d3e5747-111685

+ Details

Name: us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of income between the reporting entity and the Variable Interest Entity (VIE).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph d

-URI http://asc.fasb.org/extlink&oid=28200181&loc=d3e5747-111685

+ Details

Name: us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The carrying amount of the consolidated Variable Interest Entity's assets included in the reporting entity's statement of financial position.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (bb)

-URI http://asc.fasb.org/extlink&oid=28200181&loc=d3e5710-111685

+ Details

Name: us-gaap_VariableInterestEntityConsolidatedCarryingAmountAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The carrying amount of the consolidated Variable Interest Entity's liabilities included in the reporting entity's statement of financial position.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (bb)

-URI http://asc.fasb.org/extlink&oid=28200181&loc=d3e5710-111685

+ Details

Name: us-gaap_VariableInterestEntityConsolidatedCarryingAmountLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 37 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8

6. STOCK-BASED COMPENSATION (Tables)
9 Months Ended

Sep. 30, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK-BASED COMPENSATION
The following summarizes all of our option and warrant transactions during the nine months ended September 30, 2014:

Outstanding Options and Warrants Under the 2006 Plan and 2000 Plan Shares Weighted Average Exercise price Per Common Share Weighted Average Remaining Contractual Life (in years) Aggregate Intrinsic Value

Balance, December 31, 2013 4,701,250 $ 3.15

Granted – –

Exercised (2,283,741 ) 2.38

Canceled or expired (315,000 ) 5.91

Balance, September 30, 2014 2,102,509 3.57 1.44 $ 7,017,488

Exercisable at September 30, 2014 2,037,509 3.62 1.36 6,719,788

Non-Plan Outstanding Warrants Shares Weighted Average Exercise price Per Common Share Weighted Average Remaining Contractual Life (in years) Aggregate Intrinsic Value

Balance, December 31, 2013 200,000 $ 2.62

Granted – –

Exercised (200,000 ) 2.62

Canceled or expired – –

Balance, September 30, 2014 – – – $ –

Exercisable at September 30, 2014 – – – –

X

- Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Policies)
9 Months Ended

Sep. 30, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NATURE OF BUSINESS AND BASIS OF PRESENTATION
We provide diagnostic imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. At September 30, 2014, we operated directly or indirectly through joint ventures, 263 imaging centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York. Our operations comprise a single segment for financial reporting purposes.

The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or “Radnet Management”) and Beverly Radiology Medical Group III, a professional partnership (“BRMG”). The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc., Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc. (“DIS”), all wholly owned subsidiaries of Radnet Management. All of these affiliated entities are referred to collectively as “RadNet”, “we”, “us”, “our” or the “Company” in this report.

Accounting Standards Codification (“ASC”) Section 810-10-15-14 stipulates that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics specified in the ASC which evidence a controlling financial interest, is considered a Variable Interest Entity (“VIE”). We consolidate all VIEs in which we own a majority voting interest and all VIEs for which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE’s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.

Howard G. Berger, M.D. is our President and Chief Executive Officer, a member of our Board of Directors and is deemed to be the beneficial owner, directly and indirectly, of approximately 13.1% of our outstanding common stock as of September 30, 2014. Dr. Berger also owns, indirectly, 99% of the equity interests in BRMG. BRMG provides all of the professional medical services at the majority of our facilities located in California under a management agreement with us, and employs physicians or contracts with various other independent physicians and physician groups to provide the professional medical services at most of our other California facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly or through subsidiaries, in order to comply with California’s prohibition against the corporate practice of medicine. However, as a result of our close relationship with Dr. Berger and BRMG, we believe that we are able to better ensure that medical service is provided at our California facilities in a manner consistent with our needs and expectations and those of our referring physicians, patients and payors than if we obtained these services from unaffiliated physician groups. BRMG is a partnership of ProNet Imaging Medical Group, Inc., Breastlink Medical Group, Inc. and Beverly Radiology Medical Group, Inc., each of which is 99% or 100% owned by Dr. Berger.

John V Crues, III, M.D. is our Medical Director, a member of our Board of Directors and a 1% owner of BRMG. Dr. Crues owns a controlling interest in four medical groups (“Crues Entities”) which provide professional medical services at some of our facilities in Manhattan and Brooklyn, New York while Dr. Berger owns a controlling interest in two medical groups (“NY Berger Entities”) which provide professional medical services at one of our Manhattan, New York facilities. The Crues Entities and the NY Berger Entities are collectively hereinafter referred to as the “B&C Entities.”

RadNet provides non-medical, technical and administrative services to BRMG and the B&C Entities for which it receives a management fee, pursuant to the related management agreements. Through these management agreements and our relationship with both Dr. Berger and Dr. Crues, we have exclusive authority over all non-medical decision-making related to the ongoing business operations of BRMG and the B&C Entities and we determine the annual budget of BRMG and the B&C Entities. BRMG and the B&C Entities both have insignificant operating assets and liabilities, and de minimis equity. Through these management agreements, we are paid the fair market value of our services, the result of which is that generally all net cash flows of both BRMG and the B&C Entities are transferred to us.

We have determined that BRMG and the B&C Entities are VIEs, and that we are the primary beneficiary, and consequently, we consolidate the revenue, expenses, assets and liabilities of each such entity. BRMG and the B&C Entities on a combined basis recognized $23.6 million and $24.7 million of revenue, net of management service fees to RadNet for the three months ended September 30, 2014 and 2013, respectively, and $23.6 million and $24.7 million of operating expenses for the three months ended September 30, 2014 and 2013, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $98.0 million and $98.3 million of total billed net service fee revenue relating to these VIE’s for the three months ended September 30, 2014 and 2013, respectively, of which $74.4 million and $73.6 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the three months ended September 30, 2014 and 2013, respectively.

BRMG and the B&C Entities on a combined basis recognized $65.6 million and $58.2 million of revenue, net of management service fees to RadNet for the nine months ended September 30, 2014 and 2013, respectively, and $65.6 million and $58.2 million of operating expenses for the nine months ended September 30, 2014 and 2013, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $279.6 million and $256.6 million of total billed net service fee revenue relating to these VIE’s for the nine months ended September 30, 2014 and 2013, respectively, of which $213.9 million and $198.4 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the nine months ended September 30, 2014 and 2013, respectively.

The cash flows of BRMG and the B&C Entities are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at September 30, 2014 and December 31, 2013, we have included approximately $80.3 million and $65.2 million, respectively, of accounts receivable and approximately $9.4 million and $11.9 million, respectively, of accounts payable and accrued liabilities, related to BRMG and the B&C Entities combined.

The creditors of both BRMG and the B&C Entities do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of BRMG and the B&C Entities. However, because of the relationship RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.

Aside from certain centers in California and all of our centers in New York City where we contract with BRMG and the B&C Entities, respectively, for the provision of professional medical services, at all of our other centers, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice group’s professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us. We have no financial controlling interest in the independent (non-BRMG or non-B&C Entities) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended September 30, 2014 and 2013 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December 31, 2013 filed on March 17, 2014, as amended.

Significant Accounting Policies
Significant Accounting Policies

During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended.

Revenues
Revenues

Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payers and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the B&C Entities, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the B&C Entities as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the B&C Entities. As it relates to non-BRMG and B&C Entity centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and B&C Entity centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.

Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payers.

Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2014 and 2013 is summarized in the following table (in thousands):

Three Months Ended Nine Months Ended

September 30, September 30,

2014 2013 2014 2013

Commercial Insurance $ 109,472 $ 103,934 $ 314,300 $ 310,147

Medicare 41,203 38,276 118,627 113,916

Medicaid 6,248 5,869 18,214 18,358

Workers' Compensation/Personal Injury 7,821 8,566 22,708 27,666

Other 6,354 8,727 24,688 26,337

Service fee revenue, net of contractual allowances and discounts 171,098 165,373 498,536 496,424

Provision for bad debts (7,532 ) (7,033 ) (21,945 ) (20,810 )

Net service fee revenue 163,566 158,340 476,591 475,614

Revenue under capitation arrangements 20,493 16,848 55,426 49,034

Total net revenue $ 184,059 $ 175,188 $ 532,017 $ 524,648

Provision for Bad Debts
Provision for Bad Debts

We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patient’s ability to pay nor are revenues recognized based on an assessment of the patient’s ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.

Deferred Tax Assets
Deferred Tax Assets

Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.

Deferred Financing Costs
Deferred Financing Costs

Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.

Meaningful Use Incentive
Meaningful Use Incentive

Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a Radiology Information System (RIS) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $1.8 million during the nine months ended September 30, 2014 relating to this incentive. This amount was earned under a Medicare program to promote the use of electronic health record technology.

Liquidity and Capital Resources
Liquidity and Capital Resources

We had cash and cash equivalents of $274,000 and accounts receivable of $155.0 million at September 30, 2014, compared to cash and cash equivalents of $8.4 million and accounts receivable of $133.6 million at December 31, 2013. We had a working capital balance of $65.7 million and $58.0 million at September 30, 2014 and December 31, 2013, respectively. We had net income (loss) attributable to RadNet, Inc. common stockholders for the three months ended September 30, 2014 and 2013 of $4.5 million and ($467,000) respectively, and net (loss) income attributable to RadNet, Inc. common stockholders for the nine months ended September 30, 2014 and 2013 of ($2.8 million) and $877,000, respectively. We also had stockholders’ equity of $2.6 million and $2.2 million at September 30, 2014 and December 31, 2013, respectively.

We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.

Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.

On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.

We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.

Included in our condensed consolidated balance sheet at September 30, 2014 are $572.2 million of senior secured term loan debt (net of unamortized discounts of $12.7 million), broken down by loan agreement as follows (in thousands):

Face Value Discount Total Carrying Value

2014 First Lien Term Loans $ 404,942 $ (9,922 ) $ 395,020

Second Lien Term Loans $ 180,000 $ (2,772 ) $ 177,228

Total $ 584,942 $ (12,694 ) $ 572,248

Our revolving credit facility has a $25.1 million aggregate principal amount outstanding as of September 30, 2014.

The following describes our most recent financing activities:

2014 Amendment to the Refinance Agreement and Second Lien Credit and Guaranty Agreement:

On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:

2014 Amendment of the Refinance Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012, by that certain first amendment dated April 3, 2013 (the “2013 Amendment”) (collectively, the Refinance Agreement”), by entering into a second amendment to the Refinance Agreement (the “2014 Amendment”) to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the “2014 First Lien Term Loans”).

Second Lien Credit and Guaranty Agreement. Radnet Management entered into a Second Lien Credit and Guaranty Agreement (the “Second Lien Credit Agreement”) to provide for, among other things, the borrowing by Radnet Management of $180.0 million of second lien term loans (the “Second Lien Term Loans”). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the senior notes, as more fully described below under the heading “Senior Notes”, to pay the expenses related to the transaction and for general corporate purposes.

Revolving Credit Facility. The $101.25 million revolving credit line established in the Credit and Guaranty Agreement dated October 10, 2012 was unaltered by the agreements above and remains in place.

The 2014 Amendment provides for the following:

Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates currently payable under the Refinance Agreement, as amended by the 2013 Amendment, which are (a) the Adjusted Eurodollar Rate plus 3.25% or (b) the Base Rate (as defined in the Refinance Agreement) plus 2.25%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on all of the term loans under the Refinance Agreement. The Adjusted Eurodollar Rate at September 30, 2014 was 0.33%.

Payments. The scheduled amortization of the term loans under the Refinance Agreement has been increased from quarterly payments of $975,000 to quarterly payments of $5.2 million which started in June 2014, with the remaining balance to be paid at maturity.

The other material terms of the Refinance Agreement remain unchanged as described in our annual report on Form 10-K for the fiscal year ended December 31, 2013, as amended.

The Second Lien Credit Agreement provides for the following:

Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate plus 7.0% or (b) the Base Rate plus 6.0%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at September 30, 2014 was 0.33%.

Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. All principal will be due and payable on the termination date described below.

Termination. The termination date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by acceleration or otherwise.

Restrictive Covenants. In addition to certain customary covenants, the Second Lien Credit Agreement places restrictions on indebtedness, liens, and investments, and places limits on distributions to stockholders (including the repurchase of shares) and other junior payments.

Financial Covenants. The Second Lien Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.

Events of Default. In addition to certain customary events of default, events of default under the Second Lien Credit Agreement include failure to pay principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements, subject to applicable grace periods and/or notice requirements, or a material breach of any representation or warranty contained in the loan documents. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

These limitations are subject to a number of important qualifications and exceptions, as described in the Second Lien Credit Agreement. As of September 30, 2014, we were in compliance with all covenants.

Senior Notes

On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the “senior notes”). All payments of the senior notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Management’s current and future domestic wholly owned restricted subsidiaries. The senior notes were issued under an indenture dated April 6, 2010 (the “Indenture”), by and among Radnet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee.” We paid interest on the senior notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.

Optional Redemption. Under the Indenture, Radnet Management could redeem the senior notes, in whole or in part, at any time on or after April 1, 2014, at the redemption prices specified under the Indenture. Prior to April 1, 2014, Radnet Management was also permitted to redeem the senior notes, in whole or in part, at a redemption price equal to 100% of the principal amount redeemed, plus a make-whole premium established by the Indenture and accrued and unpaid interest, if any.

Senior Notes Tender Offer and Exercise of Optional Redemption

Radnet Management completed the retirement of its $200 million in Senior Notes on April 24, 2014 and following such retirement the Company completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:

Tender Offer and Exercise of Optional Redemption on March 7, 2014. On March 7, 2014, Radnet Management commenced a tender offer to purchase for cash any and all outstanding senior notes. In connection with the tender offer, Radnet Management also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014 (the “Initial Payment Date”), Radnet Management made a payment in cash for all senior notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the “Consent Payment Deadline”). As of the Consent Payment Deadline, Radnet Management had received tenders and consents in respect of $193,464,000 aggregate principal amount of the senior notes, representing 96.73% of the outstanding senior notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of senior notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88 (the “Total Consideration”), which amount included a consent payment (the “Consent Payment”) of $30.00 per $1,000 principal amount of senior notes. In addition, all senior notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional senior notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.

Tender Offer and Exercise on Optional Redemption of March 25, 2014. On March 25, 2014, Radnet Management called for redemption all of its remaining outstanding senior notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the “Redemption Date”). Upon redemption on April 24, 2014, the holders of the senior notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the senior notes being redeemed (or $1,051.88 per $1,000 in principal amount of the senior notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date. As of that date, Radnet Management completed the satisfaction and discharge of the Indenture in accordance with its terms and no senior notes remained outstanding. With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.

Capital Lease Investments

During the nine months ended September 30, 2014, we added capital lease debt of approximately $12.6 million relating to radiology equipment.

X

- Definition

Deferred tax assets policy text block

+ References

No definition available.

+ Details

Name: rdnt_DeferredTaxAssetsPolicy

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Meaningful Use Incentive policy text block

+ References

No definition available.

+ Details

Name: rdnt_MeaningfulUseIncentivePolicyTextBlock

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.

+ References

No definition available.

+ Details

Name: us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for costs incurred to obtain or issue debt, the effects of refinancings, method of amortizing deferred financing costs and original issue discount, and classifications of debt on the balance sheet.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

+ Details

Name: us-gaap_DebtPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for assessing the timing and amount of uncollectible revenue recognized as bad debt expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 310

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=35755819&loc=SL9156395-115594

+ Details

Name: us-gaap_HealthCareOrganizationBadDebtsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.

+ References

No definition available.

+ Details

Name: us-gaap_LiquidityDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section B

-Paragraph Question 1

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.B.Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18823-107790

+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18861-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18854-107790

+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8

6. STOCK-BASED COMPENSATION
9 Months Ended

Sep. 30, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK-BASED COMPENSATION
NOTE 6 – STOCK-BASED COMPENSATION

Stock Incentive Plans

Options and Warrants

We have two long-term incentive plans which we refer to as the 2000 Plan and the 2006 Plan. The 2000 Plan was terminated as to future grants when the 2006 Plan was approved by the stockholders in 2006 and as of September 30, 2014 no options or warrants were outstanding under our 2000 Plan. As of September 30, 2014, we have reserved for issuance under the 2006 Plan 11,000,000 shares of common stock. Certain options granted under the 2006 Plan to employees are intended to qualify as incentive stock options under existing tax regulations. In addition, we may issue non-qualified stock options and warrants under the 2006 Plan from time to time to non-employees, in connection with acquisitions and for other purposes and we may also issue restricted stock under the 2006 Plan. Stock options and warrants generally vest over two to five years and expire five to ten years from date of grant.

As of September 30, 2014, 2,037,509, or approximately 96.9%, of the 2,102,509 outstanding stock options and warrants granted under our 2006 Plan are fully vested. During the nine months ended September 30, 2014, we did not grant options or warrants under our 2006 Plan.

We have issued warrants outside the 2006 Plan under various types of arrangements to employees, and in exchange for outside services. All warrants issued to employees or consultants after our February 2007 listing on the NASDAQ Global Market have been characterized as awards under the 2006 Plan. All warrants outside the 2006 Plan have been issued with an exercise price equal to the fair value of the underlying common stock on the date of grant.

As of September 30, 2014, no warrants remain outstanding outside the 2006 Plan.

The following summarizes all of our option and warrant transactions during the nine months ended September 30, 2014:

Outstanding Options and Warrants Under the 2006 Plan and 2000 Plan Shares Weighted Average Exercise price Per Common Share Weighted Average Remaining Contractual Life (in years) Aggregate Intrinsic Value

Balance, December 31, 2013 4,701,250 $ 3.15

Granted – –

Exercised (2,283,741 ) 2.38

Canceled or expired (315,000 ) 5.91

Balance, September 30, 2014 2,102,509 3.57 1.44 $ 7,017,488

Exercisable at September 30, 2014 2,037,509 3.62 1.36 6,719,788

Non-Plan Outstanding Warrants Shares Weighted Average Exercise price Per Common Share Weighted Average Remaining Contractual Life (in years) Aggregate Intrinsic Value

Balance, December 31, 2013 200,000 $ 2.62

Granted – –

Exercised (200,000 ) 2.62

Canceled or expired – –

Balance, September 30, 2014 – – – $ –

Exercisable at September 30, 2014 – – – –

Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on September 30, 2014 and the exercise price, multiplied by the number of in-the-money options or warrants, as applicable) that would have been received by the holder had all holders exercised their options or warrants, as applicable, on September 30, 2014. Total intrinsic value of options and warrants exercised during the nine months ended September 30, 2014 and 2013 was approximately $5.9 million and $2.3 million, respectively. As of September 30, 2014, total unrecognized stock-based compensation expense related to non-vested employee awards was $39,000, which is expected to be recognized over a weighted average period of approximately 2.1 years.

Restricted Stock Awards (“RSA’s”)

The 2006 Plan permits the award of restricted stock. On January 2, 2014, we granted awards for 1,011,785 shares of our common stock to certain employees and outside directors. Of these awards granted, 337,262 shares vested on the award date, with the remaining 674,524 shares vesting at the completion of each year’s service by 337,262 shares per year over the next two years. We valued this award based on the closing market price of our stock on January 2, 2014 which was $1.62 per share.

At September 30, 2014, the total unrecognized fair value of all restricted stock awards was approximately $1.1 million, which will be recognized over the remaining vesting period of 2.50 years.

In sum, of the 11,000,000 shares of common stock reserved for issuance under the 2006 Plan, at September 30, 2014, we had 4,834,294 options, warrants and shares of restricted stock outstanding, 2,296,241 options exercised and 3,869,465 shares of common stock available for grant.

X

- Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8

7. FAIR VALUE MEASUREMENTS
9 Months Ended

Sep. 30, 2014

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS
NOTE 7 – FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS – Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:

Level 1—Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.

Level 2—Fair value is determined by using inputs other than Level 1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.

Level 3—Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.

The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):

As of September 30, 2014

Level 1 Level 2 Level 3 Total Fair Value Total Face Value

2014 First Lien Term Loans $ – $ 402,411 $ – $ 402,411 $ 404,942

Second Lien Term Loans $ 180,000 $ – 180,000 $ 180,000

As of December 31, 2013

Level 1 Level 2 Level 3 Total Total Face Value

Senior Term Loan $ – $ 380,508 $ – $ 380,508 $ 349,125

Senior Notes – 199,000 – 199,000 200,000



The carrying value of our revolving credit facility at September 30, 2014 and December 31, 2013 of $25.1 million and $0, respectively, approximated its fair value.

We consider the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.

X

- Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13537-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13433-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13504-108611

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Tables)
9 Months Ended

Sep. 30, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Service fee revenue
Our revenue, net of contractual allowances, discounts and provision for bad debts for the three and nine months ended September 30, 2014 and 2013 is summarized in the following table (in thousands):

Three Months Ended Nine Months Ended

September 30, September 30,

2014 2013 2014 2013

Commercial Insurance $ 109,472 $ 103,934 $ 314,300 $ 310,147

Medicare 41,203 38,276 118,627 113,916

Medicaid 6,248 5,869 18,214 18,358

Workers' Compensation/Personal Injury 7,821 8,566 22,708 27,666

Other 6,354 8,727 24,688 26,337

Service fee revenue, net of contractual allowances and discounts 171,098 165,373 498,536 496,424

Provision for bad debts (7,532 ) (7,033 ) (21,945 ) (20,810 )

Net service fee revenue 163,566 158,340 476,591 475,614

Revenue under capitation arrangements 20,493 16,848 55,426 49,034

Total net revenue $ 184,059 $ 175,188 $ 532,017 $ 524,648

Senior secured term loan debt
Included in our condensed consolidated balance sheet at September 30, 2014 are $572.2 million of senior secured term loan debt (net of unamortized discounts of $12.7 million), broken down by loan agreement as follows (in thousands):

Face Value Discount Total Carrying Value

2014 First Lien Term Loans $ 404,942 $ (9,922 ) $ 395,020

Second Lien Term Loans $ 180,000 $ (2,772 ) $ 177,228

Total $ 584,942 $ (12,694 ) $ 572,248

X

- Definition

Senior secured term loan debt table text block

+ References

No definition available.

+ Details

Name: rdnt_SeniorSecuredTermLoanDebtTextBlock

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 940

-SubTopic 320

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969

+ Details

Name: us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Revenue breakdown) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Commercial Insurance $ 109,472 $ 103,934 $ 314,300 $ 310,147

Medicare 41,203 38,276 118,627 113,916

Medicaid 6,248 5,869 18,214 18,358

Workers' Compensation/Personal Injury 7,821 8,566 22,708 27,666

Other 6,354 8,727 24,688 26,337

Service fee revenue, net of contractual allowances and discounts 171,098 165,373 498,536 496,424

Provision for bad debts (7,532) (7,033) (21,945) (20,810)

Net service fee revenue 163,566 158,340 476,591 475,614

Revenue under capitation arrangements 20,493 16,848 55,426 49,034

Total net revenue $ 184,059 $ 175,188 $ 532,017 $ 524,648

X

- Definition

Medicare

+ References

No definition available.

+ Details

Name: rdnt_HealthCareOrganizationMedicare

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Revenue under capitation arrangements

+ References

No definition available.

+ Details

Name: rdnt_RevenueUnderCapitationArrangements

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Workers Compensation/Personal Injury

+ References

No definition available.

+ Details

Name: rdnt_WorkersCompensationpersonalInjury

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of revenue recognized that is not otherwise disclosed.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_HealthCareOrganizationOtherRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=35755891&loc=SL9156442-115640

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755891&loc=d3e8184-115640

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35755891&loc=d3e8195-115640

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=35755915&loc=SL9156464-115641

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=35755891&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=35755891&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of the provision for bad debts related to patient service revenue.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=35755891&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of insurance premium revenue recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_HealthCareOrganizationPremiumRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Income from agency and brokerage operations (includes sales of annuities and supplemental contracts); service charges, commissions, and fees from the sale of insurance and related services; and management fees from separate accounts, deferred annuities, and universal life products.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.4)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.13(c),(d))

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 13

-Subparagraph c, d

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 4

-Article 7

+ Details

Name: us-gaap_InsuranceCommissionsAndFees

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 43 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8

5. INVESTMENT IN JOINT VENTURES (Details-Key financial data) (USD $)
In Thousands, unless otherwise specified
9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Key financial data for joint ventures

Current assets - joint ventures $ 14,181

Noncurrent assets - joint ventures 48,306

Current liabilities - joint ventures (5,623)

Noncurrent liabilities - joint ventures (6,944)

Total net assets -joint ventures 49,920

Book value of Radnet joint venture interests 23,232

Cost in excess of book value of acquired joint venture interests 3,857

Elimination of intercompany profit remaining on Radnet's consolidated balance sheet 385

Total value of Radnet joint venture interests 27,474

Total book value of other joint venture partner interests 26,688

Net revenue 73,859 68,912

Net income $ 9,801 $ 9,819

X

- Details

Name: rdnt_KeyFinancialDataForJointVenturesAbstract

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Net revenue from joint ventures

+ References

No definition available.

+ Details

Name: rdnt_NetRevenueFromJointVentures

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Total book value of other joint venture partner interests

+ References

No definition available.

+ Details

Name: rdnt_TotalBookValueOfOtherJointVenturePartnerInterests

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Total value of Radnet joint venture interests

+ References

No definition available.

+ Details

Name: rdnt_TotalValueOfRadnetJointVentureInterests

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

This element represents the aggregate cost of investments accounted for under the equity method of accounting.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 12

-Article 5

+ Details

Name: us-gaap_EquityMethodInvestmentAggregateCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

+ Details

Name: us-gaap_EquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The amount of assets reported by an equity method investment of the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(g))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph bb

-Article 1

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph g

-Subparagraph 1, 2

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph w

-Article 1

+ Details

Name: us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The amount of current assets reported by an equity method investment of the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(g))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph bb

-Article 1

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph g

-Subparagraph 1, 2

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph w

-Article 1

+ Details

Name: us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The amount of current liabilities reported by an equity method investment of the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(g))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph bb

-Article 1

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph g

-Subparagraph 1, 2

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph w

-Article 1

+ Details

Name: us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount of liabilities reported by an equity method investment of the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(g))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph bb

-Article 1

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph g

-Subparagraph 1, 2

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph w

-Article 1

+ Details

Name: us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

+ Details

Name: us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

This item represents the amount of unrealized intercompany profits and losses on transactions between the Entity and unconsolidated subsidiaries (including certain corporate joint ventures, and noncontrolled corporations), accounted for under the equity method of accounting, which have not been eliminated in preparing the Entity's financial statements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph b

-Article 3A

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 35

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=35687916&loc=d3e32367-111569

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section S99

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355119-122828

+ Details

Name: us-gaap_EquityMethodInvestmentUnrealizedIntercompanyProfitLossNotEliminatedAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 44 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Statement of Comprehensive Income [Abstract]

NET INCOME (LOSS) $ 4,509 $ (367) $ (2,610) $ 1,028

Foreign currency translation adjustments (1) 13 (38) (104)

COMPREHENSIVE INCOME (LOSS) 4,508 (354) (2,648) 924

Less comprehensive income attributable to non-controlling interests 58 100 219 151

COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS $ 4,450 $ (454) $ (2,867) $ 773

X

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=35737396

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4613674-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569643-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-Subparagraph (b,c)

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 45 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8

3. NEW ACCOUNTING STANDARDS
9 Months Ended

Sep. 30, 2014

New Accounting Standards

RECENT ACCOUNTING STANDARDS
NOTE 3 – NEW ACCOUNTING STANDARDS

In May 2014, the Financial Accounting Standard Board issued a GAAP update "Revenue from Contracts with Customers". This GAAP update requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. This GAAP update also requires more detailed disclosures to enable users of the financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The GAAP update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2016. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

X

- Details

Name: rdnt_NewAccountingStandardsAbstract

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e765-108305

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 01

-Paragraph b

-Subparagraph 6

-Article 10

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22499-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22580-107794

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Direct Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6510796

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Indirect Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6515603

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Accounting Change

-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6507316

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.10-01.(b)(6))

-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Retrospective Application

-URI http://asc.fasb.org/extlink&oid=6523989

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28359718&loc=d3e22583-107794

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6372559&loc=d3e725-108305

+ Details

Name: us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8

5. INVESTMENT IN JOINT VENTURES (Details Narrative) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Equity Method Investments and Joint Ventures [Abstract]

Management service fees from centers underlying joint ventures $ 2,300 $ 2,300 $ 6,900 $ 7,000

X

- Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Revenue, comprised of base and incentive revenue derived from the management of joint ventures, managing third-party properties, or another entity's operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(d))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_ManagementFeesRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 47 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 46 212 1 false 18 0 false 3 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://radnet.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://radnet.com/role/ConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://radnet.com/role/ConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://radnet.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://radnet.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://radnet.com/role/CondensedConsolidatedStatementOfStockholdersEquityDeficit CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) false false R7.htm 00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://radnet.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 00000008 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentation 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION false false R9.htm 00000009 - Disclosure - 2. FACILITY ACQUISITIONS Sheet http://radnet.com/role/FacilityAcquisitions 2. FACILITY ACQUISITIONS false false R10.htm 00000010 - Disclosure - 3. NEW ACCOUNTING STANDARDS Sheet http://radnet.com/role/NewAccountingStandards 3. NEW ACCOUNTING STANDARDS false false R11.htm 00000011 - Disclosure - 4. EARNINGS PER SHARE Sheet http://radnet.com/role/EarningsPerShare 4. EARNINGS PER SHARE false false R12.htm 00000012 - Disclosure - 5. INVESTMENT IN JOINT VENTURES Sheet http://radnet.com/role/InvestmentInJointVentures 5. INVESTMENT IN JOINT VENTURES false false R13.htm 00000013 - Disclosure - 6. STOCK-BASED COMPENSATION Sheet http://radnet.com/role/Stock-basedCompensation 6. STOCK-BASED COMPENSATION false false R14.htm 00000014 - Disclosure - 7. FAIR VALUE MEASUREMENTS Sheet http://radnet.com/role/FairValueMeasurements 7. FAIR VALUE MEASUREMENTS false false R15.htm 00000015 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Policies) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationPolicies 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Policies) false false R16.htm 00000016 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Tables) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationTables 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Tables) false false R17.htm 00000017 - Disclosure - 4. EARNINGS PER SHARE (Tables) Sheet http://radnet.com/role/EarningsPerShareTables 4. EARNINGS PER SHARE (Tables) false false R18.htm 00000018 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Tables) Sheet http://radnet.com/role/InvestmentInJointVenturesTables 5. INVESTMENT IN JOINT VENTURES (Tables) false false R19.htm 00000019 - Disclosure - 6. STOCK-BASED COMPENSATION (Tables) Sheet http://radnet.com/role/Stock-basedCompensationTables 6. STOCK-BASED COMPENSATION (Tables) false false R20.htm 00000020 - Disclosure - 7. FAIR VALUE MEASUREMENTS (Tables) Sheet http://radnet.com/role/FairValueMeasurementsTables 7. FAIR VALUE MEASUREMENTS (Tables) false false R21.htm 00000021 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Revenue breakdown) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationDetails-RevenueBreakdown 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Revenue breakdown) false false R22.htm 00000022 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Senior Secured Notes) Notes http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationDetails-SeniorSecuredNotes 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Senior Secured Notes) false false R23.htm 00000023 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationDetailsNarrative 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) false false R24.htm 00000024 - Disclosure - 4. EARNINGS PER SHARE (Details) Sheet http://radnet.com/role/EarningsPerShareDetails 4. EARNINGS PER SHARE (Details) false false R25.htm 00000025 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) Sheet http://radnet.com/role/InvestmentInJointVenturesDetails-JointVentures 5. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) false false R26.htm 00000026 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Details-Key financial data) Sheet http://radnet.com/role/InvestmentInJointVenturesDetails-KeyFinancialData 5. INVESTMENT IN JOINT VENTURES (Details-Key financial data) false false R27.htm 00000027 - Disclosure - 5. INVESTMENT IN JOINT VENTURES (Details Narrative) Sheet http://radnet.com/role/InvestmentInJointVenturesDetailsNarrative 5. INVESTMENT IN JOINT VENTURES (Details Narrative) false false R28.htm 00000028 - Disclosure - 6. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) Sheet http://radnet.com/role/Stock-BasedCompensationDetails-OutstandingOptionsAndWarrants 6. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) false false R29.htm 00000029 - Disclosure - 6. STOCK-BASED COMPENSATION (Details Narrative) Sheet http://radnet.com/role/Stock-BasedCompensationDetailsNarrative 6. STOCK-BASED COMPENSATION (Details Narrative) false false R30.htm 00000030 - Disclosure - 7. FAIR VALUE MEASUREMENTS (Details) Sheet http://radnet.com/role/FairValueMeasurementsDetails 7. FAIR VALUE MEASUREMENTS (Details) false false R31.htm 00000031 - Disclosure - 7. FAIR VALUE MEASUREMENTS (Details Narrative) Sheet http://radnet.com/role/FairValueMeasurementsDetailsNarrative 7. FAIR VALUE MEASUREMENTS (Details Narrative) false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Sep. 30, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Process Flow-Through: 00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS rdnt-20140930.xml rdnt-20140930.xsd rdnt-20140930_cal.xml rdnt-20140930_def.xml rdnt-20140930_lab.xml rdnt-20140930_pre.xml true true XML 48 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8

7. FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended

Sep. 30, 2014

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS
The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):

As of September 30, 2014

Level 1 Level 2 Level 3 Total Fair Value Total Face Value

2014 First Lien Term Loans $ – $ 402,411 $ – $ 402,411 $ 404,942

Second Lien Term Loans $ 180,000 $ – 180,000 $ 180,000

As of December 31, 2013

Level 1 Level 2 Level 3 Total Total Face Value

Senior Term Loan $ – $ 380,508 $ – $ 380,508 $ 349,125

Senior Notes – 199,000 – 199,000 200,000



X

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19279-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a,b,bb)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2C

-URI http://asc.fasb.org/extlink&oid=36462937&loc=SL7498348-110258

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258

+ Details

Name: us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

5. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Equity Method Investments and Joint Ventures [Abstract]
Beginning balance	$ 28,949
Equity contributions in existing joint ventures	1,161
Equity earnings in these joint ventures	4,722	4,481
Distribution of earnings	(7,358)	(5,624)
Ending balance	$ 27,474

6. STOCK-BASED COMPENSATION (Details Narrative) (USD $) In Thousands, except Share data, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Total intrinsic value of options and warrants	$ 5,900	$ 2,300
Total unrecognized stock-based compensation expense related to non-vested employee awards	39,000
Expected period of recognition over a weighted average period	2 years 1 month 6 days
2006 Plan
Common stock reserved for issuance	11,000,000
Stock options outstanding	2,102,509
Stock options vested	2,037,509
Options, warrants and RSU's outstanding	4,834,294
Options, warrants and RSU's exercised	2,296,241
Options, warrants and RSU's available for grant	3,869,465
Restricted Stock [Member]
Total unrecognized stock-based compensation expense related to non-vested employee awards	$ 1,100
Restricted Stock [Member]
Expected period of recognition over a weighted average period	2 years 9 months
Restricted stock awards granted	1,011,785

6. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) (USD $) In Thousands, except Share data, unless otherwise specified	9 Months Ended
	Sep. 30, 2014
Non-Plan Outstanding Warrants [Member]
Outstanding Warrants
Beginning balance	200,000
Warrants exercised	(200,000)
Ending balance	0
Exercisable	0
Weighted Average Exercise Price
Beginning price per share	$ 2.62
Weighted average exercise price warrants exercised	$ 2.62
Ending price per share	$ 0
Outstanding Options and Warrants [Member]
Outstanding Options
Begining Balance	4,701,250
Granted	0
Exercised	(2,283,741)
Canceled or expired	(315,000)
Ending Balance	2,102,509
Exercisable at the end	2,037,509
Weighted Average Exercise price Per Common Share
Begining Balance	$ 3.15
Granted
Exercised	$ 2.38
Canceled or expired	$ 5.91
Ending Balance	$ 3.57
Exercisable at the end	$ 3.62
Weighted Average Remaining Contractual Life
Ending Balance	1 year 5 months 9 days
Exercisable at the end	1 year 4 months 10 days
Aggregate Intrinsic Value
Aggregate value outstanding	$ 7,017,488
Aggregate value exercisable	$ 6,719,788

7. FAIR VALUE MEASUREMENTS (Details) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
FAIR VALUE MEASUREMENTS
Senior First Lien Term Loan	$ 404,942	$ 349,125
Senior Second Lien Term Loan	180,000	200,000
Total Fair Value
FAIR VALUE MEASUREMENTS
Senior First Lien Term Loan	402,411	380,508
Senior Second Lien Term Loan	180,000	199,000
Level 1
FAIR VALUE MEASUREMENTS
Senior First Lien Term Loan	0	0
Senior Second Lien Term Loan	0	0
Level 2
FAIR VALUE MEASUREMENTS
Senior First Lien Term Loan	402,411	380,508
Senior Second Lien Term Loan	180,000	199,000
Level 3
FAIR VALUE MEASUREMENTS
Senior First Lien Term Loan	0	0
Senior Second Lien Term Loan	$ 0	$ 0

7. FAIR VALUE MEASUREMENTS (Details Narrative) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Fair Value Disclosures [Abstract]
Line of credit	$ 25,100	$ 0

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
CURRENT ASSETS
Cash and cash equivalents	$ 274	$ 8,412
Accounts receivable, net	155,011	133,599
Current portion of deferred tax assets	16,692	13,321
Prepaid expenses and other current assets	25,272	21,012
Total current assets	197,249	176,344
PROPERTY AND EQUIPMENT, NET	225,597	218,547
OTHER ASSETS
Goodwill	200,304	196,395
Other intangible assets	48,392	50,042
Deferred financing costs, net of current portion	6,682	8,735
Investment in joint ventures	27,474	28,949
Deferred tax assets, net of current portion	39,004	39,914
Deposits and other	3,817	3,650
Total assets	748,519	722,576
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable, accrued expenses and other	100,931	106,316
Due to affiliates	1,120	2,655
Deferred revenue	1,948	1,344
Current portion of notes payable	19,558	3,103
Current portion of deferred rent	2,256	1,896
Current portion of obligations under capital leases	5,708	3,075
Total current liabilities	131,521	118,389
LONG-TERM LIABILITIES
Deferred rent, net of current portion	19,282	18,989
Revolving credit facility	25,100	0
Notes payable, net of current portion	555,920	572,669
Obligations under capital lease, net of current portion	7,573	2,779
Other non-current liabilities	6,505	7,540
Total liabilities	745,901	720,366
STOCKHOLDERS' EQUITY
Common stock - $.0001 par value, 200,000,000 shares authorized; 42,703,602, and 40,089,196 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively	4	4
Paid-in-capital	177,141	173,622
Accumulated other comprehensive loss	(88)	(50)
Accumulated deficit	(176,485)	(173,656)
Total RadNet, Inc.'s stockholders' equity (deficit)	572	(80)
Noncontrolling interests	2,046	2,290
Total stockholders' equity	2,618	2,210
Total liabilities and stockholders' equity	$ 748,519	$ 722,576

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $) In Thousands, except Share data	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Total Radnet, Inc.'s Stockholders' Deficit	Noncontrolling Interest	Total
Beginning balance, value at Dec. 31, 2013	$ 4	$ 173,622	$ (173,656)	$ (50)	$ (80)	$ 2,290	$ 2,210
Beginning balance, shares at Dec. 31, 2013	40,089,196
Issuance of common stock upon exercise of options/warrants, shares issued	1,572,621
Issuance of common stock upon exercise of options/warrants, value	0	1,546	0	0	1,546	0	1,546
Stock-based compensation	0	1,854	0	0	1,854	0	1,854
Issuance of restricted stock, shares	1,041,785
Issuance of restricted stock, value	0	0	0	0	0	0	0
Purchase of non-controlling interests	0	119	0	0	119	(315)	(196)
Dividends paid to noncontrolling interest	0	0	0	0	0	(148)	(148)
Change in cumulative foreign currency translation adjustment	0	0	0	(38)	(38)	0	(38)
Net (loss) income	0	0	(2,829)	0	(2,829)	219	(2,610)
Ending balance, value at Sep. 30, 2014	$ 4	$ 177,141	$ (176,485)	$ (88)	$ 572	$ 2,046	$ 2,618
Ending balance, shares at Sep. 30, 2014	42,703,602

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details - Senior Secured Notes) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014
Face Value	$ 584,942
Discount	12,694
Total Carrying Value	572,248
Senior Notes [Member] \| 2014 First Lien Term Loans [Member]
Face Value	404,942
Discount	(9,922)
Total Carrying Value	395,020
Senior Notes [Member] \| Second Lien Term Loans [Member]
Face Value	180,000
Discount	(2,772)
Total Carrying Value	$ 177,228

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net (loss) income	$ (2,610)	$ 1,028
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	45,193	44,050
Provision for bad debts	21,945	20,810
Equity in earnings of joint ventures	(4,722)	(4,481)
Distributions from joint ventures	7,358	5,624
Deferred rent amortization	653	2,893
Amortization of deferred financing costs	1,708	1,676
Write off of deferred loan costs due to refinance	665	0
Amortization of bond and term loan discounts	2,071	1,651
Loss on sale and disposal of equipment	1,581	357
Loss on early extinguishment of Senior Notes	15,927	0
Gain on Sale of Imaging Centers	0	(2,108)
Stock-based compensation	2,069	2,045
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:
Accounts receivable	(42,887)	(25,096)
Other current assets	(4,754)	(1,504)
Other assets	(72)	172
Deferred taxes	(2,461)	575
Deferred revenue	604	175
Accounts payable, accrued expenses and other	(8,225)	(5,357)
Net cash provided by operating activities	34,043	42,510
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of imaging facilities	(9,428)	(5,918)
Purchase of noncontrolling interests	(196)	0
Purchase of property and equipment	(33,895)	(39,291)
Proceeds from sale of equipment	766	510
Proceeds from sale of imaging facilities	0	3,290
Proceeds from sale of joint venture interests	0	2,640
Equity contributions in existing joint ventures	(1,161)	(1,803)
Net cash used in investing activities	(43,914)	(40,572)
CASH FLOWS FROM FINANCING ACTIVITIES
Principal payments on notes and leases payable	(16,733)	(7,476)
Proceeds from borrowings	210,000	35,122
Payments on Senior Notes	(211,344)	0
Deferred financing costs	(6,650)	(432)
Net proceeds (payments) on revolving credit facility	25,100	(29,600)
Distributions to noncontrolling interests	(148)	(11)
Proceeds from issuance of common stock upon exercise of options/warrants	1,546	469
Net cash provided by (used in) financing activities	1,771	(1,928)
EFFECT OF EXCHANGE RATE CHANGES ON CASH	(38)	(104)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(8,138)	(94)
CASH AND CASH EQUIVALENTS, beginning of period	8,412	362
CASH AND CASH EQUIVALENTS, end of period	274	268
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the period for interest	32,389	26,614
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Purchase of equipment and leasehold improvements not yet paid for	16,600	11,300
Capital lease debt relating to radiology equipment	$ 12,600

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]
Common stock - par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock - shares authorized	200,000,000	200,000,000
Common stock - shares issued	42,703,602	40,089,196
Common stock - shares outstanding	42,703,602	40,089,196

Document and Entity Information	9 Months Ended
Document and Entity Information	Sep. 30, 2014	Nov. 05, 2014
NonPlanOutstandingWarrantsMember
Entity Registrant Name	RadNet, Inc.
Entity Central Index Key	0000790526
Document Type	10-Q
Document Period End Date	Sep. 30, 2014
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer	No
Is Entity a Voluntary Filer	No
Is Entity's Reporting Status Current	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		42,710,676
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2014

5. INVESTMENT IN JOINT VENTURES (Details-Key financial data) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Key financial data for joint ventures
Current assets - joint ventures	$ 14,181
Noncurrent assets - joint ventures	48,306
Current liabilities - joint ventures	(5,623)
Noncurrent liabilities - joint ventures	(6,944)
Total net assets -joint ventures	49,920
Book value of Radnet joint venture interests	23,232
Cost in excess of book value of acquired joint venture interests	3,857
Elimination of intercompany profit remaining on Radnet's consolidated balance sheet	385
Total value of Radnet joint venture interests	27,474
Total book value of other joint venture partner interests	26,688
Net revenue	73,859	68,912
Net income	$ 9,801	$ 9,819